data_2lcc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.428 -1.542 0 CA-C-O 121.258 0.552 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.48 65.65 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 m -92.79 117.24 29.81 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -97.34 134.48 40.57 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 171.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.47 177.2 5.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.955 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -108.98 129.46 55.45 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -123.45 136.82 58.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 118.028 0.376 . . . . 0.0 111.432 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 41.0 ttmt -108.68 146.62 33.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.679 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 1.9 mptp? . . . . . 0 CA--C 1.487 -1.477 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.34 108.28 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 5.8 m-85 -108.36 167.67 9.86 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.959 -169.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.68 126.69 52.6 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.7 159.66 41.37 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.749 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.61 144.59 36.14 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.3 mm -77.15 131.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.437 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HD3' ' HB2' ' A' ' 44' ' ' HIS . 9.3 mtmt -99.62 -52.85 3.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.897 0.855 . . . . 0.0 110.115 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 m -155.08 166.87 32.24 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.153 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -136.65 143.14 43.31 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -144.64 162.36 36.86 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.288 0.566 . . . . 0.0 110.852 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.411 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.6 mp -108.3 113.14 43.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -122.83 104.6 9.39 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.107 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 57.73 64.62 1.51 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.301 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.89 -26.33 4.86 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.847 -1.07 . . . . 0.0 115.668 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.34 160.95 19.76 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 118.119 0.959 . . . . 0.0 112.8 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG21 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.64 120.86 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.291 0.567 . . . . 0.0 109.916 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 143.45 45.16 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.645 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 69.7 m-85 -108.83 149.79 28.59 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -107.77 117.63 34.61 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 175.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.4 m -117.32 153.87 19.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -173.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.417 ' HB2' ' HD3' ' A' ' 30' ' ' LYS . 82.6 t60 -117.57 114.05 22.86 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.823 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--N 1.297 -1.702 0 O-C-N 123.639 0.587 . . . . 0.0 110.268 -176.692 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.414 0.626 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.471 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 71.2 m95 -106.54 127.14 53.09 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.391 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.58 155.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -92.61 161.1 14.72 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.48 -30.37 29.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.224 1.009 . . . . 0.0 111.955 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.99 -41.08 91.3 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.213 1.005 . . . . 0.0 111.794 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.535 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 50.0 mtt180 -87.08 7.38 28.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 mt -108.97 145.42 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.8 mp -107.83 112.0 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 171.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.2 144.3 38.33 Favored Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.581 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo . . . . . 0 N--CA 1.429 -2.323 0 N-CA-C 108.358 -1.439 . . . . 0.0 108.358 173.197 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 120.813 0.339 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -23.71 31.69 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.393 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -74.1 130.26 39.44 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 37.6 pttt -87.2 136.69 32.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 174.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.34 174.31 11.26 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.666 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 1.1 tmtm? -108.41 135.79 49.12 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.2 t -124.78 144.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.665 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 85.2 tttt -140.39 104.6 4.81 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.5 t80 . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 120.704 0.288 . . . . 0.0 111.195 -169.705 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.502 -0.878 0 CA-C-O 120.618 0.247 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.4 mt -108.11 144.31 16.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.738 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -140.01 163.85 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.658 0.783 . . . . 0.0 109.214 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.92 124.95 51.48 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 167.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.22 175.68 8.26 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.906 0.384 . . . . 0.0 111.395 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 21.0 m -135.69 134.11 38.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.76 125.8 23.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 O-C-N 123.858 0.724 . . . . 0.0 109.341 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -110.85 -31.4 7.18 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -167.25 167.22 14.33 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -144.84 139.71 27.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -145.77 156.88 43.88 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.63 0.581 . . . . 0.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -108.72 129.34 63.43 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.45 104.37 8.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t70 55.17 64.34 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 125.52 1.528 . . . . 0.0 111.726 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 -25.59 5.17 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.848 -1.069 . . . . 0.0 115.193 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.9 145.77 34.84 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.985 0.892 . . . . 0.0 111.577 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -98.23 127.47 50.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 122.028 0.918 . . . . 0.0 110.681 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.74 155.72 28.41 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.926 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' CE2' ' HZ2' ' A' ' 63' ' ' TRP . 22.0 m-85 -118.11 145.8 44.61 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.925 -173.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.1 tp -107.52 105.82 15.91 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 m -119.71 151.55 22.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.612 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -118.82 140.41 50.0 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--N 1.279 -2.457 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.639 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 121.088 0.471 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -97.74 126.29 43.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.36 0.6 . . . . 0.0 112.216 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.72 144.05 38.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -89.54 164.96 14.57 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 122.136 -0.352 . . . . 0.0 110.47 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.04 28.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.378 1.071 . . . . 0.0 111.886 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.4 -24.3 64.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.925 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.665 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 13.8 mmt180 -101.16 11.55 39.22 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.785 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -120.5 140.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.7 mp -107.85 114.82 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.423 ' HZ2' ' CE2' ' A' ' 41' ' ' TYR . 93.5 m95 -89.1 145.24 33.94 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.381 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 121.851 1.701 . . . . 0.0 110.743 175.558 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 120.931 0.396 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.84 58.25 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.845 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' SER . 25.6 m -67.84 125.02 24.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.32 110.46 20.78 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.28 -179.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.441 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HZ3' ' CG ' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -111.85 138.88 47.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.4 t -130.29 137.61 55.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 118.377 0.535 . . . . 0.0 110.542 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 53.0 mtmt -108.18 106.45 16.64 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.1 t80 . . . . . 0 C--N 1.299 -1.588 0 CA-C-O 121.847 0.832 . . . . 0.0 112.197 -174.775 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HE2' ' OH ' ' A' ' 25' ' ' TYR . 18.0 pttm . . . . . 0 N--CA 1.434 -1.227 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.84 125.83 73.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' OH ' ' HE2' ' A' ' 23' ' ' LYS . 55.6 m-85 -111.45 165.54 11.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.313 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.529 ' CG ' ' HZ3' ' A' ' 13' ' ' LYS . 45.1 mt-10 -111.67 126.81 55.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.08 -178.47 6.07 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 120.882 0.372 . . . . 0.0 111.342 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' THR . 16.4 m -123.64 155.3 37.98 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.63 126.02 39.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.727 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -101.67 -46.35 4.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -159.98 171.18 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -151.17 145.52 25.48 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.09 165.11 37.24 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.277 0.36 . . . . 0.0 110.231 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -111.26 126.35 68.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.93 103.28 7.4 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t0 57.0 65.35 1.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.001 0.92 . . . . 0.0 111.585 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -26.62 5.01 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' OE2' HD23 ' A' ' 40' ' ' LEU . 11.1 pt-20 -108.47 144.4 36.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 117.843 0.822 . . . . 0.0 110.768 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -98.82 121.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-O 122.241 1.019 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' OE2' ' A' ' 38' ' ' GLU . 83.5 mt -108.62 137.95 45.72 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.692 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 35.4 m-85 -108.56 145.22 35.16 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.843 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.8 tp -108.25 117.77 35.01 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.8 146.01 22.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.486 0.66 . . . . 0.0 109.505 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -117.89 116.69 27.46 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.692 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.263 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 C--O 1.222 -0.362 0 CA-C-O 121.047 0.451 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.505 ' CE2' HD13 ' A' ' 42' ' ' LEU . 87.8 m95 -109.64 118.9 37.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.122 0.969 . . . . 0.0 111.869 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.44 157.34 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.577 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -90.85 165.14 13.77 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.7 -29.29 66.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.36 -1.76 57.34 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.6 tpt180 -100.89 4.7 42.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.418 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.59 147.07 13.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.14 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.9 mp -108.77 108.56 25.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -81.77 133.03 52.87 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.36 1.132 0 C-N-CA 124.126 3.217 . . . . 0.0 114.423 -177.034 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 120.981 0.419 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.69 8.48 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.7 m -63.82 130.07 42.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.027 0.531 . . . . 0.0 110.115 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -98.84 115.16 28.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.02 -177.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.823 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.8 mmtm -107.3 135.82 48.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -127.26 137.23 58.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -107.87 121.94 45.77 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.1 t80 . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.229 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.38 120.49 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.92 166.86 10.51 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.495 1.118 . . . . 0.0 109.725 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.23 137.2 52.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.29 42.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 118.112 0.415 . . . . 0.0 111.983 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 p -104.49 141.75 35.82 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.81 124.68 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -33.96 6.54 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 m -158.55 169.73 23.78 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.973 -0.455 . . . . 0.0 109.811 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -144.31 141.28 29.66 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -143.39 153.17 42.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.118 0.485 . . . . 0.0 110.812 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -109.07 123.87 65.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -125.6 104.14 8.23 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 50.79 65.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.877 1.271 . . . . 0.0 113.236 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -24.04 10.09 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.714 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.67 140.06 42.59 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 118.083 0.942 . . . . 0.0 112.396 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.84 117.19 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.2 mt -109.03 138.68 45.0 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 42.7 m-85 -107.74 147.24 31.06 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.442 HD22 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -107.2 105.16 15.01 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.91 154.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.544 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -128.63 125.8 38.87 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.39 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--N 1.32 -0.69 0 O-C-N 124.465 1.103 . . . . 0.0 109.235 -174.191 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 121.155 0.502 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 82.8 m95 -99.5 123.43 43.77 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.595 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.21 147.37 28.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.248 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 61' ' ' ILE . 91.8 mttt -77.68 170.25 16.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.95 67.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.143 0.497 . . . . 0.0 110.398 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.2 -31.54 71.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 109.367 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -96.66 7.54 46.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.307 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 57' ' ' LYS . 57.0 mt -120.71 151.16 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.445 HD13 ' HB3' ' A' ' 13' ' ' LYS . 5.0 mp -108.15 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -90.9 130.02 42.12 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.838 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo . . . . . 0 N--CA 1.444 -1.39 0 C-N-CA 120.817 1.012 . . . . 0.0 111.335 179.627 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.2 0.524 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.66 -12.74 68.56 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.186 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -70.38 125.38 26.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -83.22 122.63 28.66 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.08 177.22 4.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.508 0.67 . . . . 0.0 111.268 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.04 136.5 52.85 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 56' ' ' VAL . 79.1 t -127.59 131.18 70.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 118.321 0.51 . . . . 0.0 111.0 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.682 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 10.8 tmtt? -119.33 118.73 31.99 Favored 'General case' 0 C--O 1.197 -1.671 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.576 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.487 ' HD1' ' N ' ' A' ' 16' ' ' TYR 0.319 0.0 OUTLIER . . . . . 0 CA--C 1.481 -1.688 0 CA-C-N 118.416 0.553 . . . . 0.0 111.192 170.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--O 1.27 2.175 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 15' ' ' LYS . 54.2 mt -111.69 124.94 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CE1' ' HE1' ' A' ' 16' ' ' TYR . 65.8 m-85 -107.78 166.14 10.92 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.616 -174.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.5 123.25 45.85 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 45' ' ' TYR . . . -130.22 -178.57 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.141 0.496 . . . . 0.0 111.69 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -135.22 135.16 40.75 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mm -65.5 124.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -103.74 -46.6 4.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -153.02 160.22 42.97 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -133.92 141.29 47.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -145.88 161.09 40.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.646 0.591 . . . . 0.0 110.743 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -108.83 124.7 65.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -130.69 114.08 14.95 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.679 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.74 25.53 12.99 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.62 -17.72 52.38 Favored Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.928 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -108.65 152.65 24.51 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.48 122.79 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-O 122.072 0.939 . . . . 0.0 110.749 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -109.66 142.15 41.22 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.692 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -108.82 142.66 39.06 Favored 'General case' 0 C--N 1.26 -3.322 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.697 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.57 110.97 23.01 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -117.53 150.89 19.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -172.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.4 138.12 54.03 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.073 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 31.5 m-85 . . . . . 0 C--N 1.28 -2.442 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' HH ' ' A' ' 16' ' ' TYR . 9.2 tp10 . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 121.146 0.498 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -100.17 125.96 46.38 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.49 1.116 . . . . 0.0 111.48 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.426 HG13 ' CG1' ' A' ' 14' ' ' VAL . 17.6 m -138.35 152.19 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.556 ' HE2' ' OD2' ' A' ' 59' ' ' ASP . 88.9 tttt -89.51 157.91 17.9 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.46 -31.41 45.45 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.423 1.089 . . . . 0.0 112.512 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.556 ' OD2' ' HE2' ' A' ' 57' ' ' LYS . 16.1 m-20 -72.92 -13.37 61.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.906 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.682 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 30.7 mtt180 -106.97 8.23 30.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.563 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.1 mt -108.79 140.27 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 13' ' ' LYS . 4.3 mp -106.78 105.27 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -82.9 124.56 76.75 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.155 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo . . . . . 0 N--CA 1.439 -1.729 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 174.637 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.71 -35.59 4.33 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.215 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 m -62.58 128.5 36.26 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.043 0.537 . . . . 0.0 110.799 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -96.01 129.6 43.23 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.3 173.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.811 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.874 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 33.3 ttpt -119.5 138.92 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.21 134.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -109.31 103.98 13.03 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.281 -2.38 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.78 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.08 129.44 62.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.95 164.02 33.34 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 123.503 0.721 . . . . 0.0 111.157 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 38.7 mt-10 -108.33 136.5 47.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB3' ' CD1' ' A' ' 45' ' ' TYR . . . -139.56 158.59 43.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -103.82 139.05 39.56 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.01 125.06 37.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 -39.3 7.08 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -160.87 167.84 25.87 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -143.31 151.12 40.13 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.65 165.05 37.15 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.6 mp -108.83 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.51 134.02 39.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t70 67.0 24.17 9.6 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.401 1.095 . . . . 0.0 109.67 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.87 -9.18 77.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.208 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.18 164.96 13.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 117.387 0.594 . . . . 0.0 111.229 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.62 117.47 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.511 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.23 134.39 53.8 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.064 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 27.3 m-85 -108.34 146.33 33.13 Favored 'General case' 0 C--N 1.271 -2.813 0 C-N-CA 123.84 0.856 . . . . 0.0 109.057 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -107.63 107.68 18.6 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.1 148.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.156 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -118.71 126.13 51.2 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 27' ' ' ALA . 51.7 m-85 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 121.545 0.688 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.2 m95 -101.44 124.32 46.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.217 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.78 144.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -80.43 159.07 25.76 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.48 69.3 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.459 0.647 . . . . 0.0 111.294 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -60.96 -25.71 67.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.621 1.168 . . . . 0.0 111.188 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.07 -5.44 57.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.033 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -107.84 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.835 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.39 109.9 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.8 124.07 53.7 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.445 -1.359 0 N-CA-C 108.756 -1.286 . . . . 0.0 108.756 174.426 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 9.3 p . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 120.955 0.407 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.46 -11.3 72.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.205 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' SER . 26.9 m -71.68 121.41 18.8 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 107.18 19.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -113.62 178.81 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.16 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -108.98 141.6 40.84 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.7 t -127.44 130.32 70.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.722 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 86.4 tttt -122.54 104.98 9.72 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.6 t80 . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? . . . . . 0 CA--C 1.498 -1.038 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -108.8 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.05 165.78 18.84 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.609 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -108.24 134.01 51.67 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.601 ' HB1' ' CD1' ' A' ' 45' ' ' TYR . . . -137.0 174.13 10.95 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.831 0.348 . . . . 0.0 111.603 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' THR . 45.1 m -123.77 137.5 54.67 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 mm -69.17 123.67 23.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -106.86 -40.96 5.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.928 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -152.77 166.04 33.47 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -151.07 144.35 24.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.47 166.27 33.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.958 0.409 . . . . 0.0 110.862 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.425 HG13 HG23 ' A' ' 39' ' ' VAL . 1.4 mp -108.36 120.15 59.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -132.57 125.28 30.14 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.451 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.43 23.34 13.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.319 1.057 . . . . 0.0 110.229 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.36 8.34 68.44 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.603 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.12 156.74 37.85 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 117.686 0.743 . . . . 0.0 109.768 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HG13 ' A' ' 34' ' ' ILE . 11.8 t -98.78 119.31 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 CA-C-O 121.524 0.678 . . . . 0.0 110.133 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -108.77 137.25 47.0 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.745 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 26.3 m-85 -111.64 142.51 43.87 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.393 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.467 HD12 ' CE2' ' A' ' 55' ' ' TRP . 58.4 tp -108.0 111.84 24.12 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.24 142.94 42.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.569 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -120.3 142.24 49.27 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.601 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 54.3 m-85 . . . . . 0 C--N 1.282 -2.336 0 O-C-N 124.481 1.113 . . . . 0.0 111.113 -171.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 121.201 0.524 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.468 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 81.0 m95 -103.36 117.66 34.99 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.891 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 m -122.05 165.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -103.31 164.98 11.3 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.92 74.57 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.566 0.746 . . . . 0.0 113.009 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -74.08 -6.52 48.07 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.722 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 16.8 mmt-85 -104.69 11.68 33.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.327 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.62 138.64 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.278 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 mp -108.33 114.44 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -83.72 115.55 60.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.135 0 C-N-CA 122.031 1.821 . . . . 0.0 111.027 -179.579 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 -32.19 6.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.567 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 m -63.87 132.7 51.6 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.082 0.553 . . . . 0.0 110.035 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -93.11 131.23 38.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.74 -179.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.486 -172.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 28.4 mmmt -114.03 135.36 54.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -116.11 133.14 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -107.9 114.18 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.114 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.567 ' CE2' HG11 ' A' ' 56' ' ' VAL . 1.5 m-85 . . . . . 0 CA--C 1.496 -1.098 0 CA-C-O 121.015 0.436 . . . . 0.0 110.616 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.438 HG23 ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -112.63 133.61 57.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 8.7 m-85 -107.5 166.77 10.42 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -172.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -106.75 116.46 31.96 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.86 167.75 19.65 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.741 -0.599 . . . . 0.0 111.497 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.78 128.35 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 123.642 0.589 . . . . 0.0 111.145 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.346 1.058 . . . . 0.0 111.895 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 t -154.39 167.86 28.57 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -132.83 139.7 47.61 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.56 156.38 45.1 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 123.575 0.547 . . . . 0.0 110.097 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -108.77 119.92 59.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.22 131.7 32.8 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 65.64 22.03 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.397 1.094 . . . . 0.0 109.855 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.96 87.7 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.383 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -116.51 159.37 22.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 122.495 -0.415 . . . . 0.0 111.765 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.86 116.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.43 0.633 . . . . 0.0 111.093 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -112.73 139.94 47.93 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.486 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 31.2 m-85 -108.15 157.25 18.46 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.93 115.02 29.46 Favored 'General case' 0 CA--C 1.465 -2.311 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.17 142.59 43.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -117.84 125.47 50.6 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.619 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.291 -1.951 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -178.483 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 N--CA 1.44 -0.966 0 CA-C-O 121.086 0.469 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.1 m95 -98.83 126.84 44.59 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.462 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG11 ' CE2' ' A' ' 16' ' ' TYR . 34.3 m -135.94 165.22 30.17 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.831 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.69 166.47 10.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.36 74.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.654 . . . . 0.0 111.239 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.11 -15.64 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.735 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 14.6 tpt180 -95.95 0.61 52.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.825 0.821 . . . . 0.0 109.61 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.99 150.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.268 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.0 mp -107.64 104.57 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -75.81 150.83 84.2 Favored Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.346 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.448 -1.201 0 C-N-CA 122.612 2.208 . . . . 0.0 111.201 178.839 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.54 -22.22 40.73 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.794 174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -66.09 118.65 10.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -91.0 115.07 27.72 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.54 178.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 34.4 tttp -120.92 139.11 53.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.71 139.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 40.8 ttmt -125.01 104.09 8.37 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.247 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.157 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.836 0 CA-C-O 121.234 0.54 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.447 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -108.17 115.17 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.23 162.48 32.03 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.449 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG2' ' HG3' ' A' ' 13' ' ' LYS . 54.6 mt-10 -113.85 136.8 52.48 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.089 0.471 . . . . 0.0 112.071 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 45' ' ' TYR . . . -141.25 -178.04 5.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.289 -171.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -134.95 133.37 39.48 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.461 HD13 HG23 ' A' ' 43' ' ' VAL . 46.5 mm -67.78 131.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.797 0.686 . . . . 0.0 110.98 -176.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -60.92 1.45 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.7 m -147.98 164.82 32.59 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -134.29 151.98 51.56 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.12 165.57 35.22 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 123.167 0.292 . . . . 0.0 110.237 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -111.14 131.39 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.95 115.87 13.18 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 63.79 23.44 13.44 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.262 1.425 . . . . 0.0 111.623 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.79 -10.55 55.87 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.419 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.17 147.1 31.79 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.722 0.761 . . . . 0.0 109.565 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 t -98.6 118.04 44.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.96 130.06 55.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.605 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 37.4 m-85 -108.16 147.91 30.63 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.897 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.8 tp -107.55 113.07 26.14 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 HD13 ' A' ' 29' ' ' ILE . 2.4 p -118.42 147.03 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.443 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.15 125.92 51.19 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.629 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 90.2 m-85 . . . . . 0 C--N 1.304 -1.403 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.582 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 121.266 0.555 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 74.9 m95 -102.41 106.47 17.22 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.37 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 p -122.88 148.04 26.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.151 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 61' ' ' ILE . 26.3 mtmm -73.15 158.28 35.59 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.88 91.88 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.115 0.966 . . . . 0.0 113.066 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -86.05 -2.48 58.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -96.69 5.61 50.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.206 1.003 . . . . 0.0 109.016 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 57' ' ' LYS . 70.0 mt -120.48 153.32 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.084 -1.416 . . . . 0.0 107.336 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.1 mp -107.39 109.51 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -87.89 120.05 70.69 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.075 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.439 -1.695 0 C-N-CA 121.334 1.356 . . . . 0.0 109.558 175.002 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.429 -1.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.96 -11.3 48.9 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.334 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -78.28 128.22 33.39 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 121.67 34.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.812 0.815 . . . . 0.0 109.898 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.44 179.46 2.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.142 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 53.0 mtmt -108.83 143.84 37.5 Favored 'General case' 0 CA--C 1.475 -1.905 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.36 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 92.7 t -121.44 128.94 75.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.048 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.7 ttmt -107.64 104.1 13.55 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 t80 . . . . . 0 C--N 1.302 -1.471 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.878 -171.188 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 61.5 mt -108.69 112.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.55 166.93 10.73 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -107.11 119.79 40.32 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.21 177.61 6.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -129.19 128.04 42.54 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 122.203 -0.311 . . . . 0.0 110.203 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 43' ' ' VAL . 33.4 mm -65.62 130.17 30.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 O-C-N 124.1 0.875 . . . . 0.0 109.786 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -117.63 -42.82 2.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -158.3 170.18 22.83 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.908 -0.495 . . . . 0.0 109.963 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.409 HG22 ' CD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -137.12 140.58 41.99 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -145.47 155.44 43.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.747 0.419 . . . . 0.0 110.253 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.7 124.86 65.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -125.92 104.32 8.24 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.05 64.46 1.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 112.97 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -26.57 5.71 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.692 -1.14 . . . . 0.0 115.525 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.14 149.45 28.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.311 1.056 . . . . 0.0 111.215 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.45 125.59 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.448 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.1 mt -112.3 138.56 48.83 Favored 'General case' 0 N--CA 1.405 -2.722 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.372 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 30.9 m-85 -108.0 149.14 28.76 Favored 'General case' 0 C--N 1.258 -3.411 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' CE2' ' A' ' 55' ' ' TRP . 39.8 tp -107.29 104.26 13.83 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.414 HG12 HG21 ' A' ' 14' ' ' VAL . 3.8 p -118.77 138.36 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -173.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.69 143.76 47.57 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.972 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.223 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.491 ' CE2' HD12 ' A' ' 42' ' ' LEU . 75.6 m95 -98.47 122.88 42.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.37 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 HG12 HG13 ' A' ' 14' ' ' VAL . 18.1 m -130.44 152.48 37.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -79.82 153.03 29.4 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.05 -2.51 37.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 13.5 mtp180 -106.09 10.19 32.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.011 0.434 . . . . 0.0 110.498 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.5 mt -108.81 139.24 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.373 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.1 mp -108.05 107.61 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -84.88 130.41 52.75 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 122.902 2.402 . . . . 0.0 112.589 -179.409 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.431 -1.403 0 CA-C-O 121.262 0.553 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.56 0.14 82.35 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.812 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -78.22 131.78 37.28 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HZ3' ' HB3' ' A' ' 11' ' ' LYS . 1.5 mmmp? -86.22 129.98 34.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.36 175.84 9.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.2 ttpt -120.51 146.64 46.08 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -129.62 132.57 66.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.56 103.14 9.16 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 C--N 1.313 -1.009 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.112 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -107.98 124.09 63.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.5 165.63 31.59 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 124.228 1.011 . . . . 0.0 109.983 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.01 136.88 46.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . . . -131.16 -178.27 4.76 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.828 -173.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 m -138.62 139.38 38.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.3 mm -77.88 135.31 26.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.948 0.404 . . . . 0.0 111.586 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -103.42 -58.71 1.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -148.68 -178.64 6.45 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.687 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.09 145.24 41.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.42 154.02 50.91 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -116.62 119.32 61.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -135.09 119.73 18.2 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.48 23.0 12.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 110.648 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.52 -8.9 66.65 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.491 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -109.47 143.85 38.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 117.762 0.781 . . . . 0.0 110.565 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.54 123.21 50.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 122.395 1.093 . . . . 0.0 110.666 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.89 145.38 35.46 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.022 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 34.6 m-85 -113.22 151.84 30.49 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.783 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' CE2' ' A' ' 55' ' ' TRP . 40.8 tp -107.72 116.5 32.07 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -118.95 140.99 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.612 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -130.25 138.47 50.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.092 0.472 . . . . 0.0 111.121 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 20.4 m-85 . . . . . 0 C--N 1.284 -2.282 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.809 -171.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 120.914 0.388 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.466 ' CE2' HD11 ' A' ' 42' ' ' LEU . 74.6 m95 -104.37 129.08 52.29 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.93 140.23 39.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 61' ' ' ILE . 33.0 ttpt -71.68 150.66 44.35 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 120.756 0.312 . . . . 0.0 111.505 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.67 64.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.685 1.594 . . . . 0.0 113.73 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.35 -7.71 54.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.689 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.403 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -106.87 8.37 30.65 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.382 1.087 . . . . 0.0 108.707 -175.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 57' ' ' LYS . 68.1 mt -108.61 157.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.5 mp -107.07 108.6 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -97.95 146.24 31.15 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo . . . . . 0 N--CA 1.44 -1.653 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 174.032 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.436 -1.154 0 CA-C-O 121.074 0.464 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.06 -20.34 21.8 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.861 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.3 m -74.68 128.67 36.11 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 1.2 pptp? -87.9 127.4 35.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.419 0.628 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.06 176.68 6.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.94 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 1.3 mmtm -110.92 135.47 51.4 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.8 t -124.38 131.72 72.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.12 114.35 28.18 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.434 -1.261 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.822 -175.831 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 pttt . . . . . 0 N--CA 1.429 -1.508 0 CA-C-O 121.546 0.689 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.59 129.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.88 165.66 13.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.194 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -115.11 136.68 52.85 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . . . -136.94 -178.71 5.31 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 m -142.67 130.07 21.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.0 mm -57.94 127.0 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 124.071 0.857 . . . . 0.0 111.152 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.38 -46.03 5.38 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -154.43 153.79 32.14 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.42 HG21 ' CD2' ' A' ' 41' ' ' TYR . 3.2 m -126.64 133.6 50.95 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 170.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -142.09 158.86 43.26 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 123.699 0.625 . . . . 0.0 110.378 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -108.46 129.94 61.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.581 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.15 103.92 8.86 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.519 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 46.69 63.82 1.76 Allowed 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 125.601 1.56 . . . . 0.0 113.057 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 -24.46 11.51 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.12 -0.945 . . . . 0.0 115.275 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.81 149.13 29.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.466 1.133 . . . . 0.0 110.49 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -98.52 119.55 46.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.69 143.07 38.28 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.42 ' CD2' HG21 ' A' ' 32' ' ' THR . 46.7 m-85 -108.45 139.84 42.61 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.57 HD13 ' CE2' ' A' ' 55' ' ' TRP . 59.8 tp -107.61 106.59 17.02 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.82 141.91 44.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.605 -171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -118.99 146.47 44.99 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.31 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 33.5 m-85 . . . . . 0 C--N 1.29 -1.98 0 O-C-N 123.967 0.792 . . . . 0.0 110.575 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.438 -1.04 0 CA-C-O 120.746 0.308 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CE2' HD13 ' A' ' 42' ' ' LEU . 84.9 m95 -108.38 110.61 22.21 Favored 'General case' 0 C--O 1.253 1.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.316 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.5 m -135.77 139.74 45.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.018 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -80.98 168.2 18.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.1 63.19 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.485 0.714 . . . . 0.0 112.867 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.48 -19.35 53.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.341 0.591 . . . . 0.0 110.859 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -92.13 -5.24 53.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.334 1.064 . . . . 0.0 108.415 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.79 150.71 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.829 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.473 ' HB ' ' CB ' ' A' ' 13' ' ' LYS . 4.2 mp -108.65 115.21 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 172.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -81.15 108.98 11.88 Favored Pre-proline 0 C--N 1.31 -1.148 0 O-C-N 123.144 0.278 . . . . 0.0 111.013 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.441 -1.58 0 C-N-CA 122.288 1.992 . . . . 0.0 113.851 -175.552 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 30' ' ' LYS . 2.8 p . . . . . 0 N--CA 1.427 -1.589 0 CA-C-O 121.137 0.494 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.13 8.48 57.78 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.441 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 m -77.86 126.87 31.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 95.3 mttt -94.52 124.29 38.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.119 0.485 . . . . 0.0 111.387 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.99 -178.96 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.789 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 32.6 ttpt -124.79 146.47 49.21 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 56' ' ' VAL . 99.4 t -126.09 137.69 56.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 122.836 0.455 . . . . 0.0 110.238 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -110.57 107.0 16.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.305 -1.357 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.175 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 mptt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.62 108.53 25.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 170.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.57 165.09 19.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.87 -174.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.47 139.07 43.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.8 -179.68 6.75 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.199 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 6.6 m -129.47 136.87 50.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -69.85 129.63 34.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.07 -47.1 4.87 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -155.97 168.03 28.54 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -140.5 150.69 44.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.46 162.43 40.74 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.521 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.8 mp -114.26 124.7 71.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.06 108.18 10.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.025 0.441 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.32 65.0 1.01 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.521 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -26.53 3.34 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.618 -1.173 . . . . 0.0 115.181 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.11 148.69 36.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.623 0.711 . . . . 0.0 111.562 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.2 p -98.32 125.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.683 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.89 134.9 51.57 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.705 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -110.84 145.91 37.37 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.056 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.29 119.8 40.54 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -118.23 149.62 20.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -125.61 138.65 53.93 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . 0.258 58.1 m-85 . . . . . 0 C--N 1.286 -2.187 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -168.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.24 0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -104.78 122.28 45.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.686 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 14' ' ' VAL . 19.2 m -134.29 143.93 36.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -82.84 160.79 22.12 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 123.358 0.663 . . . . 0.0 110.467 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.59 61.56 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.57 0.748 . . . . 0.0 112.204 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.79 -2.57 37.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.291 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -111.88 0.53 16.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -114.64 152.69 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 111.599 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.2 mp -107.48 112.55 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.85 137.78 22.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 N--CA 1.443 -1.47 0 C-N-CA 121.92 1.746 . . . . 0.0 108.865 171.399 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.42 -1.968 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.72 -25.59 7.17 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.934 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.3 m -62.53 121.17 12.64 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.322 0.582 . . . . 0.0 109.837 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.72 122.58 40.98 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.263 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.85 -179.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.857 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB3' HD11 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -113.33 140.32 48.11 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -132.85 138.56 51.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 118.721 0.692 . . . . 0.0 111.204 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -108.61 143.68 37.35 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 . . . . . 0 C--N 1.313 -0.997 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.716 176.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -0.997 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.16 114.88 46.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 165.76 15.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.09 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -108.79 142.2 39.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.09 172.94 15.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.5 p -122.64 146.92 47.02 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 8' ' ' THR . 20.8 mm -66.72 131.92 32.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -103.24 -45.8 4.79 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -165.04 -176.55 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -150.28 165.01 34.28 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.498 0.719 . . . . 0.0 109.445 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -160.46 166.35 29.36 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.33 1.452 . . . . 0.0 110.081 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.2 117.26 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.25 114.53 15.78 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.045 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 69.15 23.61 6.36 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.895 1.278 . . . . 0.0 110.512 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.48 54.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.558 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.0 159.34 16.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.434 -0.451 . . . . 0.0 111.183 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.35 117.38 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.39 0.614 . . . . 0.0 109.739 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -111.04 154.66 23.89 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.799 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 88.9 m-85 -116.85 148.78 40.96 Favored 'General case' 0 C--N 1.255 -3.521 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.52 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' CZ2' ' A' ' 55' ' ' TRP . 36.0 tp -107.09 116.36 31.78 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.18 144.09 27.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.534 -172.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -117.37 125.57 51.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 . . . . . 0 C--N 1.304 -1.399 0 CA-C-N 114.739 -1.118 . . . . 0.0 112.969 -170.585 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 79.3 m95 -98.56 126.98 44.32 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.754 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.01 140.84 32.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.548 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -76.86 164.17 26.07 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 122.328 -0.233 . . . . 0.0 110.677 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.09 -32.08 63.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.009 0.524 . . . . 0.0 112.085 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.48 -24.75 65.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.285 1.034 . . . . 0.0 111.701 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -94.72 -6.42 43.2 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.555 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.1 147.65 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.89 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -107.72 106.65 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -82.51 136.15 45.9 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.616 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 CA--C 1.506 -0.903 0 C-N-CA 122.392 2.062 . . . . 0.0 111.114 178.023 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.423 HG22 ' HA ' ' A' ' 30' ' ' LYS . 91.0 m . . . . . 0 N--CA 1.428 -1.525 0 CA-C-O 121.238 0.542 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -16.54 50.96 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -71.88 125.38 27.04 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.049 0.452 . . . . 0.0 110.298 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -93.38 109.95 21.51 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.97 175.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.894 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 28.4 ttpt -108.83 143.79 37.56 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -125.46 129.36 72.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 123.666 0.786 . . . . 0.0 110.325 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 86.5 tttt -108.76 112.9 25.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--N 1.282 -2.357 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.255 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 N--CA 1.417 -2.122 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.87 128.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 165.78 27.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.724 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 32.3 mt-10 -111.01 134.37 52.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.617 ' HB1' ' CD2' ' A' ' 45' ' ' TYR . . . -138.21 179.24 6.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.587 0.708 . . . . 0.0 112.39 -172.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -122.4 136.28 54.86 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.56 127.46 34.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -109.3 -41.79 4.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -147.73 170.34 17.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -146.85 142.34 27.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.61 144.81 44.29 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.665 0.386 . . . . 0.0 110.809 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.44 112.86 42.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -149.54 133.39 16.97 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t70 71.93 23.35 3.56 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.982 1.313 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.14 4.73 81.18 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.998 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 11.8 pt-20 -127.18 157.48 39.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 117.153 0.477 . . . . 0.0 110.329 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.11 118.88 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-O 122.223 1.011 . . . . 0.0 109.403 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.64 136.87 47.52 Favored 'General case' 0 N--CA 1.403 -2.802 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.065 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 33.8 m-85 -107.51 145.58 32.92 Favored 'General case' 0 C--N 1.259 -3.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.419 HD22 ' CE2' ' A' ' 55' ' ' TRP . 3.2 tm? -107.49 114.48 28.51 Favored 'General case' 0 N--CA 1.39 -3.454 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.82 148.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.819 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -132.18 137.12 47.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.617 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 55.0 m-85 . . . . . 0 C--N 1.285 -2.211 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.425 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 C--O 1.238 0.478 0 CA-C-O 121.004 0.431 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.465 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 66.3 m95 -107.6 120.35 41.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.295 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.52 145.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 38' ' ' GLU . 60.6 tttm -81.91 149.45 28.24 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.11 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.605 1.162 . . . . 0.0 113.228 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.11 -25.25 65.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.181 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.592 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 33.8 mtt85 -97.19 7.74 45.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.177 0.513 . . . . 0.0 111.625 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -108.33 146.51 14.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.24 102.54 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 97.2 m95 -81.72 124.91 79.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.701 -171.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 18.5 Cg_exo . . . . . 0 N--CA 1.446 -1.3 0 C-N-CA 122.51 2.14 . . . . 0.0 113.107 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.431 -1.402 0 CA-C-O 120.85 0.357 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.51 -33.6 6.23 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -66.81 128.42 36.25 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 123.225 0.61 . . . . 0.0 111.034 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -97.65 126.03 42.74 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.83 179.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -107.7 142.81 37.12 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.483 HG12 HG11 ' A' ' 56' ' ' VAL . 85.9 t -123.45 135.95 61.62 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.182 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.196 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.8 ttmt -107.29 102.87 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' HG13 ' A' ' 56' ' ' VAL . 64.2 t80 . . . . . 0 C--N 1.271 -2.845 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 31.1 mmmt . . . . . 0 C--O 1.244 0.813 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.86 114.46 46.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 15.1 m-85 -112.72 165.78 11.97 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -105.83 131.21 53.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' HB1' ' CD1' ' A' ' 45' ' ' TYR . . . -134.71 161.83 34.05 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.788 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 m -116.43 137.27 52.3 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.7 mm -76.55 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.598 0.561 . . . . 0.0 111.83 -174.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -99.33 -61.73 1.33 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -156.15 -179.86 8.55 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.93 145.32 30.64 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.068 0.395 . . . . 0.0 110.31 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -141.48 157.22 45.42 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.844 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 mp -114.01 133.0 61.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 17.9 t70 -143.68 125.24 14.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.1 t70 59.12 22.51 10.65 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.625 1.17 . . . . 0.0 111.416 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.76 -8.73 59.94 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.781 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 25.8 pt-20 -107.33 149.04 28.26 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.76 121.36 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-O 122.415 1.103 . . . . 0.0 110.781 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 57' ' ' LYS . 1.3 mm? -108.86 131.88 54.57 Favored 'General case' 0 N--CA 1.389 -3.48 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.277 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 25.5 m-85 -107.86 146.87 31.7 Favored 'General case' 0 C--N 1.257 -3.424 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.7 OUTLIER -107.03 111.26 23.66 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -178.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.49 151.92 33.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.43 133.12 51.32 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.891 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 33.3 m-85 . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.455 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 65.3 m95 -100.59 126.05 47.02 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.749 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.483 HG11 HG12 ' A' ' 14' ' ' VAL . 20.4 m -129.96 165.63 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 86.1 mttt -99.79 171.18 8.05 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.277 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.92 93.17 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.89 0.876 . . . . 0.0 111.886 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -60.93 -26.04 67.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.702 0.763 . . . . 0.0 111.145 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 23.1 mmm180 -87.39 -0.68 57.13 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.781 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -112.19 143.27 22.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.989 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.7 108.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -90.17 159.13 42.89 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 N--CA 1.449 -1.099 0 C-N-CA 121.898 1.732 . . . . 0.0 111.239 177.358 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 30' ' ' LYS . 5.2 m . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.718 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.34 -15.66 55.98 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -83.04 130.71 35.16 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 112.95 25.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.457 1.122 . . . . 0.0 109.359 177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 34.7 m -116.94 -179.71 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.408 -169.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.03 136.76 47.18 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 96.7 t -114.56 134.61 57.01 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.712 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.913 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 38.2 ttmt -107.72 104.71 14.29 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.269 -2.926 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -179.82 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 pttt . . . . . 0 N--CA 1.421 -1.918 0 CA-C-O 120.784 0.326 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.5 mp -110.46 122.36 64.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 166.75 23.95 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.308 -175.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.1 mt-10 -105.44 120.51 41.79 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.82 0.819 . . . . 0.0 109.019 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -129.14 152.6 48.56 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.699 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 m -104.16 137.1 42.59 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.16 128.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.465 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HA ' HG22 ' A' ' 8' ' ' THR . 1.1 tmmt? -114.66 -50.65 2.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -129.71 166.97 18.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -148.98 153.15 37.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.455 ' C ' HD12 ' A' ' 34' ' ' ILE . 11.1 pt-20 -144.44 158.52 43.71 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.5 mp -122.21 109.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -139.99 139.36 36.04 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.432 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 65.19 22.51 12.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.664 1.221 . . . . 0.0 109.785 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.5 -0.68 89.52 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.96 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.57 148.75 39.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 117.111 0.456 . . . . 0.0 111.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.23 119.27 46.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.4 mt -108.76 132.59 53.82 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.974 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 54.3 m-85 -108.94 145.16 35.89 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.742 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.414 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.0 tm? -108.1 113.55 26.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.41 153.71 25.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.718 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -145.52 153.28 40.94 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.848 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 4.1 m-85 . . . . . 0 C--N 1.29 -1.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.803 -168.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.22 -0.464 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.414 ' CE2' HD23 ' A' ' 42' ' ' LEU . 83.6 m95 -112.28 113.65 26.0 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.527 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.82 149.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.481 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -89.32 162.42 15.83 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.175 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.89 65.61 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.854 1.262 . . . . 0.0 112.986 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.73 -20.54 62.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 43.1 mtt85 -92.64 3.13 56.16 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.57 145.64 15.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.078 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.92 112.15 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -93.55 119.05 67.58 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.216 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo . . . . . 0 CA--C 1.497 -1.332 0 C-N-CA 123.323 2.682 . . . . 0.0 112.485 177.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.426 -1.636 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.7 -7.11 82.47 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.39 121.49 20.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -87.55 111.86 21.65 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.044 0.925 . . . . 0.0 109.999 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.18 176.32 3.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.332 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.6 ttpt -111.64 139.1 47.38 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.87 132.32 69.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 C-N-CA 122.941 0.497 . . . . 0.0 111.297 -172.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -108.42 104.69 14.09 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 124.885 1.274 . . . . 0.0 107.715 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.6 t80 . . . . . 0 C--N 1.289 -2.051 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.126 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HD2' ' CE2' ' A' ' 25' ' ' TYR . 11.3 ptpt . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.0 mt -108.82 114.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.445 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -108.49 166.9 10.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.87 132.18 56.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 45' ' ' TYR . . . -143.51 168.14 20.56 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.292 -171.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 p -106.43 142.35 36.24 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mm -68.38 120.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -93.22 -38.85 11.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 t -169.27 173.57 6.6 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -145.93 140.29 26.84 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -142.36 155.52 45.16 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.204 0.601 . . . . 0.0 109.638 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.81 124.92 65.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.76 104.87 8.08 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.714 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 55.46 64.12 1.86 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.546 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.28 -25.57 4.86 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 114.86 -1.064 . . . . 0.0 114.858 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.47 150.1 27.89 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.735 0.768 . . . . 0.0 112.932 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 t -98.66 118.36 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.05 134.78 50.46 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -107.81 146.74 31.83 Favored 'General case' 0 C--N 1.259 -3.331 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.62 121.96 45.73 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.81 148.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-O 121.392 0.615 . . . . 0.0 109.716 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -118.44 118.01 30.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 27' ' ' ALA . 75.8 m-85 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -170.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.267 0.556 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.48 131.14 55.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.488 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.77 144.46 29.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -80.6 160.95 24.94 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.36 -34.52 57.92 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.684 0.754 . . . . 0.0 111.182 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.18 -34.15 59.79 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.455 1.502 . . . . 0.0 111.633 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -95.31 6.61 48.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.86 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -113.52 142.35 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-O 121.635 0.731 . . . . 0.0 111.732 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.3 mp -107.87 104.97 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -85.26 155.13 60.32 Favored Pre-proline 0 C--N 1.291 -1.944 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 N--CA 1.453 -0.898 0 C-N-CA 121.267 1.311 . . . . 0.0 109.066 175.723 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.91 -11.83 62.43 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.803 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.5 m -77.53 131.36 37.85 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -86.11 114.76 23.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.754 0.787 . . . . 0.0 110.843 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.28 -179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 24.2 ttmt -116.76 140.42 49.45 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.465 ' CG1' HG12 ' A' ' 56' ' ' VAL . 94.5 t -117.31 131.46 69.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 121.186 0.517 . . . . 0.0 110.303 -176.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -106.71 104.82 14.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.299 -1.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.452 -173.338 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.721 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.27 126.78 71.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.96 165.78 26.43 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.169 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 138.53 45.0 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 161.72 38.21 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -104.17 138.66 40.33 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.3 128.31 29.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.032 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 28.6 tptp -100.9 -62.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.7 m -147.19 161.44 40.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -127.19 138.27 53.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.29 161.57 37.69 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.376 0.608 . . . . 0.0 111.673 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.404 HG13 HG21 ' A' ' 39' ' ' VAL . 1.8 mp -108.91 130.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -135.82 115.91 13.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 59.7 35.11 22.23 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.548 1.139 . . . . 0.0 111.357 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.45 -12.24 66.5 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.344 -0.931 . . . . 0.0 114.238 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.98 151.99 35.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.5 0.65 . . . . 0.0 111.235 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.404 HG21 HG13 ' A' ' 34' ' ' ILE . 8.4 t -98.83 125.25 52.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.9 0.381 . . . . 0.0 110.147 -175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.67 160.33 26.05 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.481 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -114.11 144.42 43.17 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.764 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -108.23 116.52 32.11 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 m -117.67 149.12 20.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.484 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -118.35 128.02 54.25 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 C--N 1.287 -2.117 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -175.119 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.677 0.275 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.428 ' CE2' HD23 ' A' ' 42' ' ' LEU . 78.0 m95 -107.25 122.83 47.34 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.463 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.465 HG12 ' CG1' ' A' ' 14' ' ' VAL . 16.5 m -135.99 144.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.232 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -79.75 160.61 26.14 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -36.52 62.86 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.116 0.967 . . . . 0.0 112.244 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.2 -10.43 59.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -103.33 4.88 36.92 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.48 140.92 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.146 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.6 mp -107.86 112.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -86.31 132.73 42.29 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.656 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.446 -1.277 0 N-CA-C 107.518 -1.762 . . . . 0.0 107.518 173.282 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.408 HG21 ' HA ' ' A' ' 30' ' ' LYS . 16.1 m . . . . . 0 N--CA 1.418 -2.071 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.65 -18.31 7.2 Favored Glycine 0 C--N 1.31 -0.884 0 C-N-CA 119.657 -1.258 . . . . 0.0 112.965 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -73.49 129.35 37.8 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -95.03 144.17 25.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.83 179.55 3.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.0 mmmt -108.05 134.39 51.01 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.412 ' CG1' HG11 ' A' ' 56' ' ' VAL . 93.7 t -115.52 128.18 72.83 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.098 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 86.8 tttt -106.86 104.29 13.94 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CD1' HG13 ' A' ' 56' ' ' VAL . 63.4 t80 . . . . . 0 C--N 1.294 -1.825 0 CA-C-O 121.424 0.63 . . . . 0.0 110.588 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.94 129.98 67.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -129.48 166.65 19.21 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.23 1.012 . . . . 0.0 109.449 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -107.8 125.83 51.9 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.21 46.06 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 8.5 p -104.44 142.7 34.14 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.8 mm -73.76 129.55 36.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HA ' HG21 ' A' ' 8' ' ' THR . 10.6 tmtt? -98.46 -54.75 2.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -155.22 -179.89 8.52 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 41' ' ' TYR . 10.1 t -158.49 165.06 35.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.446 ' C ' HD11 ' A' ' 34' ' ' ILE . 12.7 pt-20 -148.07 158.07 43.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.345 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -119.2 111.48 33.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -123.33 122.87 39.4 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 68.67 23.03 7.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.732 1.213 . . . . 0.0 110.141 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.42 -6.55 74.97 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.522 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.27 151.04 31.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 117.73 0.765 . . . . 0.0 110.689 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 t -97.95 124.15 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.728 0.775 . . . . 0.0 110.035 -172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -108.47 125.62 51.99 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.71 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 87.0 m-85 -108.97 147.5 32.17 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.398 -176.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD13 ' NE1' ' A' ' 55' ' ' TRP . 55.6 tp -107.54 110.4 22.31 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.8 m -118.23 148.61 20.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -126.73 129.66 48.82 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 . . . . . 0 C--N 1.303 -1.451 0 O-C-N 124.145 0.903 . . . . 0.0 111.052 -172.188 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 73.6 m95 -98.24 134.08 41.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.245 0.545 . . . . 0.0 111.488 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 16' ' ' TYR . 26.8 m -133.23 165.21 32.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.1 157.42 16.89 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.24 -32.51 48.66 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.659 0.784 . . . . 0.0 112.263 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -26.15 68.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.423 1.089 . . . . 0.0 111.897 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 27.0 mmm-85 -93.91 0.58 56.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -109.31 140.36 28.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.63 -173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.7 mp -109.04 108.87 26.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -83.07 124.95 75.95 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 121.616 1.544 . . . . 0.0 109.838 177.468 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -144.23 178.04 8.18 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.265 0.555 . . . . 0.0 109.877 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -151.41 162.57 40.7 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.22 117.15 62.08 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 118.356 0.525 . . . . 0.0 109.906 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.94 177.71 5.43 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.591 2.194 . . . . 0.0 111.679 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m -82.01 91.51 6.63 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.516 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . 0.473 0.0 OUTLIER 42.73 53.09 4.95 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 178.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.61 151.29 37.84 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.537 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.48 65.65 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 m -92.79 117.24 29.81 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -97.34 134.48 40.57 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 171.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.47 177.2 5.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.955 -176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 25' ' ' TYR . 1.0 OUTLIER -108.98 129.46 55.45 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -123.45 136.82 58.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 118.028 0.376 . . . . 0.0 111.432 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.535 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 41.0 ttmt -108.68 146.62 33.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -154.26 114.98 3.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -137.62 113.23 0.98 Allowed Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.71 -1.233 . . . . 0.0 114.484 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -146.67 106.36 3.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.715 0.806 . . . . 0.0 109.976 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.94 -120.37 7.27 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.783 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -85.99 -21.46 27.81 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -80.52 77.33 7.33 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.851 0.834 . . . . 0.0 109.839 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -128.91 109.23 11.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.126 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 1.9 mptp? -140.01 165.09 28.28 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.34 108.28 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 5.8 m-85 -108.36 167.67 9.86 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.959 -169.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.68 126.69 52.6 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.7 159.66 41.37 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.749 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.61 144.59 36.14 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 50.3 mm -77.15 131.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.437 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HD3' ' HB2' ' A' ' 44' ' ' HIS . 9.3 mtmt -99.62 -52.85 3.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.897 0.855 . . . . 0.0 110.115 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 m -155.08 166.87 32.24 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.153 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -136.65 143.14 43.31 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -144.64 162.36 36.86 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.288 0.566 . . . . 0.0 110.852 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.411 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.6 mp -108.3 113.14 43.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -122.83 104.6 9.39 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.107 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 57.73 64.62 1.51 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.301 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.89 -26.33 4.86 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.847 -1.07 . . . . 0.0 115.668 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.34 160.95 19.76 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 118.119 0.959 . . . . 0.0 112.8 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.408 HG21 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.64 120.86 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.291 0.567 . . . . 0.0 109.916 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 143.45 45.16 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.645 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 69.7 m-85 -108.83 149.79 28.59 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -107.77 117.63 34.61 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 175.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.541 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 14.4 m -117.32 153.87 19.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.647 ' HA ' ' OD1' ' A' ' 53' ' ' ASP . 82.6 t60 -117.57 114.05 22.86 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.823 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -73.02 125.99 28.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 123.639 0.587 . . . . 0.0 110.268 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -85.46 96.28 9.55 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.15 -4.21 18.43 Favored Glycine 0 C--O 1.239 0.463 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.177 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -123.79 -164.68 1.25 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -34.35 100.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.608 1.563 . . . . 0.0 114.182 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.1 -7.99 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.427 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -56.56 2.34 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -87.38 -34.91 18.63 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.103 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.647 ' OD1' ' HA ' ' A' ' 44' ' ' HIS . 37.7 m-20 60.64 -161.99 0.27 Allowed 'General case' 0 C--O 1.244 0.771 0 O-C-N 123.837 0.71 . . . . 0.0 111.506 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.49 158.22 43.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.928 -176.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.471 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 71.2 m95 -106.54 127.14 53.09 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.391 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.58 155.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -92.61 161.1 14.72 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.48 -30.37 29.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.224 1.009 . . . . 0.0 111.955 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.99 -41.08 91.3 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.213 1.005 . . . . 0.0 111.794 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.535 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 50.0 mtt180 -87.08 7.38 28.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 mt -108.97 145.42 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.8 mp -107.83 112.0 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 171.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.2 144.3 38.33 Favored Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.581 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.2 118.11 5.16 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 N-CA-C 108.358 -1.439 . . . . 0.0 108.358 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -169.17 149.59 4.22 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 -176.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.46 110.34 4.69 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -121.64 26.71 8.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 170.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 47.88 1.67 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.83 142.7 30.96 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.951 -0.625 . . . . 0.0 110.689 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.51 132.01 42.4 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -142.47 37.72 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.779 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -92.79 -54.75 3.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.33 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -153.24 19.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.795 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -98.23 -46.05 5.97 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -162.43 98.06 1.01 Allowed 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.608 -175.421 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -146.56 -34.48 0.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.187 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.9 tpt -87.87 101.27 13.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.968 0.414 . . . . 0.0 110.849 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.44 141.94 57.54 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 114.39 2.17 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.202 1.935 . . . . 0.0 111.816 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 94.58 4.99 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp 72.72 -48.02 0.68 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.885 1.274 . . . . 0.0 110.916 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 m -53.59 135.6 40.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.215 1.406 . . . . 0.0 110.557 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -23.71 31.69 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.393 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -74.1 130.26 39.44 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 37.6 pttt -87.2 136.69 32.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 174.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.34 174.31 11.26 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.666 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 1.1 tmtm? -108.41 135.79 49.12 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.2 t -124.78 144.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.665 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 85.2 tttt -140.39 104.6 4.81 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.48 112.73 12.36 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 120.704 0.288 . . . . 0.0 111.195 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 176.81 171.11 40.1 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -107.14 123.26 48.0 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.2 -107.58 1.15 Allowed Glycine 0 C--N 1.319 -0.382 0 O-C-N 123.116 0.26 . . . . 0.0 113.152 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.7 -26.08 59.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.674 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.483 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 81.0 p -85.17 10.24 12.83 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.022 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.511 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 55.1 tt0 -82.93 99.86 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.811 0.339 . . . . 0.0 110.619 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HD3' ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -108.79 162.32 14.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.625 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.4 mt -108.11 144.31 16.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.738 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -140.01 163.85 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.658 0.783 . . . . 0.0 109.214 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.92 124.95 51.48 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 167.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.22 175.68 8.26 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.906 0.384 . . . . 0.0 111.395 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 21.0 m -135.69 134.11 38.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mm -65.76 125.8 23.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 O-C-N 123.858 0.724 . . . . 0.0 109.341 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -110.85 -31.4 7.18 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -167.25 167.22 14.33 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -144.84 139.71 27.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -145.77 156.88 43.88 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.63 0.581 . . . . 0.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.416 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.9 mp -108.72 129.34 63.43 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.45 104.37 8.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t70 55.17 64.34 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 125.52 1.528 . . . . 0.0 111.726 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 -25.59 5.17 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.848 -1.069 . . . . 0.0 115.193 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.9 145.77 34.84 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.985 0.892 . . . . 0.0 111.577 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.0 p -98.23 127.47 50.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 122.028 0.918 . . . . 0.0 110.681 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.74 155.72 28.41 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.926 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' CE2' ' HZ2' ' A' ' 63' ' ' TRP . 22.0 m-85 -118.11 145.8 44.61 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.925 -173.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.1 tp -107.52 105.82 15.91 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 m -119.71 151.55 22.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.612 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -118.82 140.41 50.0 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -79.0 153.03 30.6 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -120.96 161.18 22.04 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.937 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.79 -111.65 0.99 Allowed Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -98.54 -41.1 7.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -91.89 89.48 7.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.137 0.97 . . . . 0.0 108.937 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.4 t -90.36 -30.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.805 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -85.81 8.44 20.01 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.465 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -87.83 89.5 8.02 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.72 116.74 33.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.838 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -150.37 165.88 31.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.088 0.471 . . . . 0.0 111.223 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -97.74 126.29 43.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.36 0.6 . . . . 0.0 112.216 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 33.3 m -131.72 144.05 38.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -89.54 164.96 14.57 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 122.136 -0.352 . . . . 0.0 110.47 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.04 28.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.378 1.071 . . . . 0.0 111.886 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.448 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 12.7 t70 -68.4 -24.3 64.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.925 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.665 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 13.8 mmt180 -101.16 11.55 39.22 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.785 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -120.5 140.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.7 mp -107.85 114.82 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.445 ' H ' HD23 ' A' ' 69' ' ' LEU . 93.5 m95 -89.1 145.24 33.94 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.381 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.28 119.05 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.851 1.701 . . . . 0.0 110.743 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tt 177.0 87.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 103.197 -2.89 . . . . 0.0 103.197 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' CG ' ' H ' ' A' ' 67' ' ' LYS . 18.4 t70 55.95 -139.34 0.96 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -172.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.42 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 5.8 tmtt? -148.19 55.86 1.05 Allowed 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 168.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.99 1.03 56.34 Favored Glycine 0 N--CA 1.418 -2.518 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.457 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 63' ' ' TRP . 5.0 mp -88.36 109.0 19.64 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -145.66 121.51 10.6 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.589 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.448 ' CE1' ' HA ' ' A' ' 59' ' ' ASP . 23.9 m-70 -80.0 130.28 35.15 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -68.97 -17.62 63.96 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.904 0.752 . . . . 0.0 111.618 -170.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 67.1 t60 67.11 72.51 0.35 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.72 64.92 0.37 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.963 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -136.96 106.27 6.05 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.601 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -150.34 172.69 14.99 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ttt -158.81 142.51 15.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.55 119.54 63.66 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.12 86.27 0.64 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.414 2.076 . . . . 0.0 111.596 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.4 m -88.24 146.29 25.43 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.561 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.16 -21.62 33.5 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.204 0.526 . . . . 0.0 109.798 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -71.52 138.71 49.11 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.708 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.84 58.25 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.845 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 28' ' ' SER . 25.6 m -67.84 125.02 24.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.32 110.46 20.78 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.28 -179.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.441 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HZ3' ' CG ' ' A' ' 26' ' ' GLU . 0.7 OUTLIER -111.85 138.88 47.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.4 t -130.29 137.61 55.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 118.377 0.535 . . . . 0.0 110.542 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 53.0 mtmt -108.18 106.45 16.64 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -138.76 108.35 6.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.847 0.832 . . . . 0.0 112.197 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 176.94 170.78 39.82 Favored Glycine 0 C--N 1.287 -2.183 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 167.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 4.7 ppt_? -117.1 115.09 24.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.682 0.741 . . . . 0.0 111.177 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.6 -103.23 0.21 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.345 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -70.18 -27.56 64.61 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.862 0.865 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.7 m -88.63 0.91 55.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.937 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.536 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -70.43 116.2 10.49 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HE2' ' OH ' ' A' ' 25' ' ' TYR . 18.0 pttm -139.6 157.15 46.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.694 175.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.84 125.83 73.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' OH ' ' HE2' ' A' ' 23' ' ' LYS . 55.6 m-85 -111.45 165.54 11.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.313 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.529 ' CG ' ' HZ3' ' A' ' 13' ' ' LYS . 45.1 mt-10 -111.67 126.81 55.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.08 -178.47 6.07 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 120.882 0.372 . . . . 0.0 111.342 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 10' ' ' THR . 16.4 m -123.64 155.3 37.98 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.63 126.02 39.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.727 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -101.67 -46.35 4.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -159.98 171.18 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -151.17 145.52 25.48 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.09 165.11 37.24 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.277 0.36 . . . . 0.0 110.231 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -111.26 126.35 68.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.93 103.28 7.4 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t0 57.0 65.35 1.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.001 0.92 . . . . 0.0 111.585 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -26.62 5.01 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' OE2' HD23 ' A' ' 40' ' ' LEU . 11.1 pt-20 -108.47 144.4 36.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 117.843 0.822 . . . . 0.0 110.768 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.8 p -98.82 121.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-O 122.241 1.019 . . . . 0.0 110.108 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.407 HD23 ' OE2' ' A' ' 38' ' ' GLU . 83.5 mt -108.62 137.95 45.72 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.692 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 35.4 m-85 -108.56 145.22 35.16 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.843 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.8 tp -108.25 117.77 35.01 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 15.8 m -117.8 146.01 22.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.486 0.66 . . . . 0.0 109.505 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -117.89 116.69 27.46 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.692 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -70.42 129.62 39.76 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -74.1 -7.39 52.38 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -64.09 3.27 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -169.39 160.05 9.07 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.24 125.64 25.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.029 0.932 . . . . 0.0 109.922 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.482 HG22 ' H ' ' A' ' 51' ' ' ARG . 16.5 m -79.55 -65.85 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.482 ' H ' HG22 ' A' ' 50' ' ' VAL . 30.2 mmm180 -106.48 -55.94 2.26 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.24 -59.8 0.63 Allowed 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 166.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HB3' ' O ' ' A' ' 43' ' ' VAL . 49.7 m-20 -165.3 -174.53 3.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -126.73 154.01 44.74 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 120.022 1.283 . . . . 0.0 111.617 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.505 ' CE2' HD13 ' A' ' 42' ' ' LEU . 87.8 m95 -109.64 118.9 37.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.122 0.969 . . . . 0.0 111.869 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.44 157.34 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.577 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -90.85 165.14 13.77 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.7 -29.29 66.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.36 -1.76 57.34 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.6 tpt180 -100.89 4.7 42.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.418 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.59 147.07 13.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.14 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.9 mp -108.77 108.56 25.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -81.77 133.03 52.87 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.47 120.01 4.71 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.126 3.217 . . . . 0.0 114.423 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -170.51 69.39 0.05 Allowed 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 55.67 42.19 29.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 123.326 1.536 . . . . 0.0 110.413 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -134.46 103.17 5.59 Favored 'General case' 0 CA--C 1.461 -2.457 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.666 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.6 53.42 Favored Glycine 0 N--CA 1.415 -2.744 0 N-CA-C 105.783 -2.927 . . . . 0.0 105.783 163.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 tp 166.52 141.67 0.02 OUTLIER 'General case' 0 N--CA 1.391 -3.408 0 C-N-CA 130.005 3.322 . . . . 0.0 104.619 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 147.09 50.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.08 63.7 7.26 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.176 0.989 . . . . 0.0 108.37 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -91.92 -24.16 19.37 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.613 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -113.17 144.55 42.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 120.886 0.374 . . . . 0.0 110.261 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -137.54 28.12 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -147.31 123.31 10.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.526 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 C--N 1.281 -2.385 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 175.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 121.167 0.508 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -152.63 157.96 41.73 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.1 tpt -176.87 90.75 0.03 OUTLIER 'General case' 0 C--O 1.245 0.822 0 C-N-CA 124.159 0.984 . . . . 0.0 110.525 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.554 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . 64.0 mm-40 44.9 -155.85 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.924 0 O-C-N 124.963 1.414 . . . . 0.0 111.478 168.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 85.2 Cg_exo -64.81 168.36 13.68 Favored 'Trans proline' 0 C--N 1.361 1.204 0 CA-C-N 121.242 1.479 . . . . 0.0 111.076 165.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.409 ' C ' HD11 ' A' ' 7' ' ' LEU . 20.8 p -65.07 147.75 52.91 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.238 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.409 HD11 ' C ' ' A' ' 6' ' ' CYS 0.443 0.0 OUTLIER 51.68 14.03 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 179.692 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -80.68 154.61 27.22 Favored 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 121.912 -0.493 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.69 8.48 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.7 m -63.82 130.07 42.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.027 0.531 . . . . 0.0 110.115 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -98.84 115.16 28.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.02 -177.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.823 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.8 mmtm -107.3 135.82 48.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -127.26 137.23 58.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -107.87 121.94 45.77 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -132.93 115.54 15.34 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -179.29 170.35 41.91 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.612 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -139.76 112.07 7.68 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.638 1.175 . . . . 0.0 108.278 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.36 -134.42 22.78 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -21.27 44.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -76.64 74.37 3.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.156 0.979 . . . . 0.0 108.859 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.445 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 31.2 tt0 -145.8 142.98 29.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.047 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 161.12 38.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.38 120.49 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.92 166.86 10.51 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.495 1.118 . . . . 0.0 109.725 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.23 137.2 52.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.29 42.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 118.112 0.415 . . . . 0.0 111.983 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 p -104.49 141.75 35.82 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 40.0 mm -78.81 124.68 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -33.96 6.54 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 m -158.55 169.73 23.78 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.973 -0.455 . . . . 0.0 109.811 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -144.31 141.28 29.66 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -143.39 153.17 42.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.118 0.485 . . . . 0.0 110.812 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.42 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -109.07 123.87 65.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -125.6 104.14 8.23 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 50.79 65.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.877 1.271 . . . . 0.0 113.236 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -24.04 10.09 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.714 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.67 140.06 42.59 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 118.083 0.942 . . . . 0.0 112.396 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.84 117.19 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.2 mt -109.03 138.68 45.0 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 42.7 m-85 -107.74 147.24 31.06 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 HD22 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -107.2 105.16 15.01 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.91 154.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.544 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -128.63 125.8 38.87 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.39 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -66.14 109.52 2.64 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.465 1.103 . . . . 0.0 109.235 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -47.77 -67.95 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.415 1.486 . . . . 0.0 113.118 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.21 27.62 17.66 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.76 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -133.54 -55.61 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 117.333 0.566 . . . . 0.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.44 ' HB3' ' CB ' ' A' ' 52' ' ' TYR . 20.5 m120 -137.12 95.42 3.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.144 -174.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -79.06 -41.52 23.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.108 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -99.85 7.57 44.83 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.44 ' CB ' ' HB3' ' A' ' 49' ' ' ASN . 46.3 t80 -75.43 -62.59 1.52 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 61.48 108.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.44 155.18 44.09 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.591 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 82.8 m95 -99.5 123.43 43.77 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.595 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.21 147.37 28.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.248 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 61' ' ' ILE . 91.8 mttt -77.68 170.25 16.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.95 67.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.143 0.497 . . . . 0.0 110.398 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.2 -31.54 71.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 109.367 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -96.66 7.54 46.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.307 -173.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 57' ' ' LYS . 57.0 mt -120.71 151.16 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.445 HD13 ' HB3' ' A' ' 13' ' ' LYS . 5.0 mp -108.15 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -90.9 130.02 42.12 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.838 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 19.4 Cg_exo -67.92 116.73 4.45 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 120.817 1.012 . . . . 0.0 111.335 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 5.5 tt 161.42 97.14 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 62.07 -162.38 0.28 Allowed 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -139.21 1.91 2.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.621 -0.675 . . . . 0.0 110.184 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.33 -18.54 68.74 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.071 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mp 62.87 106.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.625 1.17 . . . . 0.0 113.008 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -85.36 106.49 16.78 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -74.1 96.69 2.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.455 ' HA ' ' OE1' ' A' ' 70' ' ' GLU 0.251 16.3 t60 -60.15 -44.18 95.16 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -164.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -81.41 83.35 6.96 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 118.567 -1.253 . . . . 0.0 107.731 168.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -95.42 -52.3 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.217 -168.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.11 7.84 2.92 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 . . . . . 0 C--N 1.306 -1.323 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.622 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 120.929 0.395 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.56 -65.27 0.99 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.2 ttm 170.52 102.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.94 1.696 . . . . 0.0 108.631 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.31 116.43 61.64 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.71 23.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.177 3.918 . . . . 0.0 117.019 -174.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.8 m -91.19 79.1 5.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.7 mt 71.31 -5.43 1.58 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.8 p -66.75 135.22 53.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.2 0.524 . . . . 0.0 111.702 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.66 -12.74 68.56 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.186 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -70.38 125.38 26.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -83.22 122.63 28.66 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.08 177.22 4.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.508 0.67 . . . . 0.0 111.268 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.04 136.5 52.85 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 56' ' ' VAL . 79.1 t -127.59 131.18 70.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 118.321 0.51 . . . . 0.0 111.0 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.682 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 10.8 tmtt? -119.33 118.73 31.99 Favored 'General case' 0 C--O 1.197 -1.671 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.576 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' HD1' ' N ' ' A' ' 16' ' ' TYR 0.319 0.0 OUTLIER -160.37 154.45 23.11 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-N 118.416 0.553 . . . . 0.0 111.192 170.987 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' A' ' 22' ' ' GLN . . . -168.19 139.46 5.69 Favored Glycine 1 N--CA 1.393 -4.211 0 C-N-CA 118.468 -1.825 . . . . 0.0 113.985 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -146.3 105.5 3.9 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.99 6.18 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -86.84 -7.82 57.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.083 0.468 . . . . 0.0 110.387 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -82.91 -1.01 51.04 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 121.228 0.537 . . . . 0.0 110.289 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.404 ' HA ' ' CA ' ' A' ' 17' ' ' GLY . 25.4 tp60 -73.72 108.3 6.47 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.682 0.753 . . . . 0.0 112.727 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.02 165.97 21.94 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.013 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.462 HG12 ' HG2' ' A' ' 15' ' ' LYS . 54.2 mt -111.69 124.94 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CE1' ' HE1' ' A' ' 16' ' ' TYR . 65.8 m-85 -107.78 166.14 10.92 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.616 -174.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.5 123.25 45.85 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 45' ' ' TYR . . . -130.22 -178.57 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.141 0.496 . . . . 0.0 111.69 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 m -135.22 135.16 40.75 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 171.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mm -65.5 124.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -103.74 -46.6 4.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -153.02 160.22 42.97 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -133.92 141.29 47.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -145.88 161.09 40.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.646 0.591 . . . . 0.0 110.743 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.406 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -108.83 124.7 65.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -130.69 114.08 14.95 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.679 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.74 25.53 12.99 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.62 -17.72 52.38 Favored Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.928 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -108.65 152.65 24.51 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.48 122.79 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-O 122.072 0.939 . . . . 0.0 110.749 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -109.66 142.15 41.22 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.692 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -108.82 142.66 39.06 Favored 'General case' 0 C--N 1.26 -3.322 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.697 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.57 110.97 23.01 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 m -117.53 150.89 19.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -172.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.448 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -125.4 138.12 54.03 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.073 175.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 31.5 m-85 -82.39 123.13 28.83 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.295 17.5 p90 -57.45 157.37 6.81 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -37.17 89.76 0.01 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 126.298 1.904 . . . . 0.0 116.331 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 174.02 -46.97 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.635 ' OD1' ' HB3' ' A' ' 51' ' ' ARG . 27.6 t-20 -91.22 111.18 22.55 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.432 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.75 -21.54 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.505 0.669 . . . . 0.0 110.327 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.635 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -56.28 -37.56 70.01 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 44' ' ' HIS . 3.8 t80 54.36 -94.49 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.004 2.522 . . . . 0.0 117.547 164.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -89.88 138.1 31.78 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.25 0.477 . . . . 0.0 112.015 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' HG2' ' HH ' ' A' ' 16' ' ' TYR . 9.2 tp10 -159.24 157.8 31.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.146 0.498 . . . . 0.0 110.212 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -100.17 125.96 46.38 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.49 1.116 . . . . 0.0 111.48 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.426 HG13 ' CG1' ' A' ' 14' ' ' VAL . 17.6 m -138.35 152.19 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.556 ' HE2' ' OD2' ' A' ' 59' ' ' ASP . 88.9 tttt -89.51 157.91 17.9 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.46 -31.41 45.45 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.423 1.089 . . . . 0.0 112.512 -176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.556 ' OD2' ' HE2' ' A' ' 57' ' ' LYS . 16.1 m-20 -72.92 -13.37 61.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.906 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.682 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 30.7 mtt180 -106.97 8.23 30.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.563 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.1 mt -108.79 140.27 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 13' ' ' LYS . 4.3 mp -106.78 105.27 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -82.9 124.56 76.75 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.155 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -64.35 117.62 4.65 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 179.05 79.5 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.0 t70 73.75 -33.46 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 76.33 143.17 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.008 1.723 . . . . 0.0 110.497 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.34 -38.48 3.31 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.733 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 mp 66.55 8.66 5.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.722 1.209 . . . . 0.0 111.717 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.34 113.61 2.36 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -146.64 74.59 1.36 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.625 0.77 . . . . 0.0 109.28 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -66.28 -16.1 63.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.962 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -84.76 -12.5 53.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -140.1 104.2 4.78 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.156 0.503 . . . . 0.0 109.784 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -64.74 139.18 58.74 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.333 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.3 m80 . . . . . 0 C--N 1.304 -1.393 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.353 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.493 -1.219 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.54 87.3 2.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.2 ttp -132.73 111.75 11.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.0 94.53 36.52 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -41.55 -73.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.251 3.301 . . . . 0.0 114.944 -178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 t -174.68 118.89 0.21 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 59.87 20.42 9.35 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.309 1.044 . . . . 0.0 112.87 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 p -67.14 144.37 56.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.71 -35.59 4.33 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.215 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 m -62.58 128.5 36.26 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.043 0.537 . . . . 0.0 110.799 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -96.01 129.6 43.23 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.3 173.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.811 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.874 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 33.3 ttpt -119.5 138.92 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.6 t -119.21 134.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 -174.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -109.31 103.98 13.03 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 3.3 t80 -106.79 109.96 22.01 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.76 116.64 2.81 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 94.2 mtt180 -140.68 168.52 19.6 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.14 -54.4 7.12 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 123.791 0.682 . . . . 0.0 113.719 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -94.74 -45.84 7.17 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.153 0.501 . . . . 0.0 109.872 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.473 ' HB ' ' HB2' ' A' ' 18' ' ' ARG . 8.6 m -77.1 63.49 2.38 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.631 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 21.1 tp60 -125.46 105.34 8.99 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.798 0.809 . . . . 0.0 110.07 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.76 138.47 17.0 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.681 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.08 129.44 62.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.95 164.02 33.34 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 123.503 0.721 . . . . 0.0 111.157 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 38.7 mt-10 -108.33 136.5 47.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.536 ' HB3' ' CD1' ' A' ' 45' ' ' TYR . . . -139.56 158.59 43.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -103.82 139.05 39.56 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.01 125.06 37.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HG3' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -102.75 -39.3 7.08 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -160.87 167.84 25.87 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -143.31 151.12 40.13 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.65 165.05 37.15 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.6 mp -108.83 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.51 134.02 39.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t70 67.0 24.17 9.6 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.401 1.095 . . . . 0.0 109.67 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.87 -9.18 77.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.208 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.18 164.96 13.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 117.387 0.594 . . . . 0.0 111.229 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.4 t -97.62 117.47 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.511 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.23 134.39 53.8 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.064 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 27.3 m-85 -108.34 146.33 33.13 Favored 'General case' 0 C--N 1.271 -2.813 0 C-N-CA 123.84 0.856 . . . . 0.0 109.057 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -107.63 107.68 18.6 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 m -121.1 148.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.156 -172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 17.6 t-160 -118.71 126.13 51.2 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 27' ' ' ALA . 51.7 m-85 -65.33 100.78 0.5 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 61.16 88.04 0.09 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.787 -171.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 44' ' ' HIS . . . 130.83 -179.41 16.98 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.254 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.35 172.05 8.02 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.46 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 28.0 t-20 -59.71 106.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.463 0.705 . . . . 0.0 112.755 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -91.29 -62.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.875 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -105.69 -57.8 1.99 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -153.99 -46.34 0.09 Allowed 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.406 ' OD2' ' HA ' ' A' ' 49' ' ' ASN 0.267 36.7 m-20 66.2 -170.21 0.2 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.059 178.377 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -125.76 146.21 49.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.737 -169.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.53 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.2 m95 -101.44 124.32 46.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.217 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 32.0 m -123.78 144.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -80.43 159.07 25.76 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.19 -33.48 69.3 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.459 0.647 . . . . 0.0 111.294 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -60.96 -25.71 67.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.621 1.168 . . . . 0.0 111.188 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.07 -5.44 57.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.033 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -107.84 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.835 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.39 109.9 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.8 124.07 53.7 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.75 117.53 5.19 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.756 -1.286 . . . . 0.0 108.756 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt 173.33 93.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.63 34.44 21.44 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.481 0.713 . . . . 0.0 112.764 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -77.62 -60.94 2.16 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.81 -74.47 1.57 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.272 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' N ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.28 121.47 44.98 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.65 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.81 -59.76 2.21 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.84 0.829 . . . . 0.0 110.487 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.06 74.88 2.0 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.439 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -96.3 -28.29 14.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.563 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -80.71 110.17 15.95 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.798 0.809 . . . . 0.0 111.58 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -105.18 4.61 31.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.702 0.763 . . . . 0.0 109.331 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -77.4 101.51 6.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.034 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.237 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 120.41 0.148 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.09 -60.64 2.26 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.4 ttt 164.7 132.16 0.01 OUTLIER 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.863 1.665 . . . . 0.0 109.104 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -114.89 160.29 34.16 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.8 2.333 . . . . 0.0 113.322 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' ' 8' ' ' THR . 19.5 t -145.22 134.49 22.92 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.9 mm? 71.39 -12.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.539 1.136 . . . . 0.0 111.189 -173.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 9.3 p -63.63 131.29 47.52 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.283 1.033 . . . . 0.0 112.05 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.46 -11.3 72.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.205 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 28' ' ' SER . 26.9 m -71.68 121.41 18.8 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 107.18 19.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -113.62 178.81 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.16 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -108.98 141.6 40.84 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.604 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.7 t -127.44 130.32 70.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.722 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 86.4 tttt -122.54 104.98 9.72 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -143.16 104.74 4.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.53 171.97 43.14 Favored Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.175 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 108.24 15.12 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 122.594 0.358 . . . . 0.0 111.417 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.85 -112.87 5.03 Favored Glycine 0 CA--C 1.513 -0.081 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.956 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -77.2 -30.77 54.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.623 0.725 . . . . 0.0 109.917 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -85.83 59.35 5.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 123.052 1.406 . . . . 0.0 107.547 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.48 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.8 tp60 -100.08 128.02 46.22 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.079 -1.873 . . . . 0.0 108.97 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -117.14 112.04 20.31 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.936 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -108.8 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.05 165.78 18.84 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.609 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -108.24 134.01 51.67 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.601 ' HB1' ' CD1' ' A' ' 45' ' ' TYR . . . -137.0 174.13 10.95 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.831 0.348 . . . . 0.0 111.603 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 10' ' ' THR . 45.1 m -123.77 137.5 54.67 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 mm -69.17 123.67 23.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -106.86 -40.96 5.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.928 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -152.77 166.04 33.47 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -151.07 144.35 24.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.47 166.27 33.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.958 0.409 . . . . 0.0 110.862 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.425 HG13 HG23 ' A' ' 39' ' ' VAL . 1.4 mp -108.36 120.15 59.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -132.57 125.28 30.14 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.451 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.43 23.34 13.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.319 1.057 . . . . 0.0 110.229 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.36 8.34 68.44 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.603 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.12 156.74 37.85 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 117.686 0.743 . . . . 0.0 109.768 177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 HG23 HG13 ' A' ' 34' ' ' ILE . 11.8 t -98.78 119.31 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 CA-C-O 121.524 0.678 . . . . 0.0 110.133 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -108.77 137.25 47.0 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.745 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.468 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 26.3 m-85 -111.64 142.51 43.87 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.393 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD12 ' CE2' ' A' ' 55' ' ' TRP . 58.4 tp -108.0 111.84 24.12 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.24 142.94 42.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.569 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -120.3 142.24 49.27 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.601 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 54.3 m-85 -89.42 150.61 22.43 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 124.481 1.113 . . . . 0.0 111.113 -171.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -108.39 133.93 51.9 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.698 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.03 -123.26 1.3 Allowed Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -92.57 -46.5 7.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 117.315 0.557 . . . . 0.0 110.897 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -95.19 92.15 6.64 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.37 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.19 -10.05 10.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.617 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -6.29 59.33 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.042 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -82.64 82.37 8.04 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.39 112.3 24.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -130.87 159.04 38.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.201 0.524 . . . . 0.0 111.936 -167.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.468 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 81.0 m95 -103.36 117.66 34.99 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.891 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.6 m -122.05 165.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -103.31 164.98 11.3 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.92 74.57 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.566 0.746 . . . . 0.0 113.009 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -74.08 -6.52 48.07 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.722 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 16.8 mmt-85 -104.69 11.68 33.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.327 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.62 138.64 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.278 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.9 mp -108.33 114.44 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -83.72 115.55 60.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.08 118.64 5.53 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.031 1.821 . . . . 0.0 111.027 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -160.6 98.68 1.25 Allowed 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.37 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.856 1.262 . . . . 0.0 113.278 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 84.6 mttt 70.8 98.2 0.07 Allowed 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.98 -19.66 28.17 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.79 -13.89 60.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.673 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -145.19 -150.55 0.33 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -137.1 148.85 46.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 120.27 1.395 . . . . 0.0 109.823 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -54.28 -54.89 33.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.65 0.738 . . . . 0.0 110.149 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -153.86 -163.49 1.65 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -65.92 -39.47 90.58 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -123.02 -76.86 0.59 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.096 0.474 . . . . 0.0 109.772 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 . . . . . 0 C--N 1.301 -1.516 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.571 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.33 73.39 1.37 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.039 -167.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt 56.9 76.04 0.33 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.279 1.032 . . . . 0.0 110.569 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.43 80.2 23.14 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.55 91.45 0.59 Allowed 'Trans proline' 0 C--O 1.248 1.003 0 C-N-CA 123.087 2.524 . . . . 0.0 111.377 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.1 m 62.56 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 113.433 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.22 -68.15 0.81 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.571 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -60.15 132.13 52.97 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.151 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 -32.19 6.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.567 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 m -63.87 132.7 51.6 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.082 0.553 . . . . 0.0 110.035 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -93.11 131.23 38.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.3 m -129.74 -179.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.486 -172.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 28.4 mmmt -114.03 135.36 54.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.4 t -116.11 133.14 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -107.9 114.18 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.114 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.567 ' CE2' HG11 ' A' ' 56' ' ' VAL . 1.5 m-85 -142.91 128.35 18.96 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.015 0.436 . . . . 0.0 110.616 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.38 170.16 40.12 Favored Glycine 0 N--CA 1.399 -3.77 0 C-N-CA 119.384 -1.389 . . . . 0.0 113.185 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -131.11 108.85 10.04 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.58 -121.45 12.74 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.553 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -88.45 -10.9 47.59 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.333 0.587 . . . . 0.0 110.253 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -79.96 8.19 7.47 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.422 1.106 . . . . 0.0 109.667 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.494 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 50.8 tt0 -86.76 143.18 27.65 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.264 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.24 155.53 42.74 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.438 HG23 ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -112.63 133.61 57.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 8.7 m-85 -107.5 166.77 10.42 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -172.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -106.75 116.46 31.96 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.86 167.75 19.65 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.741 -0.599 . . . . 0.0 111.497 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.7 mm -78.78 128.35 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 123.642 0.589 . . . . 0.0 111.145 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.346 1.058 . . . . 0.0 111.895 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 t -154.39 167.86 28.57 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -132.83 139.7 47.61 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.56 156.38 45.1 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 123.575 0.547 . . . . 0.0 110.097 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -108.77 119.92 59.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.22 131.7 32.8 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 65.64 22.03 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.397 1.094 . . . . 0.0 109.855 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.96 87.7 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.383 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -116.51 159.37 22.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 122.495 -0.415 . . . . 0.0 111.765 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.86 116.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.43 0.633 . . . . 0.0 111.093 -172.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -112.73 139.94 47.93 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.486 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.5 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 31.2 m-85 -108.15 157.25 18.46 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.93 115.02 29.46 Favored 'General case' 0 CA--C 1.465 -2.311 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.8 m -129.17 142.59 43.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -117.84 125.47 50.6 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.619 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.534 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 24.6 m-85 -72.04 109.82 6.11 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.275 50.6 p90 -77.67 1.0 21.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -169.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.47 87.83 1.57 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 77.96 -27.27 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.878 1.271 . . . . 0.0 113.63 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.534 ' HB2' ' O ' ' A' ' 45' ' ' TYR . 4.8 m-20 -81.42 99.94 9.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.538 0.685 . . . . 0.0 112.209 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.05 -47.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -100.88 1.31 39.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.532 0.682 . . . . 0.0 110.403 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.508 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 89.9 m-85 -86.88 75.83 9.52 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.551 1.167 . . . . 0.0 108.976 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.85 103.19 13.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -118.45 165.12 14.29 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.419 -163.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.1 m95 -98.83 126.84 44.59 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.462 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG11 ' CE2' ' A' ' 16' ' ' TYR . 34.3 m -135.94 165.22 30.17 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.831 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.69 166.47 10.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.36 74.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.654 . . . . 0.0 111.239 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.11 -15.64 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.735 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 60' ' ' ARG . 14.6 tpt180 -95.95 0.61 52.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.825 0.821 . . . . 0.0 109.61 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.99 150.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.268 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.0 mp -107.64 104.57 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 92.4 m95 -75.81 150.83 84.2 Favored Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -77.41 -178.5 4.64 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.612 2.208 . . . . 0.0 111.201 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 67' ' ' LYS 0.281 0.6 OUTLIER 51.98 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.09 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 77.71 -36.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.768 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 63' ' ' TRP . 4.3 tmtm? -73.07 99.24 2.72 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 69' ' ' LEU . . . -138.0 34.99 2.08 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 68' ' ' GLY . 3.8 mm? 74.8 104.61 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.311 1.444 . . . . 0.0 112.03 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -53.26 101.34 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.936 -1.484 . . . . 0.0 113.561 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -145.28 147.82 32.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -76.52 -23.9 53.7 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.469 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -83.32 5.12 24.42 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 122.543 1.163 . . . . 0.0 108.987 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -111.83 79.97 1.27 Allowed 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -111.19 111.8 23.14 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.003 0.906 . . . . 0.0 111.983 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--N 1.277 -2.556 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.443 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.01 142.95 51.3 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 ptp -136.94 135.85 38.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -86.08 141.75 35.54 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.52 -56.87 2.3 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.507 2.138 . . . . 0.0 111.08 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.0 p -150.45 47.51 0.89 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp 75.33 7.32 4.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.261 -1.79 . . . . 0.0 110.753 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -63.42 139.02 58.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 126.132 1.773 . . . . 0.0 112.801 -176.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.54 -22.22 40.73 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.794 174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -66.09 118.65 10.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -91.0 115.07 27.72 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.54 178.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 34.4 tttp -120.92 139.11 53.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.71 139.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.557 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 40.8 ttmt -125.01 104.09 8.37 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.83 118.39 13.91 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.157 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.76 170.66 41.74 Favored Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.627 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -119.27 107.14 13.05 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.932 0.872 . . . . 0.0 109.966 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.67 -111.73 3.32 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 22' ' ' GLN . 62.7 tttp -94.07 -10.79 32.24 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.246 0.546 . . . . 0.0 110.6 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.6 p -82.27 31.74 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.454 0.645 . . . . 0.0 110.242 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.53 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 38.5 tt0 -82.76 102.45 11.57 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.93 128.42 49.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.613 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.447 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -108.17 115.17 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.23 162.48 32.03 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.449 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HG2' ' HG3' ' A' ' 13' ' ' LYS . 54.6 mt-10 -113.85 136.8 52.48 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.089 0.471 . . . . 0.0 112.071 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 45' ' ' TYR . . . -141.25 -178.04 5.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.289 -171.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -134.95 133.37 39.48 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.461 HD13 HG23 ' A' ' 43' ' ' VAL . 46.5 mm -67.78 131.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.797 0.686 . . . . 0.0 110.98 -176.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.8 -60.92 1.45 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.7 m -147.98 164.82 32.59 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -134.29 151.98 51.56 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.12 165.57 35.22 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 123.167 0.292 . . . . 0.0 110.237 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -111.14 131.39 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.95 115.87 13.18 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 63.79 23.44 13.44 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.262 1.425 . . . . 0.0 111.623 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.79 -10.55 55.87 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.419 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.17 147.1 31.79 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.722 0.761 . . . . 0.0 109.565 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 t -98.6 118.04 44.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.96 130.06 55.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.605 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.617 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 37.4 m-85 -108.16 147.91 30.63 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.897 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.8 tp -107.55 113.07 26.14 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.461 HG23 HD13 ' A' ' 29' ' ' ILE . 2.4 p -118.42 147.03 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.443 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.15 125.92 51.19 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.629 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 90.2 m-85 -83.09 104.69 13.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.582 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.38 87.2 3.15 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.69 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.58 -120.45 0.97 Allowed Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -90.95 -39.97 11.95 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.168 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -122.67 112.72 18.3 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.62 -23.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.339 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -72.43 10.88 0.7 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -59.84 -38.99 83.64 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.772 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 45.51 81.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 125.112 1.507 . . . . 0.0 110.442 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.62 142.86 49.03 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.406 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 74.9 m95 -102.41 106.47 17.22 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.37 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.0 p -122.88 148.04 26.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.151 -174.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 61' ' ' ILE . 26.3 mtmm -73.15 158.28 35.59 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.2 -39.88 91.88 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.115 0.966 . . . . 0.0 113.066 -176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -86.05 -2.48 58.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -96.69 5.61 50.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.206 1.003 . . . . 0.0 109.016 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 57' ' ' LYS . 70.0 mt -120.48 153.32 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.084 -1.416 . . . . 0.0 107.336 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.1 mp -107.39 109.51 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -87.89 120.05 70.69 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.075 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.22 117.86 5.35 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.334 1.356 . . . . 0.0 109.558 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 177.89 84.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 t70 73.52 -75.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.097 0.873 . . . . 0.0 110.197 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.3 tptt 58.13 114.27 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.11 2.164 . . . . 0.0 112.761 178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.47 77.97 1.65 Allowed Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.81 -174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 71' ' ' HIS . 3.0 mm? -88.1 120.88 29.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 71.12 -33.87 0.28 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.823 1.649 . . . . 0.0 112.054 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 69' ' ' LEU . 66.2 m-70 -112.56 80.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -100.7 -42.5 6.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.79 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -68.4 -48.41 64.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.494 0.664 . . . . 0.0 109.285 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -114.8 90.82 3.43 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 71' ' ' HIS . 3.6 p80 -108.47 84.75 1.99 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.019 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -179.734 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.228 0.537 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -148.64 87.85 1.59 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.627 0.727 . . . . 0.0 109.885 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ttt -169.61 83.51 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.26 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -96.25 138.14 21.59 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -72.5 88.99 0.84 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.605 1.536 . . . . 0.0 108.272 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -85.28 -167.24 1.76 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.721 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.0 pt? -57.9 -33.84 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -60.77 118.79 7.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.422 1.089 . . . . 0.0 110.588 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.96 -11.3 48.9 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.334 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -78.28 128.22 33.39 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.24 121.67 34.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.812 0.815 . . . . 0.0 109.898 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.44 179.46 2.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.142 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 53.0 mtmt -108.83 143.84 37.5 Favored 'General case' 0 CA--C 1.475 -1.905 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.36 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 92.7 t -121.44 128.94 75.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.048 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.7 ttmt -107.64 104.1 13.55 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -138.84 111.35 7.57 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.878 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.33 170.31 40.98 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -107.43 105.25 15.08 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.493 0.663 . . . . 0.0 110.849 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.19 -107.03 1.61 Allowed Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.258 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 22' ' ' GLN . 60.4 tttm -74.05 -29.35 61.86 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.554 . . . . 0.0 110.408 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.2 m -81.81 30.12 0.38 Allowed 'General case' 0 CA--C 1.573 1.86 0 CA-C-O 122.647 1.213 . . . . 0.0 110.187 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.45 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.6 tp60 -76.4 114.17 14.8 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.336 1.454 . . . . 0.0 109.972 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 61.5 mt -108.69 112.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.55 166.93 10.73 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -107.11 119.79 40.32 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -126.21 177.61 6.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -129.19 128.04 42.54 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 122.203 -0.311 . . . . 0.0 110.203 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.444 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 33.4 mm -65.62 130.17 30.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 O-C-N 124.1 0.875 . . . . 0.0 109.786 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -117.63 -42.82 2.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -158.3 170.18 22.83 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.908 -0.495 . . . . 0.0 109.963 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.409 HG22 ' CD2' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -137.12 140.58 41.99 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -145.47 155.44 43.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.747 0.419 . . . . 0.0 110.253 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.7 124.86 65.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -125.92 104.32 8.24 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.05 64.46 1.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 112.97 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -26.57 5.71 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.692 -1.14 . . . . 0.0 115.525 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.14 149.45 28.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.311 1.056 . . . . 0.0 111.215 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.45 125.59 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.448 -174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.1 mt -112.3 138.56 48.83 Favored 'General case' 0 N--CA 1.405 -2.722 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.372 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 30.9 m-85 -108.0 149.14 28.76 Favored 'General case' 0 C--N 1.258 -3.411 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' CE2' ' A' ' 55' ' ' TRP . 39.8 tp -107.29 104.26 13.83 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.414 HG12 HG21 ' A' ' 14' ' ' VAL . 3.8 p -118.77 138.36 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -173.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.69 143.76 47.57 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.972 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -89.34 101.42 14.09 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -58.8 139.71 55.99 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.562 0.539 . . . . 0.0 112.054 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -51.18 2.31 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.946 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -93.47 -59.24 2.06 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.104 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 88.1 m-20 -110.07 92.87 4.22 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.044 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.91 -57.03 11.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.41 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.498 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 24.3 ttt180 -109.73 4.07 21.51 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.027 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 98.4 m-85 -80.95 67.72 6.96 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.586 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.09 144.75 50.2 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.714 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -140.08 157.81 45.05 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.491 ' CE2' HD12 ' A' ' 42' ' ' LEU . 75.6 m95 -98.47 122.88 42.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.37 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 HG12 HG13 ' A' ' 14' ' ' VAL . 18.1 m -130.44 152.48 37.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -79.82 153.03 29.4 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.05 -2.51 37.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 13.5 mtp180 -106.09 10.19 32.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.011 0.434 . . . . 0.0 110.498 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.5 mt -108.81 139.24 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.373 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.1 mp -108.05 107.61 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -84.88 130.41 52.75 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.63 120.07 7.63 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.902 2.402 . . . . 0.0 112.589 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 tt -145.37 91.72 2.16 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.54 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 33.8 t70 67.91 3.91 3.76 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.295 1.438 . . . . 0.0 113.315 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.448 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 1.0 OUTLIER -145.81 33.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.13 7.49 9.23 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.343 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 66.01 131.9 0.02 OUTLIER 'General case' 0 C--O 1.245 0.857 0 C-N-CA 125.266 1.426 . . . . 0.0 113.793 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.02 158.95 24.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.75 95.52 7.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.079 0.466 . . . . 0.0 111.046 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -76.66 -28.11 55.86 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -65.93 132.31 48.33 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.292 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -47.79 122.6 5.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.473 1.109 . . . . 0.0 109.749 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -149.06 -179.2 6.84 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 174.619 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.243 0.716 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.55 23.28 11.79 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.198 0.999 . . . . 0.0 112.642 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -156.05 167.63 29.81 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.66 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.55 150.82 38.01 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.29 101.56 0.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.959 1.773 . . . . 0.0 110.073 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 m -87.63 158.39 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.212 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.601 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.0 mm? -107.84 14.67 25.21 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 109.046 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -61.55 117.09 5.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.56 0.14 82.35 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.812 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -78.22 131.78 37.28 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HZ3' ' HB3' ' A' ' 11' ' ' LYS . 1.5 mmmp? -86.22 129.98 34.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.36 175.84 9.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.2 ttpt -120.51 146.64 46.08 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.3 t -129.62 132.57 66.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.56 103.14 9.16 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -149.27 125.29 10.65 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.22 170.06 39.87 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.636 171.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -93.37 111.54 23.23 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-O 121.009 0.433 . . . . 0.0 110.36 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.12 -102.35 0.65 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.422 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -93.82 -19.84 20.63 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.469 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.7 m -79.0 34.46 0.23 Allowed 'General case' 0 CA--C 1.574 1.899 0 CA-C-O 122.111 0.958 . . . . 0.0 110.121 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.54 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 30.1 tt0 -103.56 127.99 50.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 123.406 0.682 . . . . 0.0 111.081 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -120.14 148.6 43.43 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.802 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -107.98 124.09 63.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.5 165.63 31.59 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 124.228 1.011 . . . . 0.0 109.983 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -108.01 136.88 46.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB3' ' CE2' ' A' ' 45' ' ' TYR . . . -131.16 -178.27 4.76 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.828 -173.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.2 m -138.62 139.38 38.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.601 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 34.3 mm -77.88 135.31 26.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.948 0.404 . . . . 0.0 111.586 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -103.42 -58.71 1.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -148.68 -178.64 6.45 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.687 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.09 145.24 41.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.42 154.02 50.91 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.404 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -116.62 119.32 61.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -135.09 119.73 18.2 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.48 23.0 12.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 110.648 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.52 -8.9 66.65 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.491 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -109.47 143.85 38.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 117.762 0.781 . . . . 0.0 110.565 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.54 123.21 50.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 122.395 1.093 . . . . 0.0 110.666 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.89 145.38 35.46 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.022 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 34.6 m-85 -113.22 151.84 30.49 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.783 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.466 HD11 ' CE2' ' A' ' 55' ' ' TRP . 40.8 tp -107.72 116.5 32.07 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.9 m -118.95 140.99 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.612 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -130.25 138.47 50.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.092 0.472 . . . . 0.0 111.121 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.516 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 20.4 m-85 -95.96 133.21 40.43 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.809 -171.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.62 87.6 3.03 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.28 -65.96 0.27 Allowed Glycine 0 C--N 1.295 -1.705 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -141.36 -57.79 0.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.7 109.02 20.43 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.244 0.545 . . . . 0.0 109.806 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -79.7 -9.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -71.34 -3.13 19.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.398 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.09 81.12 5.38 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -110.03 95.71 5.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.24 151.58 38.14 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.918 -166.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.466 ' CE2' HD11 ' A' ' 42' ' ' LEU . 74.6 m95 -104.37 129.08 52.29 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.93 140.23 39.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' O ' HG13 ' A' ' 61' ' ' ILE . 33.0 ttpt -71.68 150.66 44.35 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 120.756 0.312 . . . . 0.0 111.505 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.67 64.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.685 1.594 . . . . 0.0 113.73 -170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.35 -7.71 54.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.689 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.403 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -106.87 8.37 30.65 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.382 1.087 . . . . 0.0 108.707 -175.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 57' ' ' LYS . 68.1 mt -108.61 157.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.5 mp -107.07 108.6 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -97.95 146.24 31.15 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.18 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -179.24 91.51 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.79 19.34 10.5 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.759 1.224 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -103.49 -32.38 9.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -169.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.31 2.69 17.76 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.335 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.74 -23.63 19.7 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.79 129.64 40.51 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -87.89 153.51 21.26 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.536 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -68.47 -33.98 75.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -90.45 106.96 18.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.13 138.98 43.23 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 124.027 0.829 . . . . 0.0 112.284 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -71.19 135.5 47.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.644 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.514 -0.438 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 76.65 -64.98 0.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.185 1.394 . . . . 0.0 109.25 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptm -75.16 150.6 38.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.12 119.6 72.86 Favored Pre-proline 0 C--N 1.303 -1.421 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.64 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.52 80.55 1.09 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.517 2.145 . . . . 0.0 110.35 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -87.17 -68.53 0.74 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.841 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.0 mp 65.81 -52.34 0.39 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 112.537 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.5 m -55.95 118.54 4.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 123.681 0.792 . . . . 0.0 110.311 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.06 -20.34 21.8 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.861 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.3 m -74.68 128.67 36.11 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 1.2 pptp? -87.9 127.4 35.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.419 0.628 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.06 176.68 6.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.94 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 1.3 mmtm -110.92 135.47 51.4 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.8 t -124.38 131.72 72.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.12 114.35 28.18 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -132.94 114.45 14.04 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.822 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -160.18 160.38 31.62 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.742 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -146.6 127.29 14.28 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.95 -123.71 10.98 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.737 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.9 -36.21 21.64 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -85.05 103.92 14.5 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.712 1.244 . . . . 0.0 111.041 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.461 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 35.2 tt0 -131.7 115.9 16.62 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.398 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -123.66 143.86 49.99 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.546 0.689 . . . . 0.0 111.421 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.59 129.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.88 165.66 13.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.194 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -115.11 136.68 52.85 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 45' ' ' TYR . . . -136.94 -178.71 5.31 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 m -142.67 130.07 21.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.0 mm -57.94 127.0 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 124.071 0.857 . . . . 0.0 111.152 -175.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.38 -46.03 5.38 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -154.43 153.79 32.14 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.42 HG21 ' CD2' ' A' ' 41' ' ' TYR . 3.2 m -126.64 133.6 50.95 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 170.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -142.09 158.86 43.26 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 123.699 0.625 . . . . 0.0 110.378 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.426 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -108.46 129.94 61.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.581 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.15 103.92 8.86 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.519 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 46.69 63.82 1.76 Allowed 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 125.601 1.56 . . . . 0.0 113.057 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 -24.46 11.51 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.12 -0.945 . . . . 0.0 115.275 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.81 149.13 29.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.466 1.133 . . . . 0.0 110.49 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.8 t -98.52 119.55 46.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.69 143.07 38.28 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.42 ' CD2' HG21 ' A' ' 32' ' ' THR . 46.7 m-85 -108.45 139.84 42.61 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.57 HD13 ' CE2' ' A' ' 55' ' ' TRP . 59.8 tp -107.61 106.59 17.02 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 4.1 p -125.82 141.91 44.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.605 -171.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -118.99 146.47 44.99 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.31 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 33.5 m-85 -77.89 105.85 9.36 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 123.967 0.792 . . . . 0.0 110.575 -172.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 48' ' ' TRP . 46.8 p90 -61.39 130.73 47.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -176.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.01 -40.1 1.42 Allowed Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.257 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' H ' ' C ' ' A' ' 46' ' ' TYR . 1.2 t-105 -73.82 -63.78 1.14 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.998 0.919 . . . . 0.0 109.618 -177.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -145.27 99.25 3.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.01 -25.87 10.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.0 3.95 36.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.833 0.825 . . . . 0.0 110.781 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -103.59 97.13 7.21 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.41 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 8.7 m-20 -95.06 131.0 41.52 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.059 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -120.84 154.31 35.95 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.177 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.57 ' CE2' HD13 ' A' ' 42' ' ' LEU . 84.9 m95 -108.38 110.61 22.21 Favored 'General case' 0 C--O 1.253 1.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.316 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.5 m -135.77 139.74 45.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.018 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -80.98 168.2 18.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.1 63.19 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.485 0.714 . . . . 0.0 112.867 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.48 -19.35 53.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.341 0.591 . . . . 0.0 110.859 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -92.13 -5.24 53.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.334 1.064 . . . . 0.0 108.415 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.79 150.71 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.829 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.473 ' HB ' ' CB ' ' A' ' 13' ' ' LYS . 4.2 mp -108.65 115.21 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 172.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -81.15 108.98 11.88 Favored Pre-proline 0 C--N 1.31 -1.148 0 O-C-N 123.144 0.278 . . . . 0.0 111.013 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.97 119.35 3.92 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 122.288 1.992 . . . . 0.0 113.851 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 tp -157.17 85.65 0.94 Allowed 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.874 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.9 t70 58.21 71.35 0.59 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.424 -1.716 . . . . 0.0 110.449 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -77.47 -31.78 53.94 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.059 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.72 18.93 10.15 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 mp -124.73 98.92 5.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.084 0.468 . . . . 0.0 110.441 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -91.37 -32.7 15.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 174.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -89.26 87.06 6.99 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -47.24 -47.99 24.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -79.06 -34.08 44.06 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.674 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 62.02 25.27 15.14 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.572 1.177 . . . . 0.0 108.841 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -130.48 126.62 37.35 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.029 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.4 m80 . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.239 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.491 ' HG3' ' H ' ' A' ' 3' ' ' MET . 9.7 tp10 . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -76.59 -19.06 58.26 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.905 0.383 . . . . 0.0 110.993 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.491 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 25.6 ttt -74.46 117.13 15.93 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.186 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 42.7 mt-10 -76.49 114.74 41.21 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 15.9 Cg_exo -66.9 80.85 0.35 Allowed 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 122.971 2.447 . . . . 0.0 114.65 -173.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.4 m 71.46 166.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.078 1.351 . . . . 0.0 112.379 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -113.72 21.11 15.32 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.831 0.824 . . . . 0.0 110.03 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 30' ' ' LYS . 2.8 p -69.93 113.5 7.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.322 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.13 8.48 57.78 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.441 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 m -77.86 126.87 31.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.523 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 95.3 mttt -94.52 124.29 38.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.119 0.485 . . . . 0.0 111.387 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.99 -178.96 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.789 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 32.6 ttpt -124.79 146.47 49.21 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 56' ' ' VAL . 99.4 t -126.09 137.69 56.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 122.836 0.455 . . . . 0.0 110.238 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -110.57 107.0 16.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.11 113.17 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.454 ' HA3' ' HG3' ' A' ' 22' ' ' GLN . . . -151.06 157.25 27.09 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 118.844 -1.646 . . . . 0.0 115.183 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -145.67 105.2 3.96 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.917 -1.141 . . . . 0.0 110.034 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.64 -124.12 6.98 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.375 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -81.78 -28.17 33.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.811 0.815 . . . . 0.0 108.817 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -82.39 95.25 7.59 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.226 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HG3' ' HA3' ' A' ' 17' ' ' GLY . 59.6 tt0 -139.7 128.9 23.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.699 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -125.1 134.25 52.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.62 108.53 25.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 170.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.57 165.09 19.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.87 -174.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.47 139.07 43.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.8 -179.68 6.75 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.199 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.523 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 6.6 m -129.47 136.87 50.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -69.85 129.63 34.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.07 -47.1 4.87 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -155.97 168.03 28.54 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -140.5 150.69 44.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.46 162.43 40.74 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.8 mp -114.26 124.7 71.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.06 108.18 10.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.025 0.441 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.32 65.0 1.01 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.521 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -26.53 3.34 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.618 -1.173 . . . . 0.0 115.181 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.11 148.69 36.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.623 0.711 . . . . 0.0 111.562 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.2 p -98.32 125.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.683 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.89 134.9 51.57 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.705 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -110.84 145.91 37.37 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.056 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 52.1 tp -108.29 119.8 40.54 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.5 m -118.23 149.62 20.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -125.61 138.65 53.93 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . 0.258 58.1 m-85 -80.91 118.68 22.62 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -168.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 67.05 -48.83 0.48 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.545 1.938 . . . . 0.0 115.691 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.45 -29.65 3.41 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.917 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -65.8 -47.63 74.43 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.555 ' ND2' ' HB2' ' A' ' 52' ' ' TYR . 40.0 t30 -107.23 100.55 10.01 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.97 0.89 . . . . 0.0 109.242 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.5 t -88.31 -19.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.703 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -79.5 -10.36 59.79 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.988 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.555 ' HB2' ' ND2' ' A' ' 49' ' ' ASN . 1.7 t80 -75.76 101.14 4.95 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -111.08 118.86 37.17 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.977 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.94 142.31 27.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.457 0.646 . . . . 0.0 111.163 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -104.78 122.28 45.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.686 -176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 14' ' ' VAL . 19.2 m -134.29 143.93 36.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -82.84 160.79 22.12 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 123.358 0.663 . . . . 0.0 110.467 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.59 61.56 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.57 0.748 . . . . 0.0 112.204 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.79 -2.57 37.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.291 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -111.88 0.53 16.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -114.64 152.69 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 111.599 -172.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.2 mp -107.48 112.55 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -93.85 137.78 22.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -68.53 119.93 6.9 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 121.92 1.746 . . . . 0.0 108.865 171.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 77.31 95.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 125.123 1.515 . . . . 0.0 109.422 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 74.38 -169.75 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.319 1.447 . . . . 0.0 110.557 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -130.46 -9.35 4.13 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.555 -0.716 . . . . 0.0 111.681 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.7 13.27 0.64 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.053 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.4 mt -85.92 -18.61 32.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.39 100.62 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.943 -1.48 . . . . 0.0 107.55 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -85.78 137.38 32.83 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.553 -177.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -75.67 6.97 4.19 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -171.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -94.98 25.19 4.3 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.54 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -69.96 -33.84 72.61 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 168.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.21 74.82 9.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 . . . . . 0 C--N 1.291 -1.972 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.866 179.812 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -87.66 -61.7 1.66 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.455 0.645 . . . . 0.0 109.433 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.5 ttm -114.55 107.55 15.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.9 126.12 84.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.21 97.24 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.101 1.867 . . . . 0.0 108.514 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.8 m -74.37 125.72 29.12 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 121.751 0.786 . . . . 0.0 112.22 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.468 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.0 -15.97 61.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.054 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 10.2 m -63.05 113.72 3.28 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.72 -25.59 7.17 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.934 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.3 m -62.53 121.17 12.64 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.322 0.582 . . . . 0.0 109.837 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.72 122.58 40.98 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.263 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.85 -179.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.857 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB3' HD11 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -113.33 140.32 48.11 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.868 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -132.85 138.56 51.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 118.721 0.692 . . . . 0.0 111.204 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -108.61 143.68 37.35 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -159.84 117.15 2.6 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.716 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.97 170.46 40.96 Favored Glycine 0 N--CA 1.425 -2.071 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.657 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -119.03 103.81 9.9 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 171.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 -94.26 0.06 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.115 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -75.85 -32.54 59.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -83.23 27.45 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.498 0.666 . . . . 0.0 112.106 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.51 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 51.8 tp60 -78.84 112.31 15.86 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.155 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 147.28 50.85 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.16 114.88 46.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 165.76 15.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.09 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -108.79 142.2 39.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.09 172.94 15.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.5 p -122.64 146.92 47.02 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 20.8 mm -66.72 131.92 32.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -103.24 -45.8 4.79 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -165.04 -176.55 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -150.28 165.01 34.28 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.498 0.719 . . . . 0.0 109.445 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -160.46 166.35 29.36 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.33 1.452 . . . . 0.0 110.081 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.2 117.26 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.25 114.53 15.78 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.045 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 69.15 23.61 6.36 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.895 1.278 . . . . 0.0 110.512 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.48 54.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.558 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.0 159.34 16.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.434 -0.451 . . . . 0.0 111.183 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -98.35 117.38 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.39 0.614 . . . . 0.0 109.739 -176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.2 mp -111.04 154.66 23.89 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.799 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.471 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 88.9 m-85 -116.85 148.78 40.96 Favored 'General case' 0 C--N 1.255 -3.521 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.52 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' CZ2' ' A' ' 55' ' ' TRP . 36.0 tp -107.09 116.36 31.78 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 m -118.18 144.09 27.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.534 -172.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -117.37 125.57 51.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -62.09 140.45 58.39 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.739 -1.118 . . . . 0.0 112.969 -170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -89.1 103.03 15.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.683 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.44 24.44 36.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.469 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -133.9 -166.21 1.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.78 124.76 21.38 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.526 0.516 . . . . 0.0 111.109 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.8 t -86.07 -29.62 6.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.736 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -50.83 -52.74 38.4 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.751 0.657 . . . . 0.0 112.171 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -104.38 101.11 10.82 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.416 0.627 . . . . 0.0 111.903 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.27 142.69 31.41 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.551 -1.204 . . . . 0.0 107.97 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -124.02 157.44 34.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -167.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.471 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 79.3 m95 -98.56 126.98 44.32 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.754 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.01 140.84 32.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.548 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -76.86 164.17 26.07 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 122.328 -0.233 . . . . 0.0 110.677 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.09 -32.08 63.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.009 0.524 . . . . 0.0 112.085 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.48 -24.75 65.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.285 1.034 . . . . 0.0 111.701 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -94.72 -6.42 43.2 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.555 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.1 147.65 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.89 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -107.72 106.65 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -82.51 136.15 45.9 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.616 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.96 119.54 6.86 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.392 2.062 . . . . 0.0 111.114 178.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 66' ' ' ASP . 7.9 tt -172.99 151.53 2.18 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -173.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.464 ' N ' HD22 ' A' ' 65' ' ' LEU . 19.3 t70 -65.06 101.44 0.52 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 124.28 0.987 . . . . 0.0 109.392 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -94.46 92.97 7.38 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.089 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.28 -12.83 18.92 Favored Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.853 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 69.07 -46.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.141 1.776 . . . . 0.0 114.861 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -89.94 95.07 10.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.67 0.748 . . . . 0.0 112.179 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -114.54 96.35 5.71 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -168.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -78.98 -33.65 44.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.172 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 69.38 -51.53 0.61 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.226 1.41 . . . . 0.0 111.28 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -87.71 150.45 23.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--N 1.296 -1.75 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.785 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.502 -0.887 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.75 123.07 31.5 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.4 ttp 66.63 82.93 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.454 1.096 . . . . 0.0 109.743 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.588 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.3 mt-10 -80.26 122.77 83.17 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -78.16 -23.41 9.01 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.503 2.135 . . . . 0.0 113.166 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.434 ' C ' ' H ' ' A' ' 8' ' ' THR . 63.4 m -78.98 95.94 5.61 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.1 mt 69.43 -24.52 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.358 1.063 . . . . 0.0 113.832 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 4' ' ' GLU . 91.0 m -57.36 137.92 55.53 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 125.411 1.484 . . . . 0.0 111.651 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -16.54 50.96 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -71.88 125.38 27.04 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.049 0.452 . . . . 0.0 110.298 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -93.38 109.95 21.51 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.97 175.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.894 -172.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 28.4 ttpt -108.83 143.79 37.56 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 77.7 t -125.46 129.36 72.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 123.666 0.786 . . . . 0.0 110.325 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.592 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 86.5 tttt -108.76 112.9 25.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -133.17 104.81 6.67 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 21' ' ' THR . . . -158.52 141.81 7.95 Favored Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.084 -1.531 . . . . 0.0 114.871 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -145.47 113.67 6.58 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 124.37 1.068 . . . . 0.0 109.331 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.18 -121.88 7.78 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -87.22 -18.87 29.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.982 0.896 . . . . 0.0 109.597 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.576 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 56.6 m -81.12 66.7 6.76 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.69 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.449 ' CD ' ' HA3' ' A' ' 17' ' ' GLY . 26.6 tp60 -121.34 116.97 25.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.12 128.49 15.88 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.87 128.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 165.78 27.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.724 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 32.3 mt-10 -111.01 134.37 52.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.617 ' HB1' ' CD2' ' A' ' 45' ' ' TYR . . . -138.21 179.24 6.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.587 0.708 . . . . 0.0 112.39 -172.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -122.4 136.28 54.86 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mm -72.56 127.46 34.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HA ' HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -109.3 -41.79 4.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -147.73 170.34 17.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -146.85 142.34 27.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.61 144.81 44.29 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.665 0.386 . . . . 0.0 110.809 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.44 112.86 42.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -149.54 133.39 16.97 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t70 71.93 23.35 3.56 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.982 1.313 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.14 4.73 81.18 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.998 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 11.8 pt-20 -127.18 157.48 39.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 117.153 0.477 . . . . 0.0 110.329 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.11 118.88 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-O 122.223 1.011 . . . . 0.0 109.403 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.64 136.87 47.52 Favored 'General case' 0 N--CA 1.403 -2.802 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.065 -176.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 33.8 m-85 -107.51 145.58 32.92 Favored 'General case' 0 C--N 1.259 -3.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.5 HD21 ' HB2' ' A' ' 53' ' ' ASP . 3.2 tm? -107.49 114.48 28.51 Favored 'General case' 0 N--CA 1.39 -3.454 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -117.82 148.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.819 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -132.18 137.12 47.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.617 ' CD2' ' HB1' ' A' ' 27' ' ' ALA . 55.0 m-85 -80.04 99.17 7.55 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.425 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 50.79 84.6 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.011 -1.449 . . . . 0.0 114.024 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.1 -172.06 23.35 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -96.91 157.09 16.07 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' ND2' HD12 ' A' ' 42' ' ' LEU . 22.2 p-10 -101.83 99.73 9.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.66 -48.1 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.749 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -109.77 -57.18 2.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.109 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -88.13 102.36 14.71 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.372 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.5 ' HB2' HD21 ' A' ' 42' ' ' LEU . 3.2 p-10 -114.85 127.25 55.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -131.66 134.35 45.87 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.998 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.465 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 66.3 m95 -107.6 120.35 41.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.295 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 28.3 t -125.52 145.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 38' ' ' GLU . 60.6 tttm -81.91 149.45 28.24 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.11 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.605 1.162 . . . . 0.0 113.228 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.11 -25.25 65.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.181 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.592 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 33.8 mtt85 -97.19 7.74 45.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.177 0.513 . . . . 0.0 111.625 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.0 mt -108.33 146.51 14.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.24 102.54 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 97.2 m95 -81.72 124.91 79.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.701 -171.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 18.5 Cg_exo -66.12 119.88 6.96 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.51 2.14 . . . . 0.0 113.107 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.1 tm? -141.95 71.14 1.35 Allowed 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 65' ' ' LEU . 12.4 m-20 72.69 -71.45 0.14 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.794 -171.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.4 tptt 62.18 17.05 8.88 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.409 1.484 . . . . 0.0 111.505 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.44 77.35 0.43 Allowed Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.681 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.15 -45.78 59.12 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.08 149.89 42.91 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.23 175.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -114.78 80.82 1.46 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.959 -1.096 . . . . 0.0 113.291 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.54 -16.65 17.42 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -111.61 81.95 1.53 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -91.13 -48.44 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.1 m80 66.25 -80.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.486 1.114 . . . . 0.0 111.896 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.479 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.99 81.49 8.76 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.474 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 52.7 ttp -167.23 41.73 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -116.08 86.19 16.53 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.919 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 3' ' ' MET . 11.2 Cg_exo -75.57 126.72 9.78 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.764 2.309 . . . . 0.0 110.8 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.94 -84.82 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 63.82 6.13 2.59 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.63 1.172 . . . . 0.0 112.377 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 137.5 55.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.945 0.898 . . . . 0.0 111.065 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.51 -33.6 6.23 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -66.81 128.42 36.25 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 123.225 0.61 . . . . 0.0 111.034 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -97.65 126.03 42.74 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.83 179.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -107.7 142.81 37.12 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.483 HG12 HG11 ' A' ' 56' ' ' VAL . 85.9 t -123.45 135.95 61.62 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.182 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.196 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.8 ttmt -107.29 102.87 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.444 ' CD1' HG13 ' A' ' 56' ' ' VAL . 64.2 t80 -123.61 126.88 47.42 Favored 'General case' 0 C--N 1.271 -2.845 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -179.89 156.23 17.51 Favored Glycine 1 N--CA 1.391 -4.307 0 C-N-CA 118.254 -1.927 . . . . 0.0 114.345 -177.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -126.82 104.02 7.83 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 113.745 -1.228 . . . . 0.0 108.142 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.79 -106.64 0.83 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.987 -1.006 . . . . 0.0 114.209 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -81.69 -18.95 42.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.417 0.627 . . . . 0.0 110.739 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -100.01 85.47 3.06 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -146.14 116.85 7.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -174.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 31.1 mmmt -129.15 159.41 36.12 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.86 114.46 46.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 15.1 m-85 -112.72 165.78 11.97 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -105.83 131.21 53.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' HB1' ' CD1' ' A' ' 45' ' ' TYR . . . -134.71 161.83 34.05 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.788 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 m -116.43 137.27 52.3 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.7 mm -76.55 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.598 0.561 . . . . 0.0 111.83 -174.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -99.33 -61.73 1.33 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -156.15 -179.86 8.55 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.93 145.32 30.64 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.068 0.395 . . . . 0.0 110.31 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -141.48 157.22 45.42 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.844 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 mp -114.01 133.0 61.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.567 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 17.9 t70 -143.68 125.24 14.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.1 t70 59.12 22.51 10.65 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.625 1.17 . . . . 0.0 111.416 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.76 -8.73 59.94 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.781 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 25.8 pt-20 -107.33 149.04 28.26 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.76 121.36 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-O 122.415 1.103 . . . . 0.0 110.781 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 57' ' ' LYS . 1.3 mm? -108.86 131.88 54.57 Favored 'General case' 0 N--CA 1.389 -3.48 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.277 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.455 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 25.5 m-85 -107.86 146.87 31.7 Favored 'General case' 0 C--N 1.257 -3.424 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.486 ' CD2' ' HB3' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -107.03 111.26 23.66 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -178.43 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.8 m -126.49 151.92 33.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -173.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.43 133.12 51.32 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.891 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 33.3 m-85 -84.75 101.81 12.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -59.72 -37.78 79.84 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.32 19.66 31.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.689 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -132.03 -54.99 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.232 -0.569 . . . . 0.0 110.987 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -158.51 91.98 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.88 -35.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.169 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -77.72 -0.09 25.55 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -100.46 -43.5 6.2 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.486 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 14.9 m-20 64.51 107.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.541 1.15 . . . . 0.0 108.757 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -118.18 153.77 33.29 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.455 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 65.3 m95 -100.59 126.05 47.02 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.749 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.483 HG11 HG12 ' A' ' 14' ' ' VAL . 20.4 m -129.96 165.63 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 86.1 mttt -99.79 171.18 8.05 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.277 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.92 93.17 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.89 0.876 . . . . 0.0 111.886 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -60.93 -26.04 67.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.702 0.763 . . . . 0.0 111.145 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 23.1 mmm180 -87.39 -0.68 57.13 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.781 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -112.19 143.27 22.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.989 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.7 108.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -90.17 159.13 42.89 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.96 118.79 5.75 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.898 1.732 . . . . 0.0 111.239 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.494 HD11 ' N ' ' A' ' 66' ' ' ASP . 3.4 tm? -148.59 158.61 44.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 102.033 -3.321 . . . . 0.0 102.033 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.494 ' N ' HD11 ' A' ' 65' ' ' LEU . 32.5 t70 -72.14 93.1 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.719 1.247 . . . . 0.0 114.156 -173.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.85 6.73 47.47 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.639 170.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.86 71.64 0.61 Allowed Glycine 0 N--CA 1.402 -3.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.221 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.423 ' CD1' ' HA ' ' A' ' 66' ' ' ASP . 9.4 mp -77.18 165.51 24.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.58 85.79 7.4 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.942 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.93 105.23 13.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.82 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -90.22 -40.85 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -75.16 -33.06 61.46 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.21 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -101.8 75.83 1.59 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -70.26 -31.81 69.36 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--N 1.302 -1.475 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 173.211 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.402 ' H1 ' ' CD ' ' A' ' 1' ' ' GLU . 1.9 mp0 . . . . . 0 CA--C 1.509 -0.628 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.68 159.93 15.03 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.274 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -60.16 130.26 45.8 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.669 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -92.04 125.93 55.06 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.4 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.21 91.84 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.768 2.312 . . . . 0.0 113.824 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -102.76 175.44 5.49 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -92.65 32.94 1.17 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.712 0.768 . . . . 0.0 110.782 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.462 HG22 ' HA ' ' A' ' 30' ' ' LYS . 5.2 m -57.55 136.94 56.79 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 125.378 1.471 . . . . 0.0 111.718 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.34 -15.66 55.98 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -83.04 130.71 35.16 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.93 112.95 25.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.457 1.122 . . . . 0.0 109.359 177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 34.7 m -116.94 -179.71 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.408 -169.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.03 136.76 47.18 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 96.7 t -114.56 134.61 57.01 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.712 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.913 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 38.2 ttmt -107.72 104.71 14.29 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 8.7 t80 -108.84 103.8 12.94 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.5 105.22 0.99 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -142.76 105.62 4.53 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.64 -109.09 2.14 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.143 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -90.32 -27.88 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.094 0.558 . . . . 0.0 110.323 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -87.62 88.92 7.81 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.783 1.278 . . . . 0.0 111.024 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.664 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 34.2 tt0 -120.64 116.86 26.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.185 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.5 pttt -146.22 133.75 20.9 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.026 -173.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 2.5 mp -110.46 122.36 64.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 166.75 23.95 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.308 -175.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.1 mt-10 -105.44 120.51 41.79 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.82 0.819 . . . . 0.0 109.019 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -129.14 152.6 48.56 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.699 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 m -104.16 137.1 42.59 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 177.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.2 mm -74.16 128.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.465 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HA ' HG22 ' A' ' 8' ' ' THR . 1.1 tmmt? -114.66 -50.65 2.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -129.71 166.97 18.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -148.98 153.15 37.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.455 ' C ' HD12 ' A' ' 34' ' ' ILE . 11.1 pt-20 -144.44 158.52 43.71 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.5 mp -122.21 109.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -139.99 139.36 36.04 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.432 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 65.19 22.51 12.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.664 1.221 . . . . 0.0 109.785 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.5 -0.68 89.52 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.96 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.57 148.75 39.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 117.111 0.456 . . . . 0.0 111.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.23 119.27 46.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.4 mt -108.76 132.59 53.82 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.974 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 54.3 m-85 -108.94 145.16 35.89 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.742 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.414 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.0 tm? -108.1 113.55 26.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.41 153.71 25.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.718 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -145.52 153.28 40.94 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.848 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.422 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 4.1 m-85 -102.36 99.66 9.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.803 -168.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 50.44 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.928 1.291 . . . . 0.0 113.482 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.42 -147.96 17.35 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -126.07 106.56 9.68 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 117.663 0.731 . . . . 0.0 109.725 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.83 127.46 32.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 m -80.01 -46.1 22.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -109.37 -27.78 9.31 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.411 0.624 . . . . 0.0 110.405 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -86.28 13.46 8.01 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.508 0.67 . . . . 0.0 110.396 -173.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.02 119.4 14.18 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.28 153.23 35.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -163.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.414 ' CE2' HD23 ' A' ' 42' ' ' LEU . 83.6 m95 -112.28 113.65 26.0 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.527 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.82 149.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.481 179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -89.32 162.42 15.83 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.175 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.89 65.61 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.854 1.262 . . . . 0.0 112.986 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.73 -20.54 62.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.476 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 43.1 mtt85 -92.64 3.13 56.16 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.57 145.64 15.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.078 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.92 112.15 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -93.55 119.05 67.58 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.216 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.47 122.83 11.38 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 C-N-CA 123.323 2.682 . . . . 0.0 112.485 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -165.96 81.43 0.29 Allowed 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 t70 58.72 40.85 22.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.438 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.99 166.95 21.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.93 -32.67 0.47 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.96 117.46 28.87 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.22 139.65 56.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.472 0.653 . . . . 0.0 111.818 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -93.28 69.53 4.33 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -79.71 -21.15 44.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -133.08 117.84 18.03 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -68.45 103.26 1.61 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.482 0.658 . . . . 0.0 111.03 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -89.77 -69.32 0.73 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.437 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.308 -1.226 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -177.634 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.507 -0.701 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 177.29 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ttt -163.36 86.59 0.52 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.4 137.67 71.37 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.219 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.51 -27.03 81.57 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.645 2.23 . . . . 0.0 113.52 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.493 ' C ' HD11 ' A' ' 7' ' ' LEU . 21.4 t -86.02 34.85 0.62 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.258 -0.276 . . . . 0.0 111.673 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.493 HD11 ' C ' ' A' ' 6' ' ' CYS 0.295 0.0 OUTLIER 43.89 33.31 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.872 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -73.95 149.02 41.62 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.02 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.7 -7.11 82.47 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.39 121.49 20.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -87.55 111.86 21.65 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.044 0.925 . . . . 0.0 109.999 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.18 176.32 3.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.332 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.6 ttpt -111.64 139.1 47.38 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.3 t -118.87 132.32 69.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 C-N-CA 122.941 0.497 . . . . 0.0 111.297 -172.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -108.42 104.69 14.09 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 124.885 1.274 . . . . 0.0 107.715 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 56.6 t80 -118.13 114.38 23.0 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.64 108.41 0.59 Allowed Glycine 0 N--CA 1.417 -2.573 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.399 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 8.5 ptp180 -126.89 104.98 8.32 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.05 -100.17 0.08 OUTLIER Glycine 0 C--O 1.245 0.8 0 CA-C-N 116.198 -0.455 . . . . 0.0 114.102 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -81.73 -38.39 25.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.457 0.646 . . . . 0.0 110.119 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.5 m -84.12 86.84 7.16 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.366 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 34.6 tt0 -131.37 117.75 19.33 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.935 0.398 . . . . 0.0 110.6 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HD2' ' CE2' ' A' ' 25' ' ' TYR . 11.3 ptpt -154.66 151.51 28.86 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.0 mt -108.82 114.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.445 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -108.49 166.9 10.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.05 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -114.87 132.18 56.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.421 ' HB3' ' CD1' ' A' ' 45' ' ' TYR . . . -143.51 168.14 20.56 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.292 -171.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 p -106.43 142.35 36.24 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mm -68.38 120.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -93.22 -38.85 11.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 t -169.27 173.57 6.6 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -145.93 140.29 26.84 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -142.36 155.52 45.16 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.204 0.601 . . . . 0.0 109.638 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.81 124.92 65.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.76 104.87 8.08 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.714 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 55.46 64.12 1.86 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.546 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.28 -25.57 4.86 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 114.86 -1.064 . . . . 0.0 114.858 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.47 150.1 27.89 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.735 0.768 . . . . 0.0 112.932 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.8 t -98.66 118.36 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.05 134.78 50.46 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -107.81 146.74 31.83 Favored 'General case' 0 C--N 1.259 -3.331 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.461 HD21 ' CG ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -107.62 121.96 45.73 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.9 m -118.81 148.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-O 121.392 0.615 . . . . 0.0 109.716 -176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -118.44 118.01 30.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 27' ' ' ALA . 75.8 m-85 -68.07 127.35 32.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -170.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -90.14 95.23 10.11 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.126 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.6 -35.86 4.54 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.266 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -81.57 -73.71 0.37 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.855 0.36 . . . . 0.0 110.382 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.22 105.13 11.05 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.38 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.5 m -89.0 -12.06 10.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -109.33 -20.01 13.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.084 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.55 105.93 11.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.611 0.719 . . . . 0.0 109.294 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.461 ' CG ' HD21 ' A' ' 42' ' ' LEU . 23.4 t70 -90.58 107.57 19.25 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -129.4 151.5 49.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.383 -170.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.48 131.14 55.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.488 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.77 144.46 29.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -80.6 160.95 24.94 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.36 -34.52 57.92 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.684 0.754 . . . . 0.0 111.182 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.18 -34.15 59.79 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.455 1.502 . . . . 0.0 111.633 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -95.31 6.61 48.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.86 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -113.52 142.35 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-O 121.635 0.731 . . . . 0.0 111.732 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.3 mp -107.87 104.97 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -85.26 155.13 60.32 Favored Pre-proline 0 C--N 1.291 -1.944 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.98 118.97 5.86 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.267 1.311 . . . . 0.0 109.066 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.2 mt -146.84 176.02 10.2 Favored 'General case' 0 CA--C 1.483 -1.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.605 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.12 76.27 0.23 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.186 1.554 . . . . 0.0 109.972 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -134.82 -35.0 0.88 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.379 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.6 -29.81 1.04 Allowed Glycine 0 CA--C 1.501 -0.798 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.94 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.67 -2.22 57.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.018 0.913 . . . . 0.0 109.492 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -159.86 136.42 9.07 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -153.71 96.75 2.03 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.722 0.773 . . . . 0.0 109.791 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -46.52 -28.81 1.52 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.718 1.607 . . . . 0.0 113.764 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -84.96 111.11 19.4 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -120.57 144.01 48.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -79.03 -30.58 44.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -177.43 106.49 0.06 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -81.75 138.27 35.22 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.43 92.82 38.07 Favored Pre-proline 0 C--N 1.291 -1.949 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.946 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.92 114.93 3.35 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 122.675 2.25 . . . . 0.0 109.5 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.8 m -135.12 141.64 46.05 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.584 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.4 pt? -74.38 -26.59 60.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 m -64.56 123.86 20.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.535 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.91 -11.83 62.43 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.803 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.5 m -77.53 131.36 37.85 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -86.11 114.76 23.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.754 0.787 . . . . 0.0 110.843 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.28 -179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 24.2 ttmt -116.76 140.42 49.45 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.465 ' CG1' HG12 ' A' ' 56' ' ' VAL . 94.5 t -117.31 131.46 69.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 121.186 0.517 . . . . 0.0 110.303 -176.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -106.71 104.82 14.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.61 107.33 17.77 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.452 -173.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.18 115.09 3.35 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.521 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -146.02 104.8 3.87 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 45.48 -112.13 0.71 Allowed Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.061 0.851 . . . . 0.0 114.188 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -94.65 -16.47 23.12 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.287 0.565 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.3 p -84.58 26.13 0.83 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.96 0.504 . . . . 0.0 111.212 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.92 138.44 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.964 0.506 . . . . 0.0 111.574 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.87 156.64 22.84 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.27 126.78 71.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.96 165.78 26.43 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.169 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 138.53 45.0 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 161.72 38.21 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -104.17 138.66 40.33 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 42.6 mm -66.3 128.31 29.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.032 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 28.6 tptp -100.9 -62.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.7 m -147.19 161.44 40.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -127.19 138.27 53.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.29 161.57 37.69 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.376 0.608 . . . . 0.0 111.673 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.404 HG13 HG21 ' A' ' 39' ' ' VAL . 1.8 mp -108.91 130.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -135.82 115.91 13.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 59.7 35.11 22.23 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.548 1.139 . . . . 0.0 111.357 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.45 -12.24 66.5 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.344 -0.931 . . . . 0.0 114.238 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -116.98 151.99 35.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.5 0.65 . . . . 0.0 111.235 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.404 HG21 HG13 ' A' ' 34' ' ' ILE . 8.4 t -98.83 125.25 52.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.9 0.381 . . . . 0.0 110.147 -175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.67 160.33 26.05 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.481 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -114.11 144.42 43.17 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.764 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.428 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -108.23 116.52 32.11 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 m -117.67 149.12 20.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.484 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -118.35 128.02 54.25 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.3 100.19 5.79 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 58.7 -71.04 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.954 1.702 . . . . 0.0 115.238 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.42 -98.93 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 O-C-N 123.147 0.279 . . . . 0.0 113.179 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -135.13 -160.38 1.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 122.382 -0.481 . . . . 0.0 109.932 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -61.27 109.76 1.22 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.714 0.806 . . . . 0.0 109.413 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.43 HG11 ' H ' ' A' ' 51' ' ' ARG . 4.7 p -81.72 -67.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.272 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.43 ' H ' HG11 ' A' ' 50' ' ' VAL . 26.4 ttm180 -110.1 -58.05 2.12 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.794 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -149.95 22.18 0.87 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 59.19 -160.35 0.28 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -166.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.0 148.48 27.12 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 119.972 1.26 . . . . 0.0 111.375 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.428 ' CE2' HD23 ' A' ' 42' ' ' LEU . 78.0 m95 -107.25 122.83 47.34 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.463 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.465 HG12 ' CG1' ' A' ' 14' ' ' VAL . 16.5 m -135.99 144.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.232 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -79.75 160.61 26.14 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -36.52 62.86 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.116 0.967 . . . . 0.0 112.244 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.2 -10.43 59.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -103.33 4.88 36.92 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.48 140.92 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.146 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.6 mp -107.86 112.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -86.31 132.73 42.29 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.656 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.14 117.72 4.73 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 107.518 -1.762 . . . . 0.0 107.518 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.37 -163.02 1.68 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.88 88.57 1.04 Allowed 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.751 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -149.99 22.19 0.87 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.496 178.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.38 17.36 3.61 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.5 mt -123.12 94.86 4.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.54 -52.99 4.07 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 163.27 13.15 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.475 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -74.15 -14.84 61.02 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.53 0.605 . . . . 0.0 110.091 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 72.43 18.64 4.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.539 1.136 . . . . 0.0 112.921 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -159.64 99.72 1.43 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -149.86 129.65 13.29 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.072 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t70 44.52 67.68 0.65 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.381 1.472 . . . . 0.0 110.262 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.405 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 25.3 ptm -155.47 -169.41 3.13 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.094 -170.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.65 100.5 16.42 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 3' ' ' MET . 16.5 Cg_exo -70.06 107.61 1.95 Allowed 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.608 2.205 . . . . 0.0 110.878 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.0 m 65.47 -174.6 0.18 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 123.904 0.882 . . . . 0.0 110.621 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -15.22 57.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.434 1.111 . . . . 0.0 109.708 173.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.408 HG21 ' HA ' ' A' ' 30' ' ' LYS . 16.1 m -63.87 115.45 4.86 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.761 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.65 -18.31 7.2 Favored Glycine 0 C--N 1.31 -0.884 0 C-N-CA 119.657 -1.258 . . . . 0.0 112.965 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -73.49 129.35 37.8 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -95.03 144.17 25.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.83 179.55 3.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.0 mmmt -108.05 134.39 51.01 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.412 ' CG1' HG11 ' A' ' 56' ' ' VAL . 93.7 t -115.52 128.18 72.83 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.098 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.506 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 86.8 tttt -106.86 104.29 13.94 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' CD1' HG13 ' A' ' 56' ' ' VAL . 63.4 t80 -143.73 118.91 10.13 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.424 0.63 . . . . 0.0 110.588 -173.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.482 ' H ' ' NH2' ' A' ' 60' ' ' ARG . . . 179.38 153.67 12.08 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -92.8 116.67 29.24 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.207 0.527 . . . . 0.0 112.039 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.54 -109.23 2.8 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.803 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.4 ' C ' ' H ' ' A' ' 22' ' ' GLN . 56.2 tptt -92.85 -6.32 49.03 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.832 0.825 . . . . 0.0 109.207 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 9.5 m -86.32 23.16 1.63 Allowed 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.281 1.039 . . . . 0.0 108.422 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.419 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.1 tp-100 -70.6 108.02 4.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -113.92 147.46 38.48 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.94 129.98 67.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -129.48 166.65 19.21 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.23 1.012 . . . . 0.0 109.449 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -107.8 125.83 51.9 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.21 46.06 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 8.5 p -104.44 142.7 34.14 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.8 mm -73.76 129.55 36.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HA ' HG21 ' A' ' 8' ' ' THR . 10.6 tmtt? -98.46 -54.75 2.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -155.22 -179.89 8.52 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' HB ' ' CD2' ' A' ' 41' ' ' TYR . 10.1 t -158.49 165.06 35.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.446 ' C ' HD11 ' A' ' 34' ' ' ILE . 12.7 pt-20 -148.07 158.07 43.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.345 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 HD11 ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -119.2 111.48 33.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -123.33 122.87 39.4 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 68.67 23.03 7.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.732 1.213 . . . . 0.0 110.141 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.42 -6.55 74.97 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.522 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.27 151.04 31.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 117.73 0.765 . . . . 0.0 110.689 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.2 t -97.95 124.15 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.728 0.775 . . . . 0.0 110.035 -172.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -108.47 125.62 51.99 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.71 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 87.0 m-85 -108.97 147.5 32.17 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.398 -176.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD13 ' NE1' ' A' ' 55' ' ' TRP . 55.6 tp -107.54 110.4 22.31 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.8 m -118.23 148.61 20.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -126.73 129.66 48.82 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.439 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 44.8 m-85 -71.18 132.7 45.39 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.145 0.903 . . . . 0.0 111.052 -172.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -116.7 135.05 54.08 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.29 -31.83 5.84 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -172.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -102.01 -155.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -74.42 114.62 13.01 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.579 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 7.1 p -67.08 -12.31 14.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.976 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -76.03 -7.16 54.04 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -86.72 98.21 11.02 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.368 0.604 . . . . 0.0 112.337 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -106.47 140.76 38.87 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.75 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.85 159.37 43.03 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.489 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 73.6 m95 -98.24 134.08 41.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.245 0.545 . . . . 0.0 111.488 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 16' ' ' TYR . 26.8 m -133.23 165.21 32.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.1 157.42 16.89 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.24 -32.51 48.66 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.659 0.784 . . . . 0.0 112.263 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -26.15 68.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.423 1.089 . . . . 0.0 111.897 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 27.0 mmm-85 -93.91 0.58 56.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -109.31 140.36 28.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.63 -173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.7 mp -109.04 108.87 26.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -83.07 124.95 75.95 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.1 117.84 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.616 1.544 . . . . 0.0 109.838 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.3 mt -172.38 107.22 0.19 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 124.371 1.068 . . . . 0.0 110.018 -173.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.4 t70 74.63 -60.94 0.5 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 139.35 58.49 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.715 0.293 . . . . 0.0 111.498 -176.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.12 85.5 0.49 Allowed Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -174.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.75 98.94 4.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 75.44 126.93 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.148 1.379 . . . . 0.0 111.015 -168.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -111.67 39.34 2.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -60.75 -36.25 78.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.942 -1.936 . . . . 0.0 109.567 -173.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -143.84 107.64 4.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -79.69 8.12 7.2 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -173.65 -166.56 0.32 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.602 177.146 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.428 -1.542 0 CA-C-O 121.258 0.552 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.48 65.65 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 m -92.79 117.24 29.81 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -97.34 134.48 40.57 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 171.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' HD3' ' A' ' 64' ' ' PRO . 33.9 m -126.47 177.2 5.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.955 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -108.98 129.46 55.45 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.285 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -123.45 136.82 58.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 118.028 0.376 . . . . 0.0 111.432 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 41.0 ttmt -108.68 146.62 33.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.679 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 1.9 mptp? . . . . . 0 CA--C 1.487 -1.477 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.34 108.28 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.8 m-85 -108.36 167.67 9.86 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.959 -169.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.68 126.69 52.6 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.7 159.66 41.37 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.749 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.61 144.59 36.14 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.428 HD13 HG12 ' A' ' 43' ' ' VAL . 50.3 mm -77.15 131.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.437 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' A' ' 44' ' ' HIS . 9.3 mtmt -99.62 -52.85 3.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.897 0.855 . . . . 0.0 110.115 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 m -155.08 166.87 32.24 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.153 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -136.65 143.14 43.31 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -144.64 162.36 36.86 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.288 0.566 . . . . 0.0 110.852 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -108.3 113.14 43.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -122.83 104.6 9.39 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.107 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 57.73 64.62 1.51 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.301 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.89 -26.33 4.86 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.847 -1.07 . . . . 0.0 115.668 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 10.3 pt-20 -116.34 160.95 19.76 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 118.119 0.959 . . . . 0.0 112.8 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.64 120.86 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.291 0.567 . . . . 0.0 109.916 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 143.45 45.16 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.645 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 69.7 m-85 -108.83 149.79 28.59 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -107.77 117.63 34.61 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 175.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 HD13 ' A' ' 29' ' ' ILE . 14.4 m -117.32 153.87 19.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.462 ' HB2' ' HD3' ' A' ' 30' ' ' LYS . 82.6 t60 -117.57 114.05 22.86 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.823 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--N 1.297 -1.702 0 O-C-N 123.639 0.587 . . . . 0.0 110.268 -176.692 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.414 0.626 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.449 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 71.2 m95 -106.54 127.14 53.09 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.391 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.58 155.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.1 tttt -92.61 161.1 14.72 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.48 -30.37 29.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.224 1.009 . . . . 0.0 111.955 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.99 -41.08 91.3 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.213 1.005 . . . . 0.0 111.794 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 50.0 mtt180 -87.08 7.38 28.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 mt -108.97 145.42 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.8 mp -107.83 112.0 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 171.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.2 144.3 38.33 Favored Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.581 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' HG12 ' A' ' 12' ' ' VAL . 24.2 Cg_exo . . . . . 0 N--CA 1.429 -2.323 0 N-CA-C 108.358 -1.439 . . . . 0.0 108.358 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 120.813 0.339 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -23.71 31.69 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.393 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -74.1 130.26 39.44 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 37.6 pttt -87.2 136.69 32.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 174.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.34 174.31 11.26 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.666 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.1 tmtm? -108.41 135.79 49.12 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 71.2 t -124.78 144.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 85.2 tttt -140.39 104.6 4.81 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.5 t80 . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 120.704 0.288 . . . . 0.0 111.195 -169.705 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.502 -0.878 0 CA-C-O 120.618 0.247 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.4 mt -108.11 144.31 16.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.738 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -140.01 163.85 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.658 0.783 . . . . 0.0 109.214 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.92 124.95 51.48 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 167.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.22 175.68 8.26 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.906 0.384 . . . . 0.0 111.395 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 21.0 m -135.69 134.11 38.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 HG12 ' A' ' 43' ' ' VAL . 44.2 mm -65.76 125.8 23.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 O-C-N 123.858 0.724 . . . . 0.0 109.341 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -110.85 -31.4 7.18 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -167.25 167.22 14.33 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -144.84 139.71 27.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -145.77 156.88 43.88 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.63 0.581 . . . . 0.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 1.9 mp -108.72 129.34 63.43 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.45 104.37 8.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t70 55.17 64.34 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 125.52 1.528 . . . . 0.0 111.726 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 -25.59 5.17 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.848 -1.069 . . . . 0.0 115.193 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.9 145.77 34.84 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.985 0.892 . . . . 0.0 111.577 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 p -98.23 127.47 50.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 122.028 0.918 . . . . 0.0 110.681 -175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.74 155.72 28.41 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.926 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.418 ' CE2' ' HZ2' ' A' ' 63' ' ' TRP . 22.0 m-85 -118.11 145.8 44.61 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.925 -173.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.1 tp -107.52 105.82 15.91 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 29' ' ' ILE . 9.8 m -119.71 151.55 22.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.612 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -118.82 140.41 50.0 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--N 1.279 -2.457 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.639 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 121.088 0.471 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -97.74 126.29 43.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.36 0.6 . . . . 0.0 112.216 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 14' ' ' VAL . 33.3 m -131.72 144.05 38.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -89.54 164.96 14.57 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 122.136 -0.352 . . . . 0.0 110.47 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.04 28.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.378 1.071 . . . . 0.0 111.886 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.4 -24.3 64.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.925 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.668 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 13.8 mmt180 -101.16 11.55 39.22 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.785 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -120.5 140.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.7 mp -107.85 114.82 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.418 ' HZ2' ' CE2' ' A' ' 41' ' ' TYR . 93.5 m95 -89.1 145.24 33.94 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.381 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 121.851 1.701 . . . . 0.0 110.743 175.558 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 120.931 0.396 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.84 58.25 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.845 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 28' ' ' SER . 25.6 m -67.84 125.02 24.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.32 110.46 20.78 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.28 -179.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.441 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.585 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -111.85 138.88 47.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.4 t -130.29 137.61 55.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 118.377 0.535 . . . . 0.0 110.542 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG3' HD11 ' A' ' 62' ' ' ILE . 53.0 mtmt -108.18 106.45 16.64 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.1 t80 . . . . . 0 C--N 1.299 -1.588 0 CA-C-O 121.847 0.832 . . . . 0.0 112.197 -174.775 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HE2' ' OH ' ' A' ' 25' ' ' TYR . 18.0 pttm . . . . . 0 N--CA 1.434 -1.227 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.84 125.83 73.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.561 ' OH ' ' HE2' ' A' ' 23' ' ' LYS . 55.6 m-85 -111.45 165.54 11.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.313 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.67 126.81 55.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.08 -178.47 6.07 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 120.882 0.372 . . . . 0.0 111.342 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' THR . 16.4 m -123.64 155.3 37.98 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.63 126.02 39.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.727 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -101.67 -46.35 4.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -159.98 171.18 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -151.17 145.52 25.48 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.09 165.11 37.24 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.277 0.36 . . . . 0.0 110.231 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -111.26 126.35 68.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.93 103.28 7.4 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t0 57.0 65.35 1.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.001 0.92 . . . . 0.0 111.585 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -26.62 5.01 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' OE2' HD21 ' A' ' 40' ' ' LEU . 11.1 pt-20 -108.47 144.4 36.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 117.843 0.822 . . . . 0.0 110.768 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.8 p -98.82 121.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-O 122.241 1.019 . . . . 0.0 110.108 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD21 ' OE2' ' A' ' 38' ' ' GLU . 83.5 mt -108.62 137.95 45.72 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.692 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 35.4 m-85 -108.56 145.22 35.16 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.843 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.8 tp -108.25 117.77 35.01 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.8 146.01 22.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.486 0.66 . . . . 0.0 109.505 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -117.89 116.69 27.46 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.692 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.263 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 C--O 1.222 -0.362 0 CA-C-O 121.047 0.451 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.506 ' CE2' HD13 ' A' ' 42' ' ' LEU . 87.8 m95 -109.64 118.9 37.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.122 0.969 . . . . 0.0 111.869 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.44 157.34 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.577 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -90.85 165.14 13.77 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.7 -29.29 66.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.36 -1.76 57.34 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.6 tpt180 -100.89 4.7 42.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.418 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.59 147.07 13.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.14 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.9 mp -108.77 108.56 25.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -81.77 133.03 52.87 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.36 1.132 0 C-N-CA 124.126 3.217 . . . . 0.0 114.423 -177.034 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 120.981 0.419 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.69 8.48 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.7 m -63.82 130.07 42.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.027 0.531 . . . . 0.0 110.115 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -98.84 115.16 28.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.02 -177.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.823 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.666 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.8 mmtm -107.3 135.82 48.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 43' ' ' VAL . 85.3 t -127.26 137.23 58.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -107.87 121.94 45.77 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HH21 ' A' ' 60' ' ' ARG . 41.1 t80 . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.38 120.49 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.92 166.86 10.51 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.495 1.118 . . . . 0.0 109.725 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.23 137.2 52.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.29 42.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 118.112 0.415 . . . . 0.0 111.983 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 p -104.49 141.75 35.82 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 40.0 mm -78.81 124.68 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -33.96 6.54 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 m -158.55 169.73 23.78 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.973 -0.455 . . . . 0.0 109.811 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -144.31 141.28 29.66 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -143.39 153.17 42.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.118 0.485 . . . . 0.0 110.812 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -109.07 123.87 65.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -125.6 104.14 8.23 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 50.79 65.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.877 1.271 . . . . 0.0 113.236 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -24.04 10.09 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.714 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.67 140.06 42.59 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 118.083 0.942 . . . . 0.0 112.396 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 HG13 ' A' ' 34' ' ' ILE . 5.4 t -98.84 117.19 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.2 mt -109.03 138.68 45.0 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 42.7 m-85 -107.74 147.24 31.06 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -107.2 105.16 15.01 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 8.0 m -123.91 154.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.544 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -128.63 125.8 38.87 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.39 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--N 1.32 -0.69 0 O-C-N 124.465 1.103 . . . . 0.0 109.235 -174.191 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 121.155 0.502 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 82.8 m95 -99.5 123.43 43.77 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.595 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.21 147.37 28.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.248 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 61' ' ' ILE . 91.8 mttt -77.68 170.25 16.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.95 67.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.143 0.497 . . . . 0.0 110.398 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.2 -31.54 71.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 109.367 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 16' ' ' TYR . 26.8 mmm-85 -96.66 7.54 46.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.307 -173.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 57' ' ' LYS . 57.0 mt -120.71 151.16 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 13' ' ' LYS . 5.0 mp -108.15 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 96.5 m95 -90.9 130.02 42.12 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 19.4 Cg_exo . . . . . 0 N--CA 1.444 -1.39 0 C-N-CA 120.817 1.012 . . . . 0.0 111.335 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.2 0.524 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.66 -12.74 68.56 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.186 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -70.38 125.38 26.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 64.4 mttp -83.22 122.63 28.66 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.08 177.22 4.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.508 0.67 . . . . 0.0 111.268 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.04 136.5 52.85 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG1' HG11 ' A' ' 56' ' ' VAL . 79.1 t -127.59 131.18 70.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 118.321 0.51 . . . . 0.0 111.0 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 10.8 tmtt? -119.33 118.73 31.99 Favored 'General case' 0 C--O 1.197 -1.671 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.576 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 60' ' ' ARG 0.319 0.0 OUTLIER . . . . . 0 CA--C 1.481 -1.688 0 CA-C-N 118.416 0.553 . . . . 0.0 111.192 170.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--O 1.27 2.175 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 15' ' ' LYS . 54.2 mt -111.69 124.94 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.47 ' CE1' ' HE1' ' A' ' 16' ' ' TYR . 65.8 m-85 -107.78 166.14 10.92 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.616 -174.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.5 123.25 45.85 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -130.22 -178.57 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.141 0.496 . . . . 0.0 111.69 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.4 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 24.2 m -135.22 135.16 40.75 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 171.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 43' ' ' VAL . 45.8 mm -65.5 124.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -103.74 -46.6 4.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -153.02 160.22 42.97 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -133.92 141.29 47.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -145.88 161.09 40.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.646 0.591 . . . . 0.0 110.743 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.83 124.7 65.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -130.69 114.08 14.95 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.679 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.74 25.53 12.99 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.62 -17.72 52.38 Favored Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.928 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -108.65 152.65 24.51 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.48 122.79 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-O 122.072 0.939 . . . . 0.0 110.749 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -109.66 142.15 41.22 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.692 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 42.7 m-85 -108.82 142.66 39.06 Favored 'General case' 0 C--N 1.26 -3.322 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.697 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.57 110.97 23.01 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 29' ' ' ILE . 11.4 m -117.53 150.89 19.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -172.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.4 138.12 54.03 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.073 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 31.5 m-85 . . . . . 0 C--N 1.28 -2.442 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HG2' ' OH ' ' A' ' 16' ' ' TYR . 9.2 tp10 . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 121.146 0.498 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -100.17 125.96 46.38 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.49 1.116 . . . . 0.0 111.48 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.44 HG11 ' CG1' ' A' ' 14' ' ' VAL . 17.6 m -138.35 152.19 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.557 ' HE2' ' OD2' ' A' ' 59' ' ' ASP . 88.9 tttt -89.51 157.91 17.9 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -53.46 -31.41 45.45 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.423 1.089 . . . . 0.0 112.512 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.557 ' OD2' ' HE2' ' A' ' 57' ' ' LYS . 16.1 m-20 -72.92 -13.37 61.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.906 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 16' ' ' TYR . 30.7 mtt180 -106.97 8.23 30.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.563 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 56' ' ' VAL . 49.1 mt -108.79 140.27 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.3 mp -106.78 105.27 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -82.9 124.56 76.75 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.155 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo . . . . . 0 N--CA 1.439 -1.729 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 174.637 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.71 -35.59 4.33 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.215 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 m -62.58 128.5 36.26 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.043 0.537 . . . . 0.0 110.799 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -96.01 129.6 43.23 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.3 173.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.811 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.874 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 33.3 ttpt -119.5 138.92 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 56' ' ' VAL . 59.6 t -119.21 134.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -109.31 103.98 13.03 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.281 -2.38 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.78 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.08 129.44 62.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.95 164.02 33.34 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 123.503 0.721 . . . . 0.0 111.157 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 38.7 mt-10 -108.33 136.5 47.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -139.56 158.59 43.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -103.82 139.05 39.56 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 36.8 mm -78.01 125.06 37.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 -39.3 7.08 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -160.87 167.84 25.87 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -143.31 151.12 40.13 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.65 165.05 37.15 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -108.83 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.51 134.02 39.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t70 67.0 24.17 9.6 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.401 1.095 . . . . 0.0 109.67 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.87 -9.18 77.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.208 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.18 164.96 13.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 117.387 0.594 . . . . 0.0 111.229 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 34' ' ' ILE . 3.4 t -97.62 117.47 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.511 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.23 134.39 53.8 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.064 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 27.3 m-85 -108.34 146.33 33.13 Favored 'General case' 0 C--N 1.271 -2.813 0 C-N-CA 123.84 0.856 . . . . 0.0 109.057 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -107.63 107.68 18.6 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 13.5 m -121.1 148.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.156 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -118.71 126.13 51.2 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 51.7 m-85 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 121.545 0.688 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.2 m95 -101.44 124.32 46.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.217 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 14' ' ' VAL . 32.0 m -123.78 144.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -80.43 159.07 25.76 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -58.19 -33.48 69.3 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.459 0.647 . . . . 0.0 111.294 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -60.96 -25.71 67.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.621 1.168 . . . . 0.0 111.188 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.07 -5.44 57.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.033 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -107.84 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.835 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.39 109.9 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.8 124.07 53.7 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.445 -1.359 0 N-CA-C 108.756 -1.286 . . . . 0.0 108.756 174.426 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 9.3 p . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 120.955 0.407 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.46 -11.3 72.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.205 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' SER . 26.9 m -71.68 121.41 18.8 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 107.18 19.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -113.62 178.81 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.16 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -108.98 141.6 40.84 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.604 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 56' ' ' VAL . 95.7 t -127.44 130.32 70.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 86.4 tttt -122.54 104.98 9.72 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.6 t80 . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.329 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? . . . . . 0 CA--C 1.498 -1.038 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -108.8 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.05 165.78 18.84 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.609 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -108.24 134.01 51.67 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -137.0 174.13 10.95 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.831 0.348 . . . . 0.0 111.603 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 45.1 m -123.77 137.5 54.67 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 mm -69.17 123.67 23.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -106.86 -40.96 5.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.928 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -152.77 166.04 33.47 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -151.07 144.35 24.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.47 166.27 33.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.958 0.409 . . . . 0.0 110.862 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 39' ' ' VAL . 1.4 mp -108.36 120.15 59.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 28.5 t70 -132.57 125.28 30.14 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.43 23.34 13.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.319 1.057 . . . . 0.0 110.229 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.36 8.34 68.44 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.603 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.5 pt-20 -125.12 156.74 37.85 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 117.686 0.743 . . . . 0.0 109.768 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 34' ' ' ILE . 11.8 t -98.78 119.31 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 CA-C-O 121.524 0.678 . . . . 0.0 110.133 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -108.77 137.25 47.0 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.745 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 26.3 m-85 -111.64 142.51 43.87 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.393 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD13 ' CE2' ' A' ' 55' ' ' TRP . 58.4 tp -108.0 111.84 24.12 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.24 142.94 42.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.569 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -120.3 142.24 49.27 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 54.3 m-85 . . . . . 0 C--N 1.282 -2.336 0 O-C-N 124.481 1.113 . . . . 0.0 111.113 -171.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 121.201 0.524 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 81.0 m95 -103.36 117.66 34.99 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.891 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 14' ' ' VAL . 25.6 m -122.05 165.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 80.9 tttt -103.31 164.98 11.3 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.92 74.57 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.566 0.746 . . . . 0.0 113.009 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -74.08 -6.52 48.07 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 16.8 mmt-85 -104.69 11.68 33.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.327 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.62 138.64 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.278 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 13' ' ' LYS . 3.9 mp -108.33 114.44 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -83.72 115.55 60.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.135 0 C-N-CA 122.031 1.821 . . . . 0.0 111.027 -179.579 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 -32.19 6.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.567 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 m -63.87 132.7 51.6 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.082 0.553 . . . . 0.0 110.035 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -93.11 131.23 38.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.405 HG12 ' HD3' ' A' ' 64' ' ' PRO . 35.3 m -129.74 -179.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.486 -172.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 24' ' ' ILE . 28.4 mmmt -114.03 135.36 54.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 43' ' ' VAL . 86.4 t -116.11 133.14 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -107.9 114.18 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.114 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' CE2' HG12 ' A' ' 56' ' ' VAL . 1.5 m-85 . . . . . 0 CA--C 1.496 -1.098 0 CA-C-O 121.015 0.436 . . . . 0.0 110.616 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.636 HG22 ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -112.63 133.61 57.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 8.7 m-85 -107.5 166.77 10.42 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -172.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -106.75 116.46 31.96 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.86 167.75 19.65 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.741 -0.599 . . . . 0.0 111.497 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.557 HD13 HG12 ' A' ' 43' ' ' VAL . 33.7 mm -78.78 128.35 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 123.642 0.589 . . . . 0.0 111.145 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.346 1.058 . . . . 0.0 111.895 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 t -154.39 167.86 28.57 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -132.83 139.7 47.61 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.56 156.38 45.1 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 123.575 0.547 . . . . 0.0 110.097 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.77 119.92 59.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.22 131.7 32.8 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 65.64 22.03 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.397 1.094 . . . . 0.0 109.855 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.96 87.7 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.383 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -116.51 159.37 22.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 122.495 -0.415 . . . . 0.0 111.765 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 34' ' ' ILE . 3.3 t -98.86 116.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.43 0.633 . . . . 0.0 111.093 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -112.73 139.94 47.93 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.486 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 31.2 m-85 -108.15 157.25 18.46 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.93 115.02 29.46 Favored 'General case' 0 CA--C 1.465 -2.311 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 14' ' ' VAL . 13.8 m -129.17 142.59 43.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -117.84 125.47 50.6 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.619 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.291 -1.951 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -178.483 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 N--CA 1.44 -0.966 0 CA-C-O 121.086 0.469 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.1 m95 -98.83 126.84 44.59 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.462 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 16' ' ' TYR . 34.3 m -135.94 165.22 30.17 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.831 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.69 166.47 10.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.36 74.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.654 . . . . 0.0 111.239 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.11 -15.64 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.735 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 60' ' ' ARG . 14.6 tpt180 -95.95 0.61 52.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.825 0.821 . . . . 0.0 109.61 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.99 150.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.268 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.0 mp -107.64 104.57 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -75.81 150.83 84.2 Favored Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.346 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' HG12 ' A' ' 12' ' ' VAL . 7.5 Cg_exo . . . . . 0 N--CA 1.448 -1.201 0 C-N-CA 122.612 2.208 . . . . 0.0 111.201 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 30' ' ' LYS . 1.9 m . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.54 -22.22 40.73 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.794 174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -66.09 118.65 10.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -91.0 115.07 27.72 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.54 178.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 34.4 tttp -120.92 139.11 53.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.71 139.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 40.8 ttmt -125.01 104.09 8.37 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.247 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.157 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.836 0 CA-C-O 121.234 0.54 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.459 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -108.17 115.17 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.23 162.48 32.03 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.449 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 13' ' ' LYS . 54.6 mt-10 -113.85 136.8 52.48 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.089 0.471 . . . . 0.0 112.071 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -141.25 -178.04 5.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.289 -171.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -134.95 133.37 39.48 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 43' ' ' VAL . 46.5 mm -67.78 131.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.797 0.686 . . . . 0.0 110.98 -176.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -101.8 -60.92 1.45 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.7 m -147.98 164.82 32.59 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -134.29 151.98 51.56 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.12 165.57 35.22 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 123.167 0.292 . . . . 0.0 110.237 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -111.14 131.39 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.95 115.87 13.18 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 63.79 23.44 13.44 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.262 1.425 . . . . 0.0 111.623 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.79 -10.55 55.87 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.419 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.17 147.1 31.79 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.722 0.761 . . . . 0.0 109.565 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.6 118.04 44.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.96 130.06 55.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.605 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 37.4 m-85 -108.16 147.91 30.63 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.897 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.8 tp -107.55 113.07 26.14 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 HD13 ' A' ' 29' ' ' ILE . 2.4 p -118.42 147.03 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.443 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.15 125.92 51.19 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.654 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 90.2 m-85 . . . . . 0 C--N 1.304 -1.403 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.582 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 121.266 0.555 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 74.9 m95 -102.41 106.47 17.22 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.37 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 61' ' ' ILE . 3.0 p -122.88 148.04 26.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.151 -174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 61' ' ' ILE . 26.3 mtmm -73.15 158.28 35.59 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -61.2 -39.88 91.88 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.115 0.966 . . . . 0.0 113.066 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -86.05 -2.48 58.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -96.69 5.61 50.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.206 1.003 . . . . 0.0 109.016 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 57' ' ' LYS . 70.0 mt -120.48 153.32 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.084 -1.416 . . . . 0.0 107.336 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.1 mp -107.39 109.51 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -87.89 120.05 70.69 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.075 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.439 -1.695 0 C-N-CA 121.334 1.356 . . . . 0.0 109.558 175.002 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.429 -1.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.96 -11.3 48.9 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.334 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -78.28 128.22 33.39 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -93.24 121.67 34.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.812 0.815 . . . . 0.0 109.898 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.44 179.46 2.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.142 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 53.0 mtmt -108.83 143.84 37.5 Favored 'General case' 0 CA--C 1.475 -1.905 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.36 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 56' ' ' VAL . 92.7 t -121.44 128.94 75.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.048 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.7 ttmt -107.64 104.1 13.55 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 t80 . . . . . 0 C--N 1.302 -1.471 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.878 -171.188 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 61.5 mt -108.69 112.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.55 166.93 10.73 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 13' ' ' LYS . 50.7 mt-10 -107.11 119.79 40.32 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . -126.21 177.61 6.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -129.19 128.04 42.54 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 122.203 -0.311 . . . . 0.0 110.203 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 43' ' ' VAL . 33.4 mm -65.62 130.17 30.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 O-C-N 124.1 0.875 . . . . 0.0 109.786 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -117.63 -42.82 2.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -158.3 170.18 22.83 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.908 -0.495 . . . . 0.0 109.963 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 140.58 41.99 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -145.47 155.44 43.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.747 0.419 . . . . 0.0 110.253 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.7 124.86 65.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -125.92 104.32 8.24 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.05 64.46 1.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 112.97 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -26.57 5.71 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.692 -1.14 . . . . 0.0 115.525 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.14 149.45 28.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.311 1.056 . . . . 0.0 111.215 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.45 125.59 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.448 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.1 mt -112.3 138.56 48.83 Favored 'General case' 0 N--CA 1.405 -2.722 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.372 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 30.9 m-85 -108.0 149.14 28.76 Favored 'General case' 0 C--N 1.258 -3.411 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 55' ' ' TRP . 39.8 tp -107.29 104.26 13.83 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 14' ' ' VAL . 3.8 p -118.77 138.36 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -173.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.69 143.76 47.57 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.972 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.223 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 75.6 m95 -98.47 122.88 42.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.37 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 14' ' ' VAL . 18.1 m -130.44 152.48 37.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -79.82 153.03 29.4 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.05 -2.51 37.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 13.5 mtp180 -106.09 10.19 32.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.011 0.434 . . . . 0.0 110.498 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.5 mt -108.81 139.24 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.373 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.1 mp -108.05 107.61 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -84.88 130.41 52.75 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 122.902 2.402 . . . . 0.0 112.589 -179.409 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.431 -1.403 0 CA-C-O 121.262 0.553 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.56 0.14 82.35 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.812 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' SER . 91.5 m -78.22 131.78 37.28 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -86.22 129.98 34.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.36 175.84 9.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 30.2 ttpt -120.51 146.64 46.08 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 56' ' ' VAL . 93.3 t -129.62 132.57 66.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -173.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.56 103.14 9.16 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 C--N 1.313 -1.009 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.112 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -107.98 124.09 63.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.5 165.63 31.59 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 124.228 1.011 . . . . 0.0 109.983 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.01 136.88 46.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . . . -131.16 -178.27 4.76 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.828 -173.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 m -138.62 139.38 38.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 43' ' ' VAL . 34.3 mm -77.88 135.31 26.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.948 0.404 . . . . 0.0 111.586 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -103.42 -58.71 1.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -148.68 -178.64 6.45 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.687 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.09 145.24 41.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.42 154.02 50.91 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.62 119.32 61.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -135.09 119.73 18.2 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.48 23.0 12.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 110.648 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.52 -8.9 66.65 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.491 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -109.47 143.85 38.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 117.762 0.781 . . . . 0.0 110.565 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.54 123.21 50.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 122.395 1.093 . . . . 0.0 110.666 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.89 145.38 35.46 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.022 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.541 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 34.6 m-85 -113.22 151.84 30.49 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.783 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CE2' ' A' ' 55' ' ' TRP . 40.8 tp -107.72 116.5 32.07 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 29' ' ' ILE . 5.9 m -118.95 140.99 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.612 -174.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -130.25 138.47 50.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.092 0.472 . . . . 0.0 111.121 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 20.4 m-85 . . . . . 0 C--N 1.284 -2.282 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.809 -171.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 120.914 0.388 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.477 ' CE2' HD13 ' A' ' 42' ' ' LEU . 74.6 m95 -104.37 129.08 52.29 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 14' ' ' VAL . 29.5 t -138.93 140.23 39.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' ILE . 33.0 ttpt -71.68 150.66 44.35 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 120.756 0.312 . . . . 0.0 111.505 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.541 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -52.56 -49.67 64.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.685 1.594 . . . . 0.0 113.73 -170.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.35 -7.71 54.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.689 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -106.87 8.37 30.65 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.382 1.087 . . . . 0.0 108.707 -175.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 57' ' ' LYS . 68.1 mt -108.61 157.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.07 108.6 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -97.95 146.24 31.15 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo . . . . . 0 N--CA 1.44 -1.653 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 174.032 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.436 -1.154 0 CA-C-O 121.074 0.464 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.06 -20.34 21.8 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.861 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.3 m -74.68 128.67 36.11 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 1.2 pptp? -87.9 127.4 35.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.419 0.628 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.06 176.68 6.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.94 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.3 mmtm -110.92 135.47 51.4 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 43' ' ' VAL . 96.8 t -124.38 131.72 72.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.12 114.35 28.18 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.434 -1.261 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.822 -175.831 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 pttt . . . . . 0 N--CA 1.429 -1.508 0 CA-C-O 121.546 0.689 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.59 129.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.88 165.66 13.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.194 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -115.11 136.68 52.85 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' HG22 ' A' ' 43' ' ' VAL . . . -136.94 -178.71 5.31 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 m -142.67 130.07 21.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 43' ' ' VAL . 42.0 mm -57.94 127.0 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 124.071 0.857 . . . . 0.0 111.152 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.38 -46.03 5.38 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -154.43 153.79 32.14 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -126.64 133.6 50.95 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -142.09 158.86 43.26 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 123.699 0.625 . . . . 0.0 110.378 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.401 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.46 129.94 61.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.581 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.15 103.92 8.86 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.519 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 46.69 63.82 1.76 Allowed 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 125.601 1.56 . . . . 0.0 113.057 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 -24.46 11.51 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.12 -0.945 . . . . 0.0 115.275 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.81 149.13 29.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.466 1.133 . . . . 0.0 110.49 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 34' ' ' ILE . 9.8 t -98.52 119.55 46.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.69 143.07 38.28 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -108.45 139.84 42.61 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.579 HD13 ' CE2' ' A' ' 55' ' ' TRP . 59.8 tp -107.61 106.59 17.02 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG22 ' HB1' ' A' ' 27' ' ' ALA . 4.1 p -125.82 141.91 44.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.605 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -118.99 146.47 44.99 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.31 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 33.5 m-85 . . . . . 0 C--N 1.29 -1.98 0 O-C-N 123.967 0.792 . . . . 0.0 110.575 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.438 -1.04 0 CA-C-O 120.746 0.308 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CE2' HD13 ' A' ' 42' ' ' LEU . 84.9 m95 -108.38 110.61 22.21 Favored 'General case' 0 C--O 1.253 1.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.316 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.5 m -135.77 139.74 45.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.018 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -80.98 168.2 18.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.1 63.19 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.485 0.714 . . . . 0.0 112.867 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.48 -19.35 53.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.341 0.591 . . . . 0.0 110.859 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -92.13 -5.24 53.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.334 1.064 . . . . 0.0 108.415 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.79 150.71 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.829 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -108.65 115.21 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 172.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -81.15 108.98 11.88 Favored Pre-proline 0 C--N 1.31 -1.148 0 O-C-N 123.144 0.278 . . . . 0.0 111.013 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.441 -1.58 0 C-N-CA 122.288 1.992 . . . . 0.0 113.851 -175.552 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.8 p . . . . . 0 N--CA 1.427 -1.589 0 CA-C-O 121.137 0.494 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.13 8.48 57.78 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.441 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 m -77.86 126.87 31.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 95.3 mttt -94.52 124.29 38.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.119 0.485 . . . . 0.0 111.387 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.99 -178.96 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.789 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 32.6 ttpt -124.79 146.47 49.21 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 56' ' ' VAL . 99.4 t -126.09 137.69 56.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 122.836 0.455 . . . . 0.0 110.238 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -110.57 107.0 16.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.305 -1.357 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.175 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 mptt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.62 108.53 25.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 170.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.57 165.09 19.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.87 -174.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.47 139.07 43.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.8 -179.68 6.75 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.199 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 6.6 m -129.47 136.87 50.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 43' ' ' VAL . 39.1 mm -69.85 129.63 34.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.07 -47.1 4.87 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -155.97 168.03 28.54 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -140.5 150.69 44.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.46 162.43 40.74 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -114.26 124.7 71.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.06 108.18 10.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.025 0.441 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.32 65.0 1.01 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.521 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -26.53 3.34 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.618 -1.173 . . . . 0.0 115.181 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.11 148.69 36.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.623 0.711 . . . . 0.0 111.562 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.2 p -98.32 125.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.683 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.89 134.9 51.57 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.705 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -110.84 145.91 37.37 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.056 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.1 tp -108.29 119.8 40.54 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 29' ' ' ILE . 8.5 m -118.23 149.62 20.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -125.61 138.65 53.93 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . 0.258 58.1 m-85 . . . . . 0 C--N 1.286 -2.187 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -168.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.24 0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.4 ' CE2' HD13 ' A' ' 42' ' ' LEU . 79.9 m95 -104.78 122.28 45.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.686 -176.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 14' ' ' VAL . 19.2 m -134.29 143.93 36.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -82.84 160.79 22.12 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 123.358 0.663 . . . . 0.0 110.467 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.59 61.56 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.57 0.748 . . . . 0.0 112.204 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.79 -2.57 37.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.291 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -111.88 0.53 16.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 56' ' ' VAL . 45.3 mt -114.64 152.69 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 111.599 -172.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.2 mp -107.48 112.55 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 98.7 m95 -93.85 137.78 22.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 22.8 Cg_exo . . . . . 0 N--CA 1.443 -1.47 0 C-N-CA 121.92 1.746 . . . . 0.0 108.865 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.42 -1.968 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.72 -25.59 7.17 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.934 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.3 m -62.53 121.17 12.64 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.322 0.582 . . . . 0.0 109.837 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -97.72 122.58 40.98 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.263 -176.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.85 -179.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.857 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -113.33 140.32 48.11 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 43' ' ' VAL . 86.2 t -132.85 138.56 51.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 118.721 0.692 . . . . 0.0 111.204 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HE3' HD11 ' A' ' 62' ' ' ILE . 94.1 mttt -108.61 143.68 37.35 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 . . . . . 0 C--N 1.313 -0.997 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.716 176.892 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -0.997 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.16 114.88 46.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 165.76 15.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.09 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -108.79 142.2 39.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.09 172.94 15.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.5 p -122.64 146.92 47.02 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 8' ' ' THR . 20.8 mm -66.72 131.92 32.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -103.24 -45.8 4.79 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -165.04 -176.55 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -150.28 165.01 34.28 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.498 0.719 . . . . 0.0 109.445 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -160.46 166.35 29.36 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.33 1.452 . . . . 0.0 110.081 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -107.2 117.26 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.25 114.53 15.78 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.045 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 69.15 23.61 6.36 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.895 1.278 . . . . 0.0 110.512 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.48 54.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.558 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.0 159.34 16.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.434 -0.451 . . . . 0.0 111.183 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 34' ' ' ILE . 60.8 t -98.35 117.38 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.39 0.614 . . . . 0.0 109.739 -176.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 6.2 mp -111.04 154.66 23.89 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.799 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 88.9 m-85 -116.85 148.78 40.96 Favored 'General case' 0 C--N 1.255 -3.521 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.52 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ2' ' A' ' 55' ' ' TRP . 36.0 tp -107.09 116.36 31.78 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 14' ' ' VAL . 29.4 m -118.18 144.09 27.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.534 -172.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -117.37 125.57 51.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 . . . . . 0 C--N 1.304 -1.399 0 CA-C-N 114.739 -1.118 . . . . 0.0 112.969 -170.585 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 79.3 m95 -98.56 126.98 44.32 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.754 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.01 140.84 32.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.548 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 35.5 ttpt -76.86 164.17 26.07 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 122.328 -0.233 . . . . 0.0 110.677 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.09 -32.08 63.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.009 0.524 . . . . 0.0 112.085 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.48 -24.75 65.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.285 1.034 . . . . 0.0 111.701 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -94.72 -6.42 43.2 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.555 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.1 147.65 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.89 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -107.72 106.65 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 81.9 m95 -82.51 136.15 45.9 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.616 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 51.3 Cg_exo . . . . . 0 CA--C 1.506 -0.903 0 C-N-CA 122.392 2.062 . . . . 0.0 111.114 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 30' ' ' LYS . 91.0 m . . . . . 0 N--CA 1.428 -1.525 0 CA-C-O 121.238 0.542 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -16.54 50.96 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -71.88 125.38 27.04 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.049 0.452 . . . . 0.0 110.298 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -93.38 109.95 21.51 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 61' ' ' ILE . 7.5 p -125.97 175.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.894 -172.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 12' ' ' VAL . 28.4 ttpt -108.83 143.79 37.56 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 56' ' ' VAL . 77.7 t -125.46 129.36 72.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 123.666 0.786 . . . . 0.0 110.325 -173.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 86.5 tttt -108.76 112.9 25.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--N 1.282 -2.357 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.255 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 N--CA 1.417 -2.122 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.87 128.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 165.78 27.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.724 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 32.3 mt-10 -111.01 134.37 52.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . . . -138.21 179.24 6.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.587 0.708 . . . . 0.0 112.39 -172.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -122.4 136.28 54.86 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.506 HD13 HG12 ' A' ' 43' ' ' VAL . 48.1 mm -72.56 127.46 34.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -109.3 -41.79 4.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -147.73 170.34 17.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -146.85 142.34 27.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.61 144.81 44.29 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.665 0.386 . . . . 0.0 110.809 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.44 112.86 42.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -149.54 133.39 16.97 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t70 71.93 23.35 3.56 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.982 1.313 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.14 4.73 81.18 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.998 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 11.8 pt-20 -127.18 157.48 39.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 117.153 0.477 . . . . 0.0 110.329 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.11 118.88 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-O 122.223 1.011 . . . . 0.0 109.403 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' A' ' 38' ' ' GLU . 1.9 mm? -108.64 136.87 47.52 Favored 'General case' 0 N--CA 1.403 -2.802 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.065 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 33.8 m-85 -107.51 145.58 32.92 Favored 'General case' 0 C--N 1.259 -3.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.49 114.48 28.51 Favored 'General case' 0 N--CA 1.39 -3.454 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.506 HG12 HD13 ' A' ' 29' ' ' ILE . 5.1 m -117.82 148.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.819 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -132.18 137.12 47.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 55.0 m-85 . . . . . 0 C--N 1.285 -2.211 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.425 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 C--O 1.238 0.478 0 CA-C-O 121.004 0.431 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 66.3 m95 -107.6 120.35 41.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.295 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.443 HG21 HG11 ' A' ' 14' ' ' VAL . 28.3 t -125.52 145.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 38' ' ' GLU . 60.6 tttm -81.91 149.45 28.24 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.11 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.605 1.162 . . . . 0.0 113.228 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.11 -25.25 65.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.181 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 33.8 mtt85 -97.19 7.74 45.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.177 0.513 . . . . 0.0 111.625 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.469 HG22 HG21 ' A' ' 12' ' ' VAL . 44.0 mt -108.33 146.51 14.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.24 102.54 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 97.2 m95 -81.72 124.91 79.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.701 -171.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 18.5 Cg_exo . . . . . 0 N--CA 1.446 -1.3 0 C-N-CA 122.51 2.14 . . . . 0.0 113.107 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.431 -1.402 0 CA-C-O 120.85 0.357 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.51 -33.6 6.23 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -66.81 128.42 36.25 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 123.225 0.61 . . . . 0.0 111.034 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -97.65 126.03 42.74 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.83 179.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 47.6 mtmt -107.7 142.81 37.12 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 56' ' ' VAL . 85.9 t -123.45 135.95 61.62 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.182 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.196 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.8 ttmt -107.29 102.87 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD1' HG12 ' A' ' 56' ' ' VAL . 64.2 t80 . . . . . 0 C--N 1.271 -2.845 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 31.1 mmmt . . . . . 0 C--O 1.244 0.813 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.86 114.46 46.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 15.1 m-85 -112.72 165.78 11.97 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 13' ' ' LYS . 30.2 mp0 -105.83 131.21 53.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -134.71 161.83 34.05 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.788 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 m -116.43 137.27 52.3 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 43' ' ' VAL . 38.7 mm -76.55 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.598 0.561 . . . . 0.0 111.83 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -99.33 -61.73 1.33 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -156.15 -179.86 8.55 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.93 145.32 30.64 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.068 0.395 . . . . 0.0 110.31 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -141.48 157.22 45.42 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.844 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 mp -114.01 133.0 61.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 17.9 t70 -143.68 125.24 14.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.1 t70 59.12 22.51 10.65 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.625 1.17 . . . . 0.0 111.416 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.76 -8.73 59.94 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.781 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 25.8 pt-20 -107.33 149.04 28.26 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 34' ' ' ILE . 7.6 p -109.76 121.36 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-O 122.415 1.103 . . . . 0.0 110.781 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 57' ' ' LYS . 1.3 mm? -108.86 131.88 54.57 Favored 'General case' 0 N--CA 1.389 -3.48 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.277 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 25.5 m-85 -107.86 146.87 31.7 Favored 'General case' 0 C--N 1.257 -3.424 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.7 OUTLIER -107.03 111.26 23.66 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -178.43 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 29' ' ' ILE . 12.8 m -126.49 151.92 33.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -173.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.43 133.12 51.32 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.891 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 33.3 m-85 . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 65.3 m95 -100.59 126.05 47.02 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.749 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 14' ' ' VAL . 20.4 m -129.96 165.63 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 86.1 mttt -99.79 171.18 8.05 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.277 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.92 93.17 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.89 0.876 . . . . 0.0 111.886 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -60.93 -26.04 67.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.702 0.763 . . . . 0.0 111.145 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 23.1 mmm180 -87.39 -0.68 57.13 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.781 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -112.19 143.27 22.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.989 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.7 108.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -90.17 159.13 42.89 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 N--CA 1.449 -1.099 0 C-N-CA 121.898 1.732 . . . . 0.0 111.239 177.358 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 30' ' ' LYS . 5.2 m . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.718 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.34 -15.66 55.98 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -83.04 130.71 35.16 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -110.93 112.95 25.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.457 1.122 . . . . 0.0 109.359 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 34.7 m -116.94 -179.71 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.408 -169.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.03 136.76 47.18 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 56' ' ' VAL . 96.7 t -114.56 134.61 57.01 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.712 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.913 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -107.72 104.71 14.29 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.269 -2.926 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -179.82 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.404 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 37.5 pttt . . . . . 0 N--CA 1.421 -1.918 0 CA-C-O 120.784 0.326 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.46 122.36 64.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' OH ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -143.53 166.75 23.95 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.308 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.1 mt-10 -105.44 120.51 41.79 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.82 0.819 . . . . 0.0 109.019 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -129.14 152.6 48.56 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.699 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 19.3 m -104.16 137.1 42.59 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD13 HG12 ' A' ' 43' ' ' VAL . 39.2 mm -74.16 128.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.465 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.499 ' HA ' HG23 ' A' ' 8' ' ' THR . 1.1 tmmt? -114.66 -50.65 2.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -129.71 166.97 18.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -148.98 153.15 37.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 34' ' ' ILE . 11.1 pt-20 -144.44 158.52 43.71 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.5 mp -122.21 109.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -139.99 139.36 36.04 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.432 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 65.19 22.51 12.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.664 1.221 . . . . 0.0 109.785 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.5 -0.68 89.52 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.96 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.57 148.75 39.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 117.111 0.456 . . . . 0.0 111.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.23 119.27 46.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.4 mt -108.76 132.59 53.82 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.974 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 54.3 m-85 -108.94 145.16 35.89 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.742 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.0 tm? -108.1 113.55 26.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 29' ' ' ILE . 6.2 m -121.41 153.71 25.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.718 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -145.52 153.28 40.94 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.848 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 4.1 m-85 . . . . . 0 C--N 1.29 -1.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.803 -168.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.22 -0.464 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 83.6 m95 -112.28 113.65 26.0 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.527 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 14' ' ' VAL . 23.5 m -129.82 149.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.481 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -89.32 162.42 15.83 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.175 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.89 65.61 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.854 1.262 . . . . 0.0 112.986 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.73 -20.54 62.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -92.64 3.13 56.16 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.57 145.64 15.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.078 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.92 112.15 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 95.8 m95 -93.55 119.05 67.58 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.216 -174.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 27.2 Cg_exo . . . . . 0 CA--C 1.497 -1.332 0 C-N-CA 123.323 2.682 . . . . 0.0 112.485 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.426 -1.636 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.7 -7.11 82.47 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.39 121.49 20.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -87.55 111.86 21.65 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.044 0.925 . . . . 0.0 109.999 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.18 176.32 3.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.332 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.6 ttpt -111.64 139.1 47.38 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.401 ' CG1' HG11 ' A' ' 56' ' ' VAL . 78.3 t -118.87 132.32 69.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 C-N-CA 122.941 0.497 . . . . 0.0 111.297 -172.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -108.42 104.69 14.09 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 124.885 1.274 . . . . 0.0 107.715 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.6 t80 . . . . . 0 C--N 1.289 -2.051 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.126 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 25' ' ' TYR . 11.3 ptpt . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.0 mt -108.82 114.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -108.49 166.9 10.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.05 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 45.0 mt-10 -114.87 132.18 56.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -143.51 168.14 20.56 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.292 -171.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 p -106.43 142.35 36.24 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 43' ' ' VAL . 42.5 mm -68.38 120.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -93.22 -38.85 11.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 t -169.27 173.57 6.6 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -145.93 140.29 26.84 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -142.36 155.52 45.16 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.204 0.601 . . . . 0.0 109.638 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -108.81 124.92 65.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.76 104.87 8.08 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.714 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 55.46 64.12 1.86 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.546 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.28 -25.57 4.86 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 114.86 -1.064 . . . . 0.0 114.858 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.47 150.1 27.89 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.735 0.768 . . . . 0.0 112.932 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.66 118.36 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.05 134.78 50.46 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -107.81 146.74 31.83 Favored 'General case' 0 C--N 1.259 -3.331 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.62 121.96 45.73 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 29' ' ' ILE . 12.9 m -118.81 148.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-O 121.392 0.615 . . . . 0.0 109.716 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -118.44 118.01 30.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 75.8 m-85 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -170.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.267 0.556 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.48 131.14 55.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.488 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG11 ' CG1' ' A' ' 14' ' ' VAL . 34.8 m -138.77 144.46 29.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -80.6 160.95 24.94 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.36 -34.52 57.92 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.684 0.754 . . . . 0.0 111.182 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.18 -34.15 59.79 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.455 1.502 . . . . 0.0 111.633 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -95.31 6.61 48.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.86 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -113.52 142.35 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-O 121.635 0.731 . . . . 0.0 111.732 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.3 mp -107.87 104.97 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -85.26 155.13 60.32 Favored Pre-proline 0 C--N 1.291 -1.944 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 N--CA 1.453 -0.898 0 C-N-CA 121.267 1.311 . . . . 0.0 109.066 175.723 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.91 -11.83 62.43 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.803 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.5 m -77.53 131.36 37.85 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -86.11 114.76 23.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.754 0.787 . . . . 0.0 110.843 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.28 -179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 24.2 ttmt -116.76 140.42 49.45 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG1' HG11 ' A' ' 56' ' ' VAL . 94.5 t -117.31 131.46 69.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 121.186 0.517 . . . . 0.0 110.303 -176.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -106.71 104.82 14.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.299 -1.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.452 -173.338 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.721 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.27 126.78 71.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.96 165.78 26.43 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.169 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 138.53 45.0 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 161.72 38.21 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -104.17 138.66 40.33 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.3 128.31 29.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.032 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 28.6 tptp -100.9 -62.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.7 m -147.19 161.44 40.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -127.19 138.27 53.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.29 161.57 37.69 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.376 0.608 . . . . 0.0 111.673 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.91 130.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -135.82 115.91 13.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 59.7 35.11 22.23 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.548 1.139 . . . . 0.0 111.357 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.45 -12.24 66.5 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.344 -0.931 . . . . 0.0 114.238 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.1 pt-20 -116.98 151.99 35.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.5 0.65 . . . . 0.0 111.235 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG22 HG13 ' A' ' 34' ' ' ILE . 8.4 t -98.83 125.25 52.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.9 0.381 . . . . 0.0 110.147 -175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.67 160.33 26.05 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.481 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -114.11 144.42 43.17 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.764 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' NE1' ' A' ' 55' ' ' TRP . 3.5 tm? -108.23 116.52 32.11 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 m -117.67 149.12 20.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.484 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -118.35 128.02 54.25 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 C--N 1.287 -2.117 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -175.119 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.677 0.275 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.464 ' NE1' HD23 ' A' ' 42' ' ' LEU . 78.0 m95 -107.25 122.83 47.34 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.463 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG11 ' CG1' ' A' ' 14' ' ' VAL . 16.5 m -135.99 144.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.232 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.3 tttt -79.75 160.61 26.14 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -36.52 62.86 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.116 0.967 . . . . 0.0 112.244 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.2 -10.43 59.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -103.33 4.88 36.92 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.48 140.92 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.146 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.6 mp -107.86 112.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -86.31 132.73 42.29 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.656 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.446 -1.277 0 N-CA-C 107.518 -1.762 . . . . 0.0 107.518 173.282 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 30' ' ' LYS . 16.1 m . . . . . 0 N--CA 1.418 -2.071 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.65 -18.31 7.2 Favored Glycine 0 C--N 1.31 -0.884 0 C-N-CA 119.657 -1.258 . . . . 0.0 112.965 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -73.49 129.35 37.8 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -95.03 144.17 25.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.83 179.55 3.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.0 mmmt -108.05 134.39 51.01 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 56' ' ' VAL . 93.7 t -115.52 128.18 72.83 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.098 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 86.8 tttt -106.86 104.29 13.94 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 56' ' ' VAL . 63.4 t80 . . . . . 0 C--N 1.294 -1.825 0 CA-C-O 121.424 0.63 . . . . 0.0 110.588 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.94 129.98 67.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -129.48 166.65 19.21 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.23 1.012 . . . . 0.0 109.449 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -107.8 125.83 51.9 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.21 46.06 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 8.5 p -104.44 142.7 34.14 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.479 HD13 HG12 ' A' ' 43' ' ' VAL . 32.8 mm -73.76 129.55 36.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.6 tmtt? -98.46 -54.75 2.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -155.22 -179.89 8.52 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 41' ' ' TYR . 10.1 t -158.49 165.06 35.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 34' ' ' ILE . 12.7 pt-20 -148.07 158.07 43.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.345 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.9 mp -119.2 111.48 33.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -123.33 122.87 39.4 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 68.67 23.03 7.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.732 1.213 . . . . 0.0 110.141 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.42 -6.55 74.97 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.522 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.27 151.04 31.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 117.73 0.765 . . . . 0.0 110.689 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 34' ' ' ILE . 4.2 t -97.95 124.15 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.728 0.775 . . . . 0.0 110.035 -172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -108.47 125.62 51.99 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.71 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 87.0 m-85 -108.97 147.5 32.17 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.398 -176.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.424 HD13 ' NE1' ' A' ' 55' ' ' TRP . 55.6 tp -107.54 110.4 22.31 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 29' ' ' ILE . 13.8 m -118.23 148.61 20.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -126.73 129.66 48.82 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 . . . . . 0 C--N 1.303 -1.451 0 O-C-N 124.145 0.903 . . . . 0.0 111.052 -172.188 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 73.6 m95 -98.24 134.08 41.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.245 0.545 . . . . 0.0 111.488 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 16' ' ' TYR . 26.8 m -133.23 165.21 32.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.1 157.42 16.89 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.24 -32.51 48.66 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.659 0.784 . . . . 0.0 112.263 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -26.15 68.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.423 1.089 . . . . 0.0 111.897 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 27.0 mmm-85 -93.91 0.58 56.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -109.31 140.36 28.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.63 -173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.7 mp -109.04 108.87 26.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -83.07 124.95 75.95 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 121.616 1.544 . . . . 0.0 109.838 177.468 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -144.23 178.04 8.18 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.265 0.555 . . . . 0.0 109.877 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -151.41 162.57 40.7 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.22 117.15 62.08 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 118.356 0.525 . . . . 0.0 109.906 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.94 177.71 5.43 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.591 2.194 . . . . 0.0 111.679 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m -82.01 91.51 6.63 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.516 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 29' ' ' ILE 0.473 0.0 OUTLIER 42.73 53.09 4.95 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 178.528 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.61 151.29 37.84 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.537 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.48 65.65 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 m -92.79 117.24 29.81 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -97.34 134.48 40.57 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 171.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' HD3' ' A' ' 64' ' ' PRO . 33.9 m -126.47 177.2 5.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.955 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -108.98 129.46 55.45 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.285 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -123.45 136.82 58.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 118.028 0.376 . . . . 0.0 111.432 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 41.0 ttmt -108.68 146.62 33.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -154.26 114.98 3.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 22' ' ' GLN . . . -137.62 113.23 0.98 Allowed Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.71 -1.233 . . . . 0.0 114.484 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -146.67 106.36 3.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.715 0.806 . . . . 0.0 109.976 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.94 -120.37 7.27 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.783 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -85.99 -21.46 27.81 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -80.52 77.33 7.33 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.851 0.834 . . . . 0.0 109.839 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.437 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 23.2 tp60 -128.91 109.23 11.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.126 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 1.9 mptp? -140.01 165.09 28.28 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.34 108.28 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.8 m-85 -108.36 167.67 9.86 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.959 -169.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.68 126.69 52.6 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.7 159.66 41.37 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.749 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.61 144.59 36.14 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 7' ' ' LEU . 50.3 mm -77.15 131.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.437 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' A' ' 44' ' ' HIS . 9.3 mtmt -99.62 -52.85 3.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.897 0.855 . . . . 0.0 110.115 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 m -155.08 166.87 32.24 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.153 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -136.65 143.14 43.31 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -144.64 162.36 36.86 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.288 0.566 . . . . 0.0 110.852 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -108.3 113.14 43.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -122.83 104.6 9.39 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.107 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 57.73 64.62 1.51 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.301 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.89 -26.33 4.86 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.847 -1.07 . . . . 0.0 115.668 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 10.3 pt-20 -116.34 160.95 19.76 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 118.119 0.959 . . . . 0.0 112.8 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.64 120.86 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.291 0.567 . . . . 0.0 109.916 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 143.45 45.16 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.645 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 69.7 m-85 -108.83 149.79 28.59 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -107.77 117.63 34.61 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 175.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.543 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 14.4 m -117.32 153.87 19.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.658 ' HA ' ' OD1' ' A' ' 53' ' ' ASP . 82.6 t60 -117.57 114.05 22.86 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.823 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -73.02 125.99 28.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 123.639 0.587 . . . . 0.0 110.268 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -85.46 96.28 9.55 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.15 -4.21 18.43 Favored Glycine 0 C--O 1.239 0.463 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.177 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -123.79 -164.68 1.25 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -34.35 100.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.608 1.563 . . . . 0.0 114.182 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.1 -7.99 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.427 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -56.56 2.34 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -87.38 -34.91 18.63 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.103 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.658 ' OD1' ' HA ' ' A' ' 44' ' ' HIS . 37.7 m-20 60.64 -161.99 0.27 Allowed 'General case' 0 C--O 1.244 0.771 0 O-C-N 123.837 0.71 . . . . 0.0 111.506 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.49 158.22 43.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.928 -176.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.449 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 71.2 m95 -106.54 127.14 53.09 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.391 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.58 155.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.1 tttt -92.61 161.1 14.72 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.48 -30.37 29.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.224 1.009 . . . . 0.0 111.955 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.99 -41.08 91.3 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.213 1.005 . . . . 0.0 111.794 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 50.0 mtt180 -87.08 7.38 28.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 mt -108.97 145.42 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.8 mp -107.83 112.0 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 171.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.2 144.3 38.33 Favored Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.581 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' HG12 ' A' ' 12' ' ' VAL . 24.2 Cg_exo -65.2 118.11 5.16 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 N-CA-C 108.358 -1.439 . . . . 0.0 108.358 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -169.17 149.59 4.22 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.46 110.34 4.69 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HD2' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -121.64 26.71 8.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 170.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 47.88 1.67 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.83 142.7 30.96 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.951 -0.625 . . . . 0.0 110.689 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.51 132.01 42.4 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -142.47 37.72 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.779 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -92.79 -54.75 3.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.33 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -153.24 19.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.795 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -98.23 -46.05 5.97 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -162.43 98.06 1.01 Allowed 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.608 -175.421 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -146.56 -34.48 0.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.187 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.9 tpt -87.87 101.27 13.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.968 0.414 . . . . 0.0 110.849 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.44 141.94 57.54 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 114.39 2.17 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.202 1.935 . . . . 0.0 111.816 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 94.58 4.99 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp 72.72 -48.02 0.68 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.885 1.274 . . . . 0.0 110.916 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 m -53.59 135.6 40.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.215 1.406 . . . . 0.0 110.557 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -23.71 31.69 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.393 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -74.1 130.26 39.44 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 37.6 pttt -87.2 136.69 32.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 174.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.34 174.31 11.26 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.666 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.1 tmtm? -108.41 135.79 49.12 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 71.2 t -124.78 144.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 85.2 tttt -140.39 104.6 4.81 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.48 112.73 12.36 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 120.704 0.288 . . . . 0.0 111.195 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 176.81 171.11 40.1 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -107.14 123.26 48.0 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.2 -107.58 1.15 Allowed Glycine 0 C--N 1.319 -0.382 0 O-C-N 123.116 0.26 . . . . 0.0 113.152 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.7 -26.08 59.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.674 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 81.0 p -85.17 10.24 12.83 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.022 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.641 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 9.2 tt0 -82.93 99.86 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.811 0.339 . . . . 0.0 110.619 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -108.79 162.32 14.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.625 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.4 mt -108.11 144.31 16.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.738 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -140.01 163.85 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.658 0.783 . . . . 0.0 109.214 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.92 124.95 51.48 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 167.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.22 175.68 8.26 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.906 0.384 . . . . 0.0 111.395 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 21.0 m -135.69 134.11 38.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 HG12 ' A' ' 43' ' ' VAL . 44.2 mm -65.76 125.8 23.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 O-C-N 123.858 0.724 . . . . 0.0 109.341 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -110.85 -31.4 7.18 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -167.25 167.22 14.33 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -144.84 139.71 27.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -145.77 156.88 43.88 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.63 0.581 . . . . 0.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 1.9 mp -108.72 129.34 63.43 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.45 104.37 8.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t70 55.17 64.34 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 125.52 1.528 . . . . 0.0 111.726 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 -25.59 5.17 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.848 -1.069 . . . . 0.0 115.193 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.9 145.77 34.84 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.985 0.892 . . . . 0.0 111.577 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 p -98.23 127.47 50.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 122.028 0.918 . . . . 0.0 110.681 -175.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.74 155.72 28.41 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.926 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.418 ' CE2' ' HZ2' ' A' ' 63' ' ' TRP . 22.0 m-85 -118.11 145.8 44.61 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.925 -173.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.1 tp -107.52 105.82 15.91 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 29' ' ' ILE . 9.8 m -119.71 151.55 22.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.612 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -118.82 140.41 50.0 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 22.5 m-85 -79.0 153.03 30.6 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -120.96 161.18 22.04 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.937 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.79 -111.65 0.99 Allowed Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -98.54 -41.1 7.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -91.89 89.48 7.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.137 0.97 . . . . 0.0 108.937 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 44.4 t -90.36 -30.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -85.81 8.44 20.01 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.465 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -87.83 89.5 8.02 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.72 116.74 33.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.838 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -150.37 165.88 31.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.088 0.471 . . . . 0.0 111.223 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -97.74 126.29 43.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.36 0.6 . . . . 0.0 112.216 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 14' ' ' VAL . 33.3 m -131.72 144.05 38.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -89.54 164.96 14.57 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 122.136 -0.352 . . . . 0.0 110.47 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.04 28.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.378 1.071 . . . . 0.0 111.886 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 12.7 t70 -68.4 -24.3 64.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.925 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.668 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 13.8 mmt180 -101.16 11.55 39.22 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.785 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -120.5 140.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.7 mp -107.85 114.82 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.547 ' H ' HD22 ' A' ' 69' ' ' LEU . 93.5 m95 -89.1 145.24 33.94 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.381 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.28 119.05 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.851 1.701 . . . . 0.0 110.743 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tt 177.0 87.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 103.197 -2.89 . . . . 0.0 103.197 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.4 t70 55.95 -139.34 0.96 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -148.19 55.86 1.05 Allowed 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.99 1.03 56.34 Favored Glycine 0 N--CA 1.418 -2.518 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.457 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 63' ' ' TRP . 5.0 mp -88.36 109.0 19.64 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -145.66 121.51 10.6 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.589 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 59' ' ' ASP . 23.9 m-70 -80.0 130.28 35.15 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -68.97 -17.62 63.96 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.904 0.752 . . . . 0.0 111.618 -170.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 67.1 t60 67.11 72.51 0.35 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.72 64.92 0.37 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.963 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -136.96 106.27 6.05 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.601 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -150.34 172.69 14.99 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ttt -158.81 142.51 15.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 37.2 mt-10 -66.55 119.54 63.66 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 15.3 Cg_exo -70.12 86.27 0.64 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.414 2.076 . . . . 0.0 111.596 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.4 m -88.24 146.29 25.43 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.561 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.16 -21.62 33.5 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.204 0.526 . . . . 0.0 109.798 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -71.52 138.71 49.11 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.708 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.84 58.25 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.845 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 28' ' ' SER . 25.6 m -67.84 125.02 24.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.32 110.46 20.78 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.28 -179.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.441 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.585 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -111.85 138.88 47.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.4 t -130.29 137.61 55.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 118.377 0.535 . . . . 0.0 110.542 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG3' HD11 ' A' ' 62' ' ' ILE . 53.0 mtmt -108.18 106.45 16.64 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -138.76 108.35 6.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.847 0.832 . . . . 0.0 112.197 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 176.94 170.78 39.82 Favored Glycine 0 C--N 1.287 -2.183 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 167.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 18' ' ' ARG . 4.7 ppt_? -117.1 115.09 24.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.682 0.741 . . . . 0.0 111.177 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.6 -103.23 0.21 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.345 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -70.18 -27.56 64.61 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.862 0.865 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 18' ' ' ARG . 7.7 m -88.63 0.91 55.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.937 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.661 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -70.43 116.2 10.49 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HE2' ' OH ' ' A' ' 25' ' ' TYR . 18.0 pttm -139.6 157.15 46.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.694 175.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.84 125.83 73.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.561 ' OH ' ' HE2' ' A' ' 23' ' ' LYS . 55.6 m-85 -111.45 165.54 11.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.313 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HG2' ' HZ2' ' A' ' 13' ' ' LYS . 45.1 mt-10 -111.67 126.81 55.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.08 -178.47 6.07 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 120.882 0.372 . . . . 0.0 111.342 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' THR . 16.4 m -123.64 155.3 37.98 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.63 126.02 39.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.727 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -101.67 -46.35 4.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -159.98 171.18 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -151.17 145.52 25.48 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.09 165.11 37.24 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.277 0.36 . . . . 0.0 110.231 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -111.26 126.35 68.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.93 103.28 7.4 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t0 57.0 65.35 1.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.001 0.92 . . . . 0.0 111.585 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -26.62 5.01 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' OE2' HD21 ' A' ' 40' ' ' LEU . 11.1 pt-20 -108.47 144.4 36.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 117.843 0.822 . . . . 0.0 110.768 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.8 p -98.82 121.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-O 122.241 1.019 . . . . 0.0 110.108 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD21 ' OE2' ' A' ' 38' ' ' GLU . 83.5 mt -108.62 137.95 45.72 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.692 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 35.4 m-85 -108.56 145.22 35.16 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.843 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 53' ' ' ASP . 52.8 tp -108.25 117.77 35.01 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 15.8 m -117.8 146.01 22.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.486 0.66 . . . . 0.0 109.505 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -117.89 116.69 27.46 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.692 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -70.42 129.62 39.76 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -74.1 -7.39 52.38 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -64.09 3.27 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -169.39 160.05 9.07 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.24 125.64 25.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.029 0.932 . . . . 0.0 109.922 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' H ' ' A' ' 51' ' ' ARG . 16.5 m -79.55 -65.85 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.51 ' H ' HG23 ' A' ' 50' ' ' VAL . 30.2 mmm180 -106.48 -55.94 2.26 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.24 -59.8 0.63 Allowed 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 166.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB2' HD11 ' A' ' 42' ' ' LEU . 49.7 m-20 -165.3 -174.53 3.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -126.73 154.01 44.74 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 120.022 1.283 . . . . 0.0 111.617 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.506 ' CE2' HD13 ' A' ' 42' ' ' LEU . 87.8 m95 -109.64 118.9 37.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.122 0.969 . . . . 0.0 111.869 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.44 157.34 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.577 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -90.85 165.14 13.77 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.7 -29.29 66.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.36 -1.76 57.34 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.6 tpt180 -100.89 4.7 42.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.418 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.59 147.07 13.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.14 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.9 mp -108.77 108.56 25.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -81.77 133.03 52.87 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.47 120.01 4.71 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.126 3.217 . . . . 0.0 114.423 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -170.51 69.39 0.05 Allowed 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 55.67 42.19 29.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 123.326 1.536 . . . . 0.0 110.413 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -134.46 103.17 5.59 Favored 'General case' 0 CA--C 1.461 -2.457 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.666 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.6 53.42 Favored Glycine 0 N--CA 1.415 -2.744 0 N-CA-C 105.783 -2.927 . . . . 0.0 105.783 163.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 tp 166.52 141.67 0.02 OUTLIER 'General case' 0 N--CA 1.391 -3.408 0 C-N-CA 130.005 3.322 . . . . 0.0 104.619 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 147.09 50.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.08 63.7 7.26 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.176 0.989 . . . . 0.0 108.37 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -91.92 -24.16 19.37 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.613 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -113.17 144.55 42.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 120.886 0.374 . . . . 0.0 110.261 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -137.54 28.12 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -147.31 123.31 10.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.526 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 C--N 1.281 -2.385 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 175.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 121.167 0.508 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -152.63 157.96 41.73 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.1 tpt -176.87 90.75 0.03 OUTLIER 'General case' 0 C--O 1.245 0.822 0 C-N-CA 124.159 0.984 . . . . 0.0 110.525 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . 64.0 mm-40 44.9 -155.85 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.924 0 O-C-N 124.963 1.414 . . . . 0.0 111.478 168.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.573 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 85.2 Cg_exo -64.81 168.36 13.68 Favored 'Trans proline' 0 C--N 1.361 1.204 0 CA-C-N 121.242 1.479 . . . . 0.0 111.076 165.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' C ' HD13 ' A' ' 7' ' ' LEU . 20.8 p -65.07 147.75 52.91 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.238 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD13 ' C ' ' A' ' 6' ' ' CYS 0.443 0.0 OUTLIER 51.68 14.03 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 179.692 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -80.68 154.61 27.22 Favored 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 121.912 -0.493 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.69 8.48 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.7 m -63.82 130.07 42.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.027 0.531 . . . . 0.0 110.115 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -98.84 115.16 28.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.02 -177.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.823 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.666 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.8 mmtm -107.3 135.82 48.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 43' ' ' VAL . 85.3 t -127.26 137.23 58.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -107.87 121.94 45.77 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HH21 ' A' ' 60' ' ' ARG . 41.1 t80 -132.93 115.54 15.34 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -179.29 170.35 41.91 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.612 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -139.76 112.07 7.68 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.638 1.175 . . . . 0.0 108.278 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.36 -134.42 22.78 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -21.27 44.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -76.64 74.37 3.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.156 0.979 . . . . 0.0 108.859 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.47 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 18.4 tt0 -145.8 142.98 29.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.047 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 161.12 38.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.38 120.49 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.92 166.86 10.51 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.495 1.118 . . . . 0.0 109.725 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.23 137.2 52.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.29 42.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 118.112 0.415 . . . . 0.0 111.983 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 p -104.49 141.75 35.82 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 40.0 mm -78.81 124.68 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -33.96 6.54 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 m -158.55 169.73 23.78 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.973 -0.455 . . . . 0.0 109.811 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -144.31 141.28 29.66 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -143.39 153.17 42.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.118 0.485 . . . . 0.0 110.812 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -109.07 123.87 65.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -125.6 104.14 8.23 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 50.79 65.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.877 1.271 . . . . 0.0 113.236 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -24.04 10.09 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.714 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.67 140.06 42.59 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 118.083 0.942 . . . . 0.0 112.396 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 HG13 ' A' ' 34' ' ' ILE . 5.4 t -98.84 117.19 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.2 mt -109.03 138.68 45.0 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 42.7 m-85 -107.74 147.24 31.06 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -107.2 105.16 15.01 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 8.0 m -123.91 154.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.544 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -128.63 125.8 38.87 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.39 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -66.14 109.52 2.64 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.465 1.103 . . . . 0.0 109.235 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -47.77 -67.95 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.415 1.486 . . . . 0.0 113.118 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.21 27.62 17.66 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.76 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -133.54 -55.61 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 117.333 0.566 . . . . 0.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 m120 -137.12 95.42 3.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.144 -174.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -79.06 -41.52 23.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.108 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -99.85 7.57 44.83 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 46.3 t80 -75.43 -62.59 1.52 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 61.48 108.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.44 155.18 44.09 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 82.8 m95 -99.5 123.43 43.77 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.595 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.21 147.37 28.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.248 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 61' ' ' ILE . 91.8 mttt -77.68 170.25 16.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.95 67.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.143 0.497 . . . . 0.0 110.398 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.2 -31.54 71.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 109.367 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 16' ' ' TYR . 26.8 mmm-85 -96.66 7.54 46.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.307 -173.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 57' ' ' LYS . 57.0 mt -120.71 151.16 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 13' ' ' LYS . 5.0 mp -108.15 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 96.5 m95 -90.9 130.02 42.12 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 19.4 Cg_exo -67.92 116.73 4.45 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 120.817 1.012 . . . . 0.0 111.335 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 5.5 tt 161.42 97.14 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 62.07 -162.38 0.28 Allowed 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -139.21 1.91 2.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.621 -0.675 . . . . 0.0 110.184 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.33 -18.54 68.74 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.071 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mp 62.87 106.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.625 1.17 . . . . 0.0 113.008 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -85.36 106.49 16.78 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -74.1 96.69 2.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 70' ' ' GLU 0.251 16.3 t60 -60.15 -44.18 95.16 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -164.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -81.41 83.35 6.96 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 118.567 -1.253 . . . . 0.0 107.731 168.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -95.42 -52.3 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.217 -168.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.11 7.84 2.92 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 . . . . . 0 C--N 1.306 -1.323 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.622 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 120.929 0.395 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.56 -65.27 0.99 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.2 ttm 170.52 102.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.94 1.696 . . . . 0.0 108.631 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.31 116.43 61.64 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.71 23.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.177 3.918 . . . . 0.0 117.019 -174.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.8 m -91.19 79.1 5.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.7 mt 71.31 -5.43 1.58 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.8 p -66.75 135.22 53.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.2 0.524 . . . . 0.0 111.702 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.66 -12.74 68.56 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.186 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -70.38 125.38 26.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 64.4 mttp -83.22 122.63 28.66 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.08 177.22 4.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.508 0.67 . . . . 0.0 111.268 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.04 136.5 52.85 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG1' HG11 ' A' ' 56' ' ' VAL . 79.1 t -127.59 131.18 70.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 118.321 0.51 . . . . 0.0 111.0 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 10.8 tmtt? -119.33 118.73 31.99 Favored 'General case' 0 C--O 1.197 -1.671 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.576 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 60' ' ' ARG 0.319 0.0 OUTLIER -160.37 154.45 23.11 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-N 118.416 0.553 . . . . 0.0 111.192 170.987 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 22' ' ' GLN . . . -168.19 139.46 5.69 Favored Glycine 1 N--CA 1.393 -4.211 0 C-N-CA 118.468 -1.825 . . . . 0.0 113.985 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -146.3 105.5 3.9 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.99 6.18 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -86.84 -7.82 57.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.083 0.468 . . . . 0.0 110.387 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -82.91 -1.01 51.04 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 121.228 0.537 . . . . 0.0 110.289 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' HA ' ' CA ' ' A' ' 17' ' ' GLY . 25.4 tp60 -73.72 108.3 6.47 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.682 0.753 . . . . 0.0 112.727 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.02 165.97 21.94 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.013 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 15' ' ' LYS . 54.2 mt -111.69 124.94 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.47 ' CE1' ' HE1' ' A' ' 16' ' ' TYR . 65.8 m-85 -107.78 166.14 10.92 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.616 -174.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.5 123.25 45.85 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -130.22 -178.57 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.141 0.496 . . . . 0.0 111.69 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.4 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 24.2 m -135.22 135.16 40.75 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 171.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 43' ' ' VAL . 45.8 mm -65.5 124.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -103.74 -46.6 4.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -153.02 160.22 42.97 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -133.92 141.29 47.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -145.88 161.09 40.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.646 0.591 . . . . 0.0 110.743 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.83 124.7 65.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -130.69 114.08 14.95 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.679 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.74 25.53 12.99 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.62 -17.72 52.38 Favored Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.928 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -108.65 152.65 24.51 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.48 122.79 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-O 122.072 0.939 . . . . 0.0 110.749 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -109.66 142.15 41.22 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.692 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 42.7 m-85 -108.82 142.66 39.06 Favored 'General case' 0 C--N 1.26 -3.322 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.697 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.57 110.97 23.01 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 29' ' ' ILE . 11.4 m -117.53 150.89 19.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -172.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -125.4 138.12 54.03 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.073 175.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 31.5 m-85 -82.39 123.13 28.83 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.295 17.5 p90 -57.45 157.37 6.81 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -37.17 89.76 0.01 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 126.298 1.904 . . . . 0.0 116.331 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 174.02 -46.97 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 51' ' ' ARG . 27.6 t-20 -91.22 111.18 22.55 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.432 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.75 -21.54 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.505 0.669 . . . . 0.0 110.327 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.638 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -56.28 -37.56 70.01 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 44' ' ' HIS . 3.8 t80 54.36 -94.49 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.004 2.522 . . . . 0.0 117.547 164.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -89.88 138.1 31.78 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.25 0.477 . . . . 0.0 112.015 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HG2' ' OH ' ' A' ' 16' ' ' TYR . 9.2 tp10 -159.24 157.8 31.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.146 0.498 . . . . 0.0 110.212 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -100.17 125.96 46.38 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.49 1.116 . . . . 0.0 111.48 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.44 HG11 ' CG1' ' A' ' 14' ' ' VAL . 17.6 m -138.35 152.19 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.557 ' HE2' ' OD2' ' A' ' 59' ' ' ASP . 88.9 tttt -89.51 157.91 17.9 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -53.46 -31.41 45.45 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.423 1.089 . . . . 0.0 112.512 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.557 ' OD2' ' HE2' ' A' ' 57' ' ' LYS . 16.1 m-20 -72.92 -13.37 61.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.906 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 16' ' ' TYR . 30.7 mtt180 -106.97 8.23 30.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.563 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 56' ' ' VAL . 49.1 mt -108.79 140.27 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.3 mp -106.78 105.27 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -82.9 124.56 76.75 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.155 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -64.35 117.62 4.65 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 179.05 79.5 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.0 t70 73.75 -33.46 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 76.33 143.17 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.008 1.723 . . . . 0.0 110.497 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.34 -38.48 3.31 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.733 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 mp 66.55 8.66 5.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.722 1.209 . . . . 0.0 111.717 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.34 113.61 2.36 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -146.64 74.59 1.36 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.625 0.77 . . . . 0.0 109.28 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -66.28 -16.1 63.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.962 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -84.76 -12.5 53.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -140.1 104.2 4.78 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.156 0.503 . . . . 0.0 109.784 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -64.74 139.18 58.74 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.333 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.3 m80 . . . . . 0 C--N 1.304 -1.393 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.353 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.493 -1.219 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.54 87.3 2.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.2 ttp -132.73 111.75 11.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.0 94.53 36.52 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD2' HG21 ' A' ' 8' ' ' THR . 63.9 Cg_exo -41.55 -73.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.251 3.301 . . . . 0.0 114.944 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 t -174.68 118.89 0.21 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 59.87 20.42 9.35 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.309 1.044 . . . . 0.0 112.87 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.424 HG21 ' HD2' ' A' ' 5' ' ' PRO . 1.7 p -67.14 144.37 56.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.71 -35.59 4.33 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.215 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 m -62.58 128.5 36.26 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.043 0.537 . . . . 0.0 110.799 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -96.01 129.6 43.23 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.3 173.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.811 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.874 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 33.3 ttpt -119.5 138.92 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 56' ' ' VAL . 59.6 t -119.21 134.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -109.31 103.98 13.03 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 3.3 t80 -106.79 109.96 22.01 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.76 116.64 2.81 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 94.2 mtt180 -140.68 168.52 19.6 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.14 -54.4 7.12 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 123.791 0.682 . . . . 0.0 113.719 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -94.74 -45.84 7.17 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.153 0.501 . . . . 0.0 109.872 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 18' ' ' ARG . 8.6 m -77.1 63.49 2.38 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.621 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 21.1 tp60 -125.46 105.34 8.99 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.798 0.809 . . . . 0.0 110.07 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.76 138.47 17.0 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.681 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.08 129.44 62.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.95 164.02 33.34 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 123.503 0.721 . . . . 0.0 111.157 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 38.7 mt-10 -108.33 136.5 47.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -139.56 158.59 43.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -103.82 139.05 39.56 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 36.8 mm -78.01 125.06 37.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.609 ' HG3' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -102.75 -39.3 7.08 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -160.87 167.84 25.87 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -143.31 151.12 40.13 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.65 165.05 37.15 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -108.83 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.51 134.02 39.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t70 67.0 24.17 9.6 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.401 1.095 . . . . 0.0 109.67 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.87 -9.18 77.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.208 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.18 164.96 13.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 117.387 0.594 . . . . 0.0 111.229 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 34' ' ' ILE . 3.4 t -97.62 117.47 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.511 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.23 134.39 53.8 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.064 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 27.3 m-85 -108.34 146.33 33.13 Favored 'General case' 0 C--N 1.271 -2.813 0 C-N-CA 123.84 0.856 . . . . 0.0 109.057 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -107.63 107.68 18.6 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 13.5 m -121.1 148.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.156 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 17.6 t-160 -118.71 126.13 51.2 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 51.7 m-85 -65.33 100.78 0.5 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 61.16 88.04 0.09 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.787 -171.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 44' ' ' HIS . . . 130.83 -179.41 16.98 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.254 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.35 172.05 8.02 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.609 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 7.6 t30 -59.71 106.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.463 0.705 . . . . 0.0 112.755 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -91.29 -62.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.875 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -105.69 -57.8 1.99 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -153.99 -46.34 0.09 Allowed 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.416 ' OD2' ' HA ' ' A' ' 49' ' ' ASN 0.267 36.7 m-20 66.2 -170.21 0.2 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.059 178.377 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -125.76 146.21 49.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.737 -169.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.2 m95 -101.44 124.32 46.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.217 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 14' ' ' VAL . 32.0 m -123.78 144.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -80.43 159.07 25.76 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -58.19 -33.48 69.3 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.459 0.647 . . . . 0.0 111.294 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -60.96 -25.71 67.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.621 1.168 . . . . 0.0 111.188 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.07 -5.44 57.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.033 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -107.84 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.835 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.39 109.9 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.8 124.07 53.7 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.75 117.53 5.19 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.756 -1.286 . . . . 0.0 108.756 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt 173.33 93.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.63 34.44 21.44 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.481 0.713 . . . . 0.0 112.764 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -77.62 -60.94 2.16 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.81 -74.47 1.57 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.272 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' N ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.28 121.47 44.98 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.65 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.81 -59.76 2.21 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.84 0.829 . . . . 0.0 110.487 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.06 74.88 2.0 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.439 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -96.3 -28.29 14.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.563 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -80.71 110.17 15.95 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.798 0.809 . . . . 0.0 111.58 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -105.18 4.61 31.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.702 0.763 . . . . 0.0 109.331 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -77.4 101.51 6.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.034 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.237 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 120.41 0.148 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.09 -60.64 2.26 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.4 ttt 164.7 132.16 0.01 OUTLIER 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.863 1.665 . . . . 0.0 109.104 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -114.89 160.29 34.16 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.8 2.333 . . . . 0.0 113.322 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 8' ' ' THR . 19.5 t -145.22 134.49 22.92 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.9 mm? 71.39 -12.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.539 1.136 . . . . 0.0 111.189 -173.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 9.3 p -63.63 131.29 47.52 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.283 1.033 . . . . 0.0 112.05 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.46 -11.3 72.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.205 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' SER . 26.9 m -71.68 121.41 18.8 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 107.18 19.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -113.62 178.81 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.16 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -108.98 141.6 40.84 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.604 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 56' ' ' VAL . 95.7 t -127.44 130.32 70.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 86.4 tttt -122.54 104.98 9.72 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -143.16 104.74 4.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.53 171.97 43.14 Favored Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.175 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 108.24 15.12 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 122.594 0.358 . . . . 0.0 111.417 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.85 -112.87 5.03 Favored Glycine 0 CA--C 1.513 -0.081 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.956 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -77.2 -30.77 54.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.623 0.725 . . . . 0.0 109.917 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -85.83 59.35 5.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 123.052 1.406 . . . . 0.0 107.547 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.54 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.8 tp60 -100.08 128.02 46.22 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.079 -1.873 . . . . 0.0 108.97 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -117.14 112.04 20.31 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.936 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -108.8 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.05 165.78 18.84 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.609 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -108.24 134.01 51.67 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -137.0 174.13 10.95 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.831 0.348 . . . . 0.0 111.603 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 45.1 m -123.77 137.5 54.67 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 mm -69.17 123.67 23.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -106.86 -40.96 5.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.928 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -152.77 166.04 33.47 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -151.07 144.35 24.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.47 166.27 33.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.958 0.409 . . . . 0.0 110.862 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 39' ' ' VAL . 1.4 mp -108.36 120.15 59.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 28.5 t70 -132.57 125.28 30.14 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.43 23.34 13.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.319 1.057 . . . . 0.0 110.229 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.36 8.34 68.44 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.603 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.5 pt-20 -125.12 156.74 37.85 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 117.686 0.743 . . . . 0.0 109.768 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 34' ' ' ILE . 11.8 t -98.78 119.31 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 CA-C-O 121.524 0.678 . . . . 0.0 110.133 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -108.77 137.25 47.0 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.745 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 26.3 m-85 -111.64 142.51 43.87 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.393 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD13 ' CE2' ' A' ' 55' ' ' TRP . 58.4 tp -108.0 111.84 24.12 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.24 142.94 42.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.569 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -120.3 142.24 49.27 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 54.3 m-85 -89.42 150.61 22.43 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 124.481 1.113 . . . . 0.0 111.113 -171.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -108.39 133.93 51.9 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.698 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.03 -123.26 1.3 Allowed Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -92.57 -46.5 7.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 117.315 0.557 . . . . 0.0 110.897 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -95.19 92.15 6.64 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.37 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.19 -10.05 10.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.617 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -6.29 59.33 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.042 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -82.64 82.37 8.04 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.39 112.3 24.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -130.87 159.04 38.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.201 0.524 . . . . 0.0 111.936 -167.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 81.0 m95 -103.36 117.66 34.99 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.891 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 14' ' ' VAL . 25.6 m -122.05 165.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 80.9 tttt -103.31 164.98 11.3 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.92 74.57 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.566 0.746 . . . . 0.0 113.009 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -74.08 -6.52 48.07 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 16.8 mmt-85 -104.69 11.68 33.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.327 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.62 138.64 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.278 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 13' ' ' LYS . 3.9 mp -108.33 114.44 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -83.72 115.55 60.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.08 118.64 5.53 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.031 1.821 . . . . 0.0 111.027 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -160.6 98.68 1.25 Allowed 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.37 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.856 1.262 . . . . 0.0 113.278 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 84.6 mttt 70.8 98.2 0.07 Allowed 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.98 -19.66 28.17 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.79 -13.89 60.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.673 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -145.19 -150.55 0.33 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -137.1 148.85 46.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 120.27 1.395 . . . . 0.0 109.823 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -54.28 -54.89 33.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.65 0.738 . . . . 0.0 110.149 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -153.86 -163.49 1.65 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -65.92 -39.47 90.58 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -123.02 -76.86 0.59 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.096 0.474 . . . . 0.0 109.772 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 . . . . . 0 C--N 1.301 -1.516 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.571 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.33 73.39 1.37 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.039 -167.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt 56.9 76.04 0.33 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.279 1.032 . . . . 0.0 110.569 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.43 80.2 23.14 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.55 91.45 0.59 Allowed 'Trans proline' 0 C--O 1.248 1.003 0 C-N-CA 123.087 2.524 . . . . 0.0 111.377 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.1 m 62.56 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 113.433 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.22 -68.15 0.81 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.571 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -60.15 132.13 52.97 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.151 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 -32.19 6.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.567 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 m -63.87 132.7 51.6 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.082 0.553 . . . . 0.0 110.035 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -93.11 131.23 38.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.405 HG12 ' HD3' ' A' ' 64' ' ' PRO . 35.3 m -129.74 -179.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.486 -172.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 24' ' ' ILE . 28.4 mmmt -114.03 135.36 54.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 43' ' ' VAL . 86.4 t -116.11 133.14 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -107.9 114.18 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.114 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' CE2' HG12 ' A' ' 56' ' ' VAL . 1.5 m-85 -142.91 128.35 18.96 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.015 0.436 . . . . 0.0 110.616 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.38 170.16 40.12 Favored Glycine 0 N--CA 1.399 -3.77 0 C-N-CA 119.384 -1.389 . . . . 0.0 113.185 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -131.11 108.85 10.04 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.58 -121.45 12.74 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.553 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -88.45 -10.9 47.59 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.333 0.587 . . . . 0.0 110.253 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -79.96 8.19 7.47 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.422 1.106 . . . . 0.0 109.667 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.549 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 8.1 tt0 -86.76 143.18 27.65 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.264 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.24 155.53 42.74 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.636 HG22 ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -112.63 133.61 57.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 8.7 m-85 -107.5 166.77 10.42 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -172.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -106.75 116.46 31.96 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.86 167.75 19.65 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.741 -0.599 . . . . 0.0 111.497 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.557 HD13 HG12 ' A' ' 43' ' ' VAL . 33.7 mm -78.78 128.35 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 123.642 0.589 . . . . 0.0 111.145 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.346 1.058 . . . . 0.0 111.895 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 t -154.39 167.86 28.57 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -132.83 139.7 47.61 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.56 156.38 45.1 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 123.575 0.547 . . . . 0.0 110.097 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.77 119.92 59.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.22 131.7 32.8 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 65.64 22.03 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.397 1.094 . . . . 0.0 109.855 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.96 87.7 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.383 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -116.51 159.37 22.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 122.495 -0.415 . . . . 0.0 111.765 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 34' ' ' ILE . 3.3 t -98.86 116.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.43 0.633 . . . . 0.0 111.093 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -112.73 139.94 47.93 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.486 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 31.2 m-85 -108.15 157.25 18.46 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.93 115.02 29.46 Favored 'General case' 0 CA--C 1.465 -2.311 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 14' ' ' VAL . 13.8 m -129.17 142.59 43.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -117.84 125.47 50.6 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.619 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.546 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 24.6 m-85 -72.04 109.82 6.11 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.275 50.6 p90 -77.67 1.0 21.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -169.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.47 87.83 1.57 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 77.96 -27.27 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.878 1.271 . . . . 0.0 113.63 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 4.8 m-20 -81.42 99.94 9.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.538 0.685 . . . . 0.0 112.209 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.05 -47.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -100.88 1.31 39.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.532 0.682 . . . . 0.0 110.403 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 89.9 m-85 -86.88 75.83 9.52 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.551 1.167 . . . . 0.0 108.976 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.85 103.19 13.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -118.45 165.12 14.29 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.419 -163.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.1 m95 -98.83 126.84 44.59 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.462 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 16' ' ' TYR . 34.3 m -135.94 165.22 30.17 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.831 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.69 166.47 10.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.36 74.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.654 . . . . 0.0 111.239 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.11 -15.64 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.735 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 60' ' ' ARG . 14.6 tpt180 -95.95 0.61 52.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.825 0.821 . . . . 0.0 109.61 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.99 150.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.268 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.0 mp -107.64 104.57 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.419 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 92.4 m95 -75.81 150.83 84.2 Favored Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' HG12 ' A' ' 12' ' ' VAL . 7.5 Cg_exo -77.41 -178.5 4.64 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.612 2.208 . . . . 0.0 111.201 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.281 0.6 OUTLIER 51.98 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 77.71 -36.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.768 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 63' ' ' TRP . 4.3 tmtm? -73.07 99.24 2.72 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.0 34.99 2.08 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 74.8 104.61 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.311 1.444 . . . . 0.0 112.03 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -53.26 101.34 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.936 -1.484 . . . . 0.0 113.561 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -145.28 147.82 32.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -76.52 -23.9 53.7 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.469 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -83.32 5.12 24.42 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 122.543 1.163 . . . . 0.0 108.987 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -111.83 79.97 1.27 Allowed 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -111.19 111.8 23.14 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.003 0.906 . . . . 0.0 111.983 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--N 1.277 -2.556 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.443 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.01 142.95 51.3 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 ptp -136.94 135.85 38.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -86.08 141.75 35.54 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.52 -56.87 2.3 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.507 2.138 . . . . 0.0 111.08 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.0 p -150.45 47.51 0.89 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp 75.33 7.32 4.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.261 -1.79 . . . . 0.0 110.753 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 30' ' ' LYS . 1.9 m -63.42 139.02 58.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 126.132 1.773 . . . . 0.0 112.801 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.54 -22.22 40.73 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.794 174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -66.09 118.65 10.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -91.0 115.07 27.72 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.54 178.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 34.4 tttp -120.92 139.11 53.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.71 139.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 40.8 ttmt -125.01 104.09 8.37 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.83 118.39 13.91 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.157 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.76 170.66 41.74 Favored Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.627 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -119.27 107.14 13.05 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.932 0.872 . . . . 0.0 109.966 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.67 -111.73 3.32 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -94.07 -10.79 32.24 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.246 0.546 . . . . 0.0 110.6 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.6 p -82.27 31.74 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.454 0.645 . . . . 0.0 110.242 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.62 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 38.5 tt0 -82.76 102.45 11.57 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.93 128.42 49.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.613 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.459 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -108.17 115.17 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.23 162.48 32.03 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.449 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 13' ' ' LYS . 54.6 mt-10 -113.85 136.8 52.48 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.089 0.471 . . . . 0.0 112.071 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -141.25 -178.04 5.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.289 -171.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -134.95 133.37 39.48 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 43' ' ' VAL . 46.5 mm -67.78 131.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.797 0.686 . . . . 0.0 110.98 -176.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -101.8 -60.92 1.45 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.7 m -147.98 164.82 32.59 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -134.29 151.98 51.56 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.12 165.57 35.22 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 123.167 0.292 . . . . 0.0 110.237 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -111.14 131.39 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.95 115.87 13.18 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 63.79 23.44 13.44 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.262 1.425 . . . . 0.0 111.623 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.79 -10.55 55.87 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.419 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.17 147.1 31.79 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.722 0.761 . . . . 0.0 109.565 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.6 118.04 44.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.96 130.06 55.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.605 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 37.4 m-85 -108.16 147.91 30.63 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.897 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.8 tp -107.55 113.07 26.14 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 HD13 ' A' ' 29' ' ' ILE . 2.4 p -118.42 147.03 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.443 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.15 125.92 51.19 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.654 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 90.2 m-85 -83.09 104.69 13.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.582 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.38 87.2 3.15 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.69 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.58 -120.45 0.97 Allowed Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -90.95 -39.97 11.95 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.168 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -122.67 112.72 18.3 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 39.2 t -88.62 -23.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.339 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -72.43 10.88 0.7 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -59.84 -38.99 83.64 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.772 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 45.51 81.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 125.112 1.507 . . . . 0.0 110.442 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.62 142.86 49.03 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.406 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 74.9 m95 -102.41 106.47 17.22 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.37 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 61' ' ' ILE . 3.0 p -122.88 148.04 26.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.151 -174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 61' ' ' ILE . 26.3 mtmm -73.15 158.28 35.59 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -61.2 -39.88 91.88 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.115 0.966 . . . . 0.0 113.066 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -86.05 -2.48 58.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -96.69 5.61 50.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.206 1.003 . . . . 0.0 109.016 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 57' ' ' LYS . 70.0 mt -120.48 153.32 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.084 -1.416 . . . . 0.0 107.336 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.1 mp -107.39 109.51 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -87.89 120.05 70.69 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.075 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.22 117.86 5.35 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.334 1.356 . . . . 0.0 109.558 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 177.89 84.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 t70 73.52 -75.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.097 0.873 . . . . 0.0 110.197 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 27.3 tptt 58.13 114.27 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.11 2.164 . . . . 0.0 112.761 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.47 77.97 1.65 Allowed Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.81 -174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 71' ' ' HIS . 3.0 mm? -88.1 120.88 29.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 71.12 -33.87 0.28 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.823 1.649 . . . . 0.0 112.054 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 66.2 m-70 -112.56 80.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -100.7 -42.5 6.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.79 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -68.4 -48.41 64.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.494 0.664 . . . . 0.0 109.285 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -114.8 90.82 3.43 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 71' ' ' HIS . 3.6 p80 -108.47 84.75 1.99 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.019 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -179.734 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.228 0.537 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -148.64 87.85 1.59 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.627 0.727 . . . . 0.0 109.885 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ttt -169.61 83.51 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.26 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -96.25 138.14 21.59 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -72.5 88.99 0.84 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.605 1.536 . . . . 0.0 108.272 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -85.28 -167.24 1.76 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.721 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.0 pt? -57.9 -33.84 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -60.77 118.79 7.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.422 1.089 . . . . 0.0 110.588 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.96 -11.3 48.9 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.334 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -78.28 128.22 33.39 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -93.24 121.67 34.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.812 0.815 . . . . 0.0 109.898 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.44 179.46 2.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.142 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 53.0 mtmt -108.83 143.84 37.5 Favored 'General case' 0 CA--C 1.475 -1.905 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.36 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 56' ' ' VAL . 92.7 t -121.44 128.94 75.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.048 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.7 ttmt -107.64 104.1 13.55 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -138.84 111.35 7.57 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.878 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.33 170.31 40.98 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -107.43 105.25 15.08 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.493 0.663 . . . . 0.0 110.849 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.19 -107.03 1.61 Allowed Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.258 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -74.05 -29.35 61.86 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.554 . . . . 0.0 110.408 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.2 m -81.81 30.12 0.38 Allowed 'General case' 0 CA--C 1.573 1.86 0 CA-C-O 122.647 1.213 . . . . 0.0 110.187 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.513 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.6 tp60 -76.4 114.17 14.8 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.336 1.454 . . . . 0.0 109.972 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 61.5 mt -108.69 112.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.55 166.93 10.73 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 13' ' ' LYS . 50.7 mt-10 -107.11 119.79 40.32 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . -126.21 177.61 6.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -129.19 128.04 42.54 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 122.203 -0.311 . . . . 0.0 110.203 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 43' ' ' VAL . 33.4 mm -65.62 130.17 30.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 O-C-N 124.1 0.875 . . . . 0.0 109.786 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -117.63 -42.82 2.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -158.3 170.18 22.83 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.908 -0.495 . . . . 0.0 109.963 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 140.58 41.99 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -145.47 155.44 43.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.747 0.419 . . . . 0.0 110.253 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.7 124.86 65.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -125.92 104.32 8.24 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.05 64.46 1.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 112.97 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -26.57 5.71 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.692 -1.14 . . . . 0.0 115.525 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.14 149.45 28.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.311 1.056 . . . . 0.0 111.215 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.45 125.59 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.448 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.1 mt -112.3 138.56 48.83 Favored 'General case' 0 N--CA 1.405 -2.722 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.372 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 30.9 m-85 -108.0 149.14 28.76 Favored 'General case' 0 C--N 1.258 -3.411 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 55' ' ' TRP . 39.8 tp -107.29 104.26 13.83 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 14' ' ' VAL . 3.8 p -118.77 138.36 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -173.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.69 143.76 47.57 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.972 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -89.34 101.42 14.09 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -58.8 139.71 55.99 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.562 0.539 . . . . 0.0 112.054 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -51.18 2.31 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.946 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -93.47 -59.24 2.06 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.104 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 88.1 m-20 -110.07 92.87 4.22 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.044 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.91 -57.03 11.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.41 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.5 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 24.3 ttt180 -109.73 4.07 21.51 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.027 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 98.4 m-85 -80.95 67.72 6.96 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.586 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.09 144.75 50.2 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.714 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -140.08 157.81 45.05 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 75.6 m95 -98.47 122.88 42.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.37 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 14' ' ' VAL . 18.1 m -130.44 152.48 37.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -79.82 153.03 29.4 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.05 -2.51 37.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 13.5 mtp180 -106.09 10.19 32.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.011 0.434 . . . . 0.0 110.498 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.5 mt -108.81 139.24 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.373 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.1 mp -108.05 107.61 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -84.88 130.41 52.75 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.63 120.07 7.63 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.902 2.402 . . . . 0.0 112.589 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 tt -145.37 91.72 2.16 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.54 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 33.8 t70 67.91 3.91 3.76 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.295 1.438 . . . . 0.0 113.315 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 1.0 OUTLIER -145.81 33.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.13 7.49 9.23 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.343 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 66.01 131.9 0.02 OUTLIER 'General case' 0 C--O 1.245 0.857 0 C-N-CA 125.266 1.426 . . . . 0.0 113.793 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.02 158.95 24.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.75 95.52 7.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.079 0.466 . . . . 0.0 111.046 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -76.66 -28.11 55.86 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -65.93 132.31 48.33 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.292 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -47.79 122.6 5.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.473 1.109 . . . . 0.0 109.749 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -149.06 -179.2 6.84 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 174.619 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.243 0.716 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.55 23.28 11.79 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.198 0.999 . . . . 0.0 112.642 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -156.05 167.63 29.81 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.66 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.55 150.82 38.01 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.29 101.56 0.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.959 1.773 . . . . 0.0 110.073 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 m -87.63 158.39 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.212 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.614 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.0 mm? -107.84 14.67 25.21 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 109.046 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -61.55 117.09 5.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.56 0.14 82.35 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.812 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' SER . 91.5 m -78.22 131.78 37.28 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -86.22 129.98 34.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.36 175.84 9.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 30.2 ttpt -120.51 146.64 46.08 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 56' ' ' VAL . 93.3 t -129.62 132.57 66.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -173.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.56 103.14 9.16 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -149.27 125.29 10.65 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.22 170.06 39.87 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.636 171.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -93.37 111.54 23.23 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-O 121.009 0.433 . . . . 0.0 110.36 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.12 -102.35 0.65 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.422 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -93.82 -19.84 20.63 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.469 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.7 m -79.0 34.46 0.23 Allowed 'General case' 0 CA--C 1.574 1.899 0 CA-C-O 122.111 0.958 . . . . 0.0 110.121 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.632 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 30.1 tt0 -103.56 127.99 50.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 123.406 0.682 . . . . 0.0 111.081 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -120.14 148.6 43.43 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.802 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -107.98 124.09 63.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.5 165.63 31.59 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 124.228 1.011 . . . . 0.0 109.983 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.01 136.88 46.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . . . -131.16 -178.27 4.76 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.828 -173.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 m -138.62 139.38 38.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 34.3 mm -77.88 135.31 26.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.948 0.404 . . . . 0.0 111.586 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -103.42 -58.71 1.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -148.68 -178.64 6.45 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.687 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.09 145.24 41.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.42 154.02 50.91 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.62 119.32 61.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -135.09 119.73 18.2 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.48 23.0 12.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 110.648 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.52 -8.9 66.65 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.491 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -109.47 143.85 38.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 117.762 0.781 . . . . 0.0 110.565 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.54 123.21 50.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 122.395 1.093 . . . . 0.0 110.666 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.89 145.38 35.46 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.022 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.541 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 34.6 m-85 -113.22 151.84 30.49 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.783 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CE2' ' A' ' 55' ' ' TRP . 40.8 tp -107.72 116.5 32.07 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 29' ' ' ILE . 5.9 m -118.95 140.99 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.612 -174.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -130.25 138.47 50.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.092 0.472 . . . . 0.0 111.121 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 20.4 m-85 -95.96 133.21 40.43 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.809 -171.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.62 87.6 3.03 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.28 -65.96 0.27 Allowed Glycine 0 C--N 1.295 -1.705 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -141.36 -57.79 0.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.7 109.02 20.43 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.244 0.545 . . . . 0.0 109.806 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -79.7 -9.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -71.34 -3.13 19.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.398 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.09 81.12 5.38 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -110.03 95.71 5.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.24 151.58 38.14 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.918 -166.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.477 ' CE2' HD13 ' A' ' 42' ' ' LEU . 74.6 m95 -104.37 129.08 52.29 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 14' ' ' VAL . 29.5 t -138.93 140.23 39.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' ILE . 33.0 ttpt -71.68 150.66 44.35 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 120.756 0.312 . . . . 0.0 111.505 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.541 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -52.56 -49.67 64.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.685 1.594 . . . . 0.0 113.73 -170.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.35 -7.71 54.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.689 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HD3' ' O ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -106.87 8.37 30.65 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.382 1.087 . . . . 0.0 108.707 -175.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 57' ' ' LYS . 68.1 mt -108.61 157.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.07 108.6 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -97.95 146.24 31.15 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.18 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -179.24 91.51 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.79 19.34 10.5 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.759 1.224 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -103.49 -32.38 9.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -169.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.31 2.69 17.76 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.335 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.74 -23.63 19.7 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 70' ' ' GLU . 1.7 mp0 -64.79 129.64 40.51 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -87.89 153.51 21.26 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.536 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -68.47 -33.98 75.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -90.45 106.96 18.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.13 138.98 43.23 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 124.027 0.829 . . . . 0.0 112.284 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -71.19 135.5 47.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.644 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.766 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.514 -0.438 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 76.65 -64.98 0.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.185 1.394 . . . . 0.0 109.25 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptm -75.16 150.6 38.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.12 119.6 72.86 Favored Pre-proline 0 C--N 1.303 -1.421 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.64 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.52 80.55 1.09 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.517 2.145 . . . . 0.0 110.35 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -87.17 -68.53 0.74 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.841 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 6.0 mp 65.81 -52.34 0.39 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 112.537 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.5 m -55.95 118.54 4.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 123.681 0.792 . . . . 0.0 110.311 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.06 -20.34 21.8 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.861 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.3 m -74.68 128.67 36.11 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 1.2 pptp? -87.9 127.4 35.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.419 0.628 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.06 176.68 6.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.94 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.3 mmtm -110.92 135.47 51.4 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 43' ' ' VAL . 96.8 t -124.38 131.72 72.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.12 114.35 28.18 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -132.94 114.45 14.04 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.822 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -160.18 160.38 31.62 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.742 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -146.6 127.29 14.28 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.95 -123.71 10.98 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.737 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.9 -36.21 21.64 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -85.05 103.92 14.5 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.712 1.244 . . . . 0.0 111.041 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 35.2 tt0 -131.7 115.9 16.62 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.398 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -123.66 143.86 49.99 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.546 0.689 . . . . 0.0 111.421 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.59 129.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.88 165.66 13.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.194 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -115.11 136.68 52.85 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' HG22 ' A' ' 43' ' ' VAL . . . -136.94 -178.71 5.31 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 m -142.67 130.07 21.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 43' ' ' VAL . 42.0 mm -57.94 127.0 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 124.071 0.857 . . . . 0.0 111.152 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.38 -46.03 5.38 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -154.43 153.79 32.14 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -126.64 133.6 50.95 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -142.09 158.86 43.26 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 123.699 0.625 . . . . 0.0 110.378 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.401 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.46 129.94 61.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.581 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.15 103.92 8.86 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.519 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 46.69 63.82 1.76 Allowed 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 125.601 1.56 . . . . 0.0 113.057 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 -24.46 11.51 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.12 -0.945 . . . . 0.0 115.275 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.81 149.13 29.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.466 1.133 . . . . 0.0 110.49 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 34' ' ' ILE . 9.8 t -98.52 119.55 46.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.69 143.07 38.28 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -108.45 139.84 42.61 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.579 HD13 ' CE2' ' A' ' 55' ' ' TRP . 59.8 tp -107.61 106.59 17.02 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG22 ' HB1' ' A' ' 27' ' ' ALA . 4.1 p -125.82 141.91 44.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.605 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -118.99 146.47 44.99 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.31 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 33.5 m-85 -77.89 105.85 9.36 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 123.967 0.792 . . . . 0.0 110.575 -172.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -61.39 130.73 47.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.01 -40.1 1.42 Allowed Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.257 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -73.82 -63.78 1.14 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.998 0.919 . . . . 0.0 109.618 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 21.1 m120 -145.27 99.25 3.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.01 -25.87 10.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.0 3.95 36.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.833 0.825 . . . . 0.0 110.781 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 78.3 t80 -103.59 97.13 7.21 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 8.7 m-20 -95.06 131.0 41.52 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.059 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -120.84 154.31 35.95 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.177 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CE2' HD13 ' A' ' 42' ' ' LEU . 84.9 m95 -108.38 110.61 22.21 Favored 'General case' 0 C--O 1.253 1.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.316 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.5 m -135.77 139.74 45.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.018 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -80.98 168.2 18.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.1 63.19 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.485 0.714 . . . . 0.0 112.867 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.48 -19.35 53.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.341 0.591 . . . . 0.0 110.859 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -92.13 -5.24 53.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.334 1.064 . . . . 0.0 108.415 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.79 150.71 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.829 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -108.65 115.21 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 172.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -81.15 108.98 11.88 Favored Pre-proline 0 C--N 1.31 -1.148 0 O-C-N 123.144 0.278 . . . . 0.0 111.013 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.97 119.35 3.92 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 122.288 1.992 . . . . 0.0 113.851 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 tp -157.17 85.65 0.94 Allowed 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.874 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.9 t70 58.21 71.35 0.59 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.424 -1.716 . . . . 0.0 110.449 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.415 ' HG3' HD13 ' A' ' 69' ' ' LEU . 18.4 tppt? -77.47 -31.78 53.94 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.059 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.72 18.93 10.15 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' HG3' ' A' ' 67' ' ' LYS . 7.3 mp -124.73 98.92 5.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.084 0.468 . . . . 0.0 110.441 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -91.37 -32.7 15.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 174.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -89.26 87.06 6.99 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -47.24 -47.99 24.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -79.06 -34.08 44.06 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.674 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 62.02 25.27 15.14 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.572 1.177 . . . . 0.0 108.841 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -130.48 126.62 37.35 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.029 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.4 m80 . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.239 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 3' ' ' MET . 9.7 tp10 . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -76.59 -19.06 58.26 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.905 0.383 . . . . 0.0 110.993 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.573 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 25.6 ttt -74.46 117.13 15.93 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.186 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.49 114.74 41.21 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.9 80.85 0.35 Allowed 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 122.971 2.447 . . . . 0.0 114.65 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.4 m 71.46 166.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.078 1.351 . . . . 0.0 112.379 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.565 ' H ' HD23 ' A' ' 7' ' ' LEU . 2.1 pt? -113.72 21.11 15.32 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.831 0.824 . . . . 0.0 110.03 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.8 p -69.93 113.5 7.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.322 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.13 8.48 57.78 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.441 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 m -77.86 126.87 31.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 95.3 mttt -94.52 124.29 38.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.119 0.485 . . . . 0.0 111.387 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.99 -178.96 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.789 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 32.6 ttpt -124.79 146.47 49.21 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 56' ' ' VAL . 99.4 t -126.09 137.69 56.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 122.836 0.455 . . . . 0.0 110.238 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -110.57 107.0 16.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.11 113.17 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' HA3' ' HG3' ' A' ' 22' ' ' GLN . . . -151.06 157.25 27.09 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 118.844 -1.646 . . . . 0.0 115.183 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -145.67 105.2 3.96 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.917 -1.141 . . . . 0.0 110.034 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.64 -124.12 6.98 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.375 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.61 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -81.78 -28.17 33.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.811 0.815 . . . . 0.0 108.817 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -82.39 95.25 7.59 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.226 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HG3' ' HA3' ' A' ' 17' ' ' GLY . 59.6 tt0 -139.7 128.9 23.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.699 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -125.1 134.25 52.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.62 108.53 25.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 170.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.57 165.09 19.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.87 -174.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.47 139.07 43.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.8 -179.68 6.75 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.199 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 6.6 m -129.47 136.87 50.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 43' ' ' VAL . 39.1 mm -69.85 129.63 34.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.07 -47.1 4.87 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -155.97 168.03 28.54 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -140.5 150.69 44.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.46 162.43 40.74 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -114.26 124.7 71.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.06 108.18 10.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.025 0.441 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.32 65.0 1.01 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.521 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -26.53 3.34 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.618 -1.173 . . . . 0.0 115.181 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.11 148.69 36.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.623 0.711 . . . . 0.0 111.562 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.2 p -98.32 125.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.683 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.89 134.9 51.57 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.705 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -110.84 145.91 37.37 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.056 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.1 tp -108.29 119.8 40.54 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 29' ' ' ILE . 8.5 m -118.23 149.62 20.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -125.61 138.65 53.93 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . 0.258 58.1 m-85 -80.91 118.68 22.62 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -168.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 67.05 -48.83 0.48 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.545 1.938 . . . . 0.0 115.691 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.45 -29.65 3.41 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.917 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -65.8 -47.63 74.43 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.565 ' ND2' ' HB2' ' A' ' 52' ' ' TYR . 40.0 t30 -107.23 100.55 10.01 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.97 0.89 . . . . 0.0 109.242 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.5 t -88.31 -19.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.703 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -79.5 -10.36 59.79 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.988 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.565 ' HB2' ' ND2' ' A' ' 49' ' ' ASN . 1.7 t80 -75.76 101.14 4.95 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -111.08 118.86 37.17 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.977 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.94 142.31 27.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.457 0.646 . . . . 0.0 111.163 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.4 ' CE2' HD13 ' A' ' 42' ' ' LEU . 79.9 m95 -104.78 122.28 45.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.686 -176.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 14' ' ' VAL . 19.2 m -134.29 143.93 36.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -82.84 160.79 22.12 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 123.358 0.663 . . . . 0.0 110.467 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.59 61.56 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.57 0.748 . . . . 0.0 112.204 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.79 -2.57 37.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.291 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -111.88 0.53 16.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 56' ' ' VAL . 45.3 mt -114.64 152.69 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 111.599 -172.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.2 mp -107.48 112.55 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 98.7 m95 -93.85 137.78 22.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 22.8 Cg_exo -68.53 119.93 6.9 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 121.92 1.746 . . . . 0.0 108.865 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 77.31 95.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 125.123 1.515 . . . . 0.0 109.422 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 74.38 -169.75 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.319 1.447 . . . . 0.0 110.557 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -130.46 -9.35 4.13 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.555 -0.716 . . . . 0.0 111.681 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.7 13.27 0.64 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.053 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.4 mt -85.92 -18.61 32.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.39 100.62 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.943 -1.48 . . . . 0.0 107.55 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -85.78 137.38 32.83 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.553 -177.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -75.67 6.97 4.19 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -171.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -94.98 25.19 4.3 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.54 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -69.96 -33.84 72.61 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 168.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 42.9 m80 -87.21 74.82 9.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 . . . . . 0 C--N 1.291 -1.972 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.866 179.812 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -87.66 -61.7 1.66 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.455 0.645 . . . . 0.0 109.433 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.5 ttm -114.55 107.55 15.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.9 126.12 84.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.21 97.24 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.101 1.867 . . . . 0.0 108.514 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.8 m -74.37 125.72 29.12 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 121.751 0.786 . . . . 0.0 112.22 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.0 -15.97 61.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.054 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 10.2 m -63.05 113.72 3.28 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.72 -25.59 7.17 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.934 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.3 m -62.53 121.17 12.64 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.322 0.582 . . . . 0.0 109.837 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.554 ' HD2' ' H ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -97.72 122.58 40.98 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.263 -176.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.85 -179.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.857 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -113.33 140.32 48.11 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 43' ' ' VAL . 86.2 t -132.85 138.56 51.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 118.721 0.692 . . . . 0.0 111.204 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HE3' HD11 ' A' ' 62' ' ' ILE . 94.1 mttt -108.61 143.68 37.35 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -159.84 117.15 2.6 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.716 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.97 170.46 40.96 Favored Glycine 0 N--CA 1.425 -2.071 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.657 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -119.03 103.81 9.9 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 171.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 -94.26 0.06 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.115 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -75.85 -32.54 59.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -83.23 27.45 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.498 0.666 . . . . 0.0 112.106 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.573 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 51.8 tp60 -78.84 112.31 15.86 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.155 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 147.28 50.85 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.16 114.88 46.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 165.76 15.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.09 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -108.79 142.2 39.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.09 172.94 15.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.5 p -122.64 146.92 47.02 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 20.8 mm -66.72 131.92 32.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -103.24 -45.8 4.79 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -165.04 -176.55 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -150.28 165.01 34.28 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.498 0.719 . . . . 0.0 109.445 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -160.46 166.35 29.36 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.33 1.452 . . . . 0.0 110.081 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -107.2 117.26 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.25 114.53 15.78 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.045 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 69.15 23.61 6.36 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.895 1.278 . . . . 0.0 110.512 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.48 54.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.558 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.0 159.34 16.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.434 -0.451 . . . . 0.0 111.183 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 34' ' ' ILE . 60.8 t -98.35 117.38 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.39 0.614 . . . . 0.0 109.739 -176.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 6.2 mp -111.04 154.66 23.89 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.799 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 88.9 m-85 -116.85 148.78 40.96 Favored 'General case' 0 C--N 1.255 -3.521 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.52 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ2' ' A' ' 55' ' ' TRP . 36.0 tp -107.09 116.36 31.78 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 14' ' ' VAL . 29.4 m -118.18 144.09 27.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.534 -172.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -117.37 125.57 51.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 48' ' ' TRP . 61.8 m-85 -62.09 140.45 58.39 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.739 -1.118 . . . . 0.0 112.969 -170.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -89.1 103.03 15.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.683 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.44 24.44 36.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.469 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . 88.2 m95 -133.9 -166.21 1.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.78 124.76 21.38 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.526 0.516 . . . . 0.0 111.109 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.8 t -86.07 -29.62 6.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.736 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -50.83 -52.74 38.4 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.751 0.657 . . . . 0.0 112.171 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -104.38 101.11 10.82 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.416 0.627 . . . . 0.0 111.903 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.27 142.69 31.41 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.551 -1.204 . . . . 0.0 107.97 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -124.02 157.44 34.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -167.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 79.3 m95 -98.56 126.98 44.32 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.754 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.01 140.84 32.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.548 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 35.5 ttpt -76.86 164.17 26.07 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 122.328 -0.233 . . . . 0.0 110.677 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.09 -32.08 63.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.009 0.524 . . . . 0.0 112.085 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.48 -24.75 65.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.285 1.034 . . . . 0.0 111.701 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -94.72 -6.42 43.2 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.555 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.1 147.65 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.89 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -107.72 106.65 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 81.9 m95 -82.51 136.15 45.9 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.616 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 51.3 Cg_exo -56.96 119.54 6.86 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.392 2.062 . . . . 0.0 111.114 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 66' ' ' ASP . 7.9 tt -172.99 151.53 2.18 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -173.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' N ' HD23 ' A' ' 65' ' ' LEU . 19.3 t70 -65.06 101.44 0.52 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 124.28 0.987 . . . . 0.0 109.392 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -94.46 92.97 7.38 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.089 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.28 -12.83 18.92 Favored Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.853 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 69.07 -46.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.141 1.776 . . . . 0.0 114.861 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -89.94 95.07 10.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.67 0.748 . . . . 0.0 112.179 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -114.54 96.35 5.71 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -168.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -78.98 -33.65 44.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.172 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 69.38 -51.53 0.61 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.226 1.41 . . . . 0.0 111.28 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -87.71 150.45 23.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--N 1.296 -1.75 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.785 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.502 -0.887 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.75 123.07 31.5 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.4 ttp 66.63 82.93 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.454 1.096 . . . . 0.0 109.743 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.615 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.3 mt-10 -80.26 122.77 83.17 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -78.16 -23.41 9.01 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.503 2.135 . . . . 0.0 113.166 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.412 ' C ' ' H ' ' A' ' 8' ' ' THR . 63.4 m -78.98 95.94 5.61 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.1 mt 69.43 -24.52 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.358 1.063 . . . . 0.0 113.832 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 4' ' ' GLU . 91.0 m -57.36 137.92 55.53 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 125.411 1.484 . . . . 0.0 111.651 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -16.54 50.96 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -71.88 125.38 27.04 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.049 0.452 . . . . 0.0 110.298 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -93.38 109.95 21.51 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 61' ' ' ILE . 7.5 p -125.97 175.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.894 -172.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 12' ' ' VAL . 28.4 ttpt -108.83 143.79 37.56 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 56' ' ' VAL . 77.7 t -125.46 129.36 72.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 123.666 0.786 . . . . 0.0 110.325 -173.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 86.5 tttt -108.76 112.9 25.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -133.17 104.81 6.67 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 21' ' ' THR . . . -158.52 141.81 7.95 Favored Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.084 -1.531 . . . . 0.0 114.871 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -145.47 113.67 6.58 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 124.37 1.068 . . . . 0.0 109.331 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.18 -121.88 7.78 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -87.22 -18.87 29.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.982 0.896 . . . . 0.0 109.597 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.579 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 56.6 m -81.12 66.7 6.76 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.69 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 26.6 tp60 -121.34 116.97 25.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.12 128.49 15.88 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.87 128.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 165.78 27.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.724 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 32.3 mt-10 -111.01 134.37 52.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . . . -138.21 179.24 6.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.587 0.708 . . . . 0.0 112.39 -172.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -122.4 136.28 54.86 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.506 HD13 HG12 ' A' ' 43' ' ' VAL . 48.1 mm -72.56 127.46 34.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -109.3 -41.79 4.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -147.73 170.34 17.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -146.85 142.34 27.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.61 144.81 44.29 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.665 0.386 . . . . 0.0 110.809 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.44 112.86 42.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -149.54 133.39 16.97 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t70 71.93 23.35 3.56 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.982 1.313 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.14 4.73 81.18 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.998 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 11.8 pt-20 -127.18 157.48 39.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 117.153 0.477 . . . . 0.0 110.329 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.11 118.88 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-O 122.223 1.011 . . . . 0.0 109.403 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' A' ' 38' ' ' GLU . 1.9 mm? -108.64 136.87 47.52 Favored 'General case' 0 N--CA 1.403 -2.802 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.065 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 33.8 m-85 -107.51 145.58 32.92 Favored 'General case' 0 C--N 1.259 -3.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.625 HD21 ' HB2' ' A' ' 53' ' ' ASP . 3.2 tm? -107.49 114.48 28.51 Favored 'General case' 0 N--CA 1.39 -3.454 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.506 HG12 HD13 ' A' ' 29' ' ' ILE . 5.1 m -117.82 148.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.819 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -132.18 137.12 47.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 55.0 m-85 -80.04 99.17 7.55 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.425 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 50.79 84.6 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.011 -1.449 . . . . 0.0 114.024 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.1 -172.06 23.35 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -96.91 157.09 16.07 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' ND2' HD11 ' A' ' 42' ' ' LEU . 22.2 p-10 -101.83 99.73 9.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.66 -48.1 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.749 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -109.77 -57.18 2.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.109 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -88.13 102.36 14.71 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.372 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.625 ' HB2' HD21 ' A' ' 42' ' ' LEU . 3.2 p-10 -114.85 127.25 55.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -131.66 134.35 45.87 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.998 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 66.3 m95 -107.6 120.35 41.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.295 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.443 HG21 HG11 ' A' ' 14' ' ' VAL . 28.3 t -125.52 145.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 38' ' ' GLU . 60.6 tttm -81.91 149.45 28.24 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.11 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.605 1.162 . . . . 0.0 113.228 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.11 -25.25 65.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.181 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 33.8 mtt85 -97.19 7.74 45.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.177 0.513 . . . . 0.0 111.625 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.469 HG22 HG21 ' A' ' 12' ' ' VAL . 44.0 mt -108.33 146.51 14.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.24 102.54 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 97.2 m95 -81.72 124.91 79.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.701 -171.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 18.5 Cg_exo -66.12 119.88 6.96 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.51 2.14 . . . . 0.0 113.107 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -141.95 71.14 1.35 Allowed 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 72.69 -71.45 0.14 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.794 -171.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.4 tptt 62.18 17.05 8.88 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.409 1.484 . . . . 0.0 111.505 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.44 77.35 0.43 Allowed Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.681 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.15 -45.78 59.12 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.08 149.89 42.91 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.23 175.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -114.78 80.82 1.46 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.959 -1.096 . . . . 0.0 113.291 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.54 -16.65 17.42 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -111.61 81.95 1.53 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -91.13 -48.44 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.1 m80 66.25 -80.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.486 1.114 . . . . 0.0 111.896 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.479 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.99 81.49 8.76 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.489 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 52.7 ttp -167.23 41.73 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -116.08 86.19 16.53 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.919 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 3' ' ' MET . 11.2 Cg_exo -75.57 126.72 9.78 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.764 2.309 . . . . 0.0 110.8 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.94 -84.82 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 63.82 6.13 2.59 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.63 1.172 . . . . 0.0 112.377 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 137.5 55.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.945 0.898 . . . . 0.0 111.065 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.51 -33.6 6.23 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -66.81 128.42 36.25 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 123.225 0.61 . . . . 0.0 111.034 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -97.65 126.03 42.74 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.83 179.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 47.6 mtmt -107.7 142.81 37.12 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 56' ' ' VAL . 85.9 t -123.45 135.95 61.62 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.182 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.196 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.8 ttmt -107.29 102.87 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD1' HG12 ' A' ' 56' ' ' VAL . 64.2 t80 -123.61 126.88 47.42 Favored 'General case' 0 C--N 1.271 -2.845 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -179.89 156.23 17.51 Favored Glycine 1 N--CA 1.391 -4.307 0 C-N-CA 118.254 -1.927 . . . . 0.0 114.345 -177.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -126.82 104.02 7.83 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 113.745 -1.228 . . . . 0.0 108.142 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.79 -106.64 0.83 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.987 -1.006 . . . . 0.0 114.209 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -81.69 -18.95 42.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.417 0.627 . . . . 0.0 110.739 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -100.01 85.47 3.06 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 0.7 OUTLIER -146.14 116.85 7.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -174.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 31.1 mmmt -129.15 159.41 36.12 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.86 114.46 46.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 15.1 m-85 -112.72 165.78 11.97 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 13' ' ' LYS . 30.2 mp0 -105.83 131.21 53.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -134.71 161.83 34.05 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.788 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 m -116.43 137.27 52.3 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 43' ' ' VAL . 38.7 mm -76.55 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.598 0.561 . . . . 0.0 111.83 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -99.33 -61.73 1.33 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -156.15 -179.86 8.55 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.93 145.32 30.64 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.068 0.395 . . . . 0.0 110.31 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -141.48 157.22 45.42 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.844 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 mp -114.01 133.0 61.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 17.9 t70 -143.68 125.24 14.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.1 t70 59.12 22.51 10.65 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.625 1.17 . . . . 0.0 111.416 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.76 -8.73 59.94 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.781 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 25.8 pt-20 -107.33 149.04 28.26 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 34' ' ' ILE . 7.6 p -109.76 121.36 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-O 122.415 1.103 . . . . 0.0 110.781 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 57' ' ' LYS . 1.3 mm? -108.86 131.88 54.57 Favored 'General case' 0 N--CA 1.389 -3.48 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.277 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 25.5 m-85 -107.86 146.87 31.7 Favored 'General case' 0 C--N 1.257 -3.424 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.504 ' CD2' ' HB3' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -107.03 111.26 23.66 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -178.43 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 29' ' ' ILE . 12.8 m -126.49 151.92 33.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -173.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.43 133.12 51.32 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.891 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 33.3 m-85 -84.75 101.81 12.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -59.72 -37.78 79.84 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.32 19.66 31.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.689 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -132.03 -54.99 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.232 -0.569 . . . . 0.0 110.987 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -158.51 91.98 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.88 -35.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.169 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -77.72 -0.09 25.55 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -100.46 -43.5 6.2 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.504 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 14.9 m-20 64.51 107.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.541 1.15 . . . . 0.0 108.757 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -118.18 153.77 33.29 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 65.3 m95 -100.59 126.05 47.02 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.749 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 14' ' ' VAL . 20.4 m -129.96 165.63 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 86.1 mttt -99.79 171.18 8.05 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.277 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.92 93.17 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.89 0.876 . . . . 0.0 111.886 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -60.93 -26.04 67.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.702 0.763 . . . . 0.0 111.145 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 23.1 mmm180 -87.39 -0.68 57.13 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.781 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -112.19 143.27 22.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.989 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.7 108.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -90.17 159.13 42.89 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.96 118.79 5.75 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.898 1.732 . . . . 0.0 111.239 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 66' ' ' ASP . 3.4 tm? -148.59 158.61 44.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 102.033 -3.321 . . . . 0.0 102.033 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.496 ' N ' HD13 ' A' ' 65' ' ' LEU . 32.5 t70 -72.14 93.1 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.719 1.247 . . . . 0.0 114.156 -173.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' H ' ' HD3' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.85 6.73 47.47 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.639 170.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.86 71.64 0.61 Allowed Glycine 0 N--CA 1.402 -3.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.221 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 66' ' ' ASP . 9.4 mp -77.18 165.51 24.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.58 85.79 7.4 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.942 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.93 105.23 13.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.82 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -90.22 -40.85 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -75.16 -33.06 61.46 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.21 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -101.8 75.83 1.59 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -70.26 -31.81 69.36 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--N 1.302 -1.475 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 173.211 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.509 -0.628 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.68 159.93 15.03 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.274 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -60.16 130.26 45.8 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.669 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.7 mt-10 -92.04 125.93 55.06 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.4 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 16.4 Cg_exo -66.21 91.84 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.768 2.312 . . . . 0.0 113.824 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -102.76 175.44 5.49 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -92.65 32.94 1.17 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.712 0.768 . . . . 0.0 110.782 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 30' ' ' LYS . 5.2 m -57.55 136.94 56.79 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 125.378 1.471 . . . . 0.0 111.718 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.34 -15.66 55.98 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -83.04 130.71 35.16 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -110.93 112.95 25.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.457 1.122 . . . . 0.0 109.359 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 34.7 m -116.94 -179.71 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.408 -169.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.03 136.76 47.18 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 56' ' ' VAL . 96.7 t -114.56 134.61 57.01 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.712 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.913 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -107.72 104.71 14.29 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 8.7 t80 -108.84 103.8 12.94 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.5 105.22 0.99 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -142.76 105.62 4.53 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.64 -109.09 2.14 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.143 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -90.32 -27.88 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.094 0.558 . . . . 0.0 110.323 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -87.62 88.92 7.81 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.783 1.278 . . . . 0.0 111.024 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 28.7 tt0 -120.64 116.86 26.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.185 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.404 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 37.5 pttt -146.22 133.75 20.9 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.026 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.46 122.36 64.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' OH ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -143.53 166.75 23.95 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.308 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.1 mt-10 -105.44 120.51 41.79 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.82 0.819 . . . . 0.0 109.019 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -129.14 152.6 48.56 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.699 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 19.3 m -104.16 137.1 42.59 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD13 HG12 ' A' ' 43' ' ' VAL . 39.2 mm -74.16 128.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.465 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' HA ' HG23 ' A' ' 8' ' ' THR . 1.1 tmmt? -114.66 -50.65 2.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -129.71 166.97 18.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -148.98 153.15 37.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 34' ' ' ILE . 11.1 pt-20 -144.44 158.52 43.71 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.5 mp -122.21 109.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -139.99 139.36 36.04 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.432 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 65.19 22.51 12.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.664 1.221 . . . . 0.0 109.785 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.5 -0.68 89.52 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.96 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.57 148.75 39.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 117.111 0.456 . . . . 0.0 111.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.23 119.27 46.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.4 mt -108.76 132.59 53.82 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.974 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 54.3 m-85 -108.94 145.16 35.89 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.742 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.0 tm? -108.1 113.55 26.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 29' ' ' ILE . 6.2 m -121.41 153.71 25.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.718 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -145.52 153.28 40.94 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.848 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 4.1 m-85 -102.36 99.66 9.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.803 -168.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 50.44 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.928 1.291 . . . . 0.0 113.482 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.42 -147.96 17.35 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -126.07 106.56 9.68 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 117.663 0.731 . . . . 0.0 109.725 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.83 127.46 32.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 m -80.01 -46.1 22.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -109.37 -27.78 9.31 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.411 0.624 . . . . 0.0 110.405 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -86.28 13.46 8.01 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.508 0.67 . . . . 0.0 110.396 -173.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' OD2' HD11 ' A' ' 42' ' ' LEU . 14.2 t70 -70.02 119.4 14.18 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.28 153.23 35.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -163.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 83.6 m95 -112.28 113.65 26.0 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.527 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 14' ' ' VAL . 23.5 m -129.82 149.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.481 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -89.32 162.42 15.83 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.175 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.89 65.61 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.854 1.262 . . . . 0.0 112.986 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.73 -20.54 62.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -92.64 3.13 56.16 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.57 145.64 15.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.078 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.92 112.15 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 95.8 m95 -93.55 119.05 67.58 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.216 -174.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 27.2 Cg_exo -62.47 122.83 11.38 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 C-N-CA 123.323 2.682 . . . . 0.0 112.485 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -165.96 81.43 0.29 Allowed 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 t70 58.72 40.85 22.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.438 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.99 166.95 21.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.93 -32.67 0.47 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.96 117.46 28.87 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.22 139.65 56.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.472 0.653 . . . . 0.0 111.818 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -93.28 69.53 4.33 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -79.71 -21.15 44.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -133.08 117.84 18.03 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -68.45 103.26 1.61 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.482 0.658 . . . . 0.0 111.03 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -89.77 -69.32 0.73 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.437 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.308 -1.226 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -177.634 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.507 -0.701 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 177.29 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ttt -163.36 86.59 0.52 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.4 137.67 71.37 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.219 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.51 -27.03 81.57 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.645 2.23 . . . . 0.0 113.52 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' C ' HD13 ' A' ' 7' ' ' LEU . 21.4 t -86.02 34.85 0.62 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.258 -0.276 . . . . 0.0 111.673 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 6' ' ' CYS 0.295 0.0 OUTLIER 43.89 33.31 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.872 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -73.95 149.02 41.62 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.02 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.7 -7.11 82.47 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.39 121.49 20.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -87.55 111.86 21.65 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.044 0.925 . . . . 0.0 109.999 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.18 176.32 3.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.332 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.6 ttpt -111.64 139.1 47.38 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' CG1' HG11 ' A' ' 56' ' ' VAL . 78.3 t -118.87 132.32 69.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 C-N-CA 122.941 0.497 . . . . 0.0 111.297 -172.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -108.42 104.69 14.09 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 124.885 1.274 . . . . 0.0 107.715 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 56.6 t80 -118.13 114.38 23.0 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 22' ' ' GLN . . . -139.64 108.41 0.59 Allowed Glycine 0 N--CA 1.417 -2.573 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.399 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 8.5 ptp180 -126.89 104.98 8.32 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.05 -100.17 0.08 OUTLIER Glycine 0 C--O 1.245 0.8 0 CA-C-N 116.198 -0.455 . . . . 0.0 114.102 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -81.73 -38.39 25.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.457 0.646 . . . . 0.0 110.119 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.5 m -84.12 86.84 7.16 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.366 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 27.2 tt0 -131.37 117.75 19.33 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.935 0.398 . . . . 0.0 110.6 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 25' ' ' TYR . 11.3 ptpt -154.66 151.51 28.86 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.0 mt -108.82 114.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -108.49 166.9 10.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.05 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 45.0 mt-10 -114.87 132.18 56.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -143.51 168.14 20.56 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.292 -171.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 p -106.43 142.35 36.24 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 43' ' ' VAL . 42.5 mm -68.38 120.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -93.22 -38.85 11.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 t -169.27 173.57 6.6 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -145.93 140.29 26.84 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -142.36 155.52 45.16 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.204 0.601 . . . . 0.0 109.638 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -108.81 124.92 65.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.76 104.87 8.08 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.714 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 55.46 64.12 1.86 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.546 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.28 -25.57 4.86 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 114.86 -1.064 . . . . 0.0 114.858 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.47 150.1 27.89 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.735 0.768 . . . . 0.0 112.932 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.66 118.36 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.05 134.78 50.46 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -107.81 146.74 31.83 Favored 'General case' 0 C--N 1.259 -3.331 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.453 HD21 ' CG ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -107.62 121.96 45.73 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 29' ' ' ILE . 12.9 m -118.81 148.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-O 121.392 0.615 . . . . 0.0 109.716 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -118.44 118.01 30.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 75.8 m-85 -68.07 127.35 32.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -170.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -90.14 95.23 10.11 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.126 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.6 -35.86 4.54 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.266 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -81.57 -73.71 0.37 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.855 0.36 . . . . 0.0 110.382 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.22 105.13 11.05 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.38 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.5 m -89.0 -12.06 10.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -109.33 -20.01 13.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.084 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.55 105.93 11.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.611 0.719 . . . . 0.0 109.294 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CG ' HD21 ' A' ' 42' ' ' LEU . 23.4 t70 -90.58 107.57 19.25 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -129.4 151.5 49.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.383 -170.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.48 131.14 55.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.488 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG11 ' CG1' ' A' ' 14' ' ' VAL . 34.8 m -138.77 144.46 29.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -80.6 160.95 24.94 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.36 -34.52 57.92 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.684 0.754 . . . . 0.0 111.182 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.18 -34.15 59.79 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.455 1.502 . . . . 0.0 111.633 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -95.31 6.61 48.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.86 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -113.52 142.35 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-O 121.635 0.731 . . . . 0.0 111.732 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.3 mp -107.87 104.97 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -85.26 155.13 60.32 Favored Pre-proline 0 C--N 1.291 -1.944 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.98 118.97 5.86 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.267 1.311 . . . . 0.0 109.066 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.2 mt -146.84 176.02 10.2 Favored 'General case' 0 CA--C 1.483 -1.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.605 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.12 76.27 0.23 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.186 1.554 . . . . 0.0 109.972 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -134.82 -35.0 0.88 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.379 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.6 -29.81 1.04 Allowed Glycine 0 CA--C 1.501 -0.798 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.94 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.67 -2.22 57.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.018 0.913 . . . . 0.0 109.492 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -159.86 136.42 9.07 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -153.71 96.75 2.03 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.722 0.773 . . . . 0.0 109.791 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -46.52 -28.81 1.52 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.718 1.607 . . . . 0.0 113.764 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -84.96 111.11 19.4 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -120.57 144.01 48.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -79.03 -30.58 44.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.994 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -177.43 106.49 0.06 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -81.75 138.27 35.22 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.43 92.82 38.07 Favored Pre-proline 0 C--N 1.291 -1.949 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.946 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.92 114.93 3.35 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 122.675 2.25 . . . . 0.0 109.5 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.8 m -135.12 141.64 46.05 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.584 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.419 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.4 pt? -74.38 -26.59 60.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 m -64.56 123.86 20.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.535 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.91 -11.83 62.43 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.803 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.5 m -77.53 131.36 37.85 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -86.11 114.76 23.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.754 0.787 . . . . 0.0 110.843 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.28 -179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 24.2 ttmt -116.76 140.42 49.45 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG1' HG11 ' A' ' 56' ' ' VAL . 94.5 t -117.31 131.46 69.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 121.186 0.517 . . . . 0.0 110.303 -176.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -106.71 104.82 14.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.61 107.33 17.77 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.452 -173.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.18 115.09 3.35 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.521 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -146.02 104.8 3.87 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 45.48 -112.13 0.71 Allowed Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.061 0.851 . . . . 0.0 114.188 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -94.65 -16.47 23.12 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.287 0.565 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.3 p -84.58 26.13 0.83 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.96 0.504 . . . . 0.0 111.212 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -81.92 138.44 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.964 0.506 . . . . 0.0 111.574 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.87 156.64 22.84 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.27 126.78 71.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.96 165.78 26.43 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.169 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 138.53 45.0 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 161.72 38.21 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -104.17 138.66 40.33 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 42.6 mm -66.3 128.31 29.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.032 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 28.6 tptp -100.9 -62.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.7 m -147.19 161.44 40.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -127.19 138.27 53.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.29 161.57 37.69 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.376 0.608 . . . . 0.0 111.673 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.91 130.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -135.82 115.91 13.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 59.7 35.11 22.23 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.548 1.139 . . . . 0.0 111.357 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.45 -12.24 66.5 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.344 -0.931 . . . . 0.0 114.238 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.1 pt-20 -116.98 151.99 35.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.5 0.65 . . . . 0.0 111.235 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG22 HG13 ' A' ' 34' ' ' ILE . 8.4 t -98.83 125.25 52.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.9 0.381 . . . . 0.0 110.147 -175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.67 160.33 26.05 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.481 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -114.11 144.42 43.17 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.764 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' NE1' ' A' ' 55' ' ' TRP . 3.5 tm? -108.23 116.52 32.11 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 m -117.67 149.12 20.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.484 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -118.35 128.02 54.25 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.3 100.19 5.79 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 58.7 -71.04 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.954 1.702 . . . . 0.0 115.238 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.42 -98.93 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 O-C-N 123.147 0.279 . . . . 0.0 113.179 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -135.13 -160.38 1.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 122.382 -0.481 . . . . 0.0 109.932 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.406 ' HA ' ' OD1' ' A' ' 53' ' ' ASP . 23.4 t-20 -61.27 109.76 1.22 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.714 0.806 . . . . 0.0 109.413 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 51' ' ' ARG . 4.7 p -81.72 -67.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.272 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.442 ' H ' HG13 ' A' ' 50' ' ' VAL . 26.4 ttm180 -110.1 -58.05 2.12 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.794 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -149.95 22.18 0.87 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 49' ' ' ASN . 55.0 m-20 59.19 -160.35 0.28 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -166.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.0 148.48 27.12 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 119.972 1.26 . . . . 0.0 111.375 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.464 ' NE1' HD23 ' A' ' 42' ' ' LEU . 78.0 m95 -107.25 122.83 47.34 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.463 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG11 ' CG1' ' A' ' 14' ' ' VAL . 16.5 m -135.99 144.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.232 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.3 tttt -79.75 160.61 26.14 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -36.52 62.86 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.116 0.967 . . . . 0.0 112.244 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.2 -10.43 59.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -103.33 4.88 36.92 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.48 140.92 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.146 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.6 mp -107.86 112.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -86.31 132.73 42.29 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.656 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.14 117.72 4.73 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 107.518 -1.762 . . . . 0.0 107.518 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.37 -163.02 1.68 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.88 88.57 1.04 Allowed 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.751 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -149.99 22.19 0.87 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.496 178.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.38 17.36 3.61 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.5 mt -123.12 94.86 4.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.54 -52.99 4.07 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 163.27 13.15 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.475 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -74.15 -14.84 61.02 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.53 0.605 . . . . 0.0 110.091 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 72.43 18.64 4.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.539 1.136 . . . . 0.0 112.921 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -159.64 99.72 1.43 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -149.86 129.65 13.29 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.072 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t70 44.52 67.68 0.65 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.381 1.472 . . . . 0.0 110.262 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.414 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 25.3 ptm -155.47 -169.41 3.13 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.094 -170.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.65 100.5 16.42 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 3' ' ' MET . 16.5 Cg_exo -70.06 107.61 1.95 Allowed 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.608 2.205 . . . . 0.0 110.878 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.0 m 65.47 -174.6 0.18 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 123.904 0.882 . . . . 0.0 110.621 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.621 HD13 ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -80.07 -15.22 57.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.434 1.111 . . . . 0.0 109.708 173.76 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 30' ' ' LYS . 16.1 m -63.87 115.45 4.86 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.761 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.65 -18.31 7.2 Favored Glycine 0 C--N 1.31 -0.884 0 C-N-CA 119.657 -1.258 . . . . 0.0 112.965 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -73.49 129.35 37.8 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -95.03 144.17 25.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.83 179.55 3.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.0 mmmt -108.05 134.39 51.01 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 56' ' ' VAL . 93.7 t -115.52 128.18 72.83 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.098 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 86.8 tttt -106.86 104.29 13.94 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 56' ' ' VAL . 63.4 t80 -143.73 118.91 10.13 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.424 0.63 . . . . 0.0 110.588 -173.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.507 ' H ' ' NH2' ' A' ' 60' ' ' ARG . . . 179.38 153.67 12.08 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -92.8 116.67 29.24 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.207 0.527 . . . . 0.0 112.039 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.54 -109.23 2.8 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.803 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -92.85 -6.32 49.03 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.832 0.825 . . . . 0.0 109.207 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 9.5 m -86.32 23.16 1.63 Allowed 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.281 1.039 . . . . 0.0 108.422 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.1 tp-100 -70.6 108.02 4.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -113.92 147.46 38.48 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.94 129.98 67.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -129.48 166.65 19.21 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.23 1.012 . . . . 0.0 109.449 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 37.4 mt-10 -107.8 125.83 51.9 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 168.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.21 46.06 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 8.5 p -104.44 142.7 34.14 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.479 HD13 HG12 ' A' ' 43' ' ' VAL . 32.8 mm -73.76 129.55 36.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.6 tmtt? -98.46 -54.75 2.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -155.22 -179.89 8.52 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 41' ' ' TYR . 10.1 t -158.49 165.06 35.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 34' ' ' ILE . 12.7 pt-20 -148.07 158.07 43.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.345 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.9 mp -119.2 111.48 33.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -123.33 122.87 39.4 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 68.67 23.03 7.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.732 1.213 . . . . 0.0 110.141 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.42 -6.55 74.97 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.522 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.27 151.04 31.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 117.73 0.765 . . . . 0.0 110.689 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 34' ' ' ILE . 4.2 t -97.95 124.15 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.728 0.775 . . . . 0.0 110.035 -172.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -108.47 125.62 51.99 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.71 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 87.0 m-85 -108.97 147.5 32.17 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.398 -176.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.424 HD13 ' NE1' ' A' ' 55' ' ' TRP . 55.6 tp -107.54 110.4 22.31 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 29' ' ' ILE . 13.8 m -118.23 148.61 20.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -126.73 129.66 48.82 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 44.8 m-85 -71.18 132.7 45.39 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.145 0.903 . . . . 0.0 111.052 -172.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 19.9 p90 -116.7 135.05 54.08 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.29 -31.83 5.84 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -172.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -102.01 -155.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -74.42 114.62 13.01 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.579 172.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 7.1 p -67.08 -12.31 14.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.976 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -76.03 -7.16 54.04 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -86.72 98.21 11.02 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.368 0.604 . . . . 0.0 112.337 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -106.47 140.76 38.87 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.75 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.85 159.37 43.03 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 73.6 m95 -98.24 134.08 41.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.245 0.545 . . . . 0.0 111.488 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 16' ' ' TYR . 26.8 m -133.23 165.21 32.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.1 157.42 16.89 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.24 -32.51 48.66 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.659 0.784 . . . . 0.0 112.263 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -26.15 68.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.423 1.089 . . . . 0.0 111.897 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 27.0 mmm-85 -93.91 0.58 56.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -109.31 140.36 28.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.63 -173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.7 mp -109.04 108.87 26.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TRP . . . . . 0.403 ' O ' ' HE2' ' A' ' 67' ' ' LYS . 91.0 m95 -83.07 124.95 75.95 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.1 117.84 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.616 1.544 . . . . 0.0 109.838 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.3 mt -172.38 107.22 0.19 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 124.371 1.068 . . . . 0.0 110.018 -173.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.4 t70 74.63 -60.94 0.5 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -62.19 139.35 58.49 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.715 0.293 . . . . 0.0 111.498 -176.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.12 85.5 0.49 Allowed Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -174.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.75 98.94 4.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 75.44 126.93 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.148 1.379 . . . . 0.0 111.015 -168.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -111.67 39.34 2.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -60.75 -36.25 78.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.942 -1.936 . . . . 0.0 109.567 -173.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -143.84 107.64 4.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -79.69 8.12 7.2 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -173.65 -166.56 0.32 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.602 177.146 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.428 -1.542 0 CA-C-O 121.258 0.552 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.48 65.65 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 m -92.79 117.24 29.81 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -97.34 134.48 40.57 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 171.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' HD3' ' A' ' 64' ' ' PRO . 33.9 m -126.47 177.2 5.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.955 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -108.98 129.46 55.45 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -123.45 136.82 58.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 118.028 0.376 . . . . 0.0 111.432 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 41.0 ttmt -108.68 146.62 33.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.679 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 1.9 mptp? . . . . . 0 CA--C 1.487 -1.477 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.34 108.28 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.8 m-85 -108.36 167.67 9.86 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.959 -169.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.68 126.69 52.6 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.7 159.66 41.37 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.749 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.61 144.59 36.14 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.428 HD13 HG12 ' A' ' 43' ' ' VAL . 50.3 mm -77.15 131.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.437 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' A' ' 44' ' ' HIS . 9.3 mtmt -99.62 -52.85 3.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.897 0.855 . . . . 0.0 110.115 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 m -155.08 166.87 32.24 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.153 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -136.65 143.14 43.31 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -144.64 162.36 36.86 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.288 0.566 . . . . 0.0 110.852 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -108.3 113.14 43.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -122.83 104.6 9.39 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.107 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 57.73 64.62 1.51 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.301 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.89 -26.33 4.86 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.847 -1.07 . . . . 0.0 115.668 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 10.3 pt-20 -116.34 160.95 19.76 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 118.119 0.959 . . . . 0.0 112.8 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.64 120.86 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.291 0.567 . . . . 0.0 109.916 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 143.45 45.16 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.645 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 69.7 m-85 -108.83 149.79 28.59 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -107.77 117.63 34.61 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 175.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.428 HG12 HD13 ' A' ' 29' ' ' ILE . 14.4 m -117.32 153.87 19.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.462 ' HB2' ' HD3' ' A' ' 30' ' ' LYS . 82.6 t60 -117.57 114.05 22.86 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.823 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--N 1.297 -1.702 0 O-C-N 123.639 0.587 . . . . 0.0 110.268 -176.692 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 121.414 0.626 . . . . 0.0 111.928 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.449 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 71.2 m95 -106.54 127.14 53.09 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.391 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.58 155.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.1 tttt -92.61 161.1 14.72 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.48 -30.37 29.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.224 1.009 . . . . 0.0 111.955 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.99 -41.08 91.3 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.213 1.005 . . . . 0.0 111.794 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 50.0 mtt180 -87.08 7.38 28.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 mt -108.97 145.42 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.8 mp -107.83 112.0 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 171.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.2 144.3 38.33 Favored Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.581 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' HG12 ' A' ' 12' ' ' VAL . 24.2 Cg_exo . . . . . 0 N--CA 1.429 -2.323 0 N-CA-C 108.358 -1.439 . . . . 0.0 108.358 173.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.44 -0.943 0 CA-C-O 120.813 0.339 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -23.71 31.69 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.393 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -74.1 130.26 39.44 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 37.6 pttt -87.2 136.69 32.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 174.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.34 174.31 11.26 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.666 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.1 tmtm? -108.41 135.79 49.12 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 71.2 t -124.78 144.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 85.2 tttt -140.39 104.6 4.81 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.5 t80 . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 120.704 0.288 . . . . 0.0 111.195 -169.705 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.502 -0.878 0 CA-C-O 120.618 0.247 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.4 mt -108.11 144.31 16.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.738 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -140.01 163.85 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.658 0.783 . . . . 0.0 109.214 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.92 124.95 51.48 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 167.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.22 175.68 8.26 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.906 0.384 . . . . 0.0 111.395 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 21.0 m -135.69 134.11 38.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 HG12 ' A' ' 43' ' ' VAL . 44.2 mm -65.76 125.8 23.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 O-C-N 123.858 0.724 . . . . 0.0 109.341 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -110.85 -31.4 7.18 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -167.25 167.22 14.33 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -144.84 139.71 27.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -145.77 156.88 43.88 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.63 0.581 . . . . 0.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 1.9 mp -108.72 129.34 63.43 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.45 104.37 8.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t70 55.17 64.34 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 125.52 1.528 . . . . 0.0 111.726 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 -25.59 5.17 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.848 -1.069 . . . . 0.0 115.193 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.9 145.77 34.84 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.985 0.892 . . . . 0.0 111.577 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 p -98.23 127.47 50.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 122.028 0.918 . . . . 0.0 110.681 -175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.74 155.72 28.41 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.926 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.418 ' CE2' ' HZ2' ' A' ' 63' ' ' TRP . 22.0 m-85 -118.11 145.8 44.61 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.925 -173.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.1 tp -107.52 105.82 15.91 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 29' ' ' ILE . 9.8 m -119.71 151.55 22.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.612 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -118.82 140.41 50.0 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 C--N 1.279 -2.457 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.639 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 . . . . . 0 CA--C 1.537 0.474 0 CA-C-O 121.088 0.471 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -97.74 126.29 43.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.36 0.6 . . . . 0.0 112.216 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 14' ' ' VAL . 33.3 m -131.72 144.05 38.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -89.54 164.96 14.57 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 122.136 -0.352 . . . . 0.0 110.47 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.04 28.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.378 1.071 . . . . 0.0 111.886 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.4 -24.3 64.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.925 179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.668 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 13.8 mmt180 -101.16 11.55 39.22 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.785 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -120.5 140.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.7 mp -107.85 114.82 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.418 ' HZ2' ' CE2' ' A' ' 41' ' ' TYR . 93.5 m95 -89.1 145.24 33.94 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.381 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.449 -1.094 0 C-N-CA 121.851 1.701 . . . . 0.0 110.743 175.558 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.427 -1.62 0 CA-C-O 120.931 0.396 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.84 58.25 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.845 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 28' ' ' SER . 25.6 m -67.84 125.02 24.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.32 110.46 20.78 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.28 -179.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.441 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.585 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -111.85 138.88 47.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.4 t -130.29 137.61 55.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 118.377 0.535 . . . . 0.0 110.542 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG3' HD11 ' A' ' 62' ' ' ILE . 53.0 mtmt -108.18 106.45 16.64 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.1 t80 . . . . . 0 C--N 1.299 -1.588 0 CA-C-O 121.847 0.832 . . . . 0.0 112.197 -174.775 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HE2' ' OH ' ' A' ' 25' ' ' TYR . 18.0 pttm . . . . . 0 N--CA 1.434 -1.227 0 CA-C-O 120.742 0.306 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.84 125.83 73.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.561 ' OH ' ' HE2' ' A' ' 23' ' ' LYS . 55.6 m-85 -111.45 165.54 11.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.313 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.67 126.81 55.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.08 -178.47 6.07 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 120.882 0.372 . . . . 0.0 111.342 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' THR . 16.4 m -123.64 155.3 37.98 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.63 126.02 39.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.727 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -101.67 -46.35 4.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -159.98 171.18 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -151.17 145.52 25.48 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.09 165.11 37.24 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.277 0.36 . . . . 0.0 110.231 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -111.26 126.35 68.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.93 103.28 7.4 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t0 57.0 65.35 1.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.001 0.92 . . . . 0.0 111.585 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -26.62 5.01 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' OE2' HD21 ' A' ' 40' ' ' LEU . 11.1 pt-20 -108.47 144.4 36.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 117.843 0.822 . . . . 0.0 110.768 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.8 p -98.82 121.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-O 122.241 1.019 . . . . 0.0 110.108 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD21 ' OE2' ' A' ' 38' ' ' GLU . 83.5 mt -108.62 137.95 45.72 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.692 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 35.4 m-85 -108.56 145.22 35.16 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.843 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.8 tp -108.25 117.77 35.01 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.8 146.01 22.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.486 0.66 . . . . 0.0 109.505 -175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -117.89 116.69 27.46 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.692 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.263 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 . . . . . 0 C--O 1.222 -0.362 0 CA-C-O 121.047 0.451 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.506 ' CE2' HD13 ' A' ' 42' ' ' LEU . 87.8 m95 -109.64 118.9 37.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.122 0.969 . . . . 0.0 111.869 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.44 157.34 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.577 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -90.85 165.14 13.77 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.7 -29.29 66.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.36 -1.76 57.34 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.6 tpt180 -100.89 4.7 42.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.418 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.59 147.07 13.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.14 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.9 mp -108.77 108.56 25.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -81.77 133.03 52.87 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo . . . . . 0 C--N 1.36 1.132 0 C-N-CA 124.126 3.217 . . . . 0.0 114.423 -177.034 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 120.981 0.419 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.69 8.48 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.7 m -63.82 130.07 42.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.027 0.531 . . . . 0.0 110.115 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -98.84 115.16 28.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.02 -177.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.823 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.666 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.8 mmtm -107.3 135.82 48.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 43' ' ' VAL . 85.3 t -127.26 137.23 58.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -107.87 121.94 45.77 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HH21 ' A' ' 60' ' ' ARG . 41.1 t80 . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.495 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.38 120.49 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.92 166.86 10.51 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.495 1.118 . . . . 0.0 109.725 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.23 137.2 52.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.29 42.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 118.112 0.415 . . . . 0.0 111.983 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 p -104.49 141.75 35.82 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 40.0 mm -78.81 124.68 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -33.96 6.54 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 m -158.55 169.73 23.78 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.973 -0.455 . . . . 0.0 109.811 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -144.31 141.28 29.66 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -143.39 153.17 42.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.118 0.485 . . . . 0.0 110.812 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -109.07 123.87 65.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -125.6 104.14 8.23 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 50.79 65.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.877 1.271 . . . . 0.0 113.236 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -24.04 10.09 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.714 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.67 140.06 42.59 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 118.083 0.942 . . . . 0.0 112.396 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 HG13 ' A' ' 34' ' ' ILE . 5.4 t -98.84 117.19 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.2 mt -109.03 138.68 45.0 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 42.7 m-85 -107.74 147.24 31.06 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -107.2 105.16 15.01 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 8.0 m -123.91 154.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.544 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -128.63 125.8 38.87 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.39 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 C--N 1.32 -0.69 0 O-C-N 124.465 1.103 . . . . 0.0 109.235 -174.191 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 121.155 0.502 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 82.8 m95 -99.5 123.43 43.77 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.595 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.21 147.37 28.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.248 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 61' ' ' ILE . 91.8 mttt -77.68 170.25 16.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.95 67.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.143 0.497 . . . . 0.0 110.398 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.2 -31.54 71.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 109.367 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 16' ' ' TYR . 26.8 mmm-85 -96.66 7.54 46.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.307 -173.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 57' ' ' LYS . 57.0 mt -120.71 151.16 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 13' ' ' LYS . 5.0 mp -108.15 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 96.5 m95 -90.9 130.02 42.12 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 19.4 Cg_exo . . . . . 0 N--CA 1.444 -1.39 0 C-N-CA 120.817 1.012 . . . . 0.0 111.335 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.8 p . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.2 0.524 . . . . 0.0 111.702 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.66 -12.74 68.56 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.186 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -70.38 125.38 26.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 64.4 mttp -83.22 122.63 28.66 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.08 177.22 4.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.508 0.67 . . . . 0.0 111.268 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.04 136.5 52.85 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG1' HG11 ' A' ' 56' ' ' VAL . 79.1 t -127.59 131.18 70.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 118.321 0.51 . . . . 0.0 111.0 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 10.8 tmtt? -119.33 118.73 31.99 Favored 'General case' 0 C--O 1.197 -1.671 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.576 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 60' ' ' ARG 0.319 0.0 OUTLIER . . . . . 0 CA--C 1.481 -1.688 0 CA-C-N 118.416 0.553 . . . . 0.0 111.192 170.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt . . . . . 0 C--O 1.27 2.175 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 15' ' ' LYS . 54.2 mt -111.69 124.94 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.47 ' CE1' ' HE1' ' A' ' 16' ' ' TYR . 65.8 m-85 -107.78 166.14 10.92 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.616 -174.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.5 123.25 45.85 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -130.22 -178.57 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.141 0.496 . . . . 0.0 111.69 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.4 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 24.2 m -135.22 135.16 40.75 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 171.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 43' ' ' VAL . 45.8 mm -65.5 124.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -103.74 -46.6 4.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -153.02 160.22 42.97 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -133.92 141.29 47.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -145.88 161.09 40.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.646 0.591 . . . . 0.0 110.743 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.83 124.7 65.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -130.69 114.08 14.95 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.679 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.74 25.53 12.99 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.62 -17.72 52.38 Favored Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.928 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -108.65 152.65 24.51 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.48 122.79 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-O 122.072 0.939 . . . . 0.0 110.749 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -109.66 142.15 41.22 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.692 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 42.7 m-85 -108.82 142.66 39.06 Favored 'General case' 0 C--N 1.26 -3.322 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.697 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.57 110.97 23.01 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 29' ' ' ILE . 11.4 m -117.53 150.89 19.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -172.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.4 138.12 54.03 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.073 175.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 31.5 m-85 . . . . . 0 C--N 1.28 -2.442 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HG2' ' OH ' ' A' ' 16' ' ' TYR . 9.2 tp10 . . . . . 0 N--CA 1.444 -0.768 0 CA-C-O 121.146 0.498 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -100.17 125.96 46.38 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.49 1.116 . . . . 0.0 111.48 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.44 HG11 ' CG1' ' A' ' 14' ' ' VAL . 17.6 m -138.35 152.19 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.557 ' HE2' ' OD2' ' A' ' 59' ' ' ASP . 88.9 tttt -89.51 157.91 17.9 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -53.46 -31.41 45.45 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.423 1.089 . . . . 0.0 112.512 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.557 ' OD2' ' HE2' ' A' ' 57' ' ' LYS . 16.1 m-20 -72.92 -13.37 61.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.906 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 16' ' ' TYR . 30.7 mtt180 -106.97 8.23 30.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.563 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 56' ' ' VAL . 49.1 mt -108.79 140.27 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.3 mp -106.78 105.27 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -82.9 124.56 76.75 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.155 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo . . . . . 0 N--CA 1.439 -1.729 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 174.637 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.43 -1.444 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.71 -35.59 4.33 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.215 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 m -62.58 128.5 36.26 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.043 0.537 . . . . 0.0 110.799 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -96.01 129.6 43.23 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.3 173.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.811 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.874 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 33.3 ttpt -119.5 138.92 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 56' ' ' VAL . 59.6 t -119.21 134.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -109.31 103.98 13.03 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--N 1.281 -2.38 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 179.781 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.78 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.08 129.44 62.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.95 164.02 33.34 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 123.503 0.721 . . . . 0.0 111.157 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 38.7 mt-10 -108.33 136.5 47.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -139.56 158.59 43.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -103.82 139.05 39.56 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 36.8 mm -78.01 125.06 37.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.75 -39.3 7.08 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -160.87 167.84 25.87 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -143.31 151.12 40.13 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.65 165.05 37.15 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -108.83 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.51 134.02 39.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t70 67.0 24.17 9.6 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.401 1.095 . . . . 0.0 109.67 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.87 -9.18 77.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.208 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.18 164.96 13.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 117.387 0.594 . . . . 0.0 111.229 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 34' ' ' ILE . 3.4 t -97.62 117.47 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.511 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.23 134.39 53.8 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.064 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 27.3 m-85 -108.34 146.33 33.13 Favored 'General case' 0 C--N 1.271 -2.813 0 C-N-CA 123.84 0.856 . . . . 0.0 109.057 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -107.63 107.68 18.6 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 13.5 m -121.1 148.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.156 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -118.71 126.13 51.2 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 51.7 m-85 . . . . . 0 C--N 1.306 -1.291 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.433 -1.278 0 CA-C-O 121.545 0.688 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.2 m95 -101.44 124.32 46.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.217 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 14' ' ' VAL . 32.0 m -123.78 144.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -80.43 159.07 25.76 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -58.19 -33.48 69.3 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.459 0.647 . . . . 0.0 111.294 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -60.96 -25.71 67.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.621 1.168 . . . . 0.0 111.188 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.07 -5.44 57.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.033 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -107.84 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.835 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.39 109.9 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.8 124.07 53.7 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 N--CA 1.445 -1.359 0 N-CA-C 108.756 -1.286 . . . . 0.0 108.756 174.426 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 9.3 p . . . . . 0 N--CA 1.431 -1.423 0 CA-C-O 120.955 0.407 . . . . 0.0 112.05 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.46 -11.3 72.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.205 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' SER . 26.9 m -71.68 121.41 18.8 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 107.18 19.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -113.62 178.81 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.16 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -108.98 141.6 40.84 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 56' ' ' VAL . 95.7 t -127.44 130.32 70.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 86.4 tttt -122.54 104.98 9.72 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.6 t80 . . . . . 0 C--N 1.297 -1.704 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? . . . . . 0 CA--C 1.498 -1.038 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -108.8 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.05 165.78 18.84 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.609 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -108.24 134.01 51.67 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -137.0 174.13 10.95 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.831 0.348 . . . . 0.0 111.603 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 45.1 m -123.77 137.5 54.67 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 mm -69.17 123.67 23.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -106.86 -40.96 5.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.928 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -152.77 166.04 33.47 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -151.07 144.35 24.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.47 166.27 33.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.958 0.409 . . . . 0.0 110.862 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 39' ' ' VAL . 1.4 mp -108.36 120.15 59.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 28.5 t70 -132.57 125.28 30.14 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.43 23.34 13.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.319 1.057 . . . . 0.0 110.229 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.36 8.34 68.44 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.603 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.5 pt-20 -125.12 156.74 37.85 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 117.686 0.743 . . . . 0.0 109.768 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 34' ' ' ILE . 11.8 t -98.78 119.31 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 CA-C-O 121.524 0.678 . . . . 0.0 110.133 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -108.77 137.25 47.0 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.745 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 26.3 m-85 -111.64 142.51 43.87 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.393 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD13 ' CE2' ' A' ' 55' ' ' TRP . 58.4 tp -108.0 111.84 24.12 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.24 142.94 42.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.569 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -120.3 142.24 49.27 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 54.3 m-85 . . . . . 0 C--N 1.282 -2.336 0 O-C-N 124.481 1.113 . . . . 0.0 111.113 -171.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 121.201 0.524 . . . . 0.0 111.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 81.0 m95 -103.36 117.66 34.99 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.891 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 14' ' ' VAL . 25.6 m -122.05 165.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 80.9 tttt -103.31 164.98 11.3 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.92 74.57 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.566 0.746 . . . . 0.0 113.009 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -74.08 -6.52 48.07 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 16.8 mmt-85 -104.69 11.68 33.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.327 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.62 138.64 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.278 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 13' ' ' LYS . 3.9 mp -108.33 114.44 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -83.72 115.55 60.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--O 1.251 1.135 0 C-N-CA 122.031 1.821 . . . . 0.0 111.027 -179.579 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.451 -0.413 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 -32.19 6.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.567 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 m -63.87 132.7 51.6 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.082 0.553 . . . . 0.0 110.035 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -93.11 131.23 38.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.405 HG12 ' HD3' ' A' ' 64' ' ' PRO . 35.3 m -129.74 -179.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.486 -172.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 24' ' ' ILE . 28.4 mmmt -114.03 135.36 54.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 43' ' ' VAL . 86.4 t -116.11 133.14 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -107.9 114.18 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.114 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' CE2' HG12 ' A' ' 56' ' ' VAL . 1.5 m-85 . . . . . 0 CA--C 1.496 -1.098 0 CA-C-O 121.015 0.436 . . . . 0.0 110.616 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.636 HG22 ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -112.63 133.61 57.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 8.7 m-85 -107.5 166.77 10.42 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -172.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -106.75 116.46 31.96 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.86 167.75 19.65 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.741 -0.599 . . . . 0.0 111.497 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.557 HD13 HG12 ' A' ' 43' ' ' VAL . 33.7 mm -78.78 128.35 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 123.642 0.589 . . . . 0.0 111.145 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.346 1.058 . . . . 0.0 111.895 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 t -154.39 167.86 28.57 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -132.83 139.7 47.61 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.56 156.38 45.1 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 123.575 0.547 . . . . 0.0 110.097 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.77 119.92 59.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.22 131.7 32.8 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 65.64 22.03 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.397 1.094 . . . . 0.0 109.855 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.96 87.7 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.383 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -116.51 159.37 22.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 122.495 -0.415 . . . . 0.0 111.765 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 34' ' ' ILE . 3.3 t -98.86 116.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.43 0.633 . . . . 0.0 111.093 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -112.73 139.94 47.93 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.486 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 31.2 m-85 -108.15 157.25 18.46 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.93 115.02 29.46 Favored 'General case' 0 CA--C 1.465 -2.311 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 14' ' ' VAL . 13.8 m -129.17 142.59 43.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -117.84 125.47 50.6 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.619 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 . . . . . 0 C--N 1.291 -1.951 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -178.483 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 N--CA 1.44 -0.966 0 CA-C-O 121.086 0.469 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.1 m95 -98.83 126.84 44.59 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.462 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 16' ' ' TYR . 34.3 m -135.94 165.22 30.17 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.831 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.69 166.47 10.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.36 74.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.654 . . . . 0.0 111.239 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.11 -15.64 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.735 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 60' ' ' ARG . 14.6 tpt180 -95.95 0.61 52.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.825 0.821 . . . . 0.0 109.61 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.99 150.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.268 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.0 mp -107.64 104.57 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -75.81 150.83 84.2 Favored Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.346 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' HG12 ' A' ' 12' ' ' VAL . 7.5 Cg_exo . . . . . 0 N--CA 1.448 -1.201 0 C-N-CA 122.612 2.208 . . . . 0.0 111.201 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 30' ' ' LYS . 1.9 m . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.54 -22.22 40.73 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.794 174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -66.09 118.65 10.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -91.0 115.07 27.72 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.54 178.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 34.4 tttp -120.92 139.11 53.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.71 139.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 40.8 ttmt -125.01 104.09 8.37 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.307 -1.247 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.157 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.422 -1.836 0 CA-C-O 121.234 0.54 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.459 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -108.17 115.17 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.23 162.48 32.03 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.449 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 13' ' ' LYS . 54.6 mt-10 -113.85 136.8 52.48 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.089 0.471 . . . . 0.0 112.071 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -141.25 -178.04 5.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.289 -171.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -134.95 133.37 39.48 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 43' ' ' VAL . 46.5 mm -67.78 131.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.797 0.686 . . . . 0.0 110.98 -176.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -101.8 -60.92 1.45 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.7 m -147.98 164.82 32.59 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -134.29 151.98 51.56 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.12 165.57 35.22 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 123.167 0.292 . . . . 0.0 110.237 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -111.14 131.39 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.95 115.87 13.18 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 63.79 23.44 13.44 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.262 1.425 . . . . 0.0 111.623 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.79 -10.55 55.87 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.419 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.17 147.1 31.79 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.722 0.761 . . . . 0.0 109.565 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.6 118.04 44.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.96 130.06 55.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.605 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 37.4 m-85 -108.16 147.91 30.63 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.897 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.8 tp -107.55 113.07 26.14 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 HD13 ' A' ' 29' ' ' ILE . 2.4 p -118.42 147.03 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.443 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.15 125.92 51.19 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.654 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 90.2 m-85 . . . . . 0 C--N 1.304 -1.403 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.582 -173.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 121.266 0.555 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 74.9 m95 -102.41 106.47 17.22 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.37 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 61' ' ' ILE . 3.0 p -122.88 148.04 26.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.151 -174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 61' ' ' ILE . 26.3 mtmm -73.15 158.28 35.59 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -61.2 -39.88 91.88 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.115 0.966 . . . . 0.0 113.066 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -86.05 -2.48 58.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -96.69 5.61 50.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.206 1.003 . . . . 0.0 109.016 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 57' ' ' LYS . 70.0 mt -120.48 153.32 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.084 -1.416 . . . . 0.0 107.336 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.1 mp -107.39 109.51 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -87.89 120.05 70.69 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.075 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo . . . . . 0 N--CA 1.439 -1.695 0 C-N-CA 121.334 1.356 . . . . 0.0 109.558 175.002 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.429 -1.492 0 CA-C-O 120.888 0.375 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.96 -11.3 48.9 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.334 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -78.28 128.22 33.39 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -93.24 121.67 34.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.812 0.815 . . . . 0.0 109.898 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.44 179.46 2.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.142 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 53.0 mtmt -108.83 143.84 37.5 Favored 'General case' 0 CA--C 1.475 -1.905 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.36 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 56' ' ' VAL . 92.7 t -121.44 128.94 75.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.048 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.7 ttmt -107.64 104.1 13.55 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 t80 . . . . . 0 C--N 1.302 -1.471 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.878 -171.188 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.9 mttm . . . . . 0 CA--C 1.517 -0.32 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 61.5 mt -108.69 112.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.55 166.93 10.73 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 13' ' ' LYS . 50.7 mt-10 -107.11 119.79 40.32 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . -126.21 177.61 6.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -129.19 128.04 42.54 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 122.203 -0.311 . . . . 0.0 110.203 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 43' ' ' VAL . 33.4 mm -65.62 130.17 30.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 O-C-N 124.1 0.875 . . . . 0.0 109.786 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -117.63 -42.82 2.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -158.3 170.18 22.83 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.908 -0.495 . . . . 0.0 109.963 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 140.58 41.99 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -145.47 155.44 43.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.747 0.419 . . . . 0.0 110.253 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.7 124.86 65.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -125.92 104.32 8.24 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.05 64.46 1.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 112.97 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -26.57 5.71 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.692 -1.14 . . . . 0.0 115.525 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.14 149.45 28.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.311 1.056 . . . . 0.0 111.215 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.45 125.59 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.448 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.1 mt -112.3 138.56 48.83 Favored 'General case' 0 N--CA 1.405 -2.722 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.372 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 30.9 m-85 -108.0 149.14 28.76 Favored 'General case' 0 C--N 1.258 -3.411 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 55' ' ' TRP . 39.8 tp -107.29 104.26 13.83 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 14' ' ' VAL . 3.8 p -118.77 138.36 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -173.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.69 143.76 47.57 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.972 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 . . . . . 0 C--N 1.299 -1.59 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.223 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 . . . . . 0 N--CA 1.437 -1.115 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 75.6 m95 -98.47 122.88 42.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.37 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 14' ' ' VAL . 18.1 m -130.44 152.48 37.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -79.82 153.03 29.4 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.05 -2.51 37.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 13.5 mtp180 -106.09 10.19 32.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.011 0.434 . . . . 0.0 110.498 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.5 mt -108.81 139.24 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.373 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.1 mp -108.05 107.61 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -84.88 130.41 52.75 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo . . . . . 0 C--O 1.251 1.142 0 C-N-CA 122.902 2.402 . . . . 0.0 112.589 -179.409 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.431 -1.403 0 CA-C-O 121.262 0.553 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.56 0.14 82.35 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.812 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' SER . 91.5 m -78.22 131.78 37.28 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -86.22 129.98 34.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.36 175.84 9.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 30.2 ttpt -120.51 146.64 46.08 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 56' ' ' VAL . 93.3 t -129.62 132.57 66.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -173.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.56 103.14 9.16 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.1 t80 . . . . . 0 C--N 1.313 -1.009 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.112 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? . . . . . 0 N--CA 1.429 -1.489 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -107.98 124.09 63.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.5 165.63 31.59 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 124.228 1.011 . . . . 0.0 109.983 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.01 136.88 46.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . . . -131.16 -178.27 4.76 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.828 -173.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 m -138.62 139.38 38.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.494 HD13 HG12 ' A' ' 43' ' ' VAL . 34.3 mm -77.88 135.31 26.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.948 0.404 . . . . 0.0 111.586 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -103.42 -58.71 1.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -148.68 -178.64 6.45 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.687 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.09 145.24 41.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.42 154.02 50.91 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.62 119.32 61.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -135.09 119.73 18.2 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.48 23.0 12.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 110.648 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.52 -8.9 66.65 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.491 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -109.47 143.85 38.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 117.762 0.781 . . . . 0.0 110.565 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.54 123.21 50.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 122.395 1.093 . . . . 0.0 110.666 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.89 145.38 35.46 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.022 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.541 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 34.6 m-85 -113.22 151.84 30.49 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.783 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CE2' ' A' ' 55' ' ' TRP . 40.8 tp -107.72 116.5 32.07 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 29' ' ' ILE . 5.9 m -118.95 140.99 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.612 -174.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -130.25 138.47 50.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.092 0.472 . . . . 0.0 111.121 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 20.4 m-85 . . . . . 0 C--N 1.284 -2.282 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.809 -171.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 120.914 0.388 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.477 ' CE2' HD13 ' A' ' 42' ' ' LEU . 74.6 m95 -104.37 129.08 52.29 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 14' ' ' VAL . 29.5 t -138.93 140.23 39.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' ILE . 33.0 ttpt -71.68 150.66 44.35 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 120.756 0.312 . . . . 0.0 111.505 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.541 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -52.56 -49.67 64.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.685 1.594 . . . . 0.0 113.73 -170.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.35 -7.71 54.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.689 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -106.87 8.37 30.65 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.382 1.087 . . . . 0.0 108.707 -175.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 57' ' ' LYS . 68.1 mt -108.61 157.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.07 108.6 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -97.95 146.24 31.15 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo . . . . . 0 N--CA 1.44 -1.653 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 174.032 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.5 m . . . . . 0 N--CA 1.436 -1.154 0 CA-C-O 121.074 0.464 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.06 -20.34 21.8 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.861 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.3 m -74.68 128.67 36.11 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 1.2 pptp? -87.9 127.4 35.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.419 0.628 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.06 176.68 6.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.94 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.3 mmtm -110.92 135.47 51.4 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 43' ' ' VAL . 96.8 t -124.38 131.72 72.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.12 114.35 28.18 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 . . . . . 0 N--CA 1.434 -1.261 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.822 -175.831 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 pttt . . . . . 0 N--CA 1.429 -1.508 0 CA-C-O 121.546 0.689 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.59 129.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.88 165.66 13.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.194 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -115.11 136.68 52.85 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' HG22 ' A' ' 43' ' ' VAL . . . -136.94 -178.71 5.31 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 m -142.67 130.07 21.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 43' ' ' VAL . 42.0 mm -57.94 127.0 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 124.071 0.857 . . . . 0.0 111.152 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.38 -46.03 5.38 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -154.43 153.79 32.14 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -126.64 133.6 50.95 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -142.09 158.86 43.26 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 123.699 0.625 . . . . 0.0 110.378 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.401 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.46 129.94 61.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.581 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.15 103.92 8.86 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.519 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 46.69 63.82 1.76 Allowed 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 125.601 1.56 . . . . 0.0 113.057 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 -24.46 11.51 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.12 -0.945 . . . . 0.0 115.275 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.81 149.13 29.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.466 1.133 . . . . 0.0 110.49 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 34' ' ' ILE . 9.8 t -98.52 119.55 46.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.69 143.07 38.28 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -108.45 139.84 42.61 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.579 HD13 ' CE2' ' A' ' 55' ' ' TRP . 59.8 tp -107.61 106.59 17.02 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG22 ' HB1' ' A' ' 27' ' ' ALA . 4.1 p -125.82 141.91 44.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.605 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -118.99 146.47 44.99 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.31 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 33.5 m-85 . . . . . 0 C--N 1.29 -1.98 0 O-C-N 123.967 0.792 . . . . 0.0 110.575 -172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 N--CA 1.438 -1.04 0 CA-C-O 120.746 0.308 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CE2' HD13 ' A' ' 42' ' ' LEU . 84.9 m95 -108.38 110.61 22.21 Favored 'General case' 0 C--O 1.253 1.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.316 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.5 m -135.77 139.74 45.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.018 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -80.98 168.2 18.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.1 63.19 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.485 0.714 . . . . 0.0 112.867 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.48 -19.35 53.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.341 0.591 . . . . 0.0 110.859 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -92.13 -5.24 53.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.334 1.064 . . . . 0.0 108.415 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.79 150.71 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.829 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -108.65 115.21 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 172.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -81.15 108.98 11.88 Favored Pre-proline 0 C--N 1.31 -1.148 0 O-C-N 123.144 0.278 . . . . 0.0 111.013 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.441 -1.58 0 C-N-CA 122.288 1.992 . . . . 0.0 113.851 -175.552 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.8 p . . . . . 0 N--CA 1.427 -1.589 0 CA-C-O 121.137 0.494 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.13 8.48 57.78 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.441 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 m -77.86 126.87 31.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 95.3 mttt -94.52 124.29 38.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.119 0.485 . . . . 0.0 111.387 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.99 -178.96 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.789 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 32.6 ttpt -124.79 146.47 49.21 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 56' ' ' VAL . 99.4 t -126.09 137.69 56.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 122.836 0.455 . . . . 0.0 110.238 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -110.57 107.0 16.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.305 -1.357 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.175 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 mptt . . . . . 0 N--CA 1.436 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.62 108.53 25.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 170.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.57 165.09 19.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.87 -174.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.47 139.07 43.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.8 -179.68 6.75 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.199 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 6.6 m -129.47 136.87 50.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 43' ' ' VAL . 39.1 mm -69.85 129.63 34.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.07 -47.1 4.87 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -155.97 168.03 28.54 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -140.5 150.69 44.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.46 162.43 40.74 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -114.26 124.7 71.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.06 108.18 10.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.025 0.441 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.32 65.0 1.01 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.521 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -26.53 3.34 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.618 -1.173 . . . . 0.0 115.181 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.11 148.69 36.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.623 0.711 . . . . 0.0 111.562 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.2 p -98.32 125.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.683 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.89 134.9 51.57 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.705 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -110.84 145.91 37.37 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.056 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.1 tp -108.29 119.8 40.54 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 29' ' ' ILE . 8.5 m -118.23 149.62 20.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -125.61 138.65 53.93 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . 0.258 58.1 m-85 . . . . . 0 C--N 1.286 -2.187 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -168.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 C--O 1.24 0.553 0 CA-C-O 121.457 0.646 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.4 ' CE2' HD13 ' A' ' 42' ' ' LEU . 79.9 m95 -104.78 122.28 45.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.686 -176.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 14' ' ' VAL . 19.2 m -134.29 143.93 36.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -82.84 160.79 22.12 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 123.358 0.663 . . . . 0.0 110.467 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.59 61.56 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.57 0.748 . . . . 0.0 112.204 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.79 -2.57 37.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.291 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -111.88 0.53 16.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 56' ' ' VAL . 45.3 mt -114.64 152.69 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 111.599 -172.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.2 mp -107.48 112.55 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 98.7 m95 -93.85 137.78 22.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 22.8 Cg_exo . . . . . 0 N--CA 1.443 -1.47 0 C-N-CA 121.92 1.746 . . . . 0.0 108.865 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 10.2 m . . . . . 0 N--CA 1.42 -1.968 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.72 -25.59 7.17 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.934 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.3 m -62.53 121.17 12.64 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.322 0.582 . . . . 0.0 109.837 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.554 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -97.72 122.58 40.98 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.263 -176.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.85 -179.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.857 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -113.33 140.32 48.11 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 43' ' ' VAL . 86.2 t -132.85 138.56 51.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 118.721 0.692 . . . . 0.0 111.204 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HE3' HD11 ' A' ' 62' ' ' ILE . 94.1 mttt -108.61 143.68 37.35 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 . . . . . 0 C--N 1.313 -0.997 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.716 176.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -0.997 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.16 114.88 46.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 165.76 15.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.09 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -108.79 142.2 39.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.09 172.94 15.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.5 p -122.64 146.92 47.02 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 8' ' ' THR . 20.8 mm -66.72 131.92 32.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -103.24 -45.8 4.79 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -165.04 -176.55 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -150.28 165.01 34.28 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.498 0.719 . . . . 0.0 109.445 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -160.46 166.35 29.36 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.33 1.452 . . . . 0.0 110.081 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -107.2 117.26 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.25 114.53 15.78 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.045 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 69.15 23.61 6.36 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.895 1.278 . . . . 0.0 110.512 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.48 54.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.558 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.0 159.34 16.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.434 -0.451 . . . . 0.0 111.183 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 34' ' ' ILE . 60.8 t -98.35 117.38 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.39 0.614 . . . . 0.0 109.739 -176.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 6.2 mp -111.04 154.66 23.89 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.799 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 88.9 m-85 -116.85 148.78 40.96 Favored 'General case' 0 C--N 1.255 -3.521 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.52 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ2' ' A' ' 55' ' ' TRP . 36.0 tp -107.09 116.36 31.78 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 14' ' ' VAL . 29.4 m -118.18 144.09 27.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.534 -172.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -117.37 125.57 51.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 . . . . . 0 C--N 1.304 -1.399 0 CA-C-N 114.739 -1.118 . . . . 0.0 112.969 -170.585 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 79.3 m95 -98.56 126.98 44.32 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.754 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.01 140.84 32.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.548 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 35.5 ttpt -76.86 164.17 26.07 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 122.328 -0.233 . . . . 0.0 110.677 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.09 -32.08 63.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.009 0.524 . . . . 0.0 112.085 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.48 -24.75 65.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.285 1.034 . . . . 0.0 111.701 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -94.72 -6.42 43.2 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.555 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.1 147.65 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.89 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -107.72 106.65 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 81.9 m95 -82.51 136.15 45.9 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.616 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 51.3 Cg_exo . . . . . 0 CA--C 1.506 -0.903 0 C-N-CA 122.392 2.062 . . . . 0.0 111.114 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 30' ' ' LYS . 91.0 m . . . . . 0 N--CA 1.428 -1.525 0 CA-C-O 121.238 0.542 . . . . 0.0 111.651 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -16.54 50.96 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -71.88 125.38 27.04 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.049 0.452 . . . . 0.0 110.298 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -93.38 109.95 21.51 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 61' ' ' ILE . 7.5 p -125.97 175.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.894 -172.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 12' ' ' VAL . 28.4 ttpt -108.83 143.79 37.56 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 56' ' ' VAL . 77.7 t -125.46 129.36 72.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 123.666 0.786 . . . . 0.0 110.325 -173.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 86.5 tttt -108.76 112.9 25.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--N 1.282 -2.357 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.255 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 N--CA 1.417 -2.122 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.87 128.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 165.78 27.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.724 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 32.3 mt-10 -111.01 134.37 52.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . . . -138.21 179.24 6.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.587 0.708 . . . . 0.0 112.39 -172.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -122.4 136.28 54.86 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.506 HD13 HG12 ' A' ' 43' ' ' VAL . 48.1 mm -72.56 127.46 34.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -109.3 -41.79 4.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -147.73 170.34 17.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -146.85 142.34 27.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.61 144.81 44.29 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.665 0.386 . . . . 0.0 110.809 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.44 112.86 42.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -149.54 133.39 16.97 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t70 71.93 23.35 3.56 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.982 1.313 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.14 4.73 81.18 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.998 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 11.8 pt-20 -127.18 157.48 39.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 117.153 0.477 . . . . 0.0 110.329 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.11 118.88 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-O 122.223 1.011 . . . . 0.0 109.403 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' A' ' 38' ' ' GLU . 1.9 mm? -108.64 136.87 47.52 Favored 'General case' 0 N--CA 1.403 -2.802 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.065 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 33.8 m-85 -107.51 145.58 32.92 Favored 'General case' 0 C--N 1.259 -3.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -107.49 114.48 28.51 Favored 'General case' 0 N--CA 1.39 -3.454 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.506 HG12 HD13 ' A' ' 29' ' ' ILE . 5.1 m -117.82 148.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.819 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -132.18 137.12 47.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 55.0 m-85 . . . . . 0 C--N 1.285 -2.211 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.425 -173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 . . . . . 0 C--O 1.238 0.478 0 CA-C-O 121.004 0.431 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 66.3 m95 -107.6 120.35 41.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.295 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.443 HG21 HG11 ' A' ' 14' ' ' VAL . 28.3 t -125.52 145.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 38' ' ' GLU . 60.6 tttm -81.91 149.45 28.24 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.11 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.605 1.162 . . . . 0.0 113.228 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.11 -25.25 65.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.181 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 33.8 mtt85 -97.19 7.74 45.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.177 0.513 . . . . 0.0 111.625 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.469 HG22 HG21 ' A' ' 12' ' ' VAL . 44.0 mt -108.33 146.51 14.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.24 102.54 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 97.2 m95 -81.72 124.91 79.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.701 -171.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 18.5 Cg_exo . . . . . 0 N--CA 1.446 -1.3 0 C-N-CA 122.51 2.14 . . . . 0.0 113.107 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.431 -1.402 0 CA-C-O 120.85 0.357 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.51 -33.6 6.23 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -66.81 128.42 36.25 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 123.225 0.61 . . . . 0.0 111.034 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -97.65 126.03 42.74 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.83 179.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 47.6 mtmt -107.7 142.81 37.12 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 56' ' ' VAL . 85.9 t -123.45 135.95 61.62 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.182 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.196 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.8 ttmt -107.29 102.87 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD1' HG12 ' A' ' 56' ' ' VAL . 64.2 t80 . . . . . 0 C--N 1.271 -2.845 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 31.1 mmmt . . . . . 0 C--O 1.244 0.813 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.86 114.46 46.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 15.1 m-85 -112.72 165.78 11.97 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 13' ' ' LYS . 30.2 mp0 -105.83 131.21 53.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -134.71 161.83 34.05 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.788 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 m -116.43 137.27 52.3 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 43' ' ' VAL . 38.7 mm -76.55 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.598 0.561 . . . . 0.0 111.83 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -99.33 -61.73 1.33 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -156.15 -179.86 8.55 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.93 145.32 30.64 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.068 0.395 . . . . 0.0 110.31 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -141.48 157.22 45.42 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.844 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 mp -114.01 133.0 61.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 17.9 t70 -143.68 125.24 14.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.1 t70 59.12 22.51 10.65 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.625 1.17 . . . . 0.0 111.416 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.76 -8.73 59.94 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.781 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 25.8 pt-20 -107.33 149.04 28.26 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 34' ' ' ILE . 7.6 p -109.76 121.36 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-O 122.415 1.103 . . . . 0.0 110.781 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 57' ' ' LYS . 1.3 mm? -108.86 131.88 54.57 Favored 'General case' 0 N--CA 1.389 -3.48 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.277 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 25.5 m-85 -107.86 146.87 31.7 Favored 'General case' 0 C--N 1.257 -3.424 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.7 OUTLIER -107.03 111.26 23.66 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -178.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 29' ' ' ILE . 12.8 m -126.49 151.92 33.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -173.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.43 133.12 51.32 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.891 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 33.3 m-85 . . . . . 0 C--N 1.3 -1.563 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 65.3 m95 -100.59 126.05 47.02 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.749 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 14' ' ' VAL . 20.4 m -129.96 165.63 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 86.1 mttt -99.79 171.18 8.05 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.277 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.92 93.17 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.89 0.876 . . . . 0.0 111.886 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -60.93 -26.04 67.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.702 0.763 . . . . 0.0 111.145 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 23.1 mmm180 -87.39 -0.68 57.13 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.781 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -112.19 143.27 22.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.989 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.7 108.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -90.17 159.13 42.89 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo . . . . . 0 N--CA 1.449 -1.099 0 C-N-CA 121.898 1.732 . . . . 0.0 111.239 177.358 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 30' ' ' LYS . 5.2 m . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 120.884 0.373 . . . . 0.0 111.718 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.34 -15.66 55.98 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -83.04 130.71 35.16 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -110.93 112.95 25.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.457 1.122 . . . . 0.0 109.359 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 34.7 m -116.94 -179.71 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.408 -169.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.03 136.76 47.18 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 56' ' ' VAL . 96.7 t -114.56 134.61 57.01 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.712 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.913 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -107.72 104.71 14.29 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.269 -2.926 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -179.82 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.404 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 37.5 pttt . . . . . 0 N--CA 1.421 -1.918 0 CA-C-O 120.784 0.326 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.46 122.36 64.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' OH ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -143.53 166.75 23.95 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.308 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.1 mt-10 -105.44 120.51 41.79 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.82 0.819 . . . . 0.0 109.019 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -129.14 152.6 48.56 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.699 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 19.3 m -104.16 137.1 42.59 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 HD13 HG12 ' A' ' 43' ' ' VAL . 39.2 mm -74.16 128.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.465 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.499 ' HA ' HG23 ' A' ' 8' ' ' THR . 1.1 tmmt? -114.66 -50.65 2.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -129.71 166.97 18.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -148.98 153.15 37.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 34' ' ' ILE . 11.1 pt-20 -144.44 158.52 43.71 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.5 mp -122.21 109.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -139.99 139.36 36.04 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.432 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 65.19 22.51 12.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.664 1.221 . . . . 0.0 109.785 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.5 -0.68 89.52 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.96 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.57 148.75 39.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 117.111 0.456 . . . . 0.0 111.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.23 119.27 46.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.4 mt -108.76 132.59 53.82 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.974 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 54.3 m-85 -108.94 145.16 35.89 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.742 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.0 tm? -108.1 113.55 26.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 29' ' ' ILE . 6.2 m -121.41 153.71 25.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.718 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -145.52 153.28 40.94 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.848 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 4.1 m-85 . . . . . 0 C--N 1.29 -1.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.803 -168.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--O 1.22 -0.464 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 83.6 m95 -112.28 113.65 26.0 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.527 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 14' ' ' VAL . 23.5 m -129.82 149.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.481 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -89.32 162.42 15.83 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.175 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.89 65.61 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.854 1.262 . . . . 0.0 112.986 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.73 -20.54 62.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -92.64 3.13 56.16 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.57 145.64 15.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.078 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.92 112.15 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 95.8 m95 -93.55 119.05 67.58 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.216 -174.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 27.2 Cg_exo . . . . . 0 CA--C 1.497 -1.332 0 C-N-CA 123.323 2.682 . . . . 0.0 112.485 177.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.426 -1.636 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.7 -7.11 82.47 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.39 121.49 20.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -87.55 111.86 21.65 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.044 0.925 . . . . 0.0 109.999 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.18 176.32 3.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.332 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.6 ttpt -111.64 139.1 47.38 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.401 ' CG1' HG11 ' A' ' 56' ' ' VAL . 78.3 t -118.87 132.32 69.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 C-N-CA 122.941 0.497 . . . . 0.0 111.297 -172.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -108.42 104.69 14.09 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 124.885 1.274 . . . . 0.0 107.715 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 56.6 t80 . . . . . 0 C--N 1.289 -2.051 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.126 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 25' ' ' TYR . 11.3 ptpt . . . . . 0 N--CA 1.426 -1.639 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.0 mt -108.82 114.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -108.49 166.9 10.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 45.0 mt-10 -114.87 132.18 56.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -143.51 168.14 20.56 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.292 -171.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 p -106.43 142.35 36.24 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 43' ' ' VAL . 42.5 mm -68.38 120.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -93.22 -38.85 11.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 t -169.27 173.57 6.6 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -145.93 140.29 26.84 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -142.36 155.52 45.16 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.204 0.601 . . . . 0.0 109.638 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -108.81 124.92 65.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.76 104.87 8.08 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.714 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 55.46 64.12 1.86 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.546 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.28 -25.57 4.86 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 114.86 -1.064 . . . . 0.0 114.858 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.47 150.1 27.89 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.735 0.768 . . . . 0.0 112.932 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.66 118.36 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.05 134.78 50.46 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -107.81 146.74 31.83 Favored 'General case' 0 C--N 1.259 -3.331 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -107.62 121.96 45.73 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 29' ' ' ILE . 12.9 m -118.81 148.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-O 121.392 0.615 . . . . 0.0 109.716 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -118.44 118.01 30.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 75.8 m-85 . . . . . 0 C--N 1.299 -1.594 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -170.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.267 0.556 . . . . 0.0 112.383 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.48 131.14 55.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.488 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.401 HG11 ' CG1' ' A' ' 14' ' ' VAL . 34.8 m -138.77 144.46 29.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -80.6 160.95 24.94 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.36 -34.52 57.92 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.684 0.754 . . . . 0.0 111.182 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.18 -34.15 59.79 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.455 1.502 . . . . 0.0 111.633 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -95.31 6.61 48.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.86 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -113.52 142.35 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-O 121.635 0.731 . . . . 0.0 111.732 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.3 mp -107.87 104.97 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -85.26 155.13 60.32 Favored Pre-proline 0 C--N 1.291 -1.944 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo . . . . . 0 N--CA 1.453 -0.898 0 C-N-CA 121.267 1.311 . . . . 0.0 109.066 175.723 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 m . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.91 -11.83 62.43 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.803 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.5 m -77.53 131.36 37.85 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -86.11 114.76 23.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.754 0.787 . . . . 0.0 110.843 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.28 -179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 24.2 ttmt -116.76 140.42 49.45 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG1' HG11 ' A' ' 56' ' ' VAL . 94.5 t -117.31 131.46 69.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 121.186 0.517 . . . . 0.0 110.303 -176.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -106.71 104.82 14.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.3 t80 . . . . . 0 C--N 1.299 -1.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.452 -173.338 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.721 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.27 126.78 71.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.96 165.78 26.43 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.169 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 138.53 45.0 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 161.72 38.21 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -104.17 138.66 40.33 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.6 mm -66.3 128.31 29.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.032 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 28.6 tptp -100.9 -62.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.7 m -147.19 161.44 40.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -127.19 138.27 53.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.29 161.57 37.69 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.376 0.608 . . . . 0.0 111.673 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.91 130.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -135.82 115.91 13.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 59.7 35.11 22.23 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.548 1.139 . . . . 0.0 111.357 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.45 -12.24 66.5 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.344 -0.931 . . . . 0.0 114.238 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.1 pt-20 -116.98 151.99 35.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.5 0.65 . . . . 0.0 111.235 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG22 HG13 ' A' ' 34' ' ' ILE . 8.4 t -98.83 125.25 52.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.9 0.381 . . . . 0.0 110.147 -175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.67 160.33 26.05 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.481 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -114.11 144.42 43.17 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.764 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' NE1' ' A' ' 55' ' ' TRP . 3.5 tm? -108.23 116.52 32.11 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 m -117.67 149.12 20.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.484 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -118.35 128.02 54.25 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 C--N 1.287 -2.117 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -175.119 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 . . . . . 0 C--O 1.241 0.64 0 CA-C-O 120.677 0.275 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.464 ' NE1' HD23 ' A' ' 42' ' ' LEU . 78.0 m95 -107.25 122.83 47.34 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.463 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.489 HG11 ' CG1' ' A' ' 14' ' ' VAL . 16.5 m -135.99 144.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.232 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.3 tttt -79.75 160.61 26.14 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -36.52 62.86 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.116 0.967 . . . . 0.0 112.244 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.2 -10.43 59.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -103.33 4.88 36.92 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.48 140.92 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.146 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.6 mp -107.86 112.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -86.31 132.73 42.29 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.656 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo . . . . . 0 N--CA 1.446 -1.277 0 N-CA-C 107.518 -1.762 . . . . 0.0 107.518 173.282 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 30' ' ' LYS . 16.1 m . . . . . 0 N--CA 1.418 -2.071 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.65 -18.31 7.2 Favored Glycine 0 C--N 1.31 -0.884 0 C-N-CA 119.657 -1.258 . . . . 0.0 112.965 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -73.49 129.35 37.8 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -95.03 144.17 25.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.83 179.55 3.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.0 mmmt -108.05 134.39 51.01 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 56' ' ' VAL . 93.7 t -115.52 128.18 72.83 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.098 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 86.8 tttt -106.86 104.29 13.94 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 56' ' ' VAL . 63.4 t80 . . . . . 0 C--N 1.294 -1.825 0 CA-C-O 121.424 0.63 . . . . 0.0 110.588 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.94 129.98 67.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -129.48 166.65 19.21 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.23 1.012 . . . . 0.0 109.449 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -107.8 125.83 51.9 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 168.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.21 46.06 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 8.5 p -104.44 142.7 34.14 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.479 HD13 HG12 ' A' ' 43' ' ' VAL . 32.8 mm -73.76 129.55 36.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.6 tmtt? -98.46 -54.75 2.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -155.22 -179.89 8.52 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 41' ' ' TYR . 10.1 t -158.49 165.06 35.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 34' ' ' ILE . 12.7 pt-20 -148.07 158.07 43.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.345 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.9 mp -119.2 111.48 33.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -123.33 122.87 39.4 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 68.67 23.03 7.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.732 1.213 . . . . 0.0 110.141 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.42 -6.55 74.97 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.522 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.27 151.04 31.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 117.73 0.765 . . . . 0.0 110.689 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 34' ' ' ILE . 4.2 t -97.95 124.15 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.728 0.775 . . . . 0.0 110.035 -172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -108.47 125.62 51.99 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.71 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 87.0 m-85 -108.97 147.5 32.17 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.398 -176.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.424 HD13 ' NE1' ' A' ' 55' ' ' TRP . 55.6 tp -107.54 110.4 22.31 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 29' ' ' ILE . 13.8 m -118.23 148.61 20.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -126.73 129.66 48.82 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 . . . . . 0 C--N 1.303 -1.451 0 O-C-N 124.145 0.903 . . . . 0.0 111.052 -172.188 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 73.6 m95 -98.24 134.08 41.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.245 0.545 . . . . 0.0 111.488 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 16' ' ' TYR . 26.8 m -133.23 165.21 32.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.1 157.42 16.89 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.24 -32.51 48.66 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.659 0.784 . . . . 0.0 112.263 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -26.15 68.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.423 1.089 . . . . 0.0 111.897 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 27.0 mmm-85 -93.91 0.58 56.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -109.31 140.36 28.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.63 -173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.7 mp -109.04 108.87 26.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -83.07 124.95 75.95 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 121.616 1.544 . . . . 0.0 109.838 177.468 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 . . . . . 0 CA--C 1.507 -0.699 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -144.23 178.04 8.18 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.265 0.555 . . . . 0.0 109.877 -176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -151.41 162.57 40.7 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 171.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -76.22 117.15 62.08 Favored Pre-proline 0 C--N 1.3 -1.547 0 CA-C-N 118.356 0.525 . . . . 0.0 109.906 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.94 177.71 5.43 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 122.591 2.194 . . . . 0.0 111.679 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.4 m -82.01 91.51 6.63 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.516 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 29' ' ' ILE 0.473 0.0 OUTLIER 42.73 53.09 4.95 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 178.528 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.61 151.29 37.84 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.537 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.42 -6.48 65.65 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 m -92.79 117.24 29.81 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -97.34 134.48 40.57 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 171.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.44 HG12 ' HD3' ' A' ' 64' ' ' PRO . 33.9 m -126.47 177.2 5.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 115.038 -0.983 . . . . 0.0 108.955 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.546 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -108.98 129.46 55.45 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 178.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.9 t -123.45 136.82 58.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 118.028 0.376 . . . . 0.0 111.432 -174.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 41.0 ttmt -108.68 146.62 33.17 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 175.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -154.26 114.98 3.98 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 22' ' ' GLN . . . -137.62 113.23 0.98 Allowed Glycine 0 N--CA 1.439 -1.138 0 C-N-CA 119.71 -1.233 . . . . 0.0 114.484 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -146.67 106.36 3.95 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 123.715 0.806 . . . . 0.0 109.976 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.94 -120.37 7.27 Favored Glycine 0 C--N 1.31 -0.862 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.783 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -85.99 -21.46 27.81 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 56.7 m -80.52 77.33 7.33 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 121.851 0.834 . . . . 0.0 109.839 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.437 ' HA ' ' HA2' ' A' ' 17' ' ' GLY . 23.2 tp60 -128.91 109.23 11.07 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.126 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 1.9 mptp? -140.01 165.09 28.28 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -127.34 108.28 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.173 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 171.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HD3' ' A' ' 13' ' ' LYS . 5.8 m-85 -108.36 167.67 9.86 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 123.853 0.861 . . . . 0.0 109.959 -169.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -106.68 126.69 52.6 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -137.7 159.66 41.37 Favored 'General case' 0 C--O 1.194 -1.839 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.749 -173.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -108.61 144.59 36.14 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG21 HD22 ' A' ' 7' ' ' LEU . 50.3 mm -77.15 131.43 34.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.437 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' A' ' 44' ' ' HIS . 9.3 mtmt -99.62 -52.85 3.35 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.897 0.855 . . . . 0.0 110.115 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 m -155.08 166.87 32.24 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.153 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -136.65 143.14 43.31 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -144.64 162.36 36.86 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.288 0.566 . . . . 0.0 110.852 178.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -108.3 113.14 43.11 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -122.83 104.6 9.39 Favored 'General case' 0 C--N 1.269 -2.913 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.107 -175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.0 t70 57.73 64.62 1.51 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.301 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.89 -26.33 4.86 Favored Glycine 0 CA--C 1.526 0.764 0 CA-C-N 114.847 -1.07 . . . . 0.0 115.668 173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.43 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 10.3 pt-20 -116.34 160.95 19.76 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 118.119 0.959 . . . . 0.0 112.8 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.64 120.86 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 121.291 0.567 . . . . 0.0 109.916 -176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.7 mt -115.03 143.45 45.16 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.645 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 69.7 m-85 -108.83 149.79 28.59 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.449 ' HG ' ' CE2' ' A' ' 55' ' ' TRP . 0.8 OUTLIER -107.77 117.63 34.61 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 102.699 -3.074 . . . . 0.0 102.699 175.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.543 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 14.4 m -117.32 153.87 19.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -173.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.658 ' HA ' ' OD1' ' A' ' 53' ' ' ASP . 82.6 t60 -117.57 114.05 22.86 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.823 -175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -73.02 125.99 28.91 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 123.639 0.587 . . . . 0.0 110.268 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -85.46 96.28 9.55 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.15 -4.21 18.43 Favored Glycine 0 C--O 1.239 0.463 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.177 -178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.3 m-90 -123.79 -164.68 1.25 Allowed 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -34.35 100.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.608 1.563 . . . . 0.0 114.182 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.8 p -89.1 -7.99 10.86 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.596 0 CA-C-N 114.763 -1.108 . . . . 0.0 113.427 -172.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -56.56 2.34 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -87.38 -34.91 18.63 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.103 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.658 ' OD1' ' HA ' ' A' ' 44' ' ' HIS . 37.7 m-20 60.64 -161.99 0.27 Allowed 'General case' 0 C--O 1.244 0.771 0 O-C-N 123.837 0.71 . . . . 0.0 111.506 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -150.49 158.22 43.91 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.838 -0.745 . . . . 0.0 111.928 -176.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.449 ' CE2' ' HG ' ' A' ' 42' ' ' LEU . 71.2 m95 -106.54 127.14 53.09 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.391 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.58 155.13 39.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.1 tttt -92.61 161.1 14.72 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.48 -30.37 29.66 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.224 1.009 . . . . 0.0 111.955 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -59.99 -41.08 91.3 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.213 1.005 . . . . 0.0 111.794 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.534 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 50.0 mtt180 -87.08 7.38 28.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.7 mt -108.97 145.42 15.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.8 mp -107.83 112.0 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.78 0 N-CA-C 104.948 -2.242 . . . . 0.0 104.948 171.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -86.2 144.3 38.33 Favored Pre-proline 0 C--N 1.295 -1.778 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.581 -176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HD3' HG12 ' A' ' 12' ' ' VAL . 24.2 Cg_exo -65.2 118.11 5.16 Favored 'Trans proline' 0 N--CA 1.429 -2.323 0 N-CA-C 108.358 -1.439 . . . . 0.0 108.358 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.413 ' O ' ' HD2' ' A' ' 67' ' ' LYS . 1.0 OUTLIER -169.17 149.59 4.22 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 100.786 -3.783 . . . . 0.0 100.786 -176.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -69.46 110.34 4.69 Favored 'General case' 0 C--N 1.272 -2.78 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' H ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -121.64 26.71 8.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 170.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 47.88 1.67 Allowed Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -170.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.83 142.7 30.96 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.951 -0.625 . . . . 0.0 110.689 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.51 132.01 42.4 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 23.9 m80 -142.47 37.72 1.51 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 120.833 0.349 . . . . 0.0 111.779 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -92.79 -54.75 3.63 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.33 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -153.24 19.88 0.56 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 118.337 -1.345 . . . . 0.0 112.795 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -98.23 -46.05 5.97 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 172.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -162.43 98.06 1.01 Allowed 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 174.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--N 1.299 -1.603 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.608 -175.421 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -146.56 -34.48 0.28 Allowed 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.187 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 14.9 tpt -87.87 101.27 13.56 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.968 0.414 . . . . 0.0 110.849 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -79.44 141.94 57.54 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.19 114.39 2.17 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.202 1.935 . . . . 0.0 111.816 178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.7 t -112.5 94.58 4.99 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.9 mp 72.72 -48.02 0.68 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.885 1.274 . . . . 0.0 110.916 -174.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.8 m -53.59 135.6 40.15 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.215 1.406 . . . . 0.0 110.557 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -23.71 31.69 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.393 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.3 m -74.1 130.26 39.44 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 37.6 pttt -87.2 136.69 32.83 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 106.86 -1.534 . . . . 0.0 106.86 174.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.2 m -127.34 174.31 11.26 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.666 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.543 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.1 tmtm? -108.41 135.79 49.12 Favored 'General case' 0 C--N 1.273 -2.728 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 178.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 56' ' ' VAL . 71.2 t -124.78 144.76 33.63 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 85.2 tttt -140.39 104.6 4.81 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -132.48 112.73 12.36 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 120.704 0.288 . . . . 0.0 111.195 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.641 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 176.81 171.11 40.1 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -107.14 123.26 48.0 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.2 -107.58 1.15 Allowed Glycine 0 C--N 1.319 -0.382 0 O-C-N 123.116 0.26 . . . . 0.0 113.152 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.7 -26.08 59.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.964 0.412 . . . . 0.0 110.674 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 81.0 p -85.17 10.24 12.83 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.295 -0.411 . . . . 0.0 112.022 -173.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.641 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 55.1 tt0 -82.93 99.86 10.04 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 120.811 0.339 . . . . 0.0 110.619 -178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -108.79 162.32 14.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.625 179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.4 mt -108.11 144.31 16.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.738 -174.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -140.01 163.85 31.59 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.658 0.783 . . . . 0.0 109.214 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -108.92 124.95 51.48 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 167.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.22 175.68 8.26 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 120.906 0.384 . . . . 0.0 111.395 -174.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 21.0 m -135.69 134.11 38.8 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 174.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.495 HD13 HG12 ' A' ' 43' ' ' VAL . 44.2 mm -65.76 125.8 23.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 O-C-N 123.858 0.724 . . . . 0.0 109.341 -178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -110.85 -31.4 7.18 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -167.25 167.22 14.33 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.4 m -144.84 139.71 27.9 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -145.77 156.88 43.88 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 123.63 0.581 . . . . 0.0 110.764 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 39' ' ' VAL . 1.9 mp -108.72 129.34 63.43 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -125.45 104.37 8.4 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 t70 55.17 64.34 1.82 Allowed 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 125.52 1.528 . . . . 0.0 111.726 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.79 -25.59 5.17 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-N 114.848 -1.069 . . . . 0.0 115.193 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -108.9 145.77 34.84 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 117.985 0.892 . . . . 0.0 111.577 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 11.0 p -98.23 127.47 50.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-O 122.028 0.918 . . . . 0.0 110.681 -175.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -116.74 155.72 28.41 Favored 'General case' 0 N--CA 1.407 -2.596 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.926 178.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.418 ' CE2' ' HZ2' ' A' ' 63' ' ' TRP . 22.0 m-85 -118.11 145.8 44.61 Favored 'General case' 0 C--N 1.261 -3.263 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.925 -173.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.1 tp -107.52 105.82 15.91 Favored 'General case' 0 N--CA 1.407 -2.588 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 176.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.495 HG12 HD13 ' A' ' 29' ' ' ILE . 9.8 m -119.71 151.55 22.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.612 -173.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -118.82 140.41 50.0 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 22.5 m-85 -79.0 153.03 30.6 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -120.96 161.18 22.04 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.937 177.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.79 -111.65 0.99 Allowed Glycine 0 CA--C 1.483 -1.948 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -98.54 -41.1 7.91 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -91.89 89.48 7.04 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 122.137 0.97 . . . . 0.0 108.937 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 44.4 t -90.36 -30.92 5.03 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.443 -1.253 . . . . 0.0 109.805 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 70.0 mtm180 -85.81 8.44 20.01 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.465 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -87.83 89.5 8.02 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.72 116.74 33.33 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.838 -177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -150.37 165.88 31.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.088 0.471 . . . . 0.0 111.223 -173.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -97.74 126.29 43.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 121.36 0.6 . . . . 0.0 112.216 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.472 HG11 HG11 ' A' ' 14' ' ' VAL . 33.3 m -131.72 144.05 38.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -89.54 164.96 14.57 Favored 'General case' 0 C--N 1.283 -2.31 0 O-C-N 122.136 -0.352 . . . . 0.0 110.47 -175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.57 -30.04 28.78 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.378 1.071 . . . . 0.0 111.886 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HA ' ' CE1' ' A' ' 71' ' ' HIS . 12.7 t70 -68.4 -24.3 64.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.925 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.668 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 13.8 mmt180 -101.16 11.55 39.22 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.785 -176.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.3 mt -120.5 140.82 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 120.916 0.389 . . . . 0.0 111.237 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.7 mp -107.85 114.82 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 173.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.547 ' H ' HD22 ' A' ' 69' ' ' LEU . 93.5 m95 -89.1 145.24 33.94 Favored Pre-proline 0 C--N 1.294 -1.845 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.381 178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -72.28 119.05 5.9 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 121.851 1.701 . . . . 0.0 110.743 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 tt 177.0 87.11 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 103.197 -2.89 . . . . 0.0 103.197 -175.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.4 t70 55.95 -139.34 0.96 Allowed 'General case' 0 C--O 1.253 1.26 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -172.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -148.19 55.86 1.05 Allowed 'General case' 0 N--CA 1.403 -2.794 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -99.99 1.03 56.34 Favored Glycine 0 N--CA 1.418 -2.518 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.457 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 63' ' ' TRP . 5.0 mp -88.36 109.0 19.64 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -145.66 121.51 10.6 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 114.369 -1.287 . . . . 0.0 109.589 175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 59' ' ' ASP . 23.9 m-70 -80.0 130.28 35.15 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 174.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -68.97 -17.62 63.96 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.904 0.752 . . . . 0.0 111.618 -170.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 67.1 t60 67.11 72.51 0.35 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 124.112 0.965 . . . . 0.0 111.509 174.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -159.72 64.92 0.37 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.963 175.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 18.6 t60 -136.96 106.27 6.05 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 . . . . . 0 C--N 1.29 -2.02 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.601 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.499 -0.99 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -150.34 172.69 14.99 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ttt -158.81 142.51 15.15 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 37.2 mt-10 -66.55 119.54 63.66 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 15.3 Cg_exo -70.12 86.27 0.64 Allowed 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.414 2.076 . . . . 0.0 111.596 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 71.4 m -88.24 146.29 25.43 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.561 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -83.16 -21.62 33.5 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.204 0.526 . . . . 0.0 109.798 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 p -71.52 138.71 49.11 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.708 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.84 58.25 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 121.1 -0.571 . . . . 0.0 111.845 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 28' ' ' SER . 25.6 m -67.84 125.02 24.94 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -88.32 110.46 20.78 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.5 m -115.28 -179.63 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.441 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.585 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -111.85 138.88 47.85 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 176.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.4 t -130.29 137.61 55.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 118.377 0.535 . . . . 0.0 110.542 -176.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HG3' HD11 ' A' ' 62' ' ' ILE . 53.0 mtmt -108.18 106.45 16.64 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -138.76 108.35 6.21 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.847 0.832 . . . . 0.0 112.197 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.661 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 176.94 170.78 39.82 Favored Glycine 0 C--N 1.287 -2.183 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 167.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 4.7 ppt_? -117.1 115.09 24.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 117.682 0.741 . . . . 0.0 111.177 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.6 -103.23 0.21 Allowed Glycine 0 CA--C 1.531 1.041 0 CA-C-N 116.094 -0.503 . . . . 0.0 114.345 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -70.18 -27.56 64.61 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 123.862 0.865 . . . . 0.0 109.326 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 18' ' ' ARG . 7.7 m -88.63 0.91 55.92 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.937 -178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.661 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -70.43 116.2 10.49 Favored 'General case' 0 C--O 1.245 0.824 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.561 ' HE2' ' OH ' ' A' ' 25' ' ' TYR . 18.0 pttm -139.6 157.15 46.29 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.694 175.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.6 mp -115.84 125.83 73.13 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -175.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.561 ' OH ' ' HE2' ' A' ' 23' ' ' LYS . 55.6 m-85 -111.45 165.54 11.89 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.313 -175.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HG2' ' HZ2' ' A' ' 13' ' ' LYS . 45.1 mt-10 -111.67 126.81 55.43 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 173.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.08 -178.47 6.07 Favored 'General case' 0 C--O 1.197 -1.68 0 CA-C-O 120.882 0.372 . . . . 0.0 111.342 -172.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 10' ' ' THR . 16.4 m -123.64 155.3 37.98 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.63 126.02 39.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 120.219 -0.593 . . . . 0.0 109.727 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -101.67 -46.35 4.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.948 -176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.1 m -159.98 171.18 19.83 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -151.17 145.52 25.48 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 175.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.09 165.11 37.24 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 123.277 0.36 . . . . 0.0 110.231 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.418 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -111.26 126.35 68.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -126.93 103.28 7.4 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.3 t0 57.0 65.35 1.41 Allowed 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 124.001 0.92 . . . . 0.0 111.585 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.41 -26.62 5.01 Favored Glycine 0 C--N 1.313 -0.716 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' OE2' HD21 ' A' ' 40' ' ' LEU . 11.1 pt-20 -108.47 144.4 36.15 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 117.843 0.822 . . . . 0.0 110.768 -177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.8 p -98.82 121.5 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.974 0 CA-C-O 122.241 1.019 . . . . 0.0 110.108 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD21 ' OE2' ' A' ' 38' ' ' GLU . 83.5 mt -108.62 137.95 45.72 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.692 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.435 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 35.4 m-85 -108.56 145.22 35.16 Favored 'General case' 0 C--N 1.258 -3.401 0 CA-C-N 114.271 -1.331 . . . . 0.0 109.843 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 53' ' ' ASP . 52.8 tp -108.25 117.77 35.01 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 174.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' A' ' 53' ' ' ASP . 15.8 m -117.8 146.01 22.89 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.486 0.66 . . . . 0.0 109.505 -175.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -117.89 116.69 27.46 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 114.813 -1.085 . . . . 0.0 109.692 -174.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -70.42 129.62 39.76 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -74.1 -7.39 52.38 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.29 -64.09 3.27 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -169.39 160.05 9.07 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -64.24 125.64 25.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 124.029 0.932 . . . . 0.0 109.922 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' H ' ' A' ' 51' ' ' ARG . 16.5 m -79.55 -65.85 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.51 ' H ' HG23 ' A' ' 50' ' ' VAL . 30.2 mmm180 -106.48 -55.94 2.26 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 172.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -138.24 -59.8 0.63 Allowed 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 166.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.539 ' HB2' HD11 ' A' ' 42' ' ' LEU . 49.7 m-20 -165.3 -174.53 3.25 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -126.73 154.01 44.74 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 120.022 1.283 . . . . 0.0 111.617 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.506 ' CE2' HD13 ' A' ' 42' ' ' LEU . 87.8 m95 -109.64 118.9 37.77 Favored 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 124.122 0.969 . . . . 0.0 111.869 -175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.44 157.34 41.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.577 178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -90.85 165.14 13.77 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.7 -29.29 66.54 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -173.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -85.36 -1.76 57.34 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.236 0.541 . . . . 0.0 112.022 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 2.6 tpt180 -100.89 4.7 42.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.446 0.641 . . . . 0.0 109.418 -176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.4 mm -108.59 147.07 13.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.14 -175.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.585 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.9 mp -108.77 108.56 25.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 166.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -81.77 133.03 52.87 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.635 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.47 120.01 4.71 Favored 'Trans proline' 0 C--N 1.36 1.132 0 C-N-CA 124.126 3.217 . . . . 0.0 114.423 -177.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -170.51 69.39 0.05 Allowed 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -177.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 29.2 t70 55.67 42.19 29.66 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 123.326 1.536 . . . . 0.0 110.413 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -134.46 103.17 5.59 Favored 'General case' 0 CA--C 1.461 -2.457 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.666 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -80.74 -26.6 53.42 Favored Glycine 0 N--CA 1.415 -2.744 0 N-CA-C 105.783 -2.927 . . . . 0.0 105.783 163.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 tp 166.52 141.67 0.02 OUTLIER 'General case' 0 N--CA 1.391 -3.408 0 C-N-CA 130.005 3.322 . . . . 0.0 104.619 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -70.02 147.09 50.52 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.08 63.7 7.26 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 122.176 0.989 . . . . 0.0 108.37 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -91.92 -24.16 19.37 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.24 -1.346 . . . . 0.0 109.613 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.2 m-70 -113.17 144.55 42.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 CA-C-O 120.886 0.374 . . . . 0.0 110.261 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -137.54 28.12 2.74 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 173.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 -147.31 123.31 10.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.526 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 C--N 1.281 -2.385 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 175.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 121.167 0.508 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -152.63 157.96 41.73 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 13.1 tpt -176.87 90.75 0.03 OUTLIER 'General case' 0 C--O 1.245 0.822 0 C-N-CA 124.159 0.984 . . . . 0.0 110.525 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.573 ' HB3' ' CD ' ' A' ' 5' ' ' PRO . 64.0 mm-40 44.9 -155.85 0.01 OUTLIER Pre-proline 0 CA--C 1.575 1.924 0 O-C-N 124.963 1.414 . . . . 0.0 111.478 168.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.573 ' CD ' ' HB3' ' A' ' 4' ' ' GLU . 85.2 Cg_exo -64.81 168.36 13.68 Favored 'Trans proline' 0 C--N 1.361 1.204 0 CA-C-N 121.242 1.479 . . . . 0.0 111.076 165.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' C ' HD13 ' A' ' 7' ' ' LEU . 20.8 p -65.07 147.75 52.91 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.238 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.416 HD13 ' C ' ' A' ' 6' ' ' CYS 0.443 0.0 OUTLIER 51.68 14.03 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 179.692 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.8 p -80.68 154.61 27.22 Favored 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 121.912 -0.493 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 94.11 -29.69 8.48 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.7 m -63.82 130.07 42.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 123.027 0.531 . . . . 0.0 110.115 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -98.84 115.16 28.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.02 -177.7 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.314 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.823 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.666 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.8 mmtm -107.3 135.82 48.16 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 43' ' ' VAL . 85.3 t -127.26 137.23 58.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 CA-C-O 120.919 0.39 . . . . 0.0 110.497 -175.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -107.87 121.94 45.77 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.43 ' HA ' HH21 ' A' ' 60' ' ' ARG . 41.1 t80 -132.93 115.54 15.34 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -179.29 170.35 41.91 Favored Glycine 0 N--CA 1.411 -3.002 0 C-N-CA 119.568 -1.301 . . . . 0.0 113.612 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -139.76 112.07 7.68 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.638 1.175 . . . . 0.0 108.278 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.36 -134.42 22.78 Favored Glycine 0 C--N 1.311 -0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -79.82 -21.27 44.43 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 48.4 m -76.64 74.37 3.33 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 122.156 0.979 . . . . 0.0 108.859 177.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.47 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 31.2 tt0 -145.8 142.98 29.38 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.047 -174.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.64 161.12 38.52 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.7 mp -115.38 120.49 64.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -108.92 166.86 10.51 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 124.495 1.118 . . . . 0.0 109.725 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -114.23 137.2 52.08 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 171.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.95 160.29 42.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 118.112 0.415 . . . . 0.0 111.983 -172.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.0 p -104.49 141.75 35.82 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 40.0 mm -78.81 124.68 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -33.96 6.54 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.8 m -158.55 169.73 23.78 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.973 -0.455 . . . . 0.0 109.811 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.0 m -144.31 141.28 29.66 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -143.39 153.17 42.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 121.118 0.485 . . . . 0.0 110.812 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.47 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -109.07 123.87 65.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -125.6 104.14 8.23 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.7 t70 50.79 65.03 1.59 Allowed 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 124.877 1.271 . . . . 0.0 113.236 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.13 -24.04 10.09 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 115.226 -0.897 . . . . 0.0 114.714 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -108.67 140.06 42.59 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 118.083 0.942 . . . . 0.0 112.396 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.47 HG22 HG13 ' A' ' 34' ' ' ILE . 5.4 t -98.84 117.19 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 89.2 mt -109.03 138.68 45.0 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.607 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 42.7 m-85 -107.74 147.24 31.06 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.5 tm? -107.2 105.16 15.01 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 8.0 m -123.91 154.14 30.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.544 -173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -128.63 125.8 38.87 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.39 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -66.14 109.52 2.64 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 124.465 1.103 . . . . 0.0 109.235 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -47.77 -67.95 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 125.415 1.486 . . . . 0.0 113.118 -168.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.21 27.62 17.66 Favored Glycine 0 C--N 1.309 -0.939 0 C-N-CA 120.028 -1.082 . . . . 0.0 113.76 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 32.5 m-90 -133.54 -55.61 0.89 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 117.333 0.566 . . . . 0.0 111.329 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 20.5 m120 -137.12 95.42 3.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.144 -174.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.7 m -79.06 -41.52 23.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 120.468 -0.493 . . . . 0.0 112.108 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -99.85 7.57 44.83 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.515 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 46.3 t80 -75.43 -62.59 1.52 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 61.48 108.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.448 1.099 . . . . 0.0 110.927 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -127.44 155.18 44.09 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.79 -174.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.607 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 82.8 m95 -99.5 123.43 43.77 Favored 'General case' 0 N--CA 1.422 -1.832 0 CA-C-N 114.196 -1.365 . . . . 0.0 110.595 -179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.21 147.37 28.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.248 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' O ' HG13 ' A' ' 61' ' ' ILE . 91.8 mttt -77.68 170.25 16.91 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.65 -25.95 67.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.143 0.497 . . . . 0.0 110.398 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.2 -31.54 71.3 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.95 1.3 . . . . 0.0 109.367 176.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.43 HH21 ' HA ' ' A' ' 16' ' ' TYR . 26.8 mmm-85 -96.66 7.54 46.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.793 -1.548 . . . . 0.0 111.307 -173.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 57' ' ' LYS . 57.0 mt -120.71 151.16 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 13' ' ' LYS . 5.0 mp -108.15 104.71 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.733 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 173.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 96.5 m95 -90.9 130.02 42.12 Favored Pre-proline 0 C--N 1.306 -1.291 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 19.4 Cg_exo -67.92 116.73 4.45 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 120.817 1.012 . . . . 0.0 111.335 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 64' ' ' PRO . 5.5 tt 161.42 97.14 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 -177.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.5 t70 62.07 -162.38 0.28 Allowed 'General case' 0 C--O 1.256 1.411 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -139.21 1.91 2.04 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.621 -0.675 . . . . 0.0 110.184 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.33 -18.54 68.74 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.071 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 mp 62.87 106.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.625 1.17 . . . . 0.0 113.008 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -85.36 106.49 16.78 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -74.1 96.69 2.76 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 105.917 -1.883 . . . . 0.0 105.917 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 70' ' ' GLU 0.251 16.3 t60 -60.15 -44.18 95.16 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -164.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -81.41 83.35 6.96 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 118.567 -1.253 . . . . 0.0 107.731 168.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -95.42 -52.3 4.21 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.217 -168.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -137.11 7.84 2.92 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 . . . . . 0 C--N 1.306 -1.323 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.622 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 120.929 0.395 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.56 -65.27 0.99 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.2 ttm 170.52 102.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.94 1.696 . . . . 0.0 108.631 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -80.31 116.43 61.64 Favored Pre-proline 0 C--N 1.313 -1.008 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.71 23.91 0.03 OUTLIER 'Trans proline' 0 N--CA 1.507 2.304 0 C-N-CA 125.177 3.918 . . . . 0.0 117.019 -174.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.8 m -91.19 79.1 5.76 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 30.7 mt 71.31 -5.43 1.58 Allowed 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 27.8 p -66.75 135.22 53.66 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.2 0.524 . . . . 0.0 111.702 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.66 -12.74 68.56 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.186 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -70.38 125.38 26.63 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 64.4 mttp -83.22 122.63 28.66 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -124.08 177.22 4.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-O 121.508 0.67 . . . . 0.0 111.268 -175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.04 136.5 52.85 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 177.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 ' CG1' HG11 ' A' ' 56' ' ' VAL . 79.1 t -127.59 131.18 70.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 118.321 0.51 . . . . 0.0 111.0 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 10.8 tmtt? -119.33 118.73 31.99 Favored 'General case' 0 C--O 1.197 -1.671 0 CA-C-O 118.929 -0.558 . . . . 0.0 109.576 -178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.584 ' HB3' ' HD3' ' A' ' 60' ' ' ARG 0.319 0.0 OUTLIER -160.37 154.45 23.11 Favored 'General case' 0 CA--C 1.481 -1.688 0 CA-C-N 118.416 0.553 . . . . 0.0 111.192 170.987 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 22' ' ' GLN . . . -168.19 139.46 5.69 Favored Glycine 1 N--CA 1.393 -4.211 0 C-N-CA 118.468 -1.825 . . . . 0.0 113.985 -178.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -146.3 105.5 3.9 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.98 -114.99 6.18 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.9 tppt? -86.84 -7.82 57.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 121.083 0.468 . . . . 0.0 110.387 -177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.7 m -82.91 -1.01 51.04 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 121.228 0.537 . . . . 0.0 110.289 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.435 ' HA ' ' CA ' ' A' ' 17' ' ' GLY . 25.4 tp60 -73.72 108.3 6.47 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 121.682 0.753 . . . . 0.0 112.727 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -164.02 165.97 21.94 Favored 'General case' 0 C--O 1.27 2.175 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.013 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.51 HG12 ' HG2' ' A' ' 15' ' ' LYS . 54.2 mt -111.69 124.94 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.47 ' CE1' ' HE1' ' A' ' 16' ' ' TYR . 65.8 m-85 -107.78 166.14 10.92 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.616 -174.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -117.5 123.25 45.85 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . . . -130.22 -178.57 4.8 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.141 0.496 . . . . 0.0 111.69 -171.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.4 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 24.2 m -135.22 135.16 40.75 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 171.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.476 HD13 HG12 ' A' ' 43' ' ' VAL . 45.8 mm -65.5 124.36 20.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -103.74 -46.6 4.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.3 t -153.02 160.22 42.97 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -133.92 141.29 47.28 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -145.88 161.09 40.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.646 0.591 . . . . 0.0 110.743 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.9 mp -108.83 124.7 65.62 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -130.69 114.08 14.95 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.679 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 64.74 25.53 12.99 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.62 -17.72 52.38 Favored Glycine 0 C--N 1.317 -0.476 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.928 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -108.65 152.65 24.51 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -98.48 122.79 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.264 0 CA-C-O 122.072 0.939 . . . . 0.0 110.749 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.6 mt -109.66 142.15 41.22 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-N 114.176 -1.374 . . . . 0.0 108.692 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 42.7 m-85 -108.82 142.66 39.06 Favored 'General case' 0 C--N 1.26 -3.322 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.697 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -107.57 110.97 23.01 Favored 'General case' 0 N--CA 1.402 -2.859 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.476 HG12 HD13 ' A' ' 29' ' ' ILE . 11.4 m -117.53 150.89 19.51 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -172.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' TYR . 1.0 OUTLIER -125.4 138.12 54.03 Favored 'General case' 0 C--N 1.29 -1.985 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.073 175.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 31.5 m-85 -82.39 123.13 28.83 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.295 17.5 p90 -57.45 157.37 6.81 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -172.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -37.17 89.76 0.01 OUTLIER Glycine 0 C--N 1.354 1.53 0 C-N-CA 126.298 1.904 . . . . 0.0 116.331 -172.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 174.02 -46.97 0.01 OUTLIER 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.638 ' OD1' ' HB3' ' A' ' 51' ' ' ARG . 27.6 t-20 -91.22 111.18 22.55 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.432 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.75 -21.54 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.505 0.669 . . . . 0.0 110.327 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.638 ' HB3' ' OD1' ' A' ' 49' ' ' ASN . 0.2 OUTLIER -56.28 -37.56 70.01 Favored 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 175.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 44' ' ' HIS . 3.8 t80 54.36 -94.49 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 128.004 2.522 . . . . 0.0 117.547 164.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -89.88 138.1 31.78 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.25 0.477 . . . . 0.0 112.015 -174.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' HG2' ' OH ' ' A' ' 16' ' ' TYR . 9.2 tp10 -159.24 157.8 31.37 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 121.146 0.498 . . . . 0.0 110.212 175.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -100.17 125.96 46.38 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 124.49 1.116 . . . . 0.0 111.48 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.44 HG11 ' CG1' ' A' ' 14' ' ' VAL . 17.6 m -138.35 152.19 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.971 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.557 ' HE2' ' OD2' ' A' ' 59' ' ' ASP . 88.9 tttt -89.51 157.91 17.9 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -53.46 -31.41 45.45 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.423 1.089 . . . . 0.0 112.512 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.557 ' OD2' ' HE2' ' A' ' 57' ' ' LYS . 16.1 m-20 -72.92 -13.37 61.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.906 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' A' ' 16' ' ' TYR . 30.7 mtt180 -106.97 8.23 30.35 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.783 0.325 . . . . 0.0 111.563 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 56' ' ' VAL . 49.1 mt -108.79 140.27 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.3 mp -106.78 105.27 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.184 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 175.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -82.9 124.56 76.75 Favored Pre-proline 0 C--N 1.287 -2.119 0 CA-C-N 114.593 -1.185 . . . . 0.0 109.155 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -64.35 117.62 4.65 Favored 'Trans proline' 0 N--CA 1.439 -1.729 0 N-CA-C 108.193 -1.503 . . . . 0.0 108.193 174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 179.05 79.5 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -173.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.0 t70 73.75 -33.46 0.26 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.0 tptm 76.33 143.17 0.08 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 126.008 1.723 . . . . 0.0 110.497 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 107.34 -38.48 3.31 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.733 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 mp 66.55 8.66 5.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.722 1.209 . . . . 0.0 111.717 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.34 113.61 2.36 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -146.64 74.59 1.36 Allowed 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 123.625 0.77 . . . . 0.0 109.28 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -66.28 -16.1 63.76 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.962 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -84.76 -12.5 53.59 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.725 0.298 . . . . 0.0 110.794 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -140.1 104.2 4.78 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.156 0.503 . . . . 0.0 109.784 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -64.74 139.18 58.74 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.333 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.3 m80 . . . . . 0 C--N 1.304 -1.393 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.353 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.493 -1.219 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -124.54 87.3 2.7 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.2 ttp -132.73 111.75 11.41 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -128.0 94.53 36.52 Favored Pre-proline 0 C--N 1.292 -1.934 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.424 ' HD2' HG21 ' A' ' 8' ' ' THR . 63.9 Cg_exo -41.55 -73.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 124.251 3.301 . . . . 0.0 114.944 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 14.6 t -174.68 118.89 0.21 Allowed 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 59.87 20.42 9.35 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 124.309 1.044 . . . . 0.0 112.87 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.424 HG21 ' HD2' ' A' ' 5' ' ' PRO . 1.7 p -67.14 144.37 56.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 114.621 1.341 . . . . 0.0 114.621 -172.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.71 -35.59 4.33 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.215 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 m -62.58 128.5 36.26 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.043 0.537 . . . . 0.0 110.799 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -96.01 129.6 43.23 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.3 m -122.3 173.9 7.43 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.811 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.874 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 33.3 ttpt -119.5 138.92 52.85 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 175.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 56' ' ' VAL . 59.6 t -119.21 134.93 61.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-O 120.831 0.348 . . . . 0.0 110.618 -174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -109.31 103.98 13.03 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 175.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.621 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 3.3 t80 -106.79 109.96 22.01 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -124.76 116.64 2.81 Favored Glycine 0 N--CA 1.434 -1.446 0 N-CA-C 115.562 0.985 . . . . 0.0 115.562 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 94.2 mtt180 -140.68 168.52 19.6 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 173.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -45.14 -54.4 7.12 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 123.791 0.682 . . . . 0.0 113.719 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -94.74 -45.84 7.17 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.153 0.501 . . . . 0.0 109.872 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.503 ' HB ' ' HB2' ' A' ' 18' ' ' ARG . 8.6 m -77.1 63.49 2.38 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.743 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.621 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 21.1 tp60 -125.46 105.34 8.99 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-O 121.798 0.809 . . . . 0.0 110.07 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.76 138.47 17.0 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.861 -1.518 . . . . 0.0 108.681 178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.7 mt -108.08 129.44 62.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.95 164.02 33.34 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 123.503 0.721 . . . . 0.0 111.157 -175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 38.7 mt-10 -108.33 136.5 47.88 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.563 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -139.56 158.59 43.86 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.337 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 m -103.82 139.05 39.56 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.466 HD13 HG12 ' A' ' 43' ' ' VAL . 36.8 mm -78.01 125.06 37.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 -178.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.609 ' HG3' ' H ' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -102.75 -39.3 7.08 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.8 m -160.87 167.84 25.87 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 m -143.31 151.12 40.13 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -153.65 165.05 37.15 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.6 mp -108.83 112.7 41.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -135.51 134.02 39.06 Favored 'General case' 0 C--N 1.271 -2.817 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t70 67.0 24.17 9.6 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 122.401 1.095 . . . . 0.0 109.67 -177.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.87 -9.18 77.53 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 114.208 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -117.18 164.96 13.99 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 117.387 0.594 . . . . 0.0 111.229 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG22 HG13 ' A' ' 34' ' ' ILE . 3.4 t -97.62 117.47 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.511 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.3 mt -112.23 134.39 53.8 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.528 -1.214 . . . . 0.0 109.064 -178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 27.3 m-85 -108.34 146.33 33.13 Favored 'General case' 0 C--N 1.271 -2.813 0 C-N-CA 123.84 0.856 . . . . 0.0 109.057 -178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 57.6 tp -107.63 107.68 18.6 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG12 HD13 ' A' ' 29' ' ' ILE . 13.5 m -121.1 148.36 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.102 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.156 -172.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 17.6 t-160 -118.71 126.13 51.2 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.563 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 51.7 m-85 -65.33 100.78 0.5 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 61.16 88.04 0.09 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-N 113.831 -1.531 . . . . 0.0 113.787 -171.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 44' ' ' HIS . . . 130.83 -179.41 16.98 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.254 177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 67.1 m95 -97.35 172.05 8.02 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.609 ' H ' ' HG3' ' A' ' 30' ' ' LYS . 28.0 t-20 -59.71 106.12 0.44 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.463 0.705 . . . . 0.0 112.755 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.4 m -91.29 -62.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-N 114.973 -1.012 . . . . 0.0 112.875 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -105.69 -57.8 1.99 Allowed 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -171.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -153.99 -46.34 0.09 Allowed 'General case' 0 CA--C 1.477 -1.856 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.416 ' OD2' ' HA ' ' A' ' 49' ' ' ASN 0.267 36.7 m-20 66.2 -170.21 0.2 Allowed 'General case' 0 CA--C 1.504 -0.798 0 CA-C-N 113.104 -1.862 . . . . 0.0 113.059 178.377 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -125.76 146.21 49.87 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.737 -169.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.538 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.2 m95 -101.44 124.32 46.93 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.227 -1.352 . . . . 0.0 110.217 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.585 HG11 HG11 ' A' ' 14' ' ' VAL . 32.0 m -123.78 144.3 33.97 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -80.43 159.07 25.76 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -58.19 -33.48 69.3 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.459 0.647 . . . . 0.0 111.294 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -60.96 -25.71 67.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.621 1.168 . . . . 0.0 111.188 177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.07 -5.44 57.86 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.033 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mt -107.84 146.91 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 CA-C-O 121.378 0.609 . . . . 0.0 111.835 -171.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.39 109.9 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -95.8 124.07 53.7 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -70.75 117.53 5.19 Favored 'Trans proline' 0 N--CA 1.445 -1.359 0 N-CA-C 108.756 -1.286 . . . . 0.0 108.756 174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.1 tt 173.33 93.86 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.63 34.44 21.44 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.481 0.713 . . . . 0.0 112.764 176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -77.62 -60.94 2.16 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 -178.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 75.81 -74.47 1.57 Allowed Glycine 0 CA--C 1.504 -0.599 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.272 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.433 ' N ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.28 121.47 44.98 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 123.228 0.611 . . . . 0.0 110.65 179.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.81 -59.76 2.21 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.84 0.829 . . . . 0.0 110.487 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -99.06 74.88 2.0 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.439 -174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -96.3 -28.29 14.57 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.563 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -80.71 110.17 15.95 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 121.798 0.809 . . . . 0.0 111.58 -178.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -105.18 4.61 31.46 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 121.702 0.763 . . . . 0.0 109.331 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -77.4 101.51 6.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.272 -1.331 . . . . 0.0 108.034 176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--N 1.303 -1.441 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.237 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 . . . . . 0 CA--C 1.509 -0.604 0 CA-C-O 120.41 0.148 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -80.09 -60.64 2.26 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.4 ttt 164.7 132.16 0.01 OUTLIER 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.863 1.665 . . . . 0.0 109.104 175.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -114.89 160.29 34.16 Favored Pre-proline 0 C--N 1.288 -2.079 0 N-CA-C 105.441 -2.059 . . . . 0.0 105.441 172.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -50.49 101.12 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.8 2.333 . . . . 0.0 113.322 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 8' ' ' THR . 19.5 t -145.22 134.49 22.92 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.9 mm? 71.39 -12.13 0.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.539 1.136 . . . . 0.0 111.189 -173.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 9.3 p -63.63 131.29 47.52 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 124.283 1.033 . . . . 0.0 112.05 -176.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.46 -11.3 72.43 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.205 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 28' ' ' SER . 26.9 m -71.68 121.41 18.8 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -91.02 107.18 19.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 -177.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.2 m -113.62 178.81 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.16 -175.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB3' HD13 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -108.98 141.6 40.84 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 176.604 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 56' ' ' VAL . 95.7 t -127.44 130.32 70.64 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -177.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.71 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 86.4 tttt -122.54 104.98 9.72 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -143.16 104.74 4.32 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 -169.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.53 171.97 43.14 Favored Glycine 0 N--CA 1.428 -1.892 0 C-N-CA 119.505 -1.331 . . . . 0.0 113.175 -177.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.81 108.24 15.12 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 122.594 0.358 . . . . 0.0 111.417 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.85 -112.87 5.03 Favored Glycine 0 CA--C 1.513 -0.081 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.956 175.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -77.2 -30.77 54.9 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.623 0.725 . . . . 0.0 109.917 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.2 m -85.83 59.35 5.58 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 123.052 1.406 . . . . 0.0 107.547 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.54 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.8 tp60 -100.08 128.02 46.22 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.079 -1.873 . . . . 0.0 108.97 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -117.14 112.04 20.31 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.391 -0.924 . . . . 0.0 109.936 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -108.8 104.72 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.05 165.78 18.84 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.609 -175.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -108.24 134.01 51.67 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -177.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.63 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -137.0 174.13 10.95 Favored 'General case' 0 C--O 1.204 -1.298 0 CA-C-O 120.831 0.348 . . . . 0.0 111.603 -174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 10' ' ' THR . 45.1 m -123.77 137.5 54.67 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 8' ' ' THR . 24.6 mm -69.17 123.67 23.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -106.86 -40.96 5.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.928 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 37.0 m -152.77 166.04 33.47 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.1 m -151.07 144.35 24.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -154.47 166.27 33.81 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.958 0.409 . . . . 0.0 110.862 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 HG13 HG22 ' A' ' 39' ' ' VAL . 1.4 mp -108.36 120.15 59.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 28.5 t70 -132.57 125.28 30.14 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.451 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 t70 63.43 23.34 13.65 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 122.319 1.057 . . . . 0.0 110.229 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.36 8.34 68.44 Favored Glycine 0 N--CA 1.442 -0.959 0 CA-C-N 115.278 -0.874 . . . . 0.0 113.603 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.451 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.5 pt-20 -125.12 156.74 37.85 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 117.686 0.743 . . . . 0.0 109.768 177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.449 HG22 HG13 ' A' ' 34' ' ' ILE . 11.8 t -98.78 119.31 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 CA-C-O 121.524 0.678 . . . . 0.0 110.133 -177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.2 mt -108.77 137.25 47.0 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.745 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 26.3 m-85 -111.64 142.51 43.87 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.393 -177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD13 ' CE2' ' A' ' 55' ' ' TRP . 58.4 tp -108.0 111.84 24.12 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 175.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 m -127.24 142.94 42.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.569 -173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -120.3 142.24 49.27 Favored 'General case' 0 CA--C 1.476 -1.884 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.63 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 54.3 m-85 -89.42 150.61 22.43 Favored 'General case' 0 C--N 1.282 -2.336 0 O-C-N 124.481 1.113 . . . . 0.0 111.113 -171.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -108.39 133.93 51.9 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.698 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 156.03 -123.26 1.3 Allowed Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 108.591 -1.803 . . . . 0.0 108.591 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -92.57 -46.5 7.58 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 117.315 0.557 . . . . 0.0 110.897 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.8 t-20 -95.19 92.15 6.64 Favored 'General case' 0 C--N 1.307 -1.261 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.37 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.1 t -89.19 -10.05 10.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.617 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.75 -6.29 59.33 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.042 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -82.64 82.37 8.04 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.39 112.3 24.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -130.87 159.04 38.55 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.201 0.524 . . . . 0.0 111.936 -167.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.479 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 81.0 m95 -103.36 117.66 34.99 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.891 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.49 HG11 HG11 ' A' ' 14' ' ' VAL . 25.6 m -122.05 165.09 18.28 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 80.9 tttt -103.31 164.98 11.3 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.25 -35.92 74.57 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.566 0.746 . . . . 0.0 113.009 -175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -74.08 -6.52 48.07 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.71 ' HD2' ' O ' ' A' ' 15' ' ' LYS . 16.8 mmt-85 -104.69 11.68 33.74 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.043 0.449 . . . . 0.0 111.327 -179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -119.62 138.64 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.626 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.278 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.512 HD13 ' HB3' ' A' ' 13' ' ' LYS . 3.9 mp -108.33 114.44 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.538 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -83.72 115.55 60.22 Favored Pre-proline 0 C--N 1.29 -2.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -62.08 118.64 5.53 Favored 'Trans proline' 0 C--O 1.251 1.135 0 C-N-CA 122.031 1.821 . . . . 0.0 111.027 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -160.6 98.68 1.25 Allowed 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 -178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.37 -78.67 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.856 1.262 . . . . 0.0 113.278 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 84.6 mttt 70.8 98.2 0.07 Allowed 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -95.98 -19.66 28.17 Favored Glycine 0 N--CA 1.425 -2.044 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 172.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.7 mt -74.79 -13.89 60.63 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 114.494 -0.853 . . . . 0.0 109.673 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -145.19 -150.55 0.33 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 103.636 -2.727 . . . . 0.0 103.636 -177.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -137.1 148.85 46.97 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 120.27 1.395 . . . . 0.0 109.823 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -54.28 -54.89 33.99 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.65 0.738 . . . . 0.0 110.149 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -153.86 -163.49 1.65 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -65.92 -39.47 90.58 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.494 178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -123.02 -76.86 0.59 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.096 0.474 . . . . 0.0 109.772 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 . . . . . 0 C--N 1.301 -1.516 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -177.571 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -126.33 73.39 1.37 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.039 -167.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt 56.9 76.04 0.33 Allowed 'General case' 0 C--O 1.245 0.816 0 C-N-CA 124.279 1.032 . . . . 0.0 110.569 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -139.43 80.2 23.14 Favored Pre-proline 0 C--N 1.304 -1.384 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -70.55 91.45 0.59 Allowed 'Trans proline' 0 C--O 1.248 1.003 0 C-N-CA 123.087 2.524 . . . . 0.0 111.377 175.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.1 m 62.56 -77.76 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.257 1.423 . . . . 0.0 113.433 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.4 mt -98.22 -68.15 0.81 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.571 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 20.3 p -60.15 132.13 52.97 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 123.52 0.728 . . . . 0.0 112.151 -175.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.87 -32.19 6.57 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.567 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 m -63.87 132.7 51.6 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 123.082 0.553 . . . . 0.0 110.035 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -93.11 131.23 38.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 175.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.405 HG12 ' HD3' ' A' ' 64' ' ' PRO . 35.3 m -129.74 -179.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.486 -172.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HE3' HG22 ' A' ' 24' ' ' ILE . 28.4 mmmt -114.03 135.36 54.1 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 43' ' ' VAL . 86.4 t -116.11 133.14 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE3' HE22 ' A' ' 22' ' ' GLN . 81.8 tttt -107.9 114.18 27.93 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.114 -177.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' CE2' HG12 ' A' ' 56' ' ' VAL . 1.5 m-85 -142.91 128.35 18.96 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.015 0.436 . . . . 0.0 110.616 175.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.549 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.38 170.16 40.12 Favored Glycine 0 N--CA 1.399 -3.77 0 C-N-CA 119.384 -1.389 . . . . 0.0 113.185 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -131.11 108.85 10.04 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 171.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.58 -121.45 12.74 Favored Glycine 0 N--CA 1.438 -1.233 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.553 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -88.45 -10.9 47.59 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.333 0.587 . . . . 0.0 110.253 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.2 m -79.96 8.19 7.47 Favored 'General case' 0 CA--C 1.569 1.701 0 CA-C-O 122.422 1.106 . . . . 0.0 109.667 178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.549 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 50.8 tt0 -86.76 143.18 27.65 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.264 -176.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.24 155.53 42.74 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 174.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.636 HG22 ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -112.63 133.61 57.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 175.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' LYS . 8.7 m-85 -107.5 166.77 10.42 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -172.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -106.75 116.46 31.96 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.86 167.75 19.65 Favored 'General case' 0 C--O 1.202 -1.43 0 O-C-N 121.741 -0.599 . . . . 0.0 111.497 -174.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.5 m -120.84 140.3 51.95 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.557 HD13 HG12 ' A' ' 43' ' ' VAL . 33.7 mm -78.78 128.35 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 123.642 0.589 . . . . 0.0 111.145 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -99.54 -59.26 1.75 Allowed 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 124.346 1.058 . . . . 0.0 111.895 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 t -154.39 167.86 28.57 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -132.83 139.7 47.61 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -142.56 156.38 45.1 Favored 'General case' 0 C--N 1.284 -2.243 0 O-C-N 123.575 0.547 . . . . 0.0 110.097 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.42 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.77 119.92 59.21 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -137.22 131.7 32.8 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.2 t70 65.64 22.03 11.66 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-O 122.397 1.094 . . . . 0.0 109.855 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 86.06 -1.96 87.7 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.383 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -116.51 159.37 22.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 122.495 -0.415 . . . . 0.0 111.765 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG22 HG13 ' A' ' 34' ' ' ILE . 3.3 t -98.86 116.65 42.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-O 121.43 0.633 . . . . 0.0 111.093 -172.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 77.0 mt -112.73 139.94 47.93 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.486 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 31.2 m-85 -108.15 157.25 18.46 Favored 'General case' 0 C--N 1.276 -2.621 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 12.8 mt -106.93 115.02 29.46 Favored 'General case' 0 CA--C 1.465 -2.311 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 173.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.559 HG21 HG21 ' A' ' 14' ' ' VAL . 13.8 m -129.17 142.59 43.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -117.84 125.47 50.6 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 119.29 -0.964 . . . . 0.0 109.619 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.546 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 24.6 m-85 -72.04 109.82 6.11 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . 0.275 50.6 p90 -77.67 1.0 21.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -169.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.47 87.83 1.57 Allowed Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 174.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 77.96 -27.27 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.878 1.271 . . . . 0.0 113.63 176.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.555 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 4.8 m-20 -81.42 99.94 9.0 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.538 0.685 . . . . 0.0 112.209 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.05 -47.64 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -100.88 1.31 39.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.532 0.682 . . . . 0.0 110.403 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.555 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 89.9 m-85 -86.88 75.83 9.52 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 122.551 1.167 . . . . 0.0 108.976 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -103.85 103.19 13.03 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 102.879 -3.008 . . . . 0.0 102.879 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -118.45 165.12 14.29 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.419 -163.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.521 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 80.1 m95 -98.83 126.84 44.59 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.462 -173.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.595 HG12 ' CE2' ' A' ' 16' ' ' TYR . 34.3 m -135.94 165.22 30.17 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.831 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.69 166.47 10.87 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.36 74.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.472 0.654 . . . . 0.0 111.239 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -74.11 -15.64 61.04 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.735 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 60' ' ' ARG . 14.6 tpt180 -95.95 0.61 52.06 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.825 0.821 . . . . 0.0 109.61 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -111.99 150.81 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.11 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.268 -177.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.594 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.0 mp -107.64 104.57 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 171.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.419 ' O ' ' HB3' ' A' ' 67' ' ' LYS . 92.4 m95 -75.81 150.83 84.2 Favored Pre-proline 0 C--N 1.291 -1.975 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' HG12 ' A' ' 12' ' ' VAL . 7.5 Cg_exo -77.41 -178.5 4.64 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.612 2.208 . . . . 0.0 111.201 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . 0.281 0.6 OUTLIER 51.98 102.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -179.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 77.71 -36.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.817 1.247 . . . . 0.0 111.768 172.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 63' ' ' TRP . 4.3 tmtm? -73.07 99.24 2.72 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -138.0 34.99 2.08 Favored Glycine 0 N--CA 1.435 -1.418 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 74.8 104.61 0.07 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.311 1.444 . . . . 0.0 112.03 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -53.26 101.34 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.936 -1.484 . . . . 0.0 113.561 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -145.28 147.82 32.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -76.52 -23.9 53.7 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.673 -0.411 . . . . 0.0 111.469 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 33.8 t-80 -83.32 5.12 24.42 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 122.543 1.163 . . . . 0.0 108.987 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -111.83 79.97 1.27 Allowed 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -111.19 111.8 23.14 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-O 122.003 0.906 . . . . 0.0 111.983 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 . . . . . 0 C--N 1.277 -2.556 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.443 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.67 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -126.01 142.95 51.3 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.5 ptp -136.94 135.85 38.08 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -86.08 141.75 35.54 Favored Pre-proline 0 C--N 1.29 -2.02 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.52 -56.87 2.3 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.507 2.138 . . . . 0.0 111.08 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.0 p -150.45 47.51 0.89 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 171.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.6 mp 75.33 7.32 4.05 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 113.261 -1.79 . . . . 0.0 110.753 -177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 ' HA ' ' A' ' 30' ' ' LYS . 1.9 m -63.42 139.02 58.73 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 126.132 1.773 . . . . 0.0 112.801 -176.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.54 -22.22 40.73 Favored Glycine 0 CA--C 1.499 -0.96 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.794 174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.3 m -66.09 118.65 10.15 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.0 mttm -91.0 115.07 27.72 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.54 178.77 2.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.531 -173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 34.4 tttp -120.92 139.11 53.68 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.9 t -121.71 139.81 47.65 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.57 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 40.8 ttmt -125.01 104.09 8.37 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.83 118.39 13.91 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.021 -0.671 . . . . 0.0 110.157 -171.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.62 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.76 170.66 41.74 Favored Glycine 0 CA--C 1.495 -1.19 0 C-N-CA 120.325 -0.941 . . . . 0.0 112.627 174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 18.4 ptt-85 -119.27 107.14 13.05 Favored 'General case' 0 C--O 1.253 1.24 0 CA-C-O 121.932 0.872 . . . . 0.0 109.966 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.67 -111.73 3.32 Favored Glycine 0 N--CA 1.432 -1.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.309 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -94.07 -10.79 32.24 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.246 0.546 . . . . 0.0 110.6 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 72.6 p -82.27 31.74 0.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.454 0.645 . . . . 0.0 110.242 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.62 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 38.5 tt0 -82.76 102.45 11.57 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.93 128.42 49.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.613 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.459 ' CG2' ' HE3' ' A' ' 13' ' ' LYS . 2.4 mp -108.17 115.17 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.23 162.48 32.03 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.449 -175.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.479 ' HG2' ' HG3' ' A' ' 13' ' ' LYS . 54.6 mt-10 -113.85 136.8 52.48 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.089 0.471 . . . . 0.0 112.071 -177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.654 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -141.25 -178.04 5.41 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.289 -171.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.0 p -134.95 133.37 39.48 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.585 HD13 HG23 ' A' ' 43' ' ' VAL . 46.5 mm -67.78 131.53 33.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 123.797 0.686 . . . . 0.0 110.98 -176.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -101.8 -60.92 1.45 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.7 m -147.98 164.82 32.59 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -134.29 151.98 51.56 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -153.12 165.57 35.22 Favored 'General case' 0 N--CA 1.435 -1.185 0 O-C-N 123.167 0.292 . . . . 0.0 110.237 172.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.43 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -111.14 131.39 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -135.95 115.87 13.18 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.5 t70 63.79 23.44 13.44 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.262 1.425 . . . . 0.0 111.623 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.79 -10.55 55.87 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 120.216 -0.992 . . . . 0.0 113.419 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -108.17 147.1 31.79 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 117.722 0.761 . . . . 0.0 109.565 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.43 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.6 118.04 44.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 91.3 mt -108.96 130.06 55.45 Favored 'General case' 0 N--CA 1.416 -2.16 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.605 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 37.4 m-85 -108.16 147.91 30.63 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.897 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.8 tp -107.55 113.07 26.14 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.585 HG23 HD13 ' A' ' 29' ' ' ILE . 2.4 p -118.42 147.03 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.443 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.15 125.92 51.19 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.654 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 90.2 m-85 -83.09 104.69 13.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.582 -173.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -76.38 87.2 3.15 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.69 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.58 -120.45 0.97 Allowed Glycine 0 N--CA 1.423 -2.228 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -90.95 -39.97 11.95 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.168 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -122.67 112.72 18.3 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 39.2 t -88.62 -23.83 6.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.339 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -72.43 10.88 0.7 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -174.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -59.84 -38.99 83.64 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.444 -0.502 . . . . 0.0 109.772 173.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 18.3 t70 45.51 81.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 125.112 1.507 . . . . 0.0 110.442 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -120.62 142.86 49.03 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.52 -0.872 . . . . 0.0 112.406 -167.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.633 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 74.9 m95 -102.41 106.47 17.22 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.37 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 61' ' ' ILE . 3.0 p -122.88 148.04 26.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.151 -174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' O ' HG13 ' A' ' 61' ' ' ILE . 26.3 mtmm -73.15 158.28 35.59 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -61.2 -39.88 91.88 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 124.115 0.966 . . . . 0.0 113.066 -176.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -86.05 -2.48 58.35 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.586 0.708 . . . . 0.0 110.917 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.57 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -96.69 5.61 50.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.206 1.003 . . . . 0.0 109.016 178.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 57' ' ' LYS . 70.0 mt -120.48 153.32 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 114.084 -1.416 . . . . 0.0 107.336 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 4.1 mp -107.39 109.51 28.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -87.89 120.05 70.69 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.075 -177.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -70.22 117.86 5.35 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.334 1.356 . . . . 0.0 109.558 175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 177.89 84.44 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 104.619 -2.364 . . . . 0.0 104.619 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.1 t70 73.52 -75.6 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 O-C-N 124.097 0.873 . . . . 0.0 110.197 -178.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 67' ' ' LYS . 27.3 tptt 58.13 114.27 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.11 2.164 . . . . 0.0 112.761 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -89.47 77.97 1.65 Allowed Glycine 0 N--CA 1.439 -1.136 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.81 -174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' C ' ' H ' ' A' ' 71' ' ' HIS . 3.0 mm? -88.1 120.88 29.88 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 71.12 -33.87 0.28 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 125.823 1.649 . . . . 0.0 112.054 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 75' ' ' HIS . 66.2 m-70 -112.56 80.36 1.33 Allowed 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 175.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -100.7 -42.5 6.49 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.79 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -68.4 -48.41 64.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.494 0.664 . . . . 0.0 109.285 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -114.8 90.82 3.43 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' O ' ' A' ' 71' ' ' HIS . 3.6 p80 -108.47 84.75 1.99 Allowed 'General case' 0 C--N 1.281 -2.385 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.019 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 . . . . . 0 C--N 1.295 -1.774 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 -179.734 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.228 0.537 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -148.64 87.85 1.59 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.627 0.727 . . . . 0.0 109.885 176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.6 ttt -169.61 83.51 0.12 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.26 176.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -96.25 138.14 21.59 Favored Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -72.5 88.99 0.84 Allowed 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.605 1.536 . . . . 0.0 108.272 169.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.9 m -85.28 -167.24 1.76 Allowed 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.721 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.451 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.0 pt? -57.9 -33.84 69.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.346 -0.388 . . . . 0.0 109.995 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.9 m -60.77 118.79 7.07 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 124.422 1.089 . . . . 0.0 110.588 177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 104.96 -11.3 48.9 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.334 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -78.28 128.22 33.39 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -93.24 121.67 34.85 Favored 'General case' 0 N--CA 1.426 -1.671 0 CA-C-O 121.812 0.815 . . . . 0.0 109.898 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.44 179.46 2.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.142 -175.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 53.0 mtmt -108.83 143.84 37.5 Favored 'General case' 0 CA--C 1.475 -1.905 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.36 173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 56' ' ' VAL . 92.7 t -121.44 128.94 75.98 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.048 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.7 ttmt -107.64 104.1 13.55 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -138.84 111.35 7.57 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.878 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 179.33 170.31 40.98 Favored Glycine 0 N--CA 1.416 -2.685 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 176.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -107.43 105.25 15.08 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.493 0.663 . . . . 0.0 110.849 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.19 -107.03 1.61 Allowed Glycine 0 C--N 1.315 -0.606 0 CA-C-N 115.48 -0.782 . . . . 0.0 113.258 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -74.05 -29.35 61.86 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.554 . . . . 0.0 110.408 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.2 m -81.81 30.12 0.38 Allowed 'General case' 0 CA--C 1.573 1.86 0 CA-C-O 122.647 1.213 . . . . 0.0 110.187 -176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.513 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.6 tp60 -76.4 114.17 14.8 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.336 1.454 . . . . 0.0 109.972 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 14' ' ' VAL . 61.5 mt -108.69 112.52 40.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -111.55 166.93 10.73 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 13' ' ' LYS . 50.7 mt-10 -107.11 119.79 40.32 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 170.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . -126.21 177.61 6.3 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.7 p -129.19 128.04 42.54 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 122.203 -0.311 . . . . 0.0 110.203 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 HG23 ' A' ' 43' ' ' VAL . 33.4 mm -65.62 130.17 30.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 O-C-N 124.1 0.875 . . . . 0.0 109.786 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 tmmm? -117.63 -42.82 2.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.3 m -158.3 170.18 22.83 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.908 -0.495 . . . . 0.0 109.963 178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 140.58 41.99 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -145.47 155.44 43.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.747 0.419 . . . . 0.0 110.253 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.457 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.7 124.86 65.54 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -125.92 104.32 8.24 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 52.05 64.46 1.84 Allowed 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 125.473 1.509 . . . . 0.0 112.97 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.53 -26.57 5.71 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-N 114.692 -1.14 . . . . 0.0 115.525 174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -108.14 149.45 28.49 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 118.311 1.056 . . . . 0.0 111.215 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG22 HG13 ' A' ' 34' ' ' ILE . 5.7 t -98.45 125.59 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 CA-C-O 121.581 0.705 . . . . 0.0 110.448 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.1 mt -112.3 138.56 48.83 Favored 'General case' 0 N--CA 1.405 -2.722 0 CA-C-N 114.209 -1.36 . . . . 0.0 108.372 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 30.9 m-85 -108.0 149.14 28.76 Favored 'General case' 0 C--N 1.258 -3.411 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 175.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.499 HD13 ' CE2' ' A' ' 55' ' ' TRP . 39.8 tp -107.29 104.26 13.83 Favored 'General case' 0 N--CA 1.396 -3.156 0 N-CA-C 104.516 -2.402 . . . . 0.0 104.516 176.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.503 HG11 HG21 ' A' ' 14' ' ' VAL . 3.8 p -118.77 138.36 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.949 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -173.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.69 143.76 47.57 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.579 -0.448 . . . . 0.0 109.972 178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -89.34 101.42 14.09 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -172.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -58.8 139.71 55.99 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 123.562 0.539 . . . . 0.0 112.054 -175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.73 -51.18 2.31 Favored Glycine 0 N--CA 1.44 -1.047 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.946 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -93.47 -59.24 2.06 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.104 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 88.1 m-20 -110.07 92.87 4.22 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.044 -175.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.0 m -66.91 -57.03 11.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.41 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 24.3 ttt180 -109.73 4.07 21.51 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.027 177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 49' ' ' ASN . 98.4 m-85 -80.95 67.72 6.96 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 118.543 -1.263 . . . . 0.0 109.586 175.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.09 144.75 50.2 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.087 -1.415 . . . . 0.0 107.714 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -140.08 157.81 45.05 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.509 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 75.6 m95 -98.47 122.88 42.22 Favored 'General case' 0 N--CA 1.427 -1.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.37 -173.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.636 HG11 HG11 ' A' ' 14' ' ' VAL . 18.1 m -130.44 152.48 37.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -79.82 153.03 29.4 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.5 -40.98 79.85 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.792 -178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -78.05 -2.51 37.59 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.03 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 13.5 mtp180 -106.09 10.19 32.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.011 0.434 . . . . 0.0 110.498 178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.5 mt -108.81 139.24 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.373 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.1 mp -108.05 107.61 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -84.88 130.41 52.75 Favored Pre-proline 0 C--N 1.298 -1.63 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -55.63 120.07 7.63 Favored 'Trans proline' 0 C--O 1.251 1.142 0 C-N-CA 122.902 2.402 . . . . 0.0 112.589 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.3 tt -145.37 91.72 2.16 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.54 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 33.8 t70 67.91 3.91 3.76 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.295 1.438 . . . . 0.0 113.315 174.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 66' ' ' ASP . 1.0 OUTLIER -145.81 33.5 1.03 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -123.13 7.49 9.23 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.343 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 66.01 131.9 0.02 OUTLIER 'General case' 0 C--O 1.245 0.857 0 C-N-CA 125.266 1.426 . . . . 0.0 113.793 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.02 158.95 24.95 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.75 95.52 7.89 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.079 0.466 . . . . 0.0 111.046 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -76.66 -28.11 55.86 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -65.93 132.31 48.33 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.101 -1.409 . . . . 0.0 110.292 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -47.79 122.6 5.1 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.473 1.109 . . . . 0.0 109.749 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -149.06 -179.2 6.84 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -174.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 . . . . . 0 C--N 1.297 -1.71 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 174.619 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 C--O 1.243 0.716 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 65.55 23.28 11.79 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.198 0.999 . . . . 0.0 112.642 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -156.05 167.63 29.81 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.66 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -95.55 150.82 38.01 Favored Pre-proline 0 C--N 1.292 -1.898 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.29 101.56 0.52 Allowed 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 121.959 1.773 . . . . 0.0 110.073 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.0 m -87.63 158.39 18.87 Favored 'General case' 0 N--CA 1.421 -1.918 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.212 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.614 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.0 mm? -107.84 14.67 25.21 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 109.046 -176.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.4 p -61.55 117.09 5.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 88.56 0.14 82.35 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.812 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 28' ' ' SER . 91.5 m -78.22 131.78 37.28 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -86.22 129.98 34.67 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.36 175.84 9.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 30.2 ttpt -120.51 146.64 46.08 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 56' ' ' VAL . 93.3 t -129.62 132.57 66.09 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.343 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -173.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -119.56 103.14 9.16 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -149.27 125.29 10.65 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.632 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.22 170.06 39.87 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.636 171.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -93.37 111.54 23.23 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-O 121.009 0.433 . . . . 0.0 110.36 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.12 -102.35 0.65 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.422 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -93.82 -19.84 20.63 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.137 0.494 . . . . 0.0 110.469 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.7 m -79.0 34.46 0.23 Allowed 'General case' 0 CA--C 1.574 1.899 0 CA-C-O 122.111 0.958 . . . . 0.0 110.121 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.632 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 30.1 tt0 -103.56 127.99 50.88 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 123.406 0.682 . . . . 0.0 111.081 -177.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -120.14 148.6 43.43 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.802 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 54.4 mt -107.98 124.09 63.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.5 165.63 31.59 Favored 'General case' 0 C--N 1.28 -2.433 0 C-N-CA 124.228 1.011 . . . . 0.0 109.983 -176.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.01 136.88 46.97 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 120.816 0.341 . . . . 0.0 111.281 -178.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.543 ' HB2' ' CE2' ' A' ' 45' ' ' TYR . . . -131.16 -178.27 4.76 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.828 -173.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 10' ' ' THR . 6.2 m -138.62 139.38 38.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 175.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.614 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 34.3 mm -77.88 135.31 26.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 120.948 0.404 . . . . 0.0 111.586 -175.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -103.42 -58.71 1.83 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 p -148.68 -178.64 6.45 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.687 -177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.09 145.24 41.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -136.42 154.02 50.91 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.6 mp -116.62 119.32 61.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -135.09 119.73 18.2 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.759 -174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.9 t70 64.48 23.0 12.84 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.35 1.071 . . . . 0.0 110.648 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.52 -8.9 66.65 Favored Glycine 0 N--CA 1.434 -1.474 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.491 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -109.47 143.85 38.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 117.762 0.781 . . . . 0.0 110.565 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.54 123.21 50.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 122.395 1.093 . . . . 0.0 110.666 -177.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.89 145.38 35.46 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.022 -177.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.541 ' HE1' ' HB2' ' A' ' 58' ' ' ALA . 34.6 m-85 -113.22 151.84 30.49 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.783 177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CE2' ' A' ' 55' ' ' TRP . 40.8 tp -107.72 116.5 32.07 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.494 HG12 HD13 ' A' ' 29' ' ' ILE . 5.9 m -118.95 140.99 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.612 -174.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -130.25 138.47 50.54 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.092 0.472 . . . . 0.0 111.121 173.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.543 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 20.4 m-85 -95.96 133.21 40.43 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.515 -1.22 . . . . 0.0 109.809 -171.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -102.62 87.6 3.03 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.596 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.28 -65.96 0.27 Allowed Glycine 0 C--N 1.295 -1.705 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -141.36 -57.79 0.49 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -92.7 109.02 20.43 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.244 0.545 . . . . 0.0 109.806 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 t -79.7 -9.02 11.97 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-O 121.645 0.736 . . . . 0.0 109.615 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -71.34 -3.13 19.0 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.398 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.09 81.12 5.38 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 171.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -110.03 95.71 5.77 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.24 151.58 38.14 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.918 -166.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.477 ' CE2' HD13 ' A' ' 42' ' ' LEU . 74.6 m95 -104.37 129.08 52.29 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG21 HG11 ' A' ' 14' ' ' VAL . 29.5 t -138.93 140.23 39.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 61' ' ' ILE . 33.0 ttpt -71.68 150.66 44.35 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 120.756 0.312 . . . . 0.0 111.505 178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.541 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . . . -52.56 -49.67 64.47 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 125.685 1.594 . . . . 0.0 113.73 -170.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.35 -7.71 54.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.966 -1.015 . . . . 0.0 111.689 -174.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -106.87 8.37 30.65 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 122.382 1.087 . . . . 0.0 108.707 -175.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 57' ' ' LYS . 68.1 mt -108.61 157.32 8.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.033 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.5 mp -107.07 108.6 25.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 78.5 m95 -97.95 146.24 31.15 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -69.18 116.73 4.64 Favored 'Trans proline' 0 N--CA 1.44 -1.653 0 N-CA-C 108.695 -1.31 . . . . 0.0 108.695 174.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -179.24 91.51 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.79 19.34 10.5 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.759 1.224 . . . . 0.0 110.16 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -103.49 -32.38 9.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.172 -169.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 117.31 2.69 17.76 Favored Glycine 0 C--N 1.308 -1.019 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.335 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.74 -23.63 19.7 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 70' ' ' GLU . 1.7 mp0 -64.79 129.64 40.51 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -87.89 153.51 21.26 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.536 -177.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -68.47 -33.98 75.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -178.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.4 m170 -90.45 106.96 18.85 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -55.13 138.98 43.23 Favored 'General case' 0 C--O 1.247 0.942 0 O-C-N 124.027 0.829 . . . . 0.0 112.284 -177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -71.19 135.5 47.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.644 176.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 . . . . . 0 C--N 1.299 -1.613 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 176.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.514 -0.438 0 CA-C-O 118.623 -0.703 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 76.65 -64.98 0.32 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 125.185 1.394 . . . . 0.0 109.25 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.2 ptm -75.16 150.6 38.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 172.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -70.12 119.6 72.86 Favored Pre-proline 0 C--N 1.303 -1.421 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.64 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -70.52 80.55 1.09 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.517 2.145 . . . . 0.0 110.35 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 58.7 m -87.17 -68.53 0.74 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.129 -0.941 . . . . 0.0 108.841 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.404 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 6.0 mp 65.81 -52.34 0.39 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.407 1.483 . . . . 0.0 112.537 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.5 m -55.95 118.54 4.72 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 123.681 0.792 . . . . 0.0 110.311 177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.06 -20.34 21.8 Favored Glycine 0 N--CA 1.434 -1.447 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.861 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 57.3 m -74.68 128.67 36.11 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 1.2 pptp? -87.9 127.4 35.36 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 121.419 0.628 . . . . 0.0 110.557 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.6 m -127.06 176.68 6.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.94 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.535 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.3 mmtm -110.92 135.47 51.4 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG21 HG11 ' A' ' 43' ' ' VAL . 96.8 t -124.38 131.72 72.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -108.12 114.35 28.18 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -132.94 114.45 14.04 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.822 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -160.18 160.38 31.62 Favored Glycine 0 N--CA 1.422 -2.277 0 C-N-CA 119.49 -1.338 . . . . 0.0 112.742 -178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -146.6 127.29 14.28 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.95 -123.71 10.98 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 121.048 -0.596 . . . . 0.0 111.737 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.9 -36.21 21.64 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.9 t -85.05 103.92 14.5 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.712 1.244 . . . . 0.0 111.041 -178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 35.2 tt0 -131.7 115.9 16.62 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.398 178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -123.66 143.86 49.99 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.546 0.689 . . . . 0.0 111.421 -175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.59 129.22 63.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -175.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -117.88 165.66 13.42 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.194 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -115.11 136.68 52.85 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' HB1' HG22 ' A' ' 43' ' ' VAL . . . -136.94 -178.71 5.31 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -172.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.7 m -142.67 130.07 21.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.446 HD13 HG23 ' A' ' 43' ' ' VAL . 42.0 mm -57.94 127.0 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 124.071 0.857 . . . . 0.0 111.152 -175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -100.38 -46.03 5.38 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -154.43 153.79 32.14 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.2 m -126.64 133.6 50.95 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -142.09 158.86 43.26 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 123.699 0.625 . . . . 0.0 110.378 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.401 HG13 HG22 ' A' ' 39' ' ' VAL . 1.9 mp -108.46 129.94 61.99 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.781 0 CA-C-O 121.433 0.635 . . . . 0.0 109.581 -175.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -123.15 103.92 8.86 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.519 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.6 t70 46.69 63.82 1.76 Allowed 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 125.601 1.56 . . . . 0.0 113.057 177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.25 -24.46 11.51 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.12 -0.945 . . . . 0.0 115.275 175.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -108.81 149.13 29.52 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 118.466 1.133 . . . . 0.0 110.49 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG22 HG13 ' A' ' 34' ' ' ILE . 9.8 t -98.52 119.55 46.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -176.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 74.6 mt -108.69 143.07 38.28 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.804 -0.814 . . . . 0.0 108.804 -178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -108.45 139.84 42.61 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.579 HD13 ' CE2' ' A' ' 55' ' ' TRP . 59.8 tp -107.61 106.59 17.02 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG22 ' HB1' ' A' ' 27' ' ' ALA . 4.1 p -125.82 141.91 44.13 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.605 -171.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -118.99 146.47 44.99 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.31 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 33.5 m-85 -77.89 105.85 9.36 Favored 'General case' 0 C--N 1.29 -1.98 0 O-C-N 123.967 0.792 . . . . 0.0 110.575 -172.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -61.39 130.73 47.52 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 120.637 0.256 . . . . 0.0 110.626 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.01 -40.1 1.42 Allowed Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.257 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -73.82 -63.78 1.14 Allowed 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 123.998 0.919 . . . . 0.0 109.618 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 52' ' ' TYR . 21.1 m120 -145.27 99.25 3.28 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.01 -25.87 10.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -175.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -103.0 3.95 36.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.833 0.825 . . . . 0.0 110.781 -179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 49' ' ' ASN . 78.3 t80 -103.59 97.13 7.21 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 42' ' ' LEU . 8.7 m-20 -95.06 131.0 41.52 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.059 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -120.84 154.31 35.95 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.177 -174.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.579 ' CE2' HD13 ' A' ' 42' ' ' LEU . 84.9 m95 -108.38 110.61 22.21 Favored 'General case' 0 C--O 1.253 1.279 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.316 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.5 m -135.77 139.74 45.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.018 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -80.98 168.2 18.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.73 -30.1 63.19 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.485 0.714 . . . . 0.0 112.867 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.48 -19.35 53.27 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.341 0.591 . . . . 0.0 110.859 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -92.13 -5.24 53.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 122.334 1.064 . . . . 0.0 108.415 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.79 150.71 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.799 0 CA-C-N 114.186 -1.37 . . . . 0.0 107.829 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.535 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -108.65 115.21 48.77 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 104.794 -2.298 . . . . 0.0 104.794 172.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -81.15 108.98 11.88 Favored Pre-proline 0 C--N 1.31 -1.148 0 O-C-N 123.144 0.278 . . . . 0.0 111.013 -178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -79.97 119.35 3.92 Favored 'Trans proline' 0 N--CA 1.441 -1.58 0 C-N-CA 122.288 1.992 . . . . 0.0 113.851 -175.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.6 tp -157.17 85.65 0.94 Allowed 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.432 -1.258 . . . . 0.0 108.874 171.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 37.9 t70 58.21 71.35 0.59 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 113.424 -1.716 . . . . 0.0 110.449 -175.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.415 ' HG3' HD13 ' A' ' 69' ' ' LEU . 18.4 tppt? -77.47 -31.78 53.94 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.059 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.72 18.93 10.15 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.229 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 HD13 ' HG3' ' A' ' 67' ' ' LYS . 7.3 mp -124.73 98.92 5.92 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.084 0.468 . . . . 0.0 110.441 177.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -91.37 -32.7 15.57 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 174.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -89.26 87.06 6.99 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 170.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -47.24 -47.99 24.56 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -168.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -79.06 -34.08 44.06 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.674 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 62.02 25.27 15.14 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.572 1.177 . . . . 0.0 108.841 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -130.48 126.62 37.35 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.029 -176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 71.4 m80 . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -178.239 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 3' ' ' MET . 9.7 tp10 . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -76.59 -19.06 58.26 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-O 120.905 0.383 . . . . 0.0 110.993 -178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.573 ' H ' ' HG3' ' A' ' 1' ' ' GLU . 25.6 ttt -74.46 117.13 15.93 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.186 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -76.49 114.74 41.21 Favored Pre-proline 0 C--N 1.3 -1.576 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -66.9 80.85 0.35 Allowed 'Trans proline' 0 C--O 1.246 0.901 0 C-N-CA 122.971 2.447 . . . . 0.0 114.65 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.4 m 71.46 166.25 0.3 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.078 1.351 . . . . 0.0 112.379 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.565 HD23 ' H ' ' A' ' 7' ' ' LEU . 2.1 pt? -113.72 21.11 15.32 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.831 0.824 . . . . 0.0 110.03 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 30' ' ' LYS . 2.8 p -69.93 113.5 7.22 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.322 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 96.13 8.48 57.78 Favored Glycine 0 N--CA 1.433 -1.537 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.441 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 79.0 m -77.86 126.87 31.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HG2' ' OG ' ' A' ' 28' ' ' SER . 95.3 mttt -94.52 124.29 38.46 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.119 0.485 . . . . 0.0 111.387 -176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.1 m -128.99 -178.96 2.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.789 -174.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 32.6 ttpt -124.79 146.47 49.21 Favored 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 175.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 56' ' ' VAL . 99.4 t -126.09 137.69 56.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 C-N-CA 122.836 0.455 . . . . 0.0 110.238 -172.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -110.57 107.0 16.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -132.11 113.17 13.01 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.522 ' HA3' ' HG3' ' A' ' 22' ' ' GLN . . . -151.06 157.25 27.09 Favored Glycine 0 N--CA 1.426 -1.978 0 C-N-CA 118.844 -1.646 . . . . 0.0 115.183 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -145.67 105.2 3.96 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 113.917 -1.141 . . . . 0.0 110.034 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.64 -124.12 6.98 Favored Glycine 0 N--CA 1.436 -1.355 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.375 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.61 ' HE3' ' HA ' ' A' ' 20' ' ' LYS . 0.7 OUTLIER -81.78 -28.17 33.35 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.811 0.815 . . . . 0.0 108.817 178.721 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.1 m -82.39 95.25 7.59 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.226 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HG3' ' HA3' ' A' ' 17' ' ' GLY . 59.6 tt0 -139.7 128.9 23.87 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.699 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -125.1 134.25 52.56 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.3 mt -108.62 108.53 25.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 170.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -125.57 165.09 19.15 Favored 'General case' 0 C--N 1.278 -2.525 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.87 -174.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 44.3 mt-10 -108.47 139.07 43.73 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.872 0.367 . . . . 0.0 111.155 -176.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.8 -179.68 6.75 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.199 -175.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.528 ' OG ' ' HG2' ' A' ' 11' ' ' LYS . 6.6 m -129.47 136.87 50.44 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 43' ' ' VAL . 39.1 mm -69.85 129.63 34.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.418 ' O ' HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -101.07 -47.1 4.87 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -155.97 168.03 28.54 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -140.5 150.69 44.06 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -155.46 162.43 40.74 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -114.26 124.7 71.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -129.06 108.18 10.18 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.025 0.441 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.2 t70 61.32 65.0 1.01 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.521 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.16 -26.53 3.34 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 114.618 -1.173 . . . . 0.0 115.181 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -114.11 148.69 36.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.623 0.711 . . . . 0.0 111.562 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 34' ' ' ILE . 7.2 p -98.32 125.29 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.683 -175.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 70.6 mt -109.89 134.9 51.57 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.705 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -110.84 145.91 37.37 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.056 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD13 ' CE2' ' A' ' 55' ' ' TRP . 52.1 tp -108.29 119.8 40.54 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 175.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG12 HD13 ' A' ' 29' ' ' ILE . 8.5 m -118.23 149.62 20.58 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -174.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -125.61 138.65 53.93 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . 0.258 58.1 m-85 -80.91 118.68 22.62 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 115.705 1.743 . . . . 0.0 115.705 -168.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 67.05 -48.83 0.48 Allowed 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.545 1.938 . . . . 0.0 115.691 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.45 -29.65 3.41 Favored Glycine 0 C--N 1.295 -1.711 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.917 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -65.8 -47.63 74.43 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.565 ' ND2' ' HB2' ' A' ' 52' ' ' TYR . 40.0 t30 -107.23 100.55 10.01 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.97 0.89 . . . . 0.0 109.242 177.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.5 t -88.31 -19.04 7.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.703 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -79.5 -10.36 59.79 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.988 -177.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.565 ' HB2' ' ND2' ' A' ' 49' ' ' ASN . 1.7 t80 -75.76 101.14 4.95 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -111.08 118.86 37.17 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.977 -169.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.94 142.31 27.43 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.457 0.646 . . . . 0.0 111.163 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.4 ' CE2' HD13 ' A' ' 42' ' ' LEU . 79.9 m95 -104.78 122.28 45.4 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.686 -176.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.487 HG11 HG11 ' A' ' 14' ' ' VAL . 19.2 m -134.29 143.93 36.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.654 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -82.84 160.79 22.12 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 123.358 0.663 . . . . 0.0 110.467 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.59 61.56 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.57 0.748 . . . . 0.0 112.204 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.79 -2.57 37.05 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.291 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -111.88 0.53 16.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -174.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 56' ' ' VAL . 45.3 mt -114.64 152.69 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 111.599 -172.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.2 mp -107.48 112.55 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 174.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.405 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 98.7 m95 -93.85 137.78 22.99 Favored Pre-proline 0 C--N 1.284 -2.268 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 22.8 Cg_exo -68.53 119.93 6.9 Favored 'Trans proline' 0 N--CA 1.443 -1.47 0 C-N-CA 121.92 1.746 . . . . 0.0 108.865 171.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 77.31 95.5 0.06 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 125.123 1.515 . . . . 0.0 109.422 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.8 t70 74.38 -169.75 0.11 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 125.319 1.447 . . . . 0.0 110.557 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -130.46 -9.35 4.13 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 121.555 -0.716 . . . . 0.0 111.681 -179.392 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.7 13.27 0.64 Allowed Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.053 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.4 mt -85.92 -18.61 32.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -56.39 100.62 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.943 -1.48 . . . . 0.0 107.55 174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -85.78 137.38 32.83 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.553 -177.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -75.67 6.97 4.19 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -171.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -94.98 25.19 4.3 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.35 0.595 . . . . 0.0 111.54 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -69.96 -33.84 72.61 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 168.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -87.21 74.82 9.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.7 p80 . . . . . 0 C--N 1.291 -1.972 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.866 179.812 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -87.66 -61.7 1.66 Allowed 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.455 0.645 . . . . 0.0 109.433 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.5 ttm -114.55 107.55 15.66 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -77.9 126.12 84.46 Favored Pre-proline 0 C--N 1.302 -1.489 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -64.21 97.24 0.24 Allowed 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.101 1.867 . . . . 0.0 108.514 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.8 m -74.37 125.72 29.12 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 121.751 0.786 . . . . 0.0 112.22 -172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.477 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.0 -15.97 61.08 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.056 -1.429 . . . . 0.0 111.054 175.946 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 10.2 m -63.05 113.72 3.28 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.72 -25.59 7.17 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.934 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 98.3 m -62.53 121.17 12.64 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-O 121.322 0.582 . . . . 0.0 109.837 177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.554 ' H ' ' HD2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -97.72 122.58 40.98 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.263 -176.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.85 -179.25 2.9 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.857 -173.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.562 ' HB3' HD13 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -113.33 140.32 48.11 Favored 'General case' 0 C--N 1.284 -2.239 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 177.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 43' ' ' VAL . 86.2 t -132.85 138.56 51.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 118.721 0.692 . . . . 0.0 111.204 -174.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' HE3' HD11 ' A' ' 62' ' ' ILE . 94.1 mttt -108.61 143.68 37.35 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 176.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -159.84 117.15 2.6 Favored 'General case' 0 C--N 1.313 -0.997 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.716 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.573 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . 178.97 170.46 40.96 Favored Glycine 0 N--CA 1.425 -2.071 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.657 170.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -119.03 103.81 9.9 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 171.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.54 -94.26 0.06 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.706 -0.679 . . . . 0.0 113.115 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -75.85 -32.54 59.8 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.8 p -83.23 27.45 0.57 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.498 0.666 . . . . 0.0 112.106 -176.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.573 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 51.8 tp60 -78.84 112.31 15.86 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.155 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.98 147.28 50.85 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -119.16 114.88 46.04 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.65 165.76 15.26 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.09 -175.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -108.79 142.2 39.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.09 172.94 15.54 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.5 p -122.64 146.92 47.02 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 175.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.477 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 20.8 mm -66.72 131.92 32.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -103.24 -45.8 4.79 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.4 t -165.04 -176.55 4.2 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.2 t -150.28 165.01 34.28 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 123.498 0.719 . . . . 0.0 109.445 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -160.46 166.35 29.36 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 125.33 1.452 . . . . 0.0 110.081 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.459 HG13 HG22 ' A' ' 39' ' ' VAL . 1.6 mp -107.2 117.26 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.864 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -130.25 114.53 15.78 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.045 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.2 t70 69.15 23.61 6.36 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 124.895 1.278 . . . . 0.0 110.512 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 101.64 -17.48 54.91 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.385 -0.825 . . . . 0.0 113.558 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -109.0 159.34 16.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 122.434 -0.451 . . . . 0.0 111.183 -179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 34' ' ' ILE . 60.8 t -98.35 117.38 43.19 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-O 121.39 0.614 . . . . 0.0 109.739 -176.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 6.2 mp -111.04 154.66 23.89 Favored 'General case' 0 N--CA 1.409 -2.515 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.799 176.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.476 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 88.9 m-85 -116.85 148.78 40.96 Favored 'General case' 0 C--N 1.255 -3.521 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.52 -177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' CZ2' ' A' ' 55' ' ' TRP . 36.0 tp -107.09 116.36 31.78 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 14' ' ' VAL . 29.4 m -118.18 144.09 27.21 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.534 -172.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -117.37 125.57 51.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.459 ' HB2' ' HB2' ' A' ' 48' ' ' TRP . 61.8 m-85 -62.09 140.45 58.39 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.739 -1.118 . . . . 0.0 112.969 -170.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -89.1 103.03 15.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.683 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.44 24.44 36.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.469 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 45' ' ' TYR . 88.2 m95 -133.9 -166.21 1.75 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -60.78 124.76 21.38 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 123.526 0.516 . . . . 0.0 111.109 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 98.8 t -86.07 -29.62 6.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.736 -176.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -50.83 -52.74 38.4 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 123.751 0.657 . . . . 0.0 112.171 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -104.38 101.11 10.82 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.416 0.627 . . . . 0.0 111.903 -176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -100.27 142.69 31.41 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 114.551 -1.204 . . . . 0.0 107.97 173.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -124.02 157.44 34.45 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -167.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.476 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 79.3 m95 -98.56 126.98 44.32 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.754 -176.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.01 140.84 32.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.548 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 40' ' ' LEU . 35.5 ttpt -76.86 164.17 26.07 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 122.328 -0.233 . . . . 0.0 110.677 -179.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.09 -32.08 63.83 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.009 0.524 . . . . 0.0 112.085 -178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.48 -24.75 65.62 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.285 1.034 . . . . 0.0 111.701 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -94.72 -6.42 43.2 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.555 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.9 mt -109.1 147.65 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.89 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.562 HD13 ' HB3' ' A' ' 13' ' ' LYS . 4.2 mp -107.72 106.65 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.638 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 81.9 m95 -82.51 136.15 45.9 Favored Pre-proline 0 C--N 1.293 -1.851 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.616 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 51.3 Cg_exo -56.96 119.54 6.86 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.392 2.062 . . . . 0.0 111.114 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 66' ' ' ASP . 7.9 tt -172.99 151.53 2.18 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -173.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' N ' HD23 ' A' ' 65' ' ' LEU . 19.3 t70 -65.06 101.44 0.52 Allowed 'General case' 0 C--N 1.306 -1.314 0 O-C-N 124.28 0.987 . . . . 0.0 109.392 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -94.46 92.97 7.38 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.089 -173.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.28 -12.83 18.92 Favored Glycine 0 C--N 1.317 -0.5 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.853 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 69.07 -46.99 0.57 Allowed 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.141 1.776 . . . . 0.0 114.861 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -89.94 95.07 10.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.67 0.748 . . . . 0.0 112.179 -176.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -114.54 96.35 5.71 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -69.94 -27.14 64.51 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -168.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 -78.98 -33.65 44.93 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.172 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 69.38 -51.53 0.61 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.226 1.41 . . . . 0.0 111.28 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -87.71 150.45 23.6 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 . . . . . 0 C--N 1.296 -1.75 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 173.785 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 . . . . . 0 CA--C 1.502 -0.887 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -86.75 123.07 31.5 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 58.4 ttp 66.63 82.93 0.17 Allowed 'General case' 0 C--N 1.321 -0.636 0 O-C-N 124.454 1.096 . . . . 0.0 109.743 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.615 ' O ' ' HB ' ' A' ' 8' ' ' THR . 48.3 mt-10 -80.26 122.77 83.17 Favored Pre-proline 0 C--N 1.305 -1.339 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -78.16 -23.41 9.01 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 122.503 2.135 . . . . 0.0 113.166 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.412 ' C ' ' H ' ' A' ' 8' ' ' THR . 63.4 m -78.98 95.94 5.61 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.1 mt 69.43 -24.52 0.15 Allowed 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 124.358 1.063 . . . . 0.0 113.832 174.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 4' ' ' GLU . 91.0 m -57.36 137.92 55.53 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 125.411 1.484 . . . . 0.0 111.651 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.81 -16.54 50.96 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -71.88 125.38 27.04 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.049 0.452 . . . . 0.0 110.298 179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -93.38 109.95 21.51 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 61' ' ' ILE . 7.5 p -125.97 175.9 7.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.894 -172.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 12' ' ' VAL . 28.4 ttpt -108.83 143.79 37.56 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.443 HG11 HG21 ' A' ' 56' ' ' VAL . 77.7 t -125.46 129.36 72.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 123.666 0.786 . . . . 0.0 110.325 -173.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.524 ' O ' ' HD3' ' A' ' 60' ' ' ARG . 86.5 tttt -108.76 112.9 25.42 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -133.17 104.81 6.67 Favored 'General case' 0 C--N 1.282 -2.357 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.579 ' HA2' ' O ' ' A' ' 21' ' ' THR . . . -158.52 141.81 7.95 Favored Glycine 0 N--CA 1.41 -3.067 0 C-N-CA 119.084 -1.531 . . . . 0.0 114.871 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -145.47 113.67 6.58 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 124.37 1.068 . . . . 0.0 109.331 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.18 -121.88 7.78 Favored Glycine 0 C--N 1.308 -0.976 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.7 tptt -87.22 -18.87 29.3 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.982 0.896 . . . . 0.0 109.597 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.579 ' O ' ' HA2' ' A' ' 17' ' ' GLY . 56.6 m -81.12 66.7 6.76 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.979 -1.01 . . . . 0.0 108.69 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 26.6 tp60 -121.34 116.97 25.81 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -146.12 128.49 15.88 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.87 128.38 64.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -145.41 165.78 27.52 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.724 -172.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 32.3 mt-10 -111.01 134.37 52.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.646 ' HB2' ' CD2' ' A' ' 45' ' ' TYR . . . -138.21 179.24 6.56 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.587 0.708 . . . . 0.0 112.39 -172.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.1 m -122.4 136.28 54.86 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.506 HD13 HG12 ' A' ' 43' ' ' VAL . 48.1 mm -72.56 127.46 34.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HA ' HG23 ' A' ' 8' ' ' THR . 0.1 OUTLIER -109.3 -41.79 4.55 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -147.73 170.34 17.76 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.7 m -146.85 142.34 27.56 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.61 144.81 44.29 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 122.665 0.386 . . . . 0.0 110.809 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.7 mp -113.44 112.86 42.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.289 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -149.54 133.39 16.97 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.7 t70 71.93 23.35 3.56 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.982 1.313 . . . . 0.0 110.325 179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.14 4.73 81.18 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.998 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HB2' ' HE2' ' A' ' 57' ' ' LYS . 11.8 pt-20 -127.18 157.48 39.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 117.153 0.477 . . . . 0.0 110.329 178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.11 118.88 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.461 0 CA-C-O 122.223 1.011 . . . . 0.0 109.403 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD21 ' HG3' ' A' ' 38' ' ' GLU . 1.9 mm? -108.64 136.87 47.52 Favored 'General case' 0 N--CA 1.403 -2.802 0 CA-C-N 113.938 -1.483 . . . . 0.0 108.065 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.478 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 33.8 m-85 -107.51 145.58 32.92 Favored 'General case' 0 C--N 1.259 -3.35 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.625 HD21 ' HB2' ' A' ' 53' ' ' ASP . 3.2 tm? -107.49 114.48 28.51 Favored 'General case' 0 N--CA 1.39 -3.454 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.506 HG12 HD13 ' A' ' 29' ' ' ILE . 5.1 m -117.82 148.91 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.541 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.819 -173.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -132.18 137.12 47.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.646 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 55.0 m-85 -80.04 99.17 7.55 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.425 -173.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 50.79 84.6 0.04 OUTLIER 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.011 -1.449 . . . . 0.0 114.024 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.1 -172.06 23.35 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 27.5 p90 -96.91 157.09 16.07 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.51 ' ND2' HD11 ' A' ' 42' ' ' LEU . 22.2 p-10 -101.83 99.73 9.98 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -176.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 m -89.66 -48.1 14.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.749 170.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -109.77 -57.18 2.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.109 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -88.13 102.36 14.71 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.372 -171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.625 ' HB2' HD21 ' A' ' 42' ' ' LEU . 3.2 p-10 -114.85 127.25 55.6 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -131.66 134.35 45.87 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 119.369 -0.932 . . . . 0.0 110.998 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 66.3 m95 -107.6 120.35 41.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.295 -174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.443 HG21 HG11 ' A' ' 14' ' ' VAL . 28.3 t -125.52 145.15 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -178.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HE2' ' HB2' ' A' ' 38' ' ' GLU . 60.6 tttm -81.91 149.45 28.24 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.23 -33.11 26.53 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.605 1.162 . . . . 0.0 113.228 -173.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -68.11 -25.25 65.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.181 -175.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 15' ' ' LYS . 33.8 mtt85 -97.19 7.74 45.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.177 0.513 . . . . 0.0 111.625 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.469 HG22 HG21 ' A' ' 12' ' ' VAL . 44.0 mt -108.33 146.51 14.08 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.24 102.54 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.498 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 97.2 m95 -81.72 124.91 79.24 Favored Pre-proline 0 C--N 1.294 -1.811 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.701 -171.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 18.5 Cg_exo -66.12 119.88 6.96 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.51 2.14 . . . . 0.0 113.107 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -141.95 71.14 1.35 Allowed 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 72.69 -71.45 0.14 Allowed 'General case' 0 C--O 1.24 0.557 0 CA-C-N 112.944 -1.935 . . . . 0.0 108.794 -171.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 51.4 tptt 62.18 17.05 8.88 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.409 1.484 . . . . 0.0 111.505 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -100.44 77.35 0.43 Allowed Glycine 0 N--CA 1.429 -1.807 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.681 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.15 -45.78 59.12 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.08 149.89 42.91 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.23 175.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.8 m170 -114.78 80.82 1.46 Allowed 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.959 -1.096 . . . . 0.0 113.291 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.54 -16.65 17.42 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -111.61 81.95 1.53 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -91.13 -48.44 6.95 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.443 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.1 m80 66.25 -80.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 124.486 1.114 . . . . 0.0 111.896 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--N 1.304 -1.411 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -174.479 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.504 -0.817 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -83.99 81.49 8.76 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.312 0.577 . . . . 0.0 109.623 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.489 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 52.7 ttp -167.23 41.73 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -116.08 86.19 16.53 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.919 -178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 3' ' ' MET . 11.2 Cg_exo -75.57 126.72 9.78 Favored 'Trans proline' 0 C--O 1.25 1.097 0 C-N-CA 122.764 2.309 . . . . 0.0 110.8 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.8 p -81.94 -84.82 0.11 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.6 mm? 63.82 6.13 2.59 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.63 1.172 . . . . 0.0 112.377 177.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 4.3 m -67.91 137.5 55.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 123.945 0.898 . . . . 0.0 111.065 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.51 -33.6 6.23 Favored Glycine 0 N--CA 1.438 -1.168 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 m -66.81 128.42 36.25 Favored 'General case' 0 C--O 1.248 1.002 0 C-N-CA 123.225 0.61 . . . . 0.0 111.034 -176.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -97.65 126.03 42.74 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.83 179.55 4.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 47.6 mtmt -107.7 142.81 37.12 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 172.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 56' ' ' VAL . 85.9 t -123.45 135.95 61.62 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.182 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.196 -177.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 40.8 ttmt -107.29 102.87 12.14 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 104.749 -2.315 . . . . 0.0 104.749 177.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD1' HG12 ' A' ' 56' ' ' VAL . 64.2 t80 -123.61 126.88 47.42 Favored 'General case' 0 C--N 1.271 -2.845 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -177.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 22' ' ' GLN . . . -179.89 156.23 17.51 Favored Glycine 1 N--CA 1.391 -4.307 0 C-N-CA 118.254 -1.927 . . . . 0.0 114.345 -177.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -126.82 104.02 7.83 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 113.745 -1.228 . . . . 0.0 108.142 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.79 -106.64 0.83 Allowed Glycine 0 CA--C 1.527 0.797 0 CA-C-N 114.987 -1.006 . . . . 0.0 114.209 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -81.69 -18.95 42.66 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.417 0.627 . . . . 0.0 110.739 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.1 m -100.01 85.47 3.06 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 0.3 OUTLIER -146.14 116.85 7.63 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -174.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 25' ' ' TYR . 31.1 mmmt -129.15 159.41 36.12 Favored 'General case' 0 C--O 1.244 0.813 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.2 mp -108.86 114.46 46.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 23' ' ' LYS . 15.1 m-85 -112.72 165.78 11.97 Favored 'General case' 0 C--N 1.284 -2.256 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.421 ' HG3' ' HG2' ' A' ' 13' ' ' LYS . 30.2 mp0 -105.83 131.21 53.44 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -134.71 161.83 34.05 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.788 -175.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.5 m -116.43 137.27 52.3 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.514 HD13 HG12 ' A' ' 43' ' ' VAL . 38.7 mm -76.55 130.61 36.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 O-C-N 123.598 0.561 . . . . 0.0 111.83 -174.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -99.33 -61.73 1.33 Allowed 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 40.6 m -156.15 -179.86 8.55 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 -176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.93 145.32 30.64 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 118.068 0.395 . . . . 0.0 110.31 -176.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -141.48 157.22 45.42 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 123.333 0.653 . . . . 0.0 110.844 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 mp -114.01 133.0 61.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 17.9 t70 -143.68 125.24 14.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.1 t70 59.12 22.51 10.65 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.625 1.17 . . . . 0.0 111.416 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 99.76 -8.73 59.94 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.615 -0.802 . . . . 0.0 113.781 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 35' ' ' ASP . 25.8 pt-20 -107.33 149.04 28.26 Favored 'General case' 0 CA--C 1.502 -0.886 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 34' ' ' ILE . 7.6 p -109.76 121.36 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.359 0 CA-C-O 122.415 1.103 . . . . 0.0 110.781 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 57' ' ' LYS . 1.3 mm? -108.86 131.88 54.57 Favored 'General case' 0 N--CA 1.389 -3.48 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.277 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 25.5 m-85 -107.86 146.87 31.7 Favored 'General case' 0 C--N 1.257 -3.424 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.504 ' CD2' ' HB3' ' A' ' 53' ' ' ASP . 0.7 OUTLIER -107.03 111.26 23.66 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 104.669 -2.345 . . . . 0.0 104.669 -178.43 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.514 HG12 HD13 ' A' ' 29' ' ' ILE . 12.8 m -126.49 151.92 33.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -173.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -126.43 133.12 51.32 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.891 172.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.493 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 33.3 m-85 -84.75 101.81 12.51 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -176.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -59.72 -37.78 79.84 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -171.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.32 19.66 31.52 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 119.656 -1.259 . . . . 0.0 112.689 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -132.03 -54.99 0.99 Allowed 'General case' 0 C--N 1.322 -0.597 0 O-C-N 122.232 -0.569 . . . . 0.0 110.987 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -158.51 91.98 1.11 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 p -89.88 -35.66 7.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.169 -175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.1 mtp180 -77.72 -0.09 25.55 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -100.46 -43.5 6.2 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.504 ' HB3' ' CD2' ' A' ' 42' ' ' LEU . 14.9 m-20 64.51 107.58 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.541 1.15 . . . . 0.0 108.757 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -118.18 153.77 33.29 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.062 0.458 . . . . 0.0 110.978 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 65.3 m95 -100.59 126.05 47.02 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.749 -177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 14' ' ' VAL . 20.4 m -129.96 165.63 29.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.524 ' HG2' ' CD1' ' A' ' 40' ' ' LEU . 86.1 mttt -99.79 171.18 8.05 Favored 'General case' 0 C--N 1.298 -1.643 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.277 -177.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.92 93.17 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.89 0.876 . . . . 0.0 111.886 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -60.93 -26.04 67.2 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.702 0.763 . . . . 0.0 111.145 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 23.1 mmm180 -87.39 -0.68 57.13 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.781 -173.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -112.19 143.27 22.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.989 -176.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mp -107.7 108.72 25.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -90.17 159.13 42.89 Favored Pre-proline 0 C--N 1.303 -1.442 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.499 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -64.96 118.79 5.75 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 121.898 1.732 . . . . 0.0 111.239 177.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.496 HD13 ' N ' ' A' ' 66' ' ' ASP . 3.4 tm? -148.59 158.61 44.24 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 102.033 -3.321 . . . . 0.0 102.033 -178.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.496 ' N ' HD13 ' A' ' 65' ' ' LEU . 32.5 t70 -72.14 93.1 1.4 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 122.719 1.247 . . . . 0.0 114.156 -173.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.565 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.85 6.73 47.47 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.639 170.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 111.86 71.64 0.61 Allowed Glycine 0 N--CA 1.402 -3.598 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.221 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' CD1' ' HA ' ' A' ' 66' ' ' ASP . 9.4 mp -77.18 165.51 24.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.58 85.79 7.4 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.942 -178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.93 105.23 13.76 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.82 -178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -90.22 -40.85 11.93 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.507 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -75.16 -33.06 61.46 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.21 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -101.8 75.83 1.59 Allowed 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -70.26 -31.81 69.36 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 . . . . . 0 C--N 1.302 -1.475 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 173.211 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 CA--C 1.509 -0.628 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -102.68 159.93 15.03 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.274 -178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -60.16 130.26 45.8 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.669 -177.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 44.7 mt-10 -92.04 125.93 55.06 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.4 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 4' ' ' GLU . 16.4 Cg_exo -66.21 91.84 0.27 Allowed 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.768 2.312 . . . . 0.0 113.824 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.4 m -102.76 175.44 5.49 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 173.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 6.1 mp -92.65 32.94 1.17 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.712 0.768 . . . . 0.0 110.782 -176.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 30' ' ' LYS . 5.2 m -57.55 136.94 56.79 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 125.378 1.471 . . . . 0.0 111.718 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.34 -15.66 55.98 Favored Glycine 0 C--O 1.241 0.539 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 177.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -83.04 130.71 35.16 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -110.93 112.95 25.14 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 122.457 1.122 . . . . 0.0 109.359 177.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 34.7 m -116.94 -179.71 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 CA-C-N 113.793 -1.549 . . . . 0.0 110.408 -169.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -108.03 136.76 47.18 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 56' ' ' VAL . 96.7 t -114.56 134.61 57.01 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.712 0 CA-C-N 115.203 -0.908 . . . . 0.0 108.913 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -107.72 104.71 14.29 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.651 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 8.7 t80 -108.84 103.8 12.94 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.5 105.22 0.99 Allowed Glycine 0 N--CA 1.426 -2.007 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -142.76 105.62 4.53 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.64 -109.09 2.14 Favored Glycine 0 C--N 1.317 -0.48 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.143 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -90.32 -27.88 19.11 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 123.094 0.558 . . . . 0.0 110.323 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -87.62 88.92 7.81 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-O 122.783 1.278 . . . . 0.0 111.024 -176.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.651 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 34.2 tt0 -120.64 116.86 26.13 Favored 'General case' 0 N--CA 1.432 -1.367 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.185 173.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.404 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 37.5 pttt -146.22 133.75 20.9 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.026 -173.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.46 122.36 64.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' OH ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -143.53 166.75 23.95 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.308 -175.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 45.1 mt-10 -105.44 120.51 41.79 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.82 0.819 . . . . 0.0 109.019 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -129.14 152.6 48.56 Favored 'General case' 0 N--CA 1.423 -1.803 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.699 -176.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 19.3 m -104.16 137.1 42.59 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.957 177.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 HD13 HG12 ' A' ' 43' ' ' VAL . 39.2 mm -74.16 128.82 36.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.465 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.499 ' HA ' HG23 ' A' ' 8' ' ' THR . 1.1 tmmt? -114.66 -50.65 2.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.374 176.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -129.71 166.97 18.77 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 m -148.98 153.15 37.53 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 34' ' ' ILE . 11.1 pt-20 -144.44 158.52 43.71 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.5 mp -122.21 109.46 24.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -139.99 139.36 36.04 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.432 -176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.6 t70 65.19 22.51 12.21 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.664 1.221 . . . . 0.0 109.785 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.5 -0.68 89.52 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.96 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -115.57 148.75 39.21 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 117.111 0.456 . . . . 0.0 111.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.23 119.27 46.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 76.4 mt -108.76 132.59 53.82 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.974 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 54.3 m-85 -108.94 145.16 35.89 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.742 -177.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.425 HD23 ' CE2' ' A' ' 55' ' ' TRP . 3.0 tm? -108.1 113.55 26.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 176.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.517 HG12 HD13 ' A' ' 29' ' ' ILE . 6.2 m -121.41 153.71 25.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.718 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -145.52 153.28 40.94 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.848 173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 4.1 m-85 -102.36 99.66 9.75 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.803 -168.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 50.44 97.8 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.928 1.291 . . . . 0.0 113.482 176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.42 -147.96 17.35 Favored Glycine 0 C--N 1.297 -1.624 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 -178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 31.1 m-90 -126.07 106.56 9.68 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 117.663 0.731 . . . . 0.0 109.725 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -79.83 127.46 32.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.7 m -80.01 -46.1 22.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -109.37 -27.78 9.31 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.411 0.624 . . . . 0.0 110.405 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -86.28 13.46 8.01 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.508 0.67 . . . . 0.0 110.396 -173.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.402 ' OD2' HD11 ' A' ' 42' ' ' LEU . 14.2 t70 -70.02 119.4 14.18 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 103.713 -2.699 . . . . 0.0 103.713 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.28 153.23 35.37 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -163.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 83.6 m95 -112.28 113.65 26.0 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.527 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.419 HG11 HG11 ' A' ' 14' ' ' VAL . 23.5 m -129.82 149.77 33.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.481 179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -89.32 162.42 15.83 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.175 -177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.89 65.61 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.854 1.262 . . . . 0.0 112.986 -173.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.73 -20.54 62.64 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 43.1 mtt85 -92.64 3.13 56.16 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.57 145.64 15.28 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.078 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.1 mp -107.92 112.15 38.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 95.8 m95 -93.55 119.05 67.58 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.216 -174.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 63' ' ' TRP . 27.2 Cg_exo -62.47 122.83 11.38 Favored 'Trans proline' 0 CA--C 1.497 -1.332 0 C-N-CA 123.323 2.682 . . . . 0.0 112.485 177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 tt -165.96 81.43 0.29 Allowed 'General case' 0 N--CA 1.413 -2.318 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 t70 58.72 40.85 22.76 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.438 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -79.99 166.95 21.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.93 -32.67 0.47 Allowed Glycine 0 N--CA 1.412 -2.948 0 N-CA-C 107.455 -2.258 . . . . 0.0 107.455 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.96 117.46 28.87 Favored 'General case' 0 CA--C 1.488 -1.406 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -68.22 139.65 56.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.472 0.653 . . . . 0.0 111.818 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -93.28 69.53 4.33 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -79.71 -21.15 44.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 29.8 m-70 -133.08 117.84 18.03 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 171.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -68.45 103.26 1.61 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.482 0.658 . . . . 0.0 111.03 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -89.77 -69.32 0.73 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.437 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.308 -1.226 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -177.634 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 CA--C 1.507 -0.701 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 177.29 -34.24 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.0 ttt -163.36 86.59 0.52 Allowed 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -75.4 137.67 71.37 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.219 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.51 -27.03 81.57 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 122.645 2.23 . . . . 0.0 113.52 -178.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.494 ' C ' HD13 ' A' ' 7' ' ' LEU . 21.4 t -86.02 34.85 0.62 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.258 -0.276 . . . . 0.0 111.673 -177.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.494 HD13 ' C ' ' A' ' 6' ' ' CYS 0.295 0.0 OUTLIER 43.89 33.31 0.72 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 172.872 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 16.2 p -73.95 149.02 41.62 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.02 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.7 -7.11 82.47 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.612 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.0 m -73.39 121.49 20.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -87.55 111.86 21.65 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 122.044 0.925 . . . . 0.0 109.999 178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 35.8 m -119.18 176.32 3.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.332 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 30.6 ttpt -111.64 139.1 47.38 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' CG1' HG11 ' A' ' 56' ' ' VAL . 78.3 t -118.87 132.32 69.09 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.476 0 C-N-CA 122.941 0.497 . . . . 0.0 111.297 -172.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -108.42 104.69 14.09 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 124.885 1.274 . . . . 0.0 107.715 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.523 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 56.6 t80 -118.13 114.38 23.0 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -177.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 22' ' ' GLN . . . -139.64 108.41 0.59 Allowed Glycine 0 N--CA 1.417 -2.573 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.399 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 18' ' ' ARG . 8.5 ptp180 -126.89 104.98 8.32 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.05 -100.17 0.08 OUTLIER Glycine 0 C--O 1.245 0.8 0 CA-C-N 116.198 -0.455 . . . . 0.0 114.102 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.1 tttm -81.73 -38.39 25.8 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.457 0.646 . . . . 0.0 110.119 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 45.5 m -84.12 86.84 7.16 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.366 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.523 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 34.6 tt0 -131.37 117.75 19.33 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.935 0.398 . . . . 0.0 110.6 175.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 25' ' ' TYR . 11.3 ptpt -154.66 151.51 28.86 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.0 mt -108.82 114.29 46.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.468 ' CE2' ' HD2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -108.49 166.9 10.43 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.05 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 45.0 mt-10 -114.87 132.18 56.6 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 167.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HB2' ' CD1' ' A' ' 45' ' ' TYR . . . -143.51 168.14 20.56 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.292 -171.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 p -106.43 142.35 36.24 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.41 HD13 HG12 ' A' ' 43' ' ' VAL . 42.5 mm -68.38 120.0 15.09 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -93.22 -38.85 11.33 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -175.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 t -169.27 173.57 6.6 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -145.93 140.29 26.84 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 176.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -142.36 155.52 45.16 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 123.204 0.601 . . . . 0.0 109.638 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.433 HG13 HG22 ' A' ' 39' ' ' VAL . 1.7 mp -108.81 124.92 65.76 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 107.778 -1.194 . . . . 0.0 107.778 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.76 104.87 8.08 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.714 -177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.5 t70 55.46 64.12 1.86 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.546 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.28 -25.57 4.86 Favored Glycine 0 C--N 1.312 -0.791 0 CA-C-N 114.86 -1.064 . . . . 0.0 114.858 175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.47 150.1 27.89 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.735 0.768 . . . . 0.0 112.932 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 34' ' ' ILE . 4.8 t -98.66 118.36 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -176.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 83.6 mt -108.05 134.78 50.46 Favored 'General case' 0 N--CA 1.412 -2.362 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -107.81 146.74 31.83 Favored 'General case' 0 C--N 1.259 -3.331 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.453 HD21 ' CG ' ' A' ' 53' ' ' ASP . 0.8 OUTLIER -107.62 121.96 45.73 Favored 'General case' 0 C--N 1.265 -3.106 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 177.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 29' ' ' ILE . 12.9 m -118.81 148.49 21.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-O 121.392 0.615 . . . . 0.0 109.716 -176.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -118.44 118.01 30.58 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 75.8 m-85 -68.07 127.35 32.57 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -170.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -90.14 95.23 10.11 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.126 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.6 -35.86 4.54 Favored Glycine 0 C--N 1.311 -0.809 0 CA-C-N 115.991 -0.55 . . . . 0.0 113.266 178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 3.0 t90 -81.57 -73.71 0.37 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 120.855 0.36 . . . . 0.0 110.382 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -119.22 105.13 11.05 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.38 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.5 m -89.0 -12.06 10.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -109.33 -20.01 13.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.474 -0.491 . . . . 0.0 111.084 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -79.55 105.93 11.21 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.611 0.719 . . . . 0.0 109.294 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.453 ' CG ' HD21 ' A' ' 42' ' ' LEU . 23.4 t70 -90.58 107.57 19.25 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -129.4 151.5 49.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.383 -170.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -108.48 131.14 55.1 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.488 -175.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.401 HG11 ' CG1' ' A' ' 14' ' ' VAL . 34.8 m -138.77 144.46 29.76 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.421 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -80.6 160.95 24.94 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.36 -34.52 57.92 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.684 0.754 . . . . 0.0 111.182 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.18 -34.15 59.79 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.455 1.502 . . . . 0.0 111.633 176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -95.31 6.61 48.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.86 -171.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.2 mt -113.52 142.35 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-O 121.635 0.731 . . . . 0.0 111.732 -176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 2.3 mp -107.87 104.97 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 175.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -85.26 155.13 60.32 Favored Pre-proline 0 C--N 1.291 -1.944 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -62.98 118.97 5.86 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.267 1.311 . . . . 0.0 109.066 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.2 mt -146.84 176.02 10.2 Favored 'General case' 0 CA--C 1.483 -1.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.605 -175.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -68.12 76.27 0.23 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.186 1.554 . . . . 0.0 109.972 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -134.82 -35.0 0.88 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.721 -1.581 . . . . 0.0 108.379 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.6 -29.81 1.04 Allowed Glycine 0 CA--C 1.501 -0.798 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.94 -178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.67 -2.22 57.22 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.018 0.913 . . . . 0.0 109.492 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -159.86 136.42 9.07 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 176.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -153.71 96.75 2.03 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.722 0.773 . . . . 0.0 109.791 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -46.52 -28.81 1.52 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.718 1.607 . . . . 0.0 113.764 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -84.96 111.11 19.4 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -120.57 144.01 48.32 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -79.03 -30.58 44.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 172.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 74.1 t60 . . . . . 0 N--CA 1.425 -1.708 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 175.994 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.452 -0.361 0 N-CA-C 109.981 -0.378 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -177.43 106.49 0.06 Allowed 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -81.75 138.27 35.22 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -116.43 92.82 38.07 Favored Pre-proline 0 C--N 1.291 -1.949 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.946 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.92 114.93 3.35 Favored 'Trans proline' 0 C--O 1.248 0.994 0 C-N-CA 122.675 2.25 . . . . 0.0 109.5 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.8 m -135.12 141.64 46.05 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.584 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.419 ' O ' ' HB ' ' A' ' 29' ' ' ILE . 2.4 pt? -74.38 -26.59 60.2 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 174.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.9 m -64.56 123.86 20.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.535 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.91 -11.83 62.43 Favored Glycine 0 N--CA 1.435 -1.393 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.803 -178.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.5 m -77.53 131.36 37.85 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -86.11 114.76 23.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.754 0.787 . . . . 0.0 110.843 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.2 m -109.28 -179.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 24.2 ttmt -116.76 140.42 49.45 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.489 ' CG1' HG11 ' A' ' 56' ' ' VAL . 94.5 t -117.31 131.46 69.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 121.186 0.517 . . . . 0.0 110.303 -176.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -106.71 104.82 14.6 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -108.61 107.33 17.77 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.452 -173.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -115.18 115.09 3.35 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.521 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -146.02 104.8 3.87 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 45.48 -112.13 0.71 Allowed Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.061 0.851 . . . . 0.0 114.188 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -94.65 -16.47 23.12 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.287 0.565 . . . . 0.0 110.658 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 50.3 p -84.58 26.13 0.83 Allowed 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 122.96 0.504 . . . . 0.0 111.212 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -81.92 138.44 34.99 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 122.964 0.506 . . . . 0.0 111.574 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.87 156.64 22.84 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.27 126.78 71.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.96 165.78 26.43 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.169 -177.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -108.82 138.53 45.0 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.29 161.72 38.21 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.2 m -104.17 138.66 40.33 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 42.6 mm -66.3 128.31 29.11 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-O 121.087 0.47 . . . . 0.0 111.032 -178.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 28.6 tptp -100.9 -62.11 1.28 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.7 m -147.19 161.44 40.9 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -127.19 138.27 53.1 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -142.29 161.57 37.69 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.376 0.608 . . . . 0.0 111.673 -178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.443 HG13 HG22 ' A' ' 39' ' ' VAL . 1.8 mp -108.91 130.12 62.35 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -135.82 115.91 13.33 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.9 t70 59.7 35.11 22.23 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.548 1.139 . . . . 0.0 111.357 176.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.45 -12.24 66.5 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 120.344 -0.931 . . . . 0.0 114.238 176.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 12.1 pt-20 -116.98 151.99 35.55 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 117.5 0.65 . . . . 0.0 111.235 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG22 HG13 ' A' ' 34' ' ' ILE . 8.4 t -98.83 125.25 52.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.9 0.381 . . . . 0.0 110.147 -175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.5 mp -122.67 160.33 26.05 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.481 177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -114.11 144.42 43.17 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.764 -177.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' NE1' ' A' ' 55' ' ' TRP . 3.5 tm? -108.23 116.52 32.11 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 103.937 -2.616 . . . . 0.0 103.937 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.7 m -117.67 149.12 20.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.484 -172.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -118.35 128.02 54.25 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -77.3 100.19 5.79 Favored 'General case' 0 C--N 1.287 -2.117 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.397 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 58.7 -71.04 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.954 1.702 . . . . 0.0 115.238 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.42 -98.93 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 O-C-N 123.147 0.279 . . . . 0.0 113.179 -176.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -135.13 -160.38 1.05 Allowed 'General case' 0 C--N 1.303 -1.413 0 O-C-N 122.382 -0.481 . . . . 0.0 109.932 -177.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.406 ' HA ' ' OD1' ' A' ' 53' ' ' ASP . 23.4 t-20 -61.27 109.76 1.22 Allowed 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 123.714 0.806 . . . . 0.0 109.413 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 HG13 ' H ' ' A' ' 51' ' ' ARG . 4.7 p -81.72 -67.16 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.272 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.442 ' H ' HG13 ' A' ' 50' ' ' VAL . 26.4 ttm180 -110.1 -58.05 2.12 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.794 178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -149.95 22.18 0.87 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.406 ' OD1' ' HA ' ' A' ' 49' ' ' ASN . 55.0 m-20 59.19 -160.35 0.28 Allowed 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -166.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -153.0 148.48 27.12 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 119.972 1.26 . . . . 0.0 111.375 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.464 ' NE1' HD23 ' A' ' 42' ' ' LEU . 78.0 m95 -107.25 122.83 47.34 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.463 -175.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.489 HG11 ' CG1' ' A' ' 14' ' ' VAL . 16.5 m -135.99 144.11 34.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.232 176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 38' ' ' GLU . 85.3 tttt -79.75 160.61 26.14 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -36.52 62.86 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 124.116 0.967 . . . . 0.0 112.244 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -73.2 -10.43 59.76 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.275 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -103.33 4.88 36.92 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 -177.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -115.48 140.92 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.597 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.146 -177.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 13' ' ' LYS . 3.6 mp -107.86 112.79 41.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 105.839 -1.911 . . . . 0.0 105.839 174.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -86.31 132.73 42.29 Favored Pre-proline 0 C--N 1.292 -1.924 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.656 179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -64.14 117.72 4.73 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 N-CA-C 107.518 -1.762 . . . . 0.0 107.518 173.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.37 -163.02 1.68 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -170.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -71.88 88.57 1.04 Allowed 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.751 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' C ' ' HD3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -149.99 22.19 0.87 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.496 178.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.38 17.36 3.61 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.5 mt -123.12 94.86 4.39 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -94.54 -52.99 4.07 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -107.2 163.27 13.15 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 113.082 -1.872 . . . . 0.0 106.475 173.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -74.15 -14.84 61.02 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 118.53 0.605 . . . . 0.0 110.091 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 72.43 18.64 4.47 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.539 1.136 . . . . 0.0 112.921 175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 29.1 t60 -159.64 99.72 1.43 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -149.86 129.65 13.29 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 . . . . . 0 C--N 1.295 -1.8 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -178.072 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 CA--C 1.505 -0.768 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 t70 44.52 67.68 0.65 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 125.381 1.472 . . . . 0.0 110.262 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.414 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 25.3 ptm -155.47 -169.41 3.13 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.094 -170.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -102.65 100.5 16.42 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 3' ' ' MET . 16.5 Cg_exo -70.06 107.61 1.95 Allowed 'Trans proline' 0 C--O 1.246 0.911 0 C-N-CA 122.608 2.205 . . . . 0.0 110.878 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 56.0 m 65.47 -174.6 0.18 Allowed 'General case' 0 C--O 1.247 0.973 0 C-N-CA 123.904 0.882 . . . . 0.0 110.621 -178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.621 ' H ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -80.07 -15.22 57.62 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 122.434 1.111 . . . . 0.0 109.708 173.76 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 ' HA ' ' A' ' 30' ' ' LYS . 16.1 m -63.87 115.45 4.86 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.747 -1.57 . . . . 0.0 109.761 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.65 -18.31 7.2 Favored Glycine 0 C--N 1.31 -0.884 0 C-N-CA 119.657 -1.258 . . . . 0.0 112.965 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.2 m -73.49 129.35 37.8 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -95.03 144.17 25.91 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.1 m -138.83 179.55 3.07 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 19.0 mmmt -108.05 134.39 51.01 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 173.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG11 HG11 ' A' ' 56' ' ' VAL . 93.7 t -115.52 128.18 72.83 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.098 -177.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 86.8 tttt -106.86 104.29 13.94 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 176.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 56' ' ' VAL . 63.4 t80 -143.73 118.91 10.13 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.424 0.63 . . . . 0.0 110.588 -173.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.507 ' H ' ' NH2' ' A' ' 60' ' ' ARG . . . 179.38 153.67 12.08 Favored Glycine 0 N--CA 1.418 -2.52 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 177.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 -92.8 116.67 29.24 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.207 0.527 . . . . 0.0 112.039 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.54 -109.23 2.8 Favored Glycine 0 N--CA 1.44 -1.055 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.803 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -92.85 -6.32 49.03 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.832 0.825 . . . . 0.0 109.207 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 9.5 m -86.32 23.16 1.63 Allowed 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 122.281 1.039 . . . . 0.0 108.422 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' HA ' ' HA3' ' A' ' 17' ' ' GLY . 6.1 tp-100 -70.6 108.02 4.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 -176.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -113.92 147.46 38.48 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 3.0 mp -112.94 129.98 67.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -129.48 166.65 19.21 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 124.23 1.012 . . . . 0.0 109.449 -175.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.411 ' HB3' ' CE1' ' A' ' 46' ' ' TYR . 37.4 mt-10 -107.8 125.83 51.9 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 168.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.21 46.06 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' LYS . 8.5 p -104.44 142.7 34.14 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.479 HD13 HG12 ' A' ' 43' ' ' VAL . 32.8 mm -73.76 129.55 36.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.461 ' HA ' HG23 ' A' ' 8' ' ' THR . 10.6 tmtt? -98.46 -54.75 2.95 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 71.0 m -155.22 -179.89 8.52 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 41' ' ' TYR . 10.1 t -158.49 165.06 35.5 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 34' ' ' ILE . 12.7 pt-20 -148.07 158.07 43.86 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.345 176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.429 HD12 ' C ' ' A' ' 33' ' ' GLU . 1.9 mp -119.2 111.48 33.5 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -123.33 122.87 39.4 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.92 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t70 68.67 23.03 7.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.732 1.213 . . . . 0.0 110.141 177.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.42 -6.55 74.97 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.522 178.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.27 151.04 31.6 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 117.73 0.765 . . . . 0.0 110.689 178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG22 HG13 ' A' ' 34' ' ' ILE . 4.2 t -97.95 124.15 50.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-O 121.728 0.775 . . . . 0.0 110.035 -172.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 58.0 mt -108.47 125.62 51.99 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-N 114.475 -1.238 . . . . 0.0 107.71 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' O ' ' HA ' ' A' ' 55' ' ' TRP . 87.0 m-85 -108.97 147.5 32.17 Favored 'General case' 0 C--N 1.267 -2.987 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.398 -176.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.424 HD13 ' NE1' ' A' ' 55' ' ' TRP . 55.6 tp -107.54 110.4 22.31 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 176.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 29' ' ' ILE . 13.8 m -118.23 148.61 20.95 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -174.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -126.73 129.66 48.82 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 44.8 m-85 -71.18 132.7 45.39 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 124.145 0.903 . . . . 0.0 111.052 -172.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.411 ' CE1' ' HB3' ' A' ' 26' ' ' GLU . 19.9 p90 -116.7 135.05 54.08 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 178.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.29 -31.83 5.84 Favored Glycine 0 C--N 1.296 -1.675 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 -172.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -102.01 -155.76 0.53 Allowed 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 175.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.458 HD22 ' HA ' ' A' ' 49' ' ' ASN . 7.3 m120 -74.42 114.62 13.01 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.432 -0.907 . . . . 0.0 108.579 172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 45' ' ' TYR . 7.1 p -67.08 -12.31 14.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.976 -173.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -76.03 -7.16 54.04 Favored 'General case' 0 C--O 1.215 -0.733 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.048 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -86.72 98.21 11.02 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-O 121.368 0.604 . . . . 0.0 112.337 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -106.47 140.76 38.87 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.75 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.85 159.37 43.03 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.496 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 73.6 m95 -98.24 134.08 41.77 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.245 0.545 . . . . 0.0 111.488 -176.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 16' ' ' TYR . 26.8 m -133.23 165.21 32.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -102.1 157.42 16.89 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.24 -32.51 48.66 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.659 0.784 . . . . 0.0 112.263 -176.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -62.35 -26.15 68.29 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 124.423 1.089 . . . . 0.0 111.897 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' HB3' ' O ' ' A' ' 15' ' ' LYS . 27.0 mmm-85 -93.91 0.58 56.21 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.543 -173.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.3 mt -109.31 140.36 28.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 120.837 -0.345 . . . . 0.0 111.63 -173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 13' ' ' LYS . 3.7 mp -109.04 108.87 26.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 172.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TRP . . . . . 0.403 ' O ' ' HE2' ' A' ' 67' ' ' LYS . 91.0 m95 -83.07 124.95 75.95 Favored Pre-proline 0 C--N 1.302 -1.475 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.1 117.84 4.83 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.616 1.544 . . . . 0.0 109.838 177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.3 mt -172.38 107.22 0.19 Allowed 'General case' 0 CA--C 1.487 -1.448 0 C-N-CA 124.371 1.068 . . . . 0.0 110.018 -173.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 34.4 t70 74.63 -60.94 0.5 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 172.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.403 ' HE2' ' O ' ' A' ' 63' ' ' TRP . 0.0 OUTLIER -62.19 139.35 58.49 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 120.715 0.293 . . . . 0.0 111.498 -176.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.12 85.5 0.49 Allowed Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 115.007 0.763 . . . . 0.0 115.007 -174.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -75.75 98.94 4.25 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 171.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 75.44 126.93 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 125.148 1.379 . . . . 0.0 111.015 -168.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -111.67 39.34 2.38 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 175.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -60.75 -36.25 78.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 112.942 -1.936 . . . . 0.0 109.567 -173.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -143.84 107.64 4.67 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 105.183 -2.155 . . . . 0.0 105.183 174.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -79.69 8.12 7.2 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -170.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -173.65 -166.56 0.32 Allowed 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--N 1.294 -1.813 0 C-N-CA 119.366 -0.934 . . . . 0.0 108.602 177.146 . . . . . . . . 0 0 . 1 stop_ save_